Sentence,class,file
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/a4/84/ijgm-8-247.PMC4540136.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/84/ijgm-8-247.PMC4540136.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/98/a2/clep-7-363.PMC4540137.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2015:7 363–368Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  363Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S7830 1hospital use among patients with lung cancer  complicated by bone metastases and skeletal-   related events: a population-based cohort study  in Denmark Karoline skov Dalgaard1 henrik gammelager1 Claus sværke1 Tamás Kurics1 Karynsa Cetin2 Christian Fynbo  Christiansen1 1Department of Clinical Epidemiology,   aarhus University hospital, aarhus,   Denmark; 2Center for Observational  research, amgen inc., Thousand Oaks,   Ca, Usa Correspondence: Karoline skov Dalgaard   Department of Clinical Epidemiology,  aarhus University hospital, Olof Palmes  allé 43–45, 8200 aarhus n, Denmark   Tel +45 8716 8063   Fax +45 8716 7215   Email karolinedalgaard@gmail.co mObjective:  Skeletal-related events (SREs) among patients with bone metastases from lung  cancer may be associated with considerable use of health care resources.",Non-OADS,/arxiv_data1/oa_pdf/98/a2/clep-7-363.PMC4540137.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/98/a2/clep-7-363.PMC4540137.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a0/0b/mder-8-351.PMC4540138.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 351–357Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  351ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S8526 2Dual-sided electrosurgery handpiece for  simultaneous tissue cutting and coagulation:   first report on a conceptual design validated by   an animal experiment hatem a Tawfik1 Y ousef a Fouad2 Rashad hafez3 1Department of Ophthalmology,   Oculoplastics service, ain shams  University, 2Faculty of Medicine, ain  shams University, 3Eye Subspecialty  centre, cairo, Egypt Correspondence: Hatem A Tawfik   Department of Ophthalmology,  Oculoplastics service, ain shams  University,  5 Ibn Elnafis Street,   Off Makram Ebeid Street Nasr City,  cairo, Egypt   Tel +20 101 022 513  Fax +20 2 274 9374  Email hatem35@gmail.co mObjective:  To introduce and evaluate the safety of a novel dual-sided electrosurgery handpiece  design for simultaneous tissue cutting and coagulation.",Non-OADS,/arxiv_data1/oa_pdf/a0/0b/mder-8-351.PMC4540138.pdf
Available from: http://www.glowm.com/index.,Non-OADS,/arxiv_data1/oa_pdf/a0/0b/mder-8-351.PMC4540138.pdf
Acknowledgment Our special thanks to Mr Tom Henderson from the phys - ics classroom project ( http://www.physicsclassroom.com /)  for his guidance and valuable assistance in understanding  parallel circuits.,Non-OADS,/arxiv_data1/oa_pdf/a0/0b/mder-8-351.PMC4540138.pdf
Available from: http://www.ast.,Non-OADS,/arxiv_data1/oa_pdf/a0/0b/mder-8-351.PMC4540138.pdf
"Available from: http://www.lasertraining.org/ Administrative/Library/Practical%20Electrosurgery%20Manual.pd f.  Accessed January  7, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a0/0b/mder-8-351.PMC4540138.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2015:8submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 357Dual-sided electrosurgery handpiece for tissue cutting and coagulation  14.,Non-OADS,/arxiv_data1/oa_pdf/a0/0b/mder-8-351.PMC4540138.pdf
Available from: http://www.anselleurope.com/medical/downloads/ Electrosurgery_EN .pdf.,Non-OADS,/arxiv_data1/oa_pdf/a0/0b/mder-8-351.PMC4540138.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/ndt-11-2071.PMC4540139.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2071–2078Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2071OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8883 5Poor mental health status and aggression are  associated with poor driving behavior among  male traffic offenders Nasrin abdoli1,2 Vahid Farnia3 ali Delavar4 alirez esmaeili5 Fariborz Dortaj4 Noorali Farrokhi4 Majid Karami6 Jalal shakeri3 edith holsboer-Trachsler7 serge Brand7,8 1international University of imam  reza, Mashhad, 2Kermanshah  University of Medical sciences,   Kermanshah, 3substance abuse  Prevention research center,   Psychiatry Department, Kermanshah  University of Medical sciences,   Kermanshah, 4allameh Tabataba’i  University, T ehran, 5Police University,   T ehran, 6Baharestan research center,   Kermanshah Transportation T erminal,   Kermanshah, iran, 7center for  affective, stress and sleep Disorders,   Psychiatric clinics of the University  of Basel, Basel, 8Department of sport  and health science, sport science  section, University of Basel, Basel,   switzerlandBackground:  In Iran, traffic accidents and deaths from traffic accidents are among the highest  in the world, and generally driver behavior rather than either technical failures or environmental  conditions are responsible for traffic accidents.",Non-OADS,/arxiv_data1/oa_pdf/e3/9b/ndt-11-2071.PMC4540139.pdf
"To explain correspondence: serge Brand center for affective, stress and sleep  Disorders, Psychiatric clinics of the  University of Basel, Wilhelm Klein-strasse  27, 4012 Basel, switzerland Tel +41 61 32 55 114 Fax +41 61 32 55 513 email serge.brand@upkbs.c h Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Abdoli et al Running head recto: Poor mental health status and aggression with poor driving behavior DOI: http://dx.doi.org/10.2147/NDT.S88835",Non-OADS,/arxiv_data1/oa_pdf/e3/9b/ndt-11-2071.PMC4540139.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e3/9b/ndt-11-2071.PMC4540139.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/ndt-11-2071.PMC4540139.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/22/lra-8-045.PMC4540140.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pLocal and Regional Anesthesia 2015:8 45–55Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  45Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S5532 2Regional anesthesia for the trauma patient:  improving patient outcomes Jeff Gadsden Alicia warlick Department of Anesthesiology, Duke  University, Durham, NC, USA Correspondence: Jeff Gadsden   Department of Anesthesiology, Duke  University Medical Center, 2301 erwin  Road, Durham, NC 27710, USA   Tel +1 919 681 6437   Fax +1 919 681 8994   email jeff.gadsden@duke.ed uAbstract:  Trauma is a significant health problem and a leading cause of death in all age groups.",Non-OADS,/arxiv_data1/oa_pdf/d1/22/lra-8-045.PMC4540140.pdf
"Available from: http://www.cdc.gov/nchs/fastats/injury.ht m.  Accessed March 16, 2015.",OADS,/arxiv_data1/oa_pdf/d1/22/lra-8-045.PMC4540140.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/d1/22/lra-8-045.PMC4540140.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/22/lra-8-045.PMC4540140.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/18/e2/opth-9-1457.PMC4540141.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 1457–1461Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1457Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8126 2Portable single port 23-gauge vitrectomy  in postoperative endophthalmitis Fabian höhn1,* Florian T a Kretz2,* saumil sheth3 s natarajan3 Pankaj singh4 Frank h Koch4 Michael J Koss2,5 1helios Klinikum Pforzheim,   Pforzheim, germany; 2Department  of Ophthalmology, hospital of the  ruprecht-Karls University, heidelberg,   germany; 3aditya Jyot eye hospital  Pvt.",Non-OADS,/arxiv_data1/oa_pdf/18/e2/opth-9-1457.PMC4540141.pdf
"Occasionally, patients receive Correspondence: Florian Ta Kretz Department of Ophthalmology, hospital  of the ruprecht-Karls University,  heidelberg, im neuenheimer Feld 400,  69120 heidelberg, germany Tel +49 6221 5638 469 email mail@florian-kretz.d e Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Höhn et al Running head recto: Portable single port 23-gauge vitrectomy DOI: http://dx.doi.org/10.2147/OPTH.S81262",Non-OADS,/arxiv_data1/oa_pdf/18/e2/opth-9-1457.PMC4540141.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/18/e2/opth-9-1457.PMC4540141.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/e2/opth-9-1457.PMC4540141.pdf
"The new, inter-calibrated data, named ‘AMSU IMICA’ (Inte- grated Microwave Inter-Calibration Approach) is currentlyavailable (as of January 2014) through NOAA’s NationalClimatic Record Center Climate Data Record Programsite at http://www.ncdc.noaa.gov/cdr/operationalcdrs.html.",OADS,/arxiv_data1/oa_pdf/47/7a/qj0141-0477.PMC4540154.pdf
"A detailed view of the tide behaviour reveals that there is a strong gradient of the phase from 1000 to 2000 h (solar time) around the peak of the weighting function of channel 13 (for more detail,visit http://www.hao.ucar.edu/modeling/gswm/gswm.html; for the tidal generator associated with a more recent version of c/circlecopyrt2014 The Authors.",OADS,/arxiv_data1/oa_pdf/47/7a/qj0141-0477.PMC4540154.pdf
Tidal Effects on AMSU Temperature Series 483 centre (http://www.icare.univ-lille1.fr) with the assistance of the IPSL expert centre ESPRI.,Non-OADS,/arxiv_data1/oa_pdf/47/7a/qj0141-0477.PMC4540154.pdf
NDACC data used in this work are created by NASA-JPL and are archived in theNOAA database at http://www.ndsc.ncep.noaa.gov/.,OADS,/arxiv_data1/oa_pdf/47/7a/qj0141-0477.PMC4540154.pdf
The AMSUIMICA and limb-corrected operational AMSU data used inthis study were acquired from NOAA’s National Climatic DataCenter (http://www.ncdc.noaa.gov).,OADS,/arxiv_data1/oa_pdf/47/7a/qj0141-0477.PMC4540154.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/25/0a/amep-6-509.PMC4540155.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 509–515Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  509OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S8606 8cross-cultural challenges for assessing medical  professionalism among clerkship physicians in a  Middle Eastern country (Bahrain): feasibility and  psychometric properties of multisource feedback Ahmed Al Ansari1–3 Khalid Al Khalifa1 Mohamed Al Azzawi1 rashed Al Amer1 Dana Al sharqi4 Anwar Al-Mansoor5 Fadi M Munshi6 1Department of general surgery,   Bahrain Defense Force hospital,   2surgical Department, Arabian gulf  University, 3Medical Education  Department, royal college of  surgeons in ireland - Bahrain,   4Department of internal Medicine,   5Department of Dietetics and  nutrition, Bahrain Defense Force  hospital, riffa, Kingdom of Bahrain;   6college of Medicine, King Fahad  Medical city, King saud Bin Abdulaziz  University for health sciences, riyadh,   Kingdom of saudi Arabia correspondence: Ahmed Al Ansari   Department of general surgery, Bahrain  Defense Force hospital, Off Waly Alahed  Avenue, PO Box  28743, West riffa,  Kingdom of Bahrain   Tel +973 1776 6666  Email ahmed.alansari@bdfmedical.or gBackground:  We aimed to design, implement, and evaluate the feasibility and reliability of  a multisource feedback (MSF) system to assess interns in their clerkship year in the Middle  Eastern culture, the Kingdom of Bahrain.",Non-OADS,/arxiv_data1/oa_pdf/25/0a/amep-6-509.PMC4540155.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/25/0a/amep-6-509.PMC4540155.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/0a/amep-6-509.PMC4540155.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/df/60/ott-8-2089.PMC4540156.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2089–2096OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2089Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8690 8Urine micrornas as biomarkers for bladder  cancer: a diagnostic meta-analysis Yidong cheng* Xiaheng Deng* Xiao Yang* Pengchao li Xiaolei Zhang Peng li Jun Tao Qiang lu Zengjun Wang Department of Urology, The First  affiliated hospital of nanjing Medical  University, nanjing, People’s republic  of china *These authors contributed equally  to this workBackground:  The diagnostic value of microRNA (miRNA) detection in patients with bladder  cancer (BCa) is controversial.",Non-OADS,/arxiv_data1/oa_pdf/df/60/ott-8-2089.PMC4540156.pdf
"In addition, studies on the correspondence: Qiang lu; Jun Tao Department of Urology, The First  Affiliated Hospital of Nanjing Medical  University, 300, guangzhou road,  nanjing 210029, Jiangsu Province,  People’s republic of china Tel +86 25 8371 0079 email doctorlvqiang@sina.co m;   taojun.njmu@139.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Cheng et al Running head recto: Urine microRNAs and bladder cancer DOI: http://dx.doi.org/10.2147/OTT.S86908",Non-OADS,/arxiv_data1/oa_pdf/df/60/ott-8-2089.PMC4540156.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/df/60/ott-8-2089.PMC4540156.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/60/ott-8-2089.PMC4540156.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/6e/clep-7-369.PMC4540159.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2015:7 369–380Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  369Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S8383 0spineData – a Danish clinical registry of people  with chronic back pain Peter Kent1 alice Kongsted1,2 T ue secher Jensen2,3 hanne B albert4 Berit schiøttz-Christensen3 Claus Manniche3 1Department of sports science and  Clinical Biomechanics, University  of southern Denmark, Odense,   Denmark;  2nordic institute  of Chiropractic and Clinical  Biomechanics, Odense, Denmark;   3research Department, spine Centre  of southern Denmark, hospital  lillebaelt, institute of regional health  research, University of southern  Denmark, Middelfart, Denmark;  4The  Modic Clinic, Odense, Denmark Correspondence: Peter Kent   Department of sports science   and Clinical Biomechanics, University   of southern Denmark, Denmark   Campusvej  55, Odense M,  5230,  Denmark   Tel +45 6550 1000  Email pkent@health.sdu.d kBackground:  Large-scale clinical registries are increasingly recognized as important resources  for quality assurance and research to inform clinical decision-making and health policy.",Non-OADS,/arxiv_data1/oa_pdf/8d/6e/clep-7-369.PMC4540159.pdf
Available from: http://www.nih.,Non-OADS,/arxiv_data1/oa_pdf/8d/6e/clep-7-369.PMC4540159.pdf
"Available from:  http://www.med.monash.edu.au/sphpm/depts-centres-units/registries/ sphpm-registries.htm l. Accessed May  17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8d/6e/clep-7-369.PMC4540159.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/8d/6e/clep-7-369.PMC4540159.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1e/74/ibpc-8-051.PMC4540160.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pIntegrated Blood Pressure Control 2015:8 51–55Integrated Blood Pressure Control Dove press submit your manuscript | www.dovepress.co m Dove press  51OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IBPC.S7588 8Comparison between treadmill and bicycle  ergometer exercise tests in mild-to-moderate  hypertensive nigerians Olugbenga O abiodun Michael O Balogun anthony O akintomide rasaaq a adebayo Olufemi e ajayi suraj a Ogunyemi Valentine n amadi Victor O adeyeye Cardiology Unit, Department  of Medicine, Obafemi awolowo  University Teaching hospitals  Complex (O aUThC), Ile-Ife, Osun  state, nigeria Correspondence: Olugbenga O abiodun   Cardiology Unit, Department of  Medicine, Obafemi awolowo University  Teaching hospitals Complex (OaUThC),  Ile-Ife, Osun state, nigeria   email philabiodun@yahoo.co mBackground:  Comparative cardiovascular responses to treadmill and bicycle ergometer  (bike) exercise tests in hypertensive Nigerians are not known.",Non-OADS,/arxiv_data1/oa_pdf/1e/74/ibpc-8-051.PMC4540160.pdf
"Integrated Blood Pressure Control Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/integrated-blood-pressure-control-journa lIntegrated Blood Pressure Control is an international, peer-reviewed  open-access journal focusing on the integrated approach to managing  hypertension and risk reduction.",Non-OADS,/arxiv_data1/oa_pdf/1e/74/ibpc-8-051.PMC4540160.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/74/ibpc-8-051.PMC4540160.pdf
An experiment using mixed pastures based on perennial ryegrass with enhanced levels of WSC and white clover with varia- tion in CP concentrations is being undertaken in theMultiSward project (http://www.multisward.eu).,Non-OADS,/arxiv_data1/oa_pdf/f4/a4/gfs0069-0206.PMC4540161.pdf
Available at:http://www.bmelv.de/SharedDocs/Reden/EN/2009/ 07-02-German-Farmers-Day.html (accessed 15 March 2014).,Non-OADS,/arxiv_data1/oa_pdf/f4/a4/gfs0069-0206.PMC4540161.pdf
Available at: http://alfalfa.ucdavis.edu/ +symposium/2009/ (accessed 6 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/f4/a4/gfs0069-0206.PMC4540161.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/78/opth-9-1449.PMC4540165.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1449–1456Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1449Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8677 8Oral mineralocorticoid antagonists for recalcitrant  central serous chorioretinopathy eric K Chin David rP almeida C nathaniel roybal Philip i niles Karen M gehrs elliott h sohn h Culver Boldt stephen r russell James C Folk Department of Ophthalmology and  Visual sciences, University of iowa,   iowa City, ia, UsaPurpose:  To evaluate the effect and tolerance of oral mineralocorticoid antagonists, eplerenone  and/or spironolactone, in recalcitrant central serous chorioretinopathy.",Non-OADS,/arxiv_data1/oa_pdf/37/78/opth-9-1449.PMC4540165.pdf
"Analyses of enhanced depth imaging optical  coherence tomography (EDI-OCT) images in patients with CSCR have demonstrated  diffuse choroidal thickening, which suggests that the pathogenesis of the disease may  involve choroidal vascular stress on the retinal pigment epithelium.3–5 Indocyanine  green angiography demonstrates choroidal vascular hyperpermeability in affected  and contralateral eyes.6,7Correspondence: eric K Chin Department of Ophthalmology and Visual  sciences, University of iowa, 200 hawkins  Drive, iowa City, ia 52242, Usa Tel +1 319 356 2864 Fax +1 319 356 0363 email chin.eric@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Chin et al Running head recto: Oral mineralocorticoid antagonists for recalcitrant CSCR DOI: http://dx.doi.org/10.2147/OPTH.S86778",Non-OADS,/arxiv_data1/oa_pdf/37/78/opth-9-1449.PMC4540165.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/37/78/opth-9-1449.PMC4540165.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/78/opth-9-1449.PMC4540165.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/81/prom-6-225.PMC4540166.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Related Outcome Measures 2015:6 225–228Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  225ShOR t RePOR topen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/PROM.S8629 8Developing a handheld record for patients   with cystic fibrosis Omendra Narayan1 Siobhan Davies1 Carly Tibbins2 Jh Martyn Rees3 Warren Lenney1,4 Francis J Gilchrist1,4 1Academic Department of Child  health, Royal Stoke University  hospital, Stoke-on-t rent, 2West  Midlands Medicines for Children  Research Network, Royal Stoke  University hospital, Stoke-on-t rent,   3Department of Paediatrics, Royal  Shrewsbury Hospital, Shrewsbury,   4Institute for Science and technology  in Medicine, Keele University, Guy  hilton Research Centre, Stoke-on- trent, UK Correspondence: Francis J Gilchrist   Academic Department of Child health,  Royal Stoke University hospital,  Newcastle Road, Stoke-on-trent   St4 6QG, UK   tel +44 178 2675 289   Fax +44 843 6365 389   email francis.gilchrist@uhns.nhs.u kAbstract:  Patient handheld records (PHHRs) promote self-management and empower the holder  to take a more active role in the management of their disease.",Non-OADS,/arxiv_data1/oa_pdf/8e/81/prom-6-225.PMC4540166.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/8e/81/prom-6-225.PMC4540166.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/8e/81/prom-6-225.PMC4540166.pdf
Avail - able from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615781 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/81/prom-6-225.PMC4540166.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/19/oajsm-6-259.PMC4540168.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2015:6 259–267Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  259Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S3360 5Role of nutrition in performance enhancement  and postexercise recovery Kathryn L Beck1 Jasmine S Thomson2 Richard J Swift1 Pamela R von Hurst1 1School of Food and Nutrition,   Massey institute of Food Science and  T echnology, College of Health, Massey  University Albany, Auckland, 2School of  Food and Nutrition, Massey institute  of Food Science and T echnology,   College of Health, Massey University  Manawatu, Palmerston North,    New Zealand Correspondence: Kathryn L Beck   School of Food and Nutrition, Massey  institute of Food Science and Technology,  College of Health, Massey University  Albany, Private Bag 102 904, North Shore  City 0745, Auckland, New Zealand   Tel +649 213 6662   email k .l.beck@massey.ac.n zAbstract:  A number of factors contribute to success in sport, and diet is a key component.",Non-OADS,/arxiv_data1/oa_pdf/8c/19/oajsm-6-259.PMC4540168.pdf
"Available from: http://www.ausport.gov.au/ais/ nutrition/supplements/classificatio n. Accessed March 24, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8c/19/oajsm-6-259.PMC4540168.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/8c/19/oajsm-6-259.PMC4540168.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/19/oajsm-6-259.PMC4540168.pdf
Available from https://wada-main-prod.s3.amazonaws.,Non-OADS,/arxiv_data1/oa_pdf/8c/19/oajsm-6-259.PMC4540168.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/cd/ijgm-8-261.PMC4540169.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 261–266International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  261OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S8200 6Physical symptoms in outpatients with psychiatric  disorders consulting the general internal medicine  division at a Japanese university hospital Yukiko Ishikawa1 Taro Takeshima1,2 Junichi Mise1 shizukiyo Ishikawa1 Masami Matsumura1 1Division of General Medicine,   2Division of community and Family  Medicine, center for community  Medicine, Jichi Medical University  school of Medicine, shimotsuke,   T ochigi, Japan correspondence: Yukiko Ishikawa   Division of General Medicine,   Jichi Medical University hospital,  Yakushiji 3311-1, shimotsuke,   Tochigi 329-0498, Japan   Tel +81 285 58 7394   Fax +81 285 44 0628   email yuishi@jichi.ac.j pPurpose:  General practitioners have an important role in diagnosing a variety of patients,  including psychiatric patients with complicated symptoms.",Non-OADS,/arxiv_data1/oa_pdf/41/cd/ijgm-8-261.PMC4540169.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/41/cd/ijgm-8-261.PMC4540169.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/cd/ijgm-8-261.PMC4540169.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/11/46/ijn-10-5107.PMC4540170.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5107–5119International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5107OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8430 5Pharmacological characterization of nanoparticle- induced platelet microaggregation using quartz  crystal microbalance with dissipation: comparison  with light aggregometry Maria J santos-Martinez1,2,* Krzysztof a T omaszewski1,3,* carlos Medina1  Despina Bazou4  John F gilmer1 Marek W radomski1,5,6 1school of Pharmacy and  Pharma  ceutical sciences and Trinity  Biomedical sciences Institute, 2school  of Medicine, Trinity college Dublin,   University of Dublin, Dublin, Ireland;   3Department of anatomy, Jagiellonian  University Medical college, Krakow,   Poland; 4edwin l steele laboratory,   Department of radiation Oncology,   Massachusetts general hospital and  harvard Medical school, Boston,   Ma, Usa; 5Kardio-Med silesia,   Zabrze, 6Medical University of silesia,   Katowice, Poland *These authors contributed equally  to this paperBackground:  Engineered nanoparticles (NPs) can induce platelet activation and aggregation,  but the mechanisms underlying these interactions are not well understood.",Non-OADS,/arxiv_data1/oa_pdf/11/46/ijn-10-5107.PMC4540170.pdf
"NPs could also potentially be deliberately  introduced into circulating blood during proposed medical applications.2 Once in the  bloodstream, NPs come into contact with a number of blood components, including correspondence: carlos Medina school of Pharmacy and Pharmaceutical  sciences, Panoz Institute, Trinity college  Dublin, Dublin 2, Ireland Tel +353 1 896 2823 Fax +353 1 896 3367 email carlos.medina@tcd.i e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Santos-Martinez et al Running head recto: Pharmacological modulation of NP-induced platelet microaggregation DOI: http://dx.doi.org/10.2147/IJN.S84305",Non-OADS,/arxiv_data1/oa_pdf/11/46/ijn-10-5107.PMC4540170.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/11/46/ijn-10-5107.PMC4540170.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/46/ijn-10-5107.PMC4540170.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a0/8b/rru-7-117.PMC4540172.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pResearch and Reports in Urology 2015:7 117–124Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  117ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/RRU.S8786 0Verification of relationships between  anthropometric variables among ureteral stents  recipients and ureteric lengths: a challenge for  Vitruvian-da Vinci theory Philip a acelam Walden University, College of Health  sciences, Minneapolis, M n, Usa correspondence: Philip a acelam   PO Box 7286, Columbia,   MO 65205, Usa   T el +1 573 355 4796   email piamatertyme@gmail.co mObjective:  To determine and verify how anthropometric variables correlate to ureteric lengths  and how well statistical models approximate the actual ureteric lengths.",Non-OADS,/arxiv_data1/oa_pdf/a0/8b/rru-7-117.PMC4540172.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/602592 8.,Non-OADS,/arxiv_data1/oa_pdf/a0/8b/rru-7-117.PMC4540172.pdf
doi: http://dx.doi.org/10.1016/S0022-5347(05)65666- 2.,OADS,/arxiv_data1/oa_pdf/a0/8b/rru-7-117.PMC4540172.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/a0/8b/rru-7-117.PMC4540172.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/8b/rru-7-117.PMC4540172.pdf
doi: http://dx.doi.org/10.1016/ S0022-5347(01)66539- X.,OADS,/arxiv_data1/oa_pdf/a0/8b/rru-7-117.PMC4540172.pdf
Available from: http://dx.doi.org/10.1016/0090- 4295(78)90327- 8.,OADS,/arxiv_data1/oa_pdf/a0/8b/rru-7-117.PMC4540172.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/252031 4.,Non-OADS,/arxiv_data1/oa_pdf/a0/8b/rru-7-117.PMC4540172.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/735452 3.,Non-OADS,/arxiv_data1/oa_pdf/a0/8b/rru-7-117.PMC4540172.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/9b/ceor-7-431.PMC4540173.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 431–439ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  431REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S8553 5A narrative review of cost-effectiveness analysis of  people living with Hiv treated with HAART: from  interventions to outcomes wah Fung Tse1 weimin Yang2 wenlong Huang1,3 1School of international  Pharmaceutical Business, China  Pharmaceutical University,  2Editorial  Department of Journal of Nanjing  University of Traditional Chinese  Medicine, Nanjing University of  Chinese Medicine,  3Center of Drug  Discovery, State Key Laboratory  of Natural Medicines, China  Pharmaceutical University, Nanjing,   People’s Republic of China Correspondence: wenlong Huang   School of international Pharmaceutical  Business, China Pharmaceutical  University,  639 Longmian Avenue,  Jiangning, Nanjing, Jiangsu  211198,  People’s Republic of China   Tel/fax +86 25 8327 1480  Email ydhuangwenlong@126.co mBackground:  Since its introduction in  1996, highly active antiretroviral therapy (HAART),  which involves the combination of antiretroviral drugs, has resulted in significant improve - ments in the morbidity, mortality, and life expectancy of HIV-infected patients.",Non-OADS,/arxiv_data1/oa_pdf/8c/9b/ceor-7-431.PMC4540173.pdf
Available from: http://www.who.int/hiv/data/ epi_core_dec2014.png?ua= 1.,OADS,/arxiv_data1/oa_pdf/8c/9b/ceor-7-431.PMC4540173.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/8c/9b/ceor-7-431.PMC4540173.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/9b/ceor-7-431.PMC4540173.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/54/e6/opth-9-1463.PMC4540174.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1463–1466Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1463Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8563 8Combined eye gel containing sodium hyaluronate  and xanthan gum for the treatment of the corneal  epithelial defect after pterygium surgery T olga Kocatürk1 ataman gençgönül2 Faruk Balica1 Mehmet Özba ğcivan1 harun Çakmak1 1Department of Ophthalmology,   Faculty of Medicine, adnan Menderes  University, Aydın, 2Department  of Ophthalmology, Mevki Military  hospital, ankara, T urkeyAim:  The aim of this study is to compare the effectiveness of the ophthalmic gels containing  hyaluronate, xanthan gum, and netilmycine with fusidic acid in terms of recovery periods of  corneal epithelium in the patients who underwent pterygium surgery.",Non-OADS,/arxiv_data1/oa_pdf/54/e6/opth-9-1463.PMC4540174.pdf
"The aim of this study is to compare the combined eye gel (Xanternet; SIFI SpA,  Catania, Italy) containing sodium hyaluronate 0.15% and xanthan gum 1% in addition  to netilmycine 0.3% used to close the eye after pterygium surgery and viscose eye gel Correspondence: Tolga Kocatürk adnan Menderes Üniversitesi  Tıp Fakültesi Uygulama ve Araştırma  Hastanesi, Göz Hastalıkları AD,   09100, Aydın, Turkey Tel +90 533 344 4111 email tolgakocaturk@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Kocatürk et al Running head recto: Combined eye gel after pterygium surgery DOI: http://dx.doi.org/10.2147/OPTH.S85638",Non-OADS,/arxiv_data1/oa_pdf/54/e6/opth-9-1463.PMC4540174.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/54/e6/opth-9-1463.PMC4540174.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/54/e6/opth-9-1463.PMC4540174.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)MAP4 regulates mitochondrial cardiomyocyte apoptosis JH u et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/aa/b9/cddis2014369a.PMC4540186.pdf
An energyoptimized structure of CTN06 was calculated using Merck Molecular Force Field(MMFF) as implemented in Marvin Suite v 5.11 (http://www.chemaxon.com/products/marvin).,OADS,/arxiv_data1/oa_pdf/6e/4a/cddis2014343a.PMC4540187.pdf
"To deﬁne aputative binding site for CTN06 on Btk protein structure, we ﬁrst used ablind docking approach, implemented on the SwissDock web service(http://swissdock.vital-it.ch).",OADS,/arxiv_data1/oa_pdf/6e/4a/cddis2014343a.PMC4540187.pdf
"59CHARMM27 force ﬁelds were used to calculate the potentials of Btk, while CHARMM22 (as implemented in SwissParam, http://swissparam.ch) 60force ﬁelds were used to calculate the potentials of CTN06.",OADS,/arxiv_data1/oa_pdf/6e/4a/cddis2014343a.PMC4540187.pdf
Trajectories of these simulations were visualized using VMD v1.9 (http://www.ks.uiuc.edu/Research/vmd/vmd-1.9/) and the interactions betweenthe kinase and the ligand were plotted using LigPlot þv 1.4 and PyMol (http:// www.schrodinger.com/pymol/).,OADS,/arxiv_data1/oa_pdf/6e/4a/cddis2014343a.PMC4540187.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Btk and Etk dual inhibitor in prostate cancer W Guo et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/6e/4a/cddis2014343a.PMC4540187.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Adenanthin kills liver cancer cells J-K Hou et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/99/22/cddis2014345a.PMC4540188.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Radiosensitization by S44563 in SCLC Y Loriot et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/03/e0/cddis2014365a.PMC4540189.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Caviunin-based isoﬂavonoid prevents bone loss P Kushwaha et al 16 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/94/2c/cddis2014350a.PMC4540190.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/Anti-inﬂammatory & neuroprotective effects of PEA C Scuderi et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/2b/72/cddis2014376a.PMC4540191.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)LFG repression enhances NBL aggressiveness L Planells-Ferrer et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/15/46/cddis2014356a.PMC4540192.pdf
24Images of the immunostained sections were obtained by Zeiss confocal microscope andanalyzed by using Zen Light Edition 2009 software (ZEN 2009 (Zeiss EnhancedNavigation) the free of charge digital image processing software (http://www.softpedia.com/get/Multimedia/Graphic/Graphic-Viewers/ZEN-2009-Light-Edition.shtml)).,OADS,/arxiv_data1/oa_pdf/63/db/cddis2014358a.PMC4540193.pdf
The optical density of speciﬁc bands was measured by densitometry.Densitometry analysis was carried out using ImageJ free image processingsoftware (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/63/db/cddis2014358a.PMC4540193.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Autophagy regulators control adult neurogenesis M Yazdankhah et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/63/db/cddis2014358a.PMC4540193.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)ATM function in dendritic cell development EY So and T Ouchi 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/56/a3/cddis2014362a.PMC4540194.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Caspase-dependent inhibition of glycolysis LA Pradelli et al 7 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/d6/75/cddis2014371a.PMC4540195.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)CB2R in remote SCI damage L Latini et al 14 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/4b/23/cddis2014364a.PMC4540196.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Role of different Bcl-2 proteins for BH3-mimetic resistance in SCCs P Geserick et al 14 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ca/97/cddis2014379a.PMC4540197.pdf
"Chemotherapeutics: All the chemotherapeutic drugs used are of the clinic grade 44,45(NCI Dictionary of Cancer Terms, http://www.cancer.gov/dictionary), Pi: Pirarubicin hydrochloride (Wanle, Shenzhen, China); Pa: Paclitaxel (Shuanglu,Beijing, China); Ad: Adriamycin (Haizheng, Zhejiang, China); EH: Epirubicinhydrochloride (Haizheng, Zhejiang, China).Chemoresistance proﬁling (IC 50measurements): Cells in the logarithmic phase of growth were seeded in triplicate in 96-well plates at the density of 0.5 /C2104/well and treated with four-fold serially diluted drugs for 72 h. Cell survival was then measuredby a thiazolyl blue tetrazolium bromide (MTT, 490 nm reading)-based cellproliferation assay.",Non-OADS,/arxiv_data1/oa_pdf/5d/7f/cddis2014367a.PMC4540198.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)miR-193a-3p regulates bladder cancer drug resistance LL v et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/5d/7f/cddis2014367a.PMC4540198.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)UGT1A expression levels determine CRC cells response to ganetespib H Landmann et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f2/9f/cddis2014378a.PMC4540199.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Rbf1/dE2F2 induces diap1 and buffy downregulation A Clavier et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/86/6a/cddis2014372a.PMC4540203.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)PSP94 was found elevated in ovarian cancer J-x Ma et al 7 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/5d/01/cddis2014374a.PMC4540204.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)MiR-101-DNMT3a nexus in lung tumorigenesis FY a n et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/4b/16/cddis2014380a.PMC4540207.pdf
"To view a copy of this license, visit http://creativecommo ns.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis) Figure 1 (a) Viability of OCI-AML2 and OCI-AML3 cells, untreated (CTR) and treated with TmPyP4 50 or 100 μM at the indicated time points (hours).",Non-OADS,/arxiv_data1/oa_pdf/b2/cb/cddis2014402a.PMC4540209.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/00/07/jpr-8-507.PMC4540212.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 507–521Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  507ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8099 0effects of context and individual predispositions  on hypervigilance to pain-cues: an eRP study Oliver Dittmar1 corinna Baum1,2 Raphaela schneider1 stefan lautenbacher1 1Physiological Psychology, University  of Bamberg, Bamberg, 2institute of  Psychology, Technical University of  Darmstadt, Darmstadt, germany correspondence: Oliver Dittmar   Physiological Psychology, University of  Bamberg, Markusplatz 3, 96045 Bamberg,  germany   Tel +49 951 8631874   Fax +49 951 8631976   email oliver.dittmar@uni-bamberg.d eBackground:  Hypervigilance to pain is the automatic prioritization of pain-related compared  with other stimuli.",Non-OADS,/arxiv_data1/oa_pdf/00/07/jpr-8-507.PMC4540212.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/00/07/jpr-8-507.PMC4540212.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/07/jpr-8-507.PMC4540212.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2b/f0/jpr-8-523.PMC4540213.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 523–535Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  523ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8359 9Patterns of health care utilization for low back  pain Walter F stewart1 Xiaowei Yan1 Joseph a Boscarino1 Daniel D Maeng1 Jack Mardekian2 Robert J sanchez3 Michael R Von Korff4 1geisinger center for health  Research, 2Pfizer, inc., 3Regeneron  Pharmaceuticals, inc., 4group health  Research institute, seattle, W a, Usa correspondence: Daniel D Maeng   geisinger center for health Research,  100 north academy avenue, Mc 44-00,   Danville, P a 17822, Usa   T el +1 570 214 1688   email ddmaeng@geisinger.ed uBackground:  The purpose of this study was to determine if primary care patients with low  back pain (LBP) cluster into definable care utilization subgroups that can be explained by patient  and provider characteristics.",Non-OADS,/arxiv_data1/oa_pdf/2b/f0/jpr-8-523.PMC4540213.pdf
Updated November 2012. https://www.icsi.org/guide - lines__more/catalog_guidelines_and_more/catalog_guidelines/ catalog_musculoskeletal_guidelines/low_back_pain /.,Non-OADS,/arxiv_data1/oa_pdf/2b/f0/jpr-8-523.PMC4540213.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/2b/f0/jpr-8-523.PMC4540213.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/f0/jpr-8-523.PMC4540213.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/c5/jpr-8-549.PMC4540214.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 549–555Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  549ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8570 5Mucosal versus muscle pain sensitivity   in provoked vestibulodynia Kathryn Witzeman1 Ruby hn nguyen2 alisa eanes3 sawsan as-sanie4 Denniz Zolnoun5 1Department of Obstetrics and  gynecology, Denver health Medical  center, Denver, cO, 2Division of  epidemiology and community health,   University of Minnesota, Minneapolis,   Mn, 3Pelvic Pain Research Unit,   Division of advanced laparoscopy  and Pelvic Pain, Department of  Obstetrics and gynecology, University  of north carolina school of Medicine,   chapel hill, nc, 4Department of  Obstetrics and gynecology, Division  of Minimally invasive gynecologic  surgery, University of Michigan, ann  arbor, M i, 5Department of Obstetrics  and gynecology and center for  neurosensory Disorders, University  of north carolina, chapel hill,    nc, Usa correspondence: Kathryn Witzeman   Department of Obstetrics and  gynecology, Denver health Medical  center,  777 Bannock street, Mc  0660,  Denver, cO  80204, Usa   Tel +1 303 602 9725  Fax +1 303 602 9734  email k athryn.",Non-OADS,/arxiv_data1/oa_pdf/41/c5/jpr-8-549.PMC4540214.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/41/c5/jpr-8-549.PMC4540214.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/c5/jpr-8-549.PMC4540214.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/36/b5/jir-8-137.PMC4540215.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Inflammation Research 2015:8 137–147Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  137REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S6488 8Differential inflammatory response to Helicobacter  pylori infection: etiology and clinical outcomes Jonathan Richard White1 Jody Anne Winter2 Karen Robinson1 1NIHR Biomedical Research Unit in  Gastrointestinal and Liver Diseases  at Nottingham University Hospitals  NHS Trust and The University  of Nottingham, Nottingham,   2Interdisciplinary Biomedical  Research Centre, School of Science  and Technology, Nottingham Trent  University, Nottingham, UK Correspondence: Karen Robinson   Nottingham Digestive Diseases Centre,  University of Nottingham,   Queen’s Medical Centre, Nottingham,   NG7 2UH, UK   Tel +44 115 823 1094   Fax +44 115 846 8002   Email k aren.robinson@nottingham.ac.u kAbstract:  The bacterial pathogen Helicobacter pylori  commonly colonizes the human gastric  mucosa during early childhood and persists throughout life.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/jir-8-137.PMC4540215.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/jir-8-137.PMC4540215.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/b5/jir-8-137.PMC4540215.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/43/jmdh-8-359.PMC4540216.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 359–363Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  359Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S8784 5A multidisciplinary approach to scars: a narrative  review emiliano Zanier1,2 Bruno Bordoni1,3 1AiTOP (Accademia italiana T erapia  Osteopatica Posturale), Castelvetro  (MO), italy; 2ediAcademy, Milan, italy;   3Department of Cardiology, Santa  Maria Nascente institute iRCCS, Don  Carlo Gnocchi Foundation, Milan, italy Correspondence: Bruno Bordoni   Department of Cardiology, Santa   Maria Nascente institute iRCCS,   Don Carlo Gnocchi Foundation,   via Capecelatro  66, Milan, italy   email bordonibruno@hotmail.co mAbstract:  The purpose of this article is to carry out a narrative review regarding the approach  to scars through complementary and alternative medicine focusing on osteopathy, naturopathy,  and other minor methods and traditional rehabilitative medicines, such as physiotherapy and  manual therapies.",Non-OADS,/arxiv_data1/oa_pdf/8a/43/jmdh-8-359.PMC4540216.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/8a/43/jmdh-8-359.PMC4540216.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/43/jmdh-8-359.PMC4540216.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/15/jpr-8-537.PMC4540217.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 537–547Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  537ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8820 7Migraine: treatments, comorbidities, and  quality of life, in the Usa christopher D Malone1 amrita Bhowmick2 amy B Wachholtz1 1Department of Psychiatry, University  of Massachusetts Medical school,   Worcester, M a, 2health Union,   Philadelphia, P a, Usa correspondence: amy B Wachholtz   Department of Psychiatry, University of  Massachusetts Medical school,  55 lake  avenue north, Worcester, Ma  01655,  Usa  Tel +1 50 8334 2164  email a my.wachholtz@umassmemorial.or gAbstract:  This study sought to characterize the experience of stress, treatment patterns, and  medical and disability profile in the migraineur population to better understand how the experi - ence of migraines impacts the social and psychological functioning of this group.",Non-OADS,/arxiv_data1/oa_pdf/cb/15/jpr-8-537.PMC4540217.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/cb/15/jpr-8-537.PMC4540217.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/15/jpr-8-537.PMC4540217.pdf
Avail - able at: http://migraine.com /.,Non-OADS,/arxiv_data1/oa_pdf/cb/15/jpr-8-537.PMC4540217.pdf
"Dawn (2009), “Karachi’s  rural economy”, 17 August,  available at http://www.dawn.",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/10.1177_0956247814567263.PMC4540218.pdf
"24. http://www.roadsafety.pk.gangs), opportunities for speculation and the fraudulent relocation of  land parcels.",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/10.1177_0956247814567263.PMC4540218.pdf
40. see the websites of the  Orangi Pilot Project (OPP)  (http://www.oppinstitutions.org) and Pakistan fisherfolk  forum (http://www.pff.org.pk).,Non-OADS,/arxiv_data1/oa_pdf/0a/ef/10.1177_0956247814567263.PMC4540218.pdf
"41. f or details, see the  OPP website: http://www.oppinstitutions.org.",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/10.1177_0956247814567263.PMC4540218.pdf
"Dawn (2008), “Public  transport situation worsening  in Karachi”, 30 september,  available at http://www.dawn.",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/10.1177_0956247814567263.PMC4540218.pdf
"Dawn (2008), “Public transport situation worsening  in Karachi”, 30 September, available at http://www.dawn.com/news/970556/public-transport-situation-worsening-in-karachi.",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/10.1177_0956247814567263.PMC4540218.pdf
"Dawn (2009), “Karachi’s rural economy”, 17 August,  available at http://www.dawn.com/news/967399/karachi-s-rural-economy.",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/10.1177_0956247814567263.PMC4540218.pdf
Pakistan Fisherfolk Forum website: http://www.pff.org.,Non-OADS,/arxiv_data1/oa_pdf/0a/ef/10.1177_0956247814567263.PMC4540218.pdf
"Shehri website: http://www.shehri.org.Siddiqui, Tahir (2013), “Crackdown on Qingqi  rickshaws stayed”, Daily News Karachi, 10 October.",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/10.1177_0956247814567263.PMC4540218.pdf
"A Child disaster mental health interventions, part II Timing of implementation, delivery settings and providers, and therapeutic approaches Betty Pfefferbaum1,2,*, Jennifer L Sweeton3, Elana Newman4, Vandana Varma1,2, Mary A Noffsinger5, Jon A Shaw6,   Allan K Chrisman7 and Pascal Nitiéma1,2 1Department of Psychiatry and Behavioral Sciences; College of Medicine; University of Oklahoma Health Sciences Center; Oklahoma City, OK USA; 2Terrorism  and Disaster Center; University of Oklahoma Health Sciences Center; Oklahoma City, OK USA; 3Veterans Affairs Medical Center; Oklahoma City, OK USA;  4Tulsa Institute of Trauma, Abuse and Neglect; Department of Psychology; University of Tulsa; Tulsa, OK USA; 5Courtroom Sciences, Inc.; Irving, TX USA;  6Division of Child and Adolescent Psychiatry; University of Miami School of Medicine; Miami, FL USA; 7Duke Child and Family Study Center; Department of  Psychiatry and Behavioral Sciences; Duke University Medical Center; Durham, NC USA Keywords : children, disaster,  intervention, parent, posttraumatic stress, posttraumatic stress disorder, recovery, terrorism, therapy, treatment *Correspondence to: Betty Pfefferbaum;   Email: betty-pfefferbaum@ouhsc.edu Submitted: 08/12/13Revised: 11/20/13Accepted: 12/15/13http://dx.doi.org/10.4161/dish.27535",Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J Trauma Stress 2011; 24:155-65;  PMID:21425191 ; http://dx.doi.org/10.1002/ jts.20622 2.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J Clin Child  Adolesc Psychol 2008; 37:156-83; PMID:18444057 ;  http://dx.doi.org/10.1080/15374410701818293 3.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Am J Prev Med 2008; 35:287- 313; PMID:18692745 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J Trauma Stress  2007; 20:541-51;  PMID:17721962 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J Adolesc Health  2012; 51:453-61;  PMID:23084166 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Psychother Psychosom 2009; 78:364-71; PMID:19738402 ;  http://dx.doi.org/10.1159/000235976 11.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Harv Rev Psychiatry  2004; 12:187-98;  PMID :15371061 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J Child Adolesc Trauma 2010; 3:330-43;  http://dx.doi.org/10.1080/19361521.2010.523063,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
BMC Psychiatry 2009; 9:22; PMID:19439099 ;  http://dx.doi.org/10.1186/1471-244X-9-22 14.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J Trauma Stress 2010; 23:699- 707; PMID:21171130 ; http://dx.doi.org/10.1002/ jts.20594 15.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J Clin Psychol 2002; 58:99-112; PMID:11748599 ;  http://dx.doi.org/10.1002/jclp.1131 16.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Arch Pediatr Adolesc Med  2002 ; 156 :211-6 ;  PMID:11876663 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
"Clin Child Fam Psychol Rev 2009; 12:55- 64; PMID:19224365 ; http://dx.doi.org/10.1007/ s10567-009-0039-2 18. de Roos C, Greenwald R, den Hollander-Gijsman M, Noorthoorn E, van Buuren S, de Jongh A.",Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J Am Acad Child Psychiatry  1986; 25:357-63; http://dx.doi.org/10.1016/S0002-7138(09)60257-0 22.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J Child Psychol  Psychiatry 2009; 50:962-71; PMID:19207621 ;  http://dx.doi.org/10.1111/j.1469-7610.2008.02021.x 23.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Clin Child Psychol Psychiatry 2006;  11:543-53;  PMID:17163223 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J Am Acad Child Adolesc Psychiatry  2010; 49:1034-42;  PMID:20855048 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Am J Psychiatry 2005; 162:2302-8; PMID:16330594 ; http://dx.doi.org/10.1176/appi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Harv Rev Psychiatry 2004; 12:199-212; PMID:15371062 ;  http://dx.doi.org/10.1080/10673220490509534 28.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Issues Ment Health Nurs  2002; 23:537-51;  PMID:12217220 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Am J Clin Hypn 2009; 52:23-34; PMID:19678557 ;  http://dx.doi.org/10.1080/00029157.2009.10401689 32.,OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Brief Treat Crisis Interv 2009; 8:313-26; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Disaster Prev Manag 1999; 8:169-76; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Risk Anal  2003; 23:1009-20;  PMID :12969415 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Traumatology 2011; 17:41-9;  http://dx.doi.org/10.1177/1534765610395624 39.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J Clin Child Adolesc Psychol 2008; 37:495-507;  PMID:18645741 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Behav Res Ther 2012; 50:169-79;  PMID:22317753 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J Child Psychol Psychiatry 2011; 52:853-60;  PMID :21155776 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Int J Play Ther 2002; 11:43-63;  http://dx.doi.org/10.1037/h0088856 43.,OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J Adolesc Health 2008; 42:466- 72; PMID:18407041 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Int Rev Psychiatry  2006; 18:515-22;  PMID:17162691 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J  Appl Dev Psychol 2009; 30:218-26; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J Trauma Stress 2011; 24:309-16; PMID:21618288 ; http://dx.doi.org/10.1002/ jts.20638 49.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
"J Am Acad Child Adolesc Psychiatry 2011; 50:340-8, e1-2;  PMID:21421174 ; http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
J Child Psychol Psychiatry 2005; 46:1161-8;  PMID:16238663 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Child Adolesc Psychiatr Clin N Am 2003; 12:363-81;  PMID:12725016 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Psychother Psychosom 1992; 57:200-5;  PMID:1410197 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
Br J Clin Psychol  1991; 30:131-8;  PMID:2059745 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/kdsh-02-01-10927535.PMC4540222.pdf
"The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .Non- commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is  properly attributed.",Non-OADS,/arxiv_data1/oa_pdf/8d/46/nihms679090.PMC4540366.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.php Correspondence: Dorie E Apollonio, University of California, San Francisco, 3333 California Street, Suite 420, San Francisco, CA  94143-0613, USA, Tel +1 415 502 1942, Fax +1 415 502 0792, dorie.apollonio@ucsf.edu.",Non-OADS,/arxiv_data1/oa_pdf/8d/46/nihms679090.PMC4540366.pdf
"Available from: https://www.ascp.com/ providerstatus/states  [Accessed June 20, 2014] 6.",Non-OADS,/arxiv_data1/oa_pdf/8d/46/nihms679090.PMC4540366.pdf
"Available from: http://www.cms.gov/Medicare/Prescription-Drug- Coverage/PrescriptionDrugCovContra/MTM.html  [Accessed June 20, 2014] 15.",Non-OADS,/arxiv_data1/oa_pdf/8d/46/nihms679090.PMC4540366.pdf
"Available from:  http://us.gsk.com/html/about-us/index.html  [Accessed April 14, 2014] 34.",Non-OADS,/arxiv_data1/oa_pdf/8d/46/nihms679090.PMC4540366.pdf
"Available from: http://www.jnj.com/about-jnj/company-structure/pharmaceutical-companies  [Accessed April 14, 2014] 35.",Non-OADS,/arxiv_data1/oa_pdf/8d/46/nihms679090.PMC4540366.pdf
"Available from:  http://www.roche.com/about_roche/management/ceo_message.htm  [Accessed April 14, 2014] 36.",Non-OADS,/arxiv_data1/oa_pdf/8d/46/nihms679090.PMC4540366.pdf
Available from: http://online.wsj.com/news/articles/ SB124691728092502381 38.,Non-OADS,/arxiv_data1/oa_pdf/8d/46/nihms679090.PMC4540366.pdf
Open access This article is Open Access: CC BY-NC  3.0 license (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/82/bjgpsep-2015-65-638-e617-oa.PMC4540402.pdf
"CASE REPORT The case of a boy with nevus of Ota, extensive Mongolian spot,  nevus ﬂ ammeus, nevus anemicus and cutis marmorata  telangiectatica congenita: a unique instance of phacomatosis  pigmentovascularis* Han MA1 Mengsi Liao1 Shu Qiu1  Ruijun Luo1 Rongbiao Lu1 Chun Lu1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153466  Abstract:   Phacomatosis pigmentovascularis is a rare, congenital condition characterized by a combination of  cutaneous melanocytic lesions and vascular malformation.",Non-OADS,/arxiv_data1/oa_pdf/b7/42/abd-90-03-s1-0010.PMC4540495.pdf
CASE REPORT  Dermatoscopic ﬁ ndings as a complementary tool in the  differential diagnosis of the etiological agent of tinea capitis* Regina Casz Schechtman1 Nanashara Diane Valgas Silva1 Maria Victória Quaresma 1 Fred Bernardes Filho1 Alice Mota Buçard1 Celso Tavares Sodré1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153787   Abstract:    Tinea capitis  is a scalp infection caused by fungi.,Non-OADS,/arxiv_data1/oa_pdf/0b/f0/abd-90-03-s1-0013.PMC4540496.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153733   Abstract:    Tufted angioma is a rare vascular tumor whose name derives from its histopathological appearance,  characterized by tufts of capillaries within the dermis.",Non-OADS,/arxiv_data1/oa_pdf/ea/c1/abd-90-03-s1-0016.PMC4540497.pdf
"22CASE REPORT Anaphylaxis caused by stings from the Solenopsis invicta ,  lava-pés ant or red imported ﬁ re ant* Vidal Haddad Junior1 Carlos Eduardo Larsson2  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153420   Abstract:   Ants are social insects with species of medical interest, such as the ﬁ re ants ( Solenopsis sp.).",Non-OADS,/arxiv_data1/oa_pdf/89/a3/abd-90-03-s1-0022.PMC4540499.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153540   Abstract:    Pili torti also known as ‘twisted hairs’ (Latin: pili=hair; torti=twisted) is a rare, congenital or acquired  clinical presentation, in which the hair shaft is ﬂ attened at irregular intervals and twisted 180º along its axis.",Non-OADS,/arxiv_data1/oa_pdf/7b/4c/abd-90-03-s1-0029.PMC4540501.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153782   Abstract:    We present a case of disseminated cutaneous histoplasmosis in a male patient, rural worker, HIV pos- itive for 20 years, with a history of irregular use of antiretroviral therapy, T cell counts below 50 cells/mm3 and with good response to treatment with Itraconazole.",Non-OADS,/arxiv_data1/oa_pdf/b8/5e/abd-90-03-s1-0032.PMC4540502.pdf
"36CASE REPORT Microcystic adnexal carcinoma simulating scarring alopecia* Maria Christina Marques Nogueira Castanon1 Sandra Maria Gasparete Casali3 Raul Fernando Binato Lamim2 Marina Vieira Nagahama1 Camila Bastos Xavier Vassimon Silva1 Rafael Guerra Nannetti de Carvalho1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153445   Abstract:    The microcystic adnexal carcinoma is a rare, locally aggressive malignant adnexal neoplasm associated  with signi ﬁ cant morbidity.",Non-OADS,/arxiv_data1/oa_pdf/00/a9/abd-90-03-s1-0036.PMC4540503.pdf
©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153845   Abstract:    Collision tumors are characterized by the coexistence of two cancers in the same anatomical site and its  pathogenesis remains controversial.,Non-OADS,/arxiv_data1/oa_pdf/16/d2/abd-90-03-s1-0039.PMC4540504.pdf
©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153692   Abstract:    Methotrexate has been widely used for many years in the treatment of a variety of diseases.,Non-OADS,/arxiv_data1/oa_pdf/48/f5/abd-90-03-s1-0043.PMC4540505.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153829   Abstract:    We report the case of a 38-year-old man, who developed cutaneous metastases in the left inguinal  groove 15 years after curative gastrectomy for advanced gastric adenocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/4c/40/abd-90-03-s1-0046.PMC4540506.pdf
"2015;90(3 Suppl 1):S51-4.CASE REPORT Dapsone in the treatment of pemphigus vulgaris: adverse effects  and its importance as a corticosteroid sparing agent* Maria Victória Quaresma1 Fred Bernardes Filho1 Janaína Hezel1 Murilo Calvo Peretti1 Bernard Kawa Kac1 Luna Azulay-Abula ﬁ a1,2  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153408   Abstract:    Pemphigus vulgaris is an autoimmune disease characterized by suprabasal blisters with acantholysis,  which has a fatal course in a large number of untreated patients.",Non-OADS,/arxiv_data1/oa_pdf/88/ff/abd-90-03-s1-0051.PMC4540507.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153462   Abstract:    Human T cell lymphotropic virus type 1 (HTLV-1)-associated infective dermatitis (ID) is a chronic,  severe and recurrent eczema occurring during childhood in patients vertically infected with HTLV-1.",Non-OADS,/arxiv_data1/oa_pdf/77/0b/abd-90-03-s1-0055.PMC4540508.pdf
"59CASE REPORT Dermatosis neglecta* Elisa Mayumi Kubo Sasaya1 Carolina Ghislandi1 Flávia Trevisan1 Talita Beithum Ribeiro1 Fabiane Mulinari-Brenner1 Caroline Balvedi Gaiewski1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153656   Abstract:    Dermatosis neglecta is the name of a skin condition characterized by papules and polygonal plaques,  which are sometimes warty, brownish and hyperpigmented, adherent and symmetric, though removable with ethyl or isopropyl alcohol.",Non-OADS,/arxiv_data1/oa_pdf/65/0f/abd-90-03-s1-0059.PMC4540509.pdf
©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153581   Abstract:    Darier’s disease is a rare autosomal dominant genodermatosis.,Non-OADS,/arxiv_data1/oa_pdf/49/e7/abd-90-03-s1-0062.PMC4540510.pdf
"Available from: http://emedicine.medscape.com/article/1107340-treatment  MAILING   ADDRESS : Paula Mota MedeirosAlameda Jauaperi, 887, apto 124, MoemaCEP: 04523-014 - São Paulo - SPBrazilE-mail: paula_mota@hotmail.com  An Bras Dermatol.",Non-OADS,/arxiv_data1/oa_pdf/49/e7/abd-90-03-s1-0062.PMC4540510.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153620   Abstract:    Darier’s disease is characterized by dense keratotic lesions in the seborrheic areas of the body such as  scalp, forehead, nasolabial folds, trunk and inguinal region.",Non-OADS,/arxiv_data1/oa_pdf/0f/2c/abd-90-03-s1-0066.PMC4540511.pdf
©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153415   Abstract:  Eccrine poroma is a benign adnexal tumour of the uppermost portion of the intraepidermal eccrine  sweat gland duct and acrosyringium.,Non-OADS,/arxiv_data1/oa_pdf/b9/05/abd-90-03-s1-0069.PMC4540512.pdf
©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153781   Abstract:    Leprosy is aneasily recognizable disease due to its dermato-neurological manifestations.,Non-OADS,/arxiv_data1/oa_pdf/51/fc/abd-90-03-s1-0073.PMC4540513.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153624   Abstract:  Palpable migratory arciform erythema is an entity of unknown etiology, with few published cases in the  literature.",Non-OADS,/arxiv_data1/oa_pdf/e4/08/abd-90-03-s1-0077.PMC4540514.pdf
"81CASE REPORT Scleredema associated with Sjögren’s syndrome* João Alves1 Tiago Judas1 Tiago Ferreira1 Diogo Matos1 Elvira Bártolo1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153779   Abstract:  Scleredema adultorum of Buschke is a rare disorder characterized by diffuse swelling and non-pitting  induration of the skin usually involving the face, neck, arms and upper trunk.",Non-OADS,/arxiv_data1/oa_pdf/db/57/abd-90-03-s1-0081.PMC4540515.pdf
84 CASE REPORT Sporotrichosis in an unusual location - Case report* Brisa Dondoni Reis1 Fernanda Oliveira Cobucci1 Luciana Helena Zacaron1 Antonio Macedo D’Acri1 Ricardo Barbosa Lima1 Carlos José Martins1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153721   Abstract:    Sporotrichosis is the most common subcutaneous mycosis.,Non-OADS,/arxiv_data1/oa_pdf/24/20/abd-90-03-s1-0084.PMC4540516.pdf
"8888CASE REPORT Eosinophilic ulcer of the tongue - Case report* Dario Didona1 Giovanni Paolino2 Michele Donati3 Biagio Didona1 Stefano Calvieri2  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153600   Abstract:    Eosinophilic ulcer of the oral mucosa is a rare, self-limiting, chronic and benign lesion of unknown  pathogenesis that affects the oral mucosa.",Non-OADS,/arxiv_data1/oa_pdf/4c/61/abd-90-03-s1-0088.PMC4540517.pdf
"2015;90(3 Suppl 1):S91-3.CASE REPORT Wolf’s isotopic response, presenting as lichen planus* Mariana Thomaz da Silva Queiroz1 José Roberto Paes de Almeida1 Ângelo Sementilli2 Sandra Lopes Mattos e Dinato1 Ney Romiti ( In memoriam )1   DOI: http://dx.doi.org/10.1590/abd1806-4841.20153763   Abstract:  The term “Wolf’s isotopic response” describes the occurrence of a new skin disorder at the site of an- other unrelated and already healed skin disease.",Non-OADS,/arxiv_data1/oa_pdf/2f/9f/abd-90-03-s1-0091.PMC4540518.pdf
"2015;90(3 Suppl 1):S94-6.Rogerio Nabor Kondo1 Rubens Pontello Junior1 Francine Milenkovich Belinetti1 Caroline Cilião1 Vanessa Regina Bulla Vasconcellos1 Dora Maria Grimaldi2  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153972   Abstract:    Proliferating pilomatricoma is proliferative, rare tumor variant of pilomatricoma.",Non-OADS,/arxiv_data1/oa_pdf/3f/95/abd-90-03-s1-0094.PMC4540519.pdf
2015;90(3 Suppl 1):S97-100.CASE REPORT Type 2 segmental glomangioma - Case report* Camila Raposo Cabral1 Jayme de Oliveira Filho1 Julliene Lika Matsumoto1 Stela Cignachi1 Ana Carolina Franco Tebet1 Kássila da Rosa Nasser1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20152483   Abstract:  Glomus tumors originate from modi ﬁ ed perivascular muscle cells.,Non-OADS,/arxiv_data1/oa_pdf/b1/73/abd-90-03-s1-0097.PMC4540520.pdf
"2015;90(3 Suppl 1):S101-3.CASE REPORT Granulomatosis with polyangiitis, a new nomenclature  for Wegener’s Granulomatosis - Case report* Alexandre Moretti de Lima1 Pedro de Freitas Silva Torraca1 Sheila Pereira da Rocha2 Carmelia Matos Reis Santiago3 Fabio Humberto Ribeiro Paes Ferraz3   DOI: http://dx.doi.org/10.1590/abd1806-4841.20153455   Abstract:  The granulomatosis with polyangiitis, initially known as Wegener’s granulomatosis, is a small and me- dium vessels vasculitis.",Non-OADS,/arxiv_data1/oa_pdf/d0/22/abd-90-03-s1-0101.PMC4540521.pdf
Available from: http://emedicine.medscape.com/article/1085290.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/abd-90-03-s1-0101.PMC4540521.pdf
104CASE REPORT Cutaneous histoplasmosis as a complication after anti-TNF  use - Case report*  ▲104 Gabrielle Aline Zattar1 Fernanda Cardoso1 Sadamitsu Nakandakari1 Cleverson Teixeira Soares1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153545   Abstract:    Anti-TNF agents are effective in the treatment of psoriasis.,Non-OADS,/arxiv_data1/oa_pdf/36/1f/abd-90-03-s1-0104.PMC4540522.pdf
"108CASE REPORT Post-kala-azar dermal Leishmaniasis in two  different clinical contexts*  ▲108 Daniel Holanda Barroso1 Claúdia Elise Ferraz Silva2 Ana Carolina Depes Perdigao e Vasconcelos1 Silvana Maria de Morais Cavalcanti1 Maria Edileuza Felinto de Brito3 Angela Cristina Rapela Medeiros1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153373   Abstract:    In Brazil, visceral Leishmaniasis is caused by Leishmania chagasi.",Non-OADS,/arxiv_data1/oa_pdf/c6/6a/abd-90-03-s1-0108.PMC4540523.pdf
2015;90(3 Suppl 1):S111-4.CASE REPORT Primary cutaneous follicle center lymphoma simulating  basal-cell carcinoma on the nasal ala * Mariana Isis Wanczinsnki1 Clóvis Antonio Lopes Pinto1 Flávia Trevisan2 Paulo Rowilson Cunha1 Luz Marina Hannah Grohs1   DOI: http://dx.doi.org/10.1590/abd1806-4841.20153768   Abstract:  Primary cutaneous B-cell lymphomas (PCBCLs) constitute 25% of all primary cutaneous lymphomas.,Non-OADS,/arxiv_data1/oa_pdf/bc/a4/abd-90-03-s1-0111.PMC4540524.pdf
2015;90(3 Suppl 1):S115-7.CASE REPORT Membranous lipodystrophy: case report and review  of the literature* Fatma Akpinar1 Ektan Demir1 Duygu Dusmez Apa1   DOI: http://dx.doi.org/10.1590/abd1806-4841.20153677   Abstract:  Membranous lipodystrophy is a distinct type of membranocystic fat necrosis.,Non-OADS,/arxiv_data1/oa_pdf/de/0d/abd-90-03-s1-0115.PMC4540525.pdf
"2015;90(3 Suppl 1):S118-20.CASE REPORT Bullous and hemorrhagic lichen sclerosus - Case report *  ▲118 Raquel Sucupira Andrade Lima1 Gustavo Ávila Maquiné1 Antônio Pedro Mendes Schettini1 Mônica Santos1,2  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153502   Abstract:  Lichen sclerosus is a chronic in ﬂ ammatory disease, usually located in the genital area.",Non-OADS,/arxiv_data1/oa_pdf/45/9b/abd-90-03-s1-0118.PMC4540526.pdf
2015;90(3 Suppl 1):S121-4.CASE REPORT Drug-induced lupus with leukocytoclastic vasculitis:  a rare expression associated with adalimumab* Carolina Forte Amarante1 Livia Mendes Sabia Acedo1 Fátima Maria de Oliveira Rabay1 Benedito do Espírito Santo Campos1 Márcia Lanzoni de Alvarenga Lira1 Samuel Henrique Mandelbaum1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153834   Abstract:  TNF alpha antagonist-induced lupus-like syndrome is a rare condition which predominantly affects  women (4:1).,Non-OADS,/arxiv_data1/oa_pdf/ec/ee/abd-90-03-s1-0121.PMC4540527.pdf
2015;90(3 Suppl 1):S125-9.CASE REPORT Anti-TNF- α and hydralazine drug-induced lupus* Maria Victória Quaresma1 Fred Bernardes Filho1 Fernanda Brandão de Oliveira1 Mercedes Prates Pockstaller1 Maria Fernanda Reis Gavazzoni Dias1 David Rubem Azulay1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153893   Abstract:  Drug-induced lupus is a rare drug reaction featuring the same symptoms as idiopathic lupus erythema- tosus.,Non-OADS,/arxiv_data1/oa_pdf/c7/a1/abd-90-03-s1-0125.PMC4540528.pdf
130CASE REPORT Frontal cutaneous meningioma – Case report*  ▲130 Leonor Ramos1 Ines Coutinho1 José Carlos Cardoso1 Helena Garcia1 Margarida Robalo Cordeiro1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153798   Abstract:  Cutaneous meningiomas are rare tumors most commonly located on the scalp.,Non-OADS,/arxiv_data1/oa_pdf/34/fe/abd-90-03-s1-0130.PMC4540529.pdf
"134CASE REPORT Cutaneous metastasis of a breast cancer diagnosed  13 years before*  ▲134 Maraya de Jesus Semblano Bittencourt1 Alessandra Haber Carvalho1 Bianca Angelina Macêdo do Nascimento1 Lívia Karlla Marinho Freitas1 Amanda Magno de Parijós2   DOI: http://dx.doi.org/10.1590/abd1806-4841.20153842   Abstract:  Metastasis is de ﬁ ned as a neoplastic lesion originating from another primary tumor, with which it is  no longer in contact.",Non-OADS,/arxiv_data1/oa_pdf/91/99/abd-90-03-s1-0134.PMC4540530.pdf
"138CASE REPORT Disseminated cutaneous atypical mycobacteriosis by M.  chelonae  after sclerotherapy of varicose veins in a  immunocompetent patient: a case report*  ▲138 Nathalia Dias Negrão Murback1 Minoru German Higa Júnior1 Maurício Antônio Pompílio1 Eunice Stella Jardim Cury1 Gunter Hans Filho1 Luiz Carlos Takita1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153504   Abstract:  Atypical mycobacteria are saprophytic organisms not transmitted from person to person, which affect  mainly immunosuppressed but also immunocompetent individuals.",Non-OADS,/arxiv_data1/oa_pdf/14/65/abd-90-03-s1-0138.PMC4540531.pdf
2015;90(3 Suppl 1):S143-6.CASE REPORT Pre-tibial myxedema: treatment with intralesional corticosteroid* Luana Oliveira Ramos1 Paloma Corrêa Mattos1 Giuseppe Lemos Pertoti de Figueredo1 Alef Alioscha Andrade Maia1 Sandra Adol ﬁ na Reys Romero1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153651   Abstract:  The pretibial myxedema is a manifestation of Graves’ disease characterized by accumulation of gly- cosaminoglycans in the reticular dermis.,Non-OADS,/arxiv_data1/oa_pdf/77/b7/abd-90-03-s1-0143.PMC4540532.pdf
"2015;90(3 Suppl 1):S147-9.CASE REPORT Follicular mucinosis: an important differential diagnosis  of leprosy in an endemic area* Danielle Cristine Westphal1 Silmara Navarro Pennini1 Petra Pereira de Souza1 Gustavo Ávila Maquiné2 Antônio Pedro Mendes Schettini1 Mônica Santos1,3  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153450   Abstract:  Primary follicular mucinosis is a rare dermatosis characterized by the accumulation of mucin in the  follicular epithelium and sebaceous glands.",Non-OADS,/arxiv_data1/oa_pdf/a7/51/abd-90-03-s1-0147.PMC4540533.pdf
150CASE REPORT Multiple giant angiokeratoma of Fordyce on the shaft  of the penis masquerading as keratoacanthoma*  ▲150 Sudip Kumar Ghosh1 Shouvik Ghosh1 Megha Agarwal1   DOI: http://dx.doi.org/10.1590/abd1806-4841.20153876   Abstract:  The term ‘angiokeratoma’ includes a wide range of dermatological conditions of hyperkeratotic vas- cular disorders with a similar histologic combination of hyperkeratosis and super ﬁ cial dermal vascular ectasia.,Non-OADS,/arxiv_data1/oa_pdf/17/8a/abd-90-03-s1-0150.PMC4540534.pdf
"2015;90(3 Suppl 1):S153-5.CASE REPORT Multiple minute digitate hyperkeratosis - a peculiar entity*  ▲153 Inês Coutinho1 Ana Rita Gameiro1 Miguel Pinto Gouveia1 José Carlos Cardoso1 Américo Figueiredo1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153440   Abstract:  Multiple minute digitate hyperkeratosis is a rare, non-follicular dermatosis, with fewer than 30 cases  described worldwide.",Non-OADS,/arxiv_data1/oa_pdf/89/01/abd-90-03-s1-0153.PMC4540535.pdf
"2015;90(3 Suppl 1):S156-9.CASE REPORT Cellular neurothekeoma: case report and its (un)  relation with nerve sheath myxoma* Cristián Navarrete-Dechent1 Maximiliano Curi-Tuma1 Celeste Marín1 Sergio González1 Mauricio Sandoval-Osses1   DOI: http://dx.doi.org/10.1590/abd1806-4841.20153402   Abstract:  Neurothekeoma is an uncommon, benign neoplasm presenting in young adults, primarily on the head  and neck.",Non-OADS,/arxiv_data1/oa_pdf/0e/2a/abd-90-03-s1-0156.PMC4540536.pdf
"2015;90(3 Suppl 1):S160-1.CASE REPORT Nevus sebáceo cerebriforme: uma rara apresentação* Roberto Rheingantz da Cunha Filho1 Aline Peluso Fezer1 Nádia Aparecida Lorencette1    DOI: http://dx.doi.org/10.1590/abd1806-4841.20153433   Abstract:  A 13-year-old boy presented congenital, raised, yellowish colored plaques with ﬁ broelastic consistency,  which were velvety in appearance, alopecic, with clearly de ﬁ ned limits and sulci or well-marked meandering in- vaginations, a cerebriform appearance on the upper part of the right ear, accompanied by alopecia in the temporo-mandibular region-parietal.",Non-OADS,/arxiv_data1/oa_pdf/5d/df/abd-90-03-s1-0160.PMC4540537.pdf
162CASE REPORT Azathioprine-induced accelerated cutaneous and pulmonary  nodulosis in a patient with rheumatoid arthritis* Cristian Vera Kellet1 Romina Andino Navarrete1 Sergio González Bombardieri1 Juan Manriquez1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153750   Abstract:  We report the case of a 42-year-old female with a 5-year history of rheumatoid arthritis treated with  Rituximab and Azathioprine.,Non-OADS,/arxiv_data1/oa_pdf/55/30/abd-90-03-s1-0162.PMC4540538.pdf
"2015;90(3 Suppl 1):S165-7.CASE REPORT New drugs, new challenges for dermatologists: mucocutaneous  ulcers secondary to everolimus*  ▲165 Victor Pavan Pasin1 Amanda Regio Pereira1 Kalline Andrade de Carvalho1 João Marcos Góes de Paiva1 Milvia Maria Simões e Silva Enokihara1 Adriana Maria Porro1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153672   Abstract:  Everolimus, a mammalian target of rapamycin inhibitor, is an emerging drug, which is being increas- ingly applied in oncology and solid organ transplantation.",Non-OADS,/arxiv_data1/oa_pdf/72/09/abd-90-03-s1-0165.PMC4540539.pdf
2015;90(3 Suppl 1):S168-70.CASE REPORT The role of immunohistochemistry in the Muir-Torre Syndrome* Cláudia Marina Puga Barbosa Oliveira1 Jullyene Gomes de Campos1 Maiko Ramacos Maia1 Larissa Eva dos Santos Lobo1 Fábio Francesconi do Valle1   DOI: http://dx.doi.org/10.1590/abd1806-4841.20153406   Abstract:  Muir-Torre Syndrome is de ﬁ ned by the coexistence of sebaceous skin tumors and internal malignan- cies.,Non-OADS,/arxiv_data1/oa_pdf/8e/28/abd-90-03-s1-0168.PMC4540540.pdf
"2015;90(3 Suppl 1):S171-4.CASE REPORT Use of tumor necrosis factor alpha (TNF  α) antagonists in  a patient with psoriasis and Chagas disease*  ▲171 Cristián Navarrete-Dechent1 Daniela Majerson1 Marisa Torres1 Daniela Armijo1 Mahir Patel2 Alan Menter2 Claudia de la Cruz1,3  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153538   Abstract:  There are several studies on the bene ﬁ ts of using TNF α antagonists in the treatment of psoriasis, but few  studies addressing the interaction of these drugs with chronic infections.",Non-OADS,/arxiv_data1/oa_pdf/99/b3/abd-90-03-s1-0171.PMC4540541.pdf
175CASE REPORT Palmar and plantar lichen planus: a case report and review  of the literature* Ana Maria Abreu Velez1 Michael S Howard1 Neville Pereyo2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20153034   Abstract:  Palmoplantar lichen planus is an uncommon dermatosis.,Non-OADS,/arxiv_data1/oa_pdf/28/46/abd-90-03-s1-0175.PMC4540542.pdf
©2015 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20153769   Abstract:  Piloleiomyoma is an uncommon benign neoplasm arising from the erector pilorum muscle.,Non-OADS,/arxiv_data1/oa_pdf/81/be/abd-90-03-s1-0178.PMC4540543.pdf
2015;90(3 Suppl 1):S181-4.CASE REPORT Pityriasis lichenoides et varioliformis acuta after in ﬂ uenza  vaccine* Breno Augusto Campos de Castro1 Juliana Milagres Macedo Pereira1 Renata Leal Bregunci Meyer1 Fernanda Marques Trindade1 Moises Salgado Pedrosa1 André Costa Cruz Piancastelli1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20153492   Abstract:  The etiology of pityriasis lichenoides is unknown.,Non-OADS,/arxiv_data1/oa_pdf/87/c2/abd-90-03-s1-0181.PMC4540544.pdf
"185CASE REPORT Actinic comedonal plaque-variant of Favre-Racouchot syndrome:  report of two cases * Fernanda Cardoso1 Sadamitsu Nakandakari1 Gabrielle Aline Zattar1 Cleverson Teixeira Soares1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20153543  Abstract:  The actinic comedonal plaque is characterized by papules, cysts and comedones forming a yellowish  plaque in areas of chronic sun exposure skin.",Non-OADS,/arxiv_data1/oa_pdf/3c/b9/abd-90-03-s1-0185.PMC4540545.pdf
©2015 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20153856   Abstract:  Polyarteritis nodosa is a rare vasculitis in children characterized by necrotizing in ﬂ ammation in small  and medium size arteries.,Non-OADS,/arxiv_data1/oa_pdf/21/b3/abd-90-03-s1-0188.PMC4540546.pdf
"2015;90(3 Suppl 1):S191-3.CASE REPORT Porokeratosis ptychotropica of the scrotum: dermoscopic  evaluation of an atypical presentation * Joana Cabete1 Ana Fidalgo1 André Lencastre1 Filipa Diamantino1 Alexandre João1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20153473  Abstract:  Porokeratosis ptychotropica is a rare variant of porokeratosis that is classically located on the gluteal  and perianal regions, seldom extending to the genitalia.",Non-OADS,/arxiv_data1/oa_pdf/31/29/abd-90-03-s1-0191.PMC4540547.pdf
©2015 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20153838   Abstract:  Atypical and unusual locations of psoriasis are very frequent.,Non-OADS,/arxiv_data1/oa_pdf/bd/c9/abd-90-03-s1-0194.PMC4540548.pdf
"197CASE REPORT A case of generalized ostraceous psoriasis mimicking  dermatitis neglecta * Bianca Angelina Macêdo do Nascimento1 Alessandra Haber Carvalho1 Carolina Moraes Dias2 Thaiane Lima Lage2 Clívia Maria Oliveira Carneiro1 Maraya de Jesus Semblano Bittencourt1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20153858  Abstract:  Lithium has been implicated in the exacerbation of pre-existing psoriasis, in the induction of psoriasis  on previously uninvolved skin of psoriasis patients, and in the triggering of psoriasis for the ﬁ rst time in patients  without a personal or family history.",Non-OADS,/arxiv_data1/oa_pdf/b2/e5/abd-90-03-s1-0197.PMC4540549.pdf
"©2015 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20153762   Abstract:    We present the rare case of a 47-year-old patient, suffering from cheilitis granulomatosa and lupus ery- thematosus discoid: this association is really exceptional because only once reported in English literature.",Non-OADS,/arxiv_data1/oa_pdf/5b/3a/abd-90-03-s1-0200.PMC4540550.pdf
©2015 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20153527   Abstract:    Paracoccidioidomycosis is an infectious disease whose etiological agent belongs to the Paracoccidioi- des genus.,Non-OADS,/arxiv_data1/oa_pdf/a2/97/abd-90-03-s1-0203.PMC4540551.pdf
"CASE REPORT Lower lip reconstruction with nasolabial ﬂ ap - going back  to basics * Inês Coutinho1 Leonor Ramos1 Ana Rita Gameiro1 Ricardo Vieira1 Américo Figueiredo1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20153714   Abstract:  Squamous cell carcinoma of the lower lip is frequent, and radical excision sometimes leads to complex  defects.",Non-OADS,/arxiv_data1/oa_pdf/a5/4f/abd-90-03-s1-0206.PMC4540552.pdf
©2015 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20153708   Abstract:    Pegylated liposomal doxorubicin is an important antineoplastic agent with activity in a variety of solid  tumors.,Non-OADS,/arxiv_data1/oa_pdf/19/ab/abd-90-03-s1-0209.PMC4540553.pdf
"2015;90(3 Suppl 1):S212-5.CASE REPORT Syphilis associated with paretic neurosyphilis mimicking Reiter’s  syndrome in HIV-infected patients * Thales Costa Bastos1 Daniela Cristina Caetano Maia2 Nathália Matos Gomes3 Carla Kellen da Silva Menezes4 Valeska Francesconi5,6 Fabio Francesconi4,6 DOI: http://dx.doi.org/10.1590/abd1806-4841.20153625   Abstract:  HIV/syphilis co-infection  is common because both conditions affect similar risk groups.",Non-OADS,/arxiv_data1/oa_pdf/cf/68/abd-90-03-s1-0212.PMC4540554.pdf
"CASE REPORT A case of secondary syphilis mimicking palmoplantar psoriasis  in HIV infected patient * Maraya de Jesus Semblano Bittencourt1 Arival Cardoso de Brito1 Bianca Angelina Macêdo do Nascimento1 Alessandra Haber Carvalho1 Manoel Dias do Nascimento1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20153399   Abstract:  Due to diverse clinical and histopathological presentations, diagnosis of secondary syphilis can oc- casionally prove challenging.",Non-OADS,/arxiv_data1/oa_pdf/48/da/abd-90-03-s1-0216.PMC4540555.pdf
CASE REPORT Ehlers-Danlos Syndrome associated with cardiomyopathy  hypertrophic obstructive * Raimundo José Almeida de Oliveira Pinto1 Adaílton Araújo dos Santos1 Mablo de Castro Azevedo1  Saulo Sacramento Meira1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20153824   Abstract:  Ehlers-Danlos syndrome is a rare clinical condition caused by a genetic change that results in the forma- tion of structurally or functionally altered collagen.,Non-OADS,/arxiv_data1/oa_pdf/1e/71/abd-90-03-s1-0220.PMC4540556.pdf
"©2015 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20153840   Abstract:    Laugier-Hunziker syndrome is a rare, acquired disorder characterized by lenticular hyperpigmentation  of the oral mucosa and longitudinal melanonychia.",Non-OADS,/arxiv_data1/oa_pdf/5f/66/abd-90-03-s1-0223.PMC4540557.pdf
"CASE REPORT Rendu-Osler-Weber syndrome: dermatological approach * Aline Blanco Barbosa1 Günter Hans Filho2 Carolina Faria dos Santos Vicari1 Marcelo Zanolli Medeiros2 Daíne Vargas Couto2 Luiz Carlos Takita2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20152563   Abstract:  The Rendu-Osler-Weber syndrome is a rare systemic ﬁ brovascular dysplasia, recognized by mucocuta- neous telangiectasias, arteriovenous malformations, epistaxis and family history.",Non-OADS,/arxiv_data1/oa_pdf/38/d0/abd-90-03-s1-0226.PMC4540558.pdf
2015;90(3 Suppl 1):S229-31.CASE REPORT Stewart Treves Syndrome * Elisangela Samartin Pegas Pereira1 Elisa Trino de Moraes1 Daniela Melo Siqueira1 Marcel Alex Soares dos Santos1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20153685   Abstract:  Stewart-Treves Syndrome is characterized by the presence of lymphangiosarcoma on limb extremities.,Non-OADS,/arxiv_data1/oa_pdf/bc/fb/abd-90-03-s1-0229.PMC4540559.pdf
©2015 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20153926   Abstract:    Stewart-Treves syndrome is a rare cutaneous angiosarcoma that develops in long-standing chronic  lymphedema.,Non-OADS,/arxiv_data1/oa_pdf/d6/66/abd-90-03-s1-0232.PMC4540560.pdf
2015;90(3 Suppl 1):S235-8.CASE REPORT Solitary eccrine syringo ﬁ broadenoma - Case Report * Caroline Bertolini Bottino1 Tais Ferreira Guimarães1 Flávio Rezende Gomes1 Antonio Macedo D’Acri1 Ricardo Barbosa Lima1 Carlos José Martins1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20153802   Abstract:  Eccrine syringo ﬁ broadenoma is a rare benign adnexal neoplasm derived from cells of the acrosyrin- gium of eccrine sweat glands.,Non-OADS,/arxiv_data1/oa_pdf/9b/c0/abd-90-03-s1-0235.PMC4540561.pdf
"CASE REPORT Late-onset of eruptive syringomas: a diagnostic challenge * Cristina Resende1 Catarina Araújo1 Rui Santos1 Teresa Pereira1 Celeste Brito1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20153899   Abstract:  Syringoma is a benign, adnexal tumor of the eccrine sweat gland ducts.",Non-OADS,/arxiv_data1/oa_pdf/23/b4/abd-90-03-s1-0239.PMC4540562.pdf
242CASE REPORT Vemurafenib and cutaneous adverse events - report  of ﬁ ve cases * Giselle de Barros Silva1 Adriana Pessoa Mendes1 Mariana Petaccia de Macedo1 Clóvis Antônio Lopes Pinto1 Ivana Lameiras Gibbons1 João Pedreira Duprat Neto1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20153841   Abstract:  Vemurafenib is a selective inhibitor of V600E-mutant BRAF protein used to treat metastatic and unre- sectable melanoma.,Non-OADS,/arxiv_data1/oa_pdf/d6/29/abd-90-03-s1-0242.PMC4540563.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/a5/dddt-9-3645.PMC4540747.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3645–3652Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3645Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8605 4synthesis, antimicrobial and in vitro antitumor  activities of a series of 1,2,3-thiadiazole and   1,2,3-selenadiazole derivatives nizar M Mhaidat1,2 Mousa al-smadi3 Fouad al-Momani4 Karem h alzoubi1 iman Mansi2 Qosay al-Balas5 1Department of clinical Pharmacy,   Faculty of Pharmacy, Jordan  University of science and T echnology,   irbid, 2Faculty of Pharmaceutical  sciences, hashemite University,   Zarqa, 3Department of applied  chemical sciences, 4Department of  applied Biological sciences, Faculty  of science and arts, 5Department  of Medicinal chemistry and  Pharmacognosy,  Faculty of Pharmacy,   Jordan University of science and  T echnology, irbid, JordanAbstract:  Three derivatives of substituted 1,2,3-thia- or 1,2,3-selenadiazole (4a–c) were  prepared and characterized by different chemical techniques.",Non-OADS,/arxiv_data1/oa_pdf/d3/a5/dddt-9-3645.PMC4540747.pdf
"Other heterocyclic compounds containing  triazole, oxazole, benzoxazole, quinazoline, pyridazoline, pyridazine, pyrazole, and  thiazole have been found to be biologically active substances.8–10 Heterocyclic ring systems are present in numerous antiparasitic, antifungal,  anthelmintic, and anti-inflammatory drugs.11 The beta-lactam antibiotics derivatized  with a 1,2,3-thiadiazole-5-mercapto moiety have been found to be active against correspondence: nizar M Mhaidat Department of clinical Pharmacy, Faculty  of Pharmacy, Jordan University of science  and Technology, PO Box 3030, irbid,  22110, Jordan Tel +962 2 720 1000, ext 23542 Fax +962 2 720 1075 email nizarm@just.edu.j oJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Mhaidat et al Running head recto: Synthesis and activity of 1,2,3-thia- and 1,2,3-selenadiazole DOI: http://dx.doi.org/10.2147/DDDT.S86054",Non-OADS,/arxiv_data1/oa_pdf/d3/a5/dddt-9-3645.PMC4540747.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d3/a5/dddt-9-3645.PMC4540747.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/a5/dddt-9-3645.PMC4540747.pdf
"Published by Oxford University Press on behalf of the UK Environmental Mutagen Society.643Mutagenesis , 2015, 30, 643–649 doi:10.1093/mutage/gev023 Original Article Advance Access publication 22 April 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/25/gev023.PMC4540787.pdf
"Published by Oxford University Press on behalf of the UK Environmental Mutagen Society.635Mutagenesis , 2015, 30, 635–642 doi:10.1093/mutage/gev027 Original Article Advance Access publication 22 April 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/b4/gev027.PMC4540789.pdf
"According to the International  Classification of Functioning, Disability and Health9), (ICF,  formerly ICIDH-2 http://www.who.int/classification/icf),  activity limitations are the difficulties that an individual may  have in executing a task or an action, while participation re-strictions are the problems an individual may experience in  involvement in life situations.",Non-OADS,/arxiv_data1/oa_pdf/c0/39/jpts-27-2023.PMC4540810.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c0/39/jpts-27-2023.PMC4540810.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/09/e1/jpts-27-2029.PMC4540811.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/cf/a1/jpts-27-2035.PMC4540812.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/43/21/jpts-27-2039.PMC4540813.pdf
http://www.unicef.org/in - fobycountry/ saudiarabia_statistics.html#123 (Accessed Mar.,Non-OADS,/arxiv_data1/oa_pdf/43/21/jpts-27-2039.PMC4540813.pdf
"2010, http://www.dsr.wa.gov.au/brain-boost-sport-and-physical-activ - ity-enhance-childrens-learning (Accessed June 2, 2014).",Non-OADS,/arxiv_data1/oa_pdf/43/21/jpts-27-2039.PMC4540813.pdf
28) GLOOM: Ways to increase your IQ score (Intelligence Quotient) Avail - able at http://www.sciencedaily.com/releases/2009/12/091202101751 (Ac - cessed Apr.,Non-OADS,/arxiv_data1/oa_pdf/43/21/jpts-27-2039.PMC4540813.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c5/76/jpts-27-2045.PMC4540814.pdf
"[Medline]   [CrossRef] 54) IPAQ website: 2008, http://www.ipaq.ki.se/.",Non-OADS,/arxiv_data1/oa_pdf/c5/76/jpts-27-2045.PMC4540814.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/41/42/jpts-27-2053.PMC4540815.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a8/6e/jpts-27-2057.PMC4540816.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/bb/7b/jpts-27-2061.PMC4540817.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/1e/1e/jpts-27-2065.PMC4540818.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/jpts-27-2069.PMC4540819.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e3/22/jpts-27-2073.PMC4540820.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/44/08/jpts-27-2077.PMC4540821.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/92/67/jpts-27-2083.PMC4540822.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/86/d3/jpts-27-2087.PMC4540823.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/04/d0/jpts-27-2091.PMC4540824.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/bf/80/jpts-27-2097.PMC4540825.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/20/bd/jpts-27-2101.PMC4540826.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/ad/b3/jpts-27-2105.PMC4540827.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/4f/fe/jpts-27-2109.PMC4540828.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f0/fe/jpts-27-2113.PMC4540829.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/86/f5/jpts-27-2117.PMC4540830.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/05/50/jpts-27-2121.PMC4540831.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/25/6a/jpts-27-2125.PMC4540832.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c3/23/jpts-27-2129.PMC4540833.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/d1/d8/jpts-27-2133.PMC4540834.pdf
32)	 http://www.tuik.gov.tr/PreHaberBultenleri.do?id=13618.,Non-OADS,/arxiv_data1/oa_pdf/d1/d8/jpts-27-2133.PMC4540834.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/6c/56/jpts-27-2139.PMC4540835.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/5d/75/jpts-27-2143.PMC4540836.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a4/b2/jpts-27-2147.PMC4540837.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f1/39/jpts-27-2151.PMC4540838.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/f4/f2/jpts-27-2155.PMC4540839.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/cb/30/jpts-27-2159.PMC4540840.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/90/bd/jpts-27-2163.PMC4540841.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3d/b5/jpts-27-2167.PMC4540842.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/86/14/jpts-27-2171.PMC4540843.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3e/15/jpts-27-2175.PMC4540844.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f1/96/jpts-27-2179.PMC4540845.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/99/4f/jpts-27-2183.PMC4540846.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/60/18/jpts-27-2189.PMC4540847.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/fe/52/jpts-27-2195.PMC4540848.pdf
http://www.american - heart.org/downloadable/ heart/ 1200082005246HS_Stats%202008.final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fe/52/jpts-27-2195.PMC4540848.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/be/9e/jpts-27-2201.PMC4540849.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e9/fd/jpts-27-2207.PMC4540850.pdf
"[Medline]    [CrossRef] 14) Ministry of Health: Labour and Welfare of Japan [homepage on the Inter - net]: Physical Activity Reference for Health Promotion 2013, http://www.mhlw.go.jp/stf/houdou/2r9852000002xple.html (in Japanese).",Non-OADS,/arxiv_data1/oa_pdf/e9/fd/jpts-27-2207.PMC4540850.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c5/88/jpts-27-2213.PMC4540851.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/75/cd/jpts-27-2217.PMC4540852.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c6/fa/jpts-27-2221.PMC4540853.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/35/28/jpts-27-2225.PMC4540854.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/19/72/jpts-27-2233.PMC4540855.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/85/ad/jpts-27-2239.PMC4540856.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f7/97/jpts-27-2247.PMC4540857.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c6/d1/jpts-27-2253.PMC4540858.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/0e/02/jpts-27-2257.PMC4540859.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3d/58/jpts-27-2261.PMC4540860.pdf
"2011, http://www.nof.org (Accessed May 2012) 73) Heaney RP: Effects of caffeine on bone and the calcium economy.",Non-OADS,/arxiv_data1/oa_pdf/3d/58/jpts-27-2261.PMC4540860.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f8/6d/jpts-27-2271.PMC4540861.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/cd/62/jpts-27-2275.PMC4540862.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/cf/c0/jpts-27-2279.PMC4540863.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/0e/fc/jpts-27-2285.PMC4540864.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/bf/e8/jpts-27-2289.PMC4540865.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/9c/be/jpts-27-2293.PMC4540866.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/a1/db/jpts-27-2299.PMC4540867.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/01/08/jpts-27-2303.PMC4540868.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/6e/c1/jpts-27-2307.PMC4540869.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/74/ec/jpts-27-2313.PMC4540870.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/be/94/jpts-27-2317.PMC4540871.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/27/ea/jpts-27-2323.PMC4540872.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e2/14/jpts-27-2327.PMC4540873.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/06/62/jpts-27-2333.PMC4540874.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/45/d5/jpts-27-2337.PMC4540875.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c8/25/jpts-27-2341.PMC4540876.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/b9/0b/jpts-27-2343.PMC4540877.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c9/e6/jpts-27-2347.PMC4540878.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/18/73/jpts-27-2349.PMC4540879.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/da/ec/jpts-27-2353.PMC4540880.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/0f/ad/jpts-27-2357.PMC4540881.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/9f/bc/jpts-27-2361.PMC4540882.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/b8/3f/jpts-27-2365.PMC4540883.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/10/88/jpts-27-2373.PMC4540884.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review,Non-OADS,/arxiv_data1/oa_pdf/1d/aa/jpts-27-2377.PMC4540885.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review,Non-OADS,/arxiv_data1/oa_pdf/67/50/jpts-27-2381.PMC4540886.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review,Non-OADS,/arxiv_data1/oa_pdf/1a/59/jpts-27-2387.PMC4540887.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review,Non-OADS,/arxiv_data1/oa_pdf/94/d1/jpts-27-2391.PMC4540888.pdf
"REFERENCES 1) Statistic Korea: Statistic report according to death cause in 2010 years,  Statistic Korea, 2011. http://kosis.kr/.",Non-OADS,/arxiv_data1/oa_pdf/94/d1/jpts-27-2391.PMC4540888.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review,Non-OADS,/arxiv_data1/oa_pdf/8b/7b/jpts-27-2395.PMC4540889.pdf
[Medline]   [CrossRef] 25) Cochrane Collaboration guidelines: http://handbook.cochrane.org/.,OADS,/arxiv_data1/oa_pdf/8b/7b/jpts-27-2395.PMC4540889.pdf
26) McMaster university hierachy of evidence: http://fhs.mcmaster.ca/medi - cine/residency/halfday_ebm.html.,Non-OADS,/arxiv_data1/oa_pdf/8b/7b/jpts-27-2395.PMC4540889.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case Study,Non-OADS,/arxiv_data1/oa_pdf/36/69/jpts-27-2405.PMC4540890.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case Study,Non-OADS,/arxiv_data1/oa_pdf/b8/b2/jpts-27-2407.PMC4540891.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case	Study,Non-OADS,/arxiv_data1/oa_pdf/83/c6/jpts-27-2409.PMC4540892.pdf
http://dx.doi.org/10.1128/JCM.05316-11 .,Non-OADS,/arxiv_data1/oa_pdf/17/1e/zjm2832.PMC4540904.pdf
http://dx.doi.org/10.1128/JCM.03322-12 .,Non-OADS,/arxiv_data1/oa_pdf/17/1e/zjm2832.PMC4540904.pdf
http://dx.doi.org/10.1016/S1473-3099(13)70076-8 .,OADS,/arxiv_data1/oa_pdf/17/1e/zjm2832.PMC4540904.pdf
ClinInfect Dis 60:405– 414. http://dx.doi.org/10.1093/cid/ciu833 .,OADS,/arxiv_data1/oa_pdf/17/1e/zjm2832.PMC4540904.pdf
http://dx.doi.org /10.1016/j.jinf.2013.04.020 .,OADS,/arxiv_data1/oa_pdf/17/1e/zjm2832.PMC4540904.pdf
http://dx.doi.org/10.1136/jcp.2008.063321 .,Non-OADS,/arxiv_data1/oa_pdf/17/1e/zjm2832.PMC4540904.pdf
http://dx.doi.org/10 .1128/JCM.00906-15 .,Non-OADS,/arxiv_data1/oa_pdf/17/1e/zjm2832.PMC4540904.pdf
http://dx.doi.org/10.1086/588660 .,OADS,/arxiv_data1/oa_pdf/17/1e/zjm2832.PMC4540904.pdf
Clin Infect Dis 42:479 – 486. http://dx.doi.org/10 .1086/499949 .,Non-OADS,/arxiv_data1/oa_pdf/17/1e/zjm2832.PMC4540904.pdf
Stat Med 17:873– 890. http://dx.doi.org/10.1002/(SICI)1097-0258(19980430)17:8 /H11021873::AI D-SIM779 /H110223.0.CO;2-I .,OADS,/arxiv_data1/oa_pdf/17/1e/zjm2832.PMC4540904.pdf
J Clin Microbiol 42:4154 – 4157. http://dx.doi.org/10.1128 /JCM.42.9.4154-4157.2004 .,OADS,/arxiv_data1/oa_pdf/17/1e/zjm2832.PMC4540904.pdf
http://dx.doi.org/10.1128 /JCM.43.10.5097-5101.2005 .,Non-OADS,/arxiv_data1/oa_pdf/17/1e/zjm2832.PMC4540904.pdf
"In addition, thequality of molecular diagnostics has advanced through numerousexternal quality assessment initiatives, including the EAPCRI, theMinimum Information for Publication of Quantitative Real-TimePCR Experiments (MIQE) guidelines ( 11), and the Quality Con- trol for Molecular Diagnostics (QCMD) ( http://www.qcmd.org ).",Non-OADS,/arxiv_data1/oa_pdf/f9/62/zjm2838.PMC4540929.pdf
http://dx.doi.org/10.1086/588660 .,OADS,/arxiv_data1/oa_pdf/f9/62/zjm2838.PMC4540929.pdf
http://dx.doi .org/10.1128/JCM.01767-09 .,Non-OADS,/arxiv_data1/oa_pdf/f9/62/zjm2838.PMC4540929.pdf
http://dx.doi.org/10.1128/JCM.05316-11 .,Non-OADS,/arxiv_data1/oa_pdf/f9/62/zjm2838.PMC4540929.pdf
"http://dx.doi .org/10.1128/JCM.00905-15 .White PL, Barnes RA, Springer J, Klingspor L, Cuenca-Estrella M, Morton CO, Lagrou K, Bretagne S, Melchers WJ G,Mengoli C, Donnelly JP, Heinz WJ, Loefﬂer J.",OADS,/arxiv_data1/oa_pdf/f9/62/zjm2838.PMC4540929.pdf
Clin Infect Dis 42:479 – 486. http://dx.doi.org/10 .1086/499949 .,Non-OADS,/arxiv_data1/oa_pdf/f9/62/zjm2838.PMC4540929.pdf
http://dx.doi.org/10.1128/JCM.03322-12 .,Non-OADS,/arxiv_data1/oa_pdf/f9/62/zjm2838.PMC4540929.pdf
J Clin Microbiol 48:811– 816. http://dx.doi.org/10.1128/JCM.01650-09 .,OADS,/arxiv_data1/oa_pdf/f9/62/zjm2838.PMC4540929.pdf
http://dx.doi.org/10.1128/JCM.40.4.1567-1568 .2002 .,Non-OADS,/arxiv_data1/oa_pdf/f9/62/zjm2838.PMC4540929.pdf
http://dx.doi.org/10.1136/jcp.2008.063321 .Aspergillus PCR Testing of Simulated Serum and Plasma September 2015 Volume 53 Number 9 jcm.asm.org 2845 Journal of Clinical Microbiology,Non-OADS,/arxiv_data1/oa_pdf/f9/62/zjm2838.PMC4540929.pdf
"Editor: K. C. Carroll Address correspondence to Daniela M. Cirillo, cirillo.daniela@hsr.it.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /JCM.01257-15 .",Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10.1183 /09031936.05.00111304 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10.1128/JCM.00521-07 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10.1128/JCM.00201-10 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10.1128/JCM.01066-07 .Tagliani et al.,OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10.1128/JCM.00039-12 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
Eur Respir J 40:690 – 698. http://dx.doi.org/10.1183/09031936.00164111 .,OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10.1128/JCM.02513-12 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10.1093/jac/dks178 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10.1128/JCM.00197-11 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10 .1073/pnas.0907925106 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
BMC Infect Dis 9:142. http://dx.doi.org/10.1186 /1471-2334-9-142 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10.1093 /fampra/cmh103 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10.1002/humu.20980 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org /10.1128/AAC.02066-13 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10.1371 /journal.pone.0033275 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
BMC Infect Dis 13:240. http://dx.doi .org/10.1186/1471-2334-13-240 .,OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
J Clin Microbiol 50:2026 – 2033. http://dx.doi.org/10.1128/JCM.06664-11 .,OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10.1128/JCM .02059-14 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10 .1371/journal.pone.0049433 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10 .1128/JCM.00081-09 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10.1128/AAC.49.8.3192-3197.2005 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
J Antimicrob Che-mother 67:819 – 831. http://dx.doi.org/10.1093/jac/dkr566 .,OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10.1371/journal.pone.0039754 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
http://dx.doi.org/10.1093 /jac/dkt358 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
Am J Respir Crit Care Med 182:684 – 692. http://dx.doi.org/10.1164/rccm.201001-0077OC .Performance of MTBDR slv2.0: a Multicenter Study September 2015 Volume 53 Number 9 jcm.asm.org 2969 Journal of Clinical Microbiology,Non-OADS,/arxiv_data1/oa_pdf/3f/2a/zjm2961.PMC4540937.pdf
"Editor: D. J. Diekema Address correspondence to Werner Ruppitsch, werner.ruppitsch@ages.at.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /JCM.01193-15 .",Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
"contigs)NCBI RefSeq or ENA SRA accession number(s) EGD-e (reference genome) 35 II Lm02 1/2a NAcNC_003210 07PF0776 4 I Lm01 4b NA NC_017728 08-5578 292 II Lm02 1/2a NA NC_013766 08-5923 120 II Lm02 1/2a NA NC_013768 10403S 85 II Lm02 1/2a NA NC_017544 ATCC 19117 2 I Lm01 4d NA NC_018584 C1-387 155 II Lm02 1/2a NA NC_021823 Clip81459 4 I Lm01 4b NA NC_012488 F2365 1 I Lm01 4b NA NC_002973 Finland 1998 155 II Lm02 3a NA NC_017547 FSL R2-561 9 II Lm02 1/2c NA NC_017546 HCC23 201 III Lm04 4a NA NC_011660 J0161 11 II Lm02 1/2a NA NC_017545 J1-220 2 I Lm01 4b NA NC_021830 J1776 6 I Lm01 4b NA NC_021839 J1816 6 I Lm01 4b NA NC_021829 J1817 6 I Lm01 4b NA NC_021827 J1926 6 I Lm01 4b NA NC_021840 J2-031 394 II Lm02 1/2c NA NC_021837 J2-064 5 I Lm01 1/2b NA NC_021824 J2-1091 1 I Lm01 1/2a NA NC_021825 L312 4 I Lm01 4b NA NC_018642 L99 201 III Lm04 4a NA NC_017529 LL195 1 I Lm01 4b NA NC_019556 M7 201 III Lm04 4a NA NC_017537 N1-011A 3 I Lm01 1/2b NA NC_021826 R2-502 3 I Lm01 1/2b NA NC_021838 SLCC0717 518 III Lm03 1/2a 163 (21) ERR664778 SLCC0759 481 III Lm03 1/2a 156 (23) ERR664779SLCC1042 18 III Lm03 1/2a 124 (20) ERR664780SLCC2372 122 II Lm02 1/2c NA NC_018588 SLCC2376 71 III Lm04 4c NA NC_018590 SLCC2378 73 I Lm01 4e NA NC_018585 SLCC2479 9 II Lm02 3c NA NC_018589 SLCC2482 3 I Lm01 7 NA NC_018591 SLCC2540 617 I Lm01 3b NA NC_018586 SLCC2755 66 I Lm01 1/2b NA NC_018587 SLCC3287 427 III Lm03 1/2a 132 (18) ERR664782SLCC4771 467 IV Lm07 4c 162 (25) ERR664786, ERR664787SLCC5850 12 II Lm02 1/2a NA NC_018592 SLCC6263 466 III Lm03 1/2a 180 (16) ERR664785SLCC7179 91 II Lm02 3a NA NC_018593 aMLST typing in accordance with http://www.pasteur.fr/recherche/genopole/PF8/mlst/Lmono.html .",Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
bMLST typing in accordance to http://www.pasteur.fr/recherche/genopole/PF8/mlst/Lmono.html .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
All raw reads generated were submitted to the European Nucleotide Archive ( http://www.ebi.ac.uk /ena/ ) under the study accession number PRJEB6551.,OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
"The SpaServer ( http://spaserver.ridom .de), which automatically hosts the nomenclature of the Staphylo- coccus aureus protein A gene typing ( spa) and now contains /H11022300,000 typing entries originating from /H11022100 countries, might serve as a blueprint for such service ( 36).",Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi.org /10.1586/14787210.2015.1003809 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
Wien Klin Wochenschr 121:113– 119. http://dx.doi.org/10.1007/s00508-008-1130-2 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
J Med Micro- biol 55:645– 659. http://dx.doi.org/10.1099/jmm.0.46495-0 .,OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
Int J Food Microbiol 65:55– 62. http://dx.doi.org/10.1016 /S0168-1605(00)00501-8 .,OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi.org/10.1128 /JCM.41.4.1574-1585.2003 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
Environ Microbiol 16:405– 416. http://dx.doi.org/10.1111/1462-2920.12342 .,OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
J Clin Microbiol 44:619 – 621. http://dx.doi.org/10.1128/JCM.44.2.619-621.2006 .,OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
BMC Bioinformatics5:86. http://dx.doi.org/10.1186/1471-2105-5-86 .,OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi .org/10.1128/JCM.41.2.757-762.2003 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi.org/10.1128/AEM.70.2.913-920.2004 .,OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi.org/10.1371/journal.ppat.1000146 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi.org/10.1371/journal.pone.0022751 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi.org/10 .1038/nrmicro3093 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi.org/10.1007/s00508-009 -1137-3 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://www.eurosurveillance.org/ViewArticle .aspx?ArticleId /H1100519543 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://www.eurosurveillance.org/ViewArticle .aspx?ArticleId /H1100519543 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
Genome Res 18:821– 829. http://dx.doi .org/10.1101/gr.074492.107 .,OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi.org/10.1038/nbt.2522 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
Enhanced Bayesian modelling in BAPS software for learning genetic structures of populations.BMC Bioinformatics 9:539. http://dx.doi.org/10.1186/1471-2105-9-539 .,OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi.org/10.1371/journal .pcbi.1003788 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi .org/10.1093/nar/gkh340 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
Future Microbiol 9:623– 630. http://dx.doi.org/10.2217/fmb.14.24 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi.org/10.1128/JCM .00567-14 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi.org/10.1128 /JCM.00262-14 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
BMCMicrobiol 13:302. http://dx.doi.org/10.1186/1471-2180-13-302 .,OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
J Mol Diagn 13:57– 63. http://dx.doi.org/10.1016/j.jmoldx.2010.11.002 .,OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi.org /10.1371/journal.pone.0089964 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi.org /10.3201/eid/1811.120453 .,Non-OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
http://dx.doi.org/10.1371/journal .pmed.0030033 .Ruppitsch et al.,OADS,/arxiv_data1/oa_pdf/39/a7/zjm2869.PMC4540939.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/49/msv102.PMC4540962.pdf
"Available from: http://cran.r-project.org/web/packages/abctools/in dex.html Ober C, Hyslop T, Hauck WW.",Non-OADS,/arxiv_data1/oa_pdf/f7/49/msv102.PMC4540962.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/19/msv103.PMC4540963.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/6a/msv110.PMC4540966.pdf
"To obtain Ae.a r a b i - cum, whole loci sequences paired-end next generation sequencing reads of Ae.a r a b i c u m genomic sequence (http://mustang.biol.mcgill.ca :8885/cgi-bin/hgGateway?org= A.+arabicum&db=aa_4&hgsid=1696 , last accessed May 19, 2015) were de novo assembled using CLC Genomics Workbench (CLC Bio) with standard parameters.",OADS,/arxiv_data1/oa_pdf/b8/6a/msv110.PMC4540966.pdf
Supplementary Material Supplementary tables S1–S5 and ﬁgures S1–S8 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/b8/6a/msv110.PMC4540966.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/55/msv117.PMC4540969.pdf
"Data Access Amphimedon queenslandica genome assembly ampQue1 (http://metazoa.ensembl.org /Amphimedon_queenslandica/ Info/Index , last accessed May 25, 2015) was used throughout the study.",OADS,/arxiv_data1/oa_pdf/17/55/msv117.PMC4540969.pdf
"The complete set of lncRNAs and protein-coding genes, alongwith the Trinity assembled transcriptomes, can be accessedand visualized in our website: http://amphimedon.qcloud.",OADS,/arxiv_data1/oa_pdf/17/55/msv117.PMC4540969.pdf
"The codes used for the gene coexpression analysis are available for down-load at: https://bitbucket.org/selene_fernandez/amphime- don-lncrnas (last accessed May 25, 2015).",OADS,/arxiv_data1/oa_pdf/17/55/msv117.PMC4540969.pdf
Supplementary Material Supplementary tables S1–S11 and ﬁgures S1–S4 are available atMolecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/17/55/msv117.PMC4540969.pdf
"Available from: http://www.repeatmasker.org Smith JE, Alvarez-Dominguez JR, Kline N, Huynh NJ, Geisler S, Hu W, Coller J, Baker KE.",Non-OADS,/arxiv_data1/oa_pdf/17/55/msv117.PMC4540969.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/f8/msv122.PMC4540971.pdf
"DNA was ext racted using a QIAGEN DNeasy Kit (Germantown, MD) according to the manufacturer’s in- structions except for CCMP1764 which was extracted using aprotocol for genome quality DNA ( http://www.mbari.org/ phyto-genome/Resources.html , last accessed June 8, 2015).",Non-OADS,/arxiv_data1/oa_pdf/da/f8/msv122.PMC4540971.pdf
"Searches for RNA Structure IE sequences were submitted to the mFold server http://mfold.rna.albany.edu/?q=mfold (last accessed June 8, 2015) and the mFold output ( Zuker 2003 )f o rd i f f e r e n tI E s was evaluated by inspection.",OADS,/arxiv_data1/oa_pdf/da/f8/msv122.PMC4540971.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/f0/msv125.PMC4540973.pdf
"Filtered sequencing reads were cleaned using CUTADAPT (https://github.com/marcelm/- cutadapt , last accessed June 22, 2015) to remove adapters and sorted by FASTQCOMBINEPAIREDEND.PY to makepaired-end ﬁles ( https://github.com/enormandeau/Scripts/ blob/master/fastqCombinePairedEnd.py , last accessed June 22, 2015).",Non-OADS,/arxiv_data1/oa_pdf/1c/f0/msv125.PMC4540973.pdf
Identification of HET Domain Genes and Synteny Analyses HET domain sequences predicted in the N. crassa reference genome (Broad Institute N. crassa database) were aligned to de novo assemblies using BLAST+ (Basic Local AlignmentSearch Tool) ( ftp://ftp.ncbi.nlm.nih.g ov/blast/executables/bla st+/).,OADS,/arxiv_data1/oa_pdf/1c/f0/msv125.PMC4540973.pdf
Multiple alignments were visualized using JALVIEW ( http://www.jalview.org ).,OADS,/arxiv_data1/oa_pdf/1c/f0/msv125.PMC4540973.pdf
"tetrasperma ,N. discreta, and P. anserina were obtained from the U.S. Department of Energy Joint Genome Institute database ( http://genome.jgi-psf.org/programs/fungi/index.",OADS,/arxiv_data1/oa_pdf/1c/f0/msv125.PMC4540973.pdf
Sordaria macrospora genome assembly was downloaded from http://fungidb.org/fungidb/ and the A. oryzae genome assembly was obtained from Comparative Database ( http://www.broadinstitute.org/anno- tation/genome/aspergillu s_group/MultiHome.html ).,OADS,/arxiv_data1/oa_pdf/1c/f0/msv125.PMC4540973.pdf
2004 ).Synteny analyses for het-e used FungiDB ( http://fungidb.org/fungidb/ ).,OADS,/arxiv_data1/oa_pdf/1c/f0/msv125.PMC4540973.pdf
"To identify HET domain genes in other species, we searched Pfam database ( http://pfam.xfam.org ).",OADS,/arxiv_data1/oa_pdf/1c/f0/msv125.PMC4540973.pdf
"Neighbor-joining gene genealogies were constructed for all candidate hetloci using the F84 model of nucleotide substitution, as imple- mented in the PHYLIP package ( http://evolution.genetics.",OADS,/arxiv_data1/oa_pdf/1c/f0/msv125.PMC4540973.pdf
"Anti-PMA1 antibody(1:3,000 dilution) was kindly provided by Dr K. Allen (Yale School of Medicine) and anti-ERV25 antibody (1:1,000 dilu- tion) kindly provided by Dr T. Starr (Energy BiosciencesInstitute, University of California, Berkeley).Supplementary Material Supplementary ﬁgures S1–S4 and tables S1–S6 are available at Molecular Biology and Evolution online ( http://www.mbe.",Non-OADS,/arxiv_data1/oa_pdf/1c/f0/msv125.PMC4540973.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/fe/3a/jjm-08-06-17712.PMC4541022.pdf
"VV ECMO (PLS;  Maquet, Rastatt, Germany) was established via bilateral femo-ral cannulation under local anest hesia (Biomedicus 21 Fr ve-Korean J Thorac Cardiovasc Surg 2015;48:289-293 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.4.289",Non-OADS,/arxiv_data1/oa_pdf/24/14/kjtcv-48-289.PMC4541049.pdf
"1B) revealed extensive non-enhancing soft tissue lesions in the posterior mediastinum and neck, Korean J Thorac Cardiovasc Surg 2015;48:298-301 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.4.298",Non-OADS,/arxiv_data1/oa_pdf/bd/88/kjtcv-48-298.PMC4541050.pdf
"However, median ster-Korean J Thorac Cardiovasc Surg 2015;48:258-264 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.4.258",Non-OADS,/arxiv_data1/oa_pdf/cd/99/kjtcv-48-258.PMC4541051.pdf
AgedKorean J Thorac Cardiovasc Surg 2015;48:252-257 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.4.252,Non-OADS,/arxiv_data1/oa_pdf/ec/1f/kjtcv-48-252.PMC4541052.pdf
Available from: http://seer.cancer.gov/  csr/1975_2005/.,Non-OADS,/arxiv_data1/oa_pdf/ec/1f/kjtcv-48-252.PMC4541052.pdf
"The shape of  the normal trachea is an extended  half circle with the posteri- or portion nearly flat and made of soft tissue, which com-Korean J Thorac Cardiovasc Surg 2015;48:231-237 □ Review  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.4.231",Non-OADS,/arxiv_data1/oa_pdf/65/b1/kjtcv-48-231.PMC4541053.pdf
Korean J Thorac Cardiovasc Surg 2015;48:265-271 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.4.265,Non-OADS,/arxiv_data1/oa_pdf/c6/1c/kjtcv-48-265.PMC4541054.pdf
Available from: http://www.pion eersurgical.com/cardiothoracic/  Cable-System/Pioneer-Sternal-Cable-System/.,Non-OADS,/arxiv_data1/oa_pdf/c6/1c/kjtcv-48-265.PMC4541054.pdf
"We detected a dis- section of the left main artery,  the left anterior descending a r- tery (LAD), and the circumflex  artery, originating from the Korean J Thorac Cardiovasc Surg 2015;48:281-284 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.4.281",Non-OADS,/arxiv_data1/oa_pdf/1f/cd/kjtcv-48-281.PMC4541055.pdf
SUPPLEMENTARY MATERIALS Supplementary materials can be found via http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/cd/kjtcv-48-281.PMC4541055.pdf
"DISCUSSION Pseudoaneurysm has been repor ted as a complication after  arthroscopy, arthroplasty, ligam ent repair, synovectomy, pene-Korean J Thorac Cardiovasc Surg 2015;48:302-305 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.4.302",Non-OADS,/arxiv_data1/oa_pdf/7f/7c/kjtcv-48-302.PMC4541056.pdf
"After the identification of a chronic inno minate vein occlusion, the tu-Korean J Thorac Cardiovasc Surg 2015;48:294-297 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.4.294",Non-OADS,/arxiv_data1/oa_pdf/c7/91/kjtcv-48-294.PMC4541057.pdf
After the aorta was cross- Korean J Thorac Cardiovasc Surg 2015;48:272-276 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.4.272,Non-OADS,/arxiv_data1/oa_pdf/9d/2f/kjtcv-48-272.PMC4541058.pdf
"Therefore, valvular replacement Korean J Thorac Cardiovasc Surg 2015;48:277-280 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.4.277",Non-OADS,/arxiv_data1/oa_pdf/52/6a/kjtcv-48-277.PMC4541059.pdf
Some patients show favorable  changes in the remaining  false lumen after conventional repair of acute type A dis-Korean J Thorac Cardiovasc Surg 2015;48:238-245 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.4.238,Non-OADS,/arxiv_data1/oa_pdf/7c/9d/kjtcv-48-238.PMC4541060.pdf
The distal ends  of both internal thoracic ar-Korean J Thorac Cardiovasc Surg 2015;48:285-288 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.4.285,Non-OADS,/arxiv_data1/oa_pdf/3b/51/kjtcv-48-285.PMC4541061.pdf
"This study prese nts a review of the epidemiol- ogy, etiology, and clinical char acteristics of upper limb ische - mia, as well as an analysis of the factors affecting functional   sequelae after treatment.Korean J Thorac Cardiovasc Surg 2015;48:246-251 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.4.246",Non-OADS,/arxiv_data1/oa_pdf/14/5f/kjtcv-48-246.PMC4541062.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/11/77/jjm-08-06-17296.PMC4541063.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/cc/34/jjm-08-06-16851.PMC4541065.pdf
"P53is a direct target of SOX30 To investigate whether p53 is a direct target of SOX30, we searched the putative SOX transcription factor-binding sites in p53 promoter using Jaspar (http://jaspar.genereg.net/).",OADS,/arxiv_data1/oa_pdf/9e/58/onc2014370a.PMC4541146.pdf
"To further determined the SOX30-binding sites in the p53 promoter, different regions ofthe p53 promoter were analyzed by luciferase reporter assays, and the SOX30-binding site was very likely on the CACTTTG (+115 to +121) locus of the p53 promoter region using both Jaspar andConSite (http://consite.genereg.net/cgi-bin/consite) searching (Figure 7d, Supplementary Figure S5D).",Non-OADS,/arxiv_data1/oa_pdf/9e/58/onc2014370a.PMC4541146.pdf
"Sequence data were used to determine genomicinformation, using the NCBI ’s BLAST program (http://blast.ncbi.nlm.nih.gov).",OADS,/arxiv_data1/oa_pdf/9e/58/onc2014370a.PMC4541146.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)SOX30, methylation, apoptosis, p53 and lung cancer F Han et al 4402 Oncogene (2015) 4391 –4402 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/9e/58/onc2014370a.PMC4541146.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/9d/c4/JCIS-5-43.PMC4541161.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/86/45/JCIS-5-40.PMC4541162.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?,Non-OADS,/arxiv_data1/oa_pdf/a4/85/JCIS-5-39.PMC4541163.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/85/3d/JCIS-5-42.PMC4541164.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/1e/a6/JCIS-5-41.PMC4541165.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/30/aa/JCIS-5-44.PMC4541166.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/68/79/jjm-08-06-18591.PMC4541167.pdf
Available from:  http://www.historyhouse.com/in_history/cocaine/.,Non-OADS,/arxiv_data1/oa_pdf/79/05/JOACP-31-291.PMC4541171.pdf
"Available from: http://www.payscale.com/research/IN/ Job=Physician_%2F_Doctor,_Anesthetist/Salary.",Non-OADS,/arxiv_data1/oa_pdf/79/05/JOACP-31-291.PMC4541171.pdf
Available  from: http://www.healthcareworkersalary.com/physicians/ anesthesiologist-salary/.,Non-OADS,/arxiv_data1/oa_pdf/79/05/JOACP-31-291.PMC4541171.pdf
Available from: http://www.medscape.com/ features/slideshow/compensation/2014/public/overview#2.,Non-OADS,/arxiv_data1/oa_pdf/79/05/JOACP-31-291.PMC4541171.pdf
Available  from: https://www.medicareaustralia.gov.au/forms/10621.pdf.,Non-OADS,/arxiv_data1/oa_pdf/79/05/JOACP-31-291.PMC4541171.pdf
Available  from: http://www.cms.gov/Regulations-and-Guidance/Guidance/ Manuals/downloads/clm104c12.pdf.,Non-OADS,/arxiv_data1/oa_pdf/79/05/JOACP-31-291.PMC4541171.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/79/05/JOACP-31-291.PMC4541171.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/79/05/JOACP-31-291.PMC4541171.pdf
http://www.ema.europa.eu/ema/index.jsp?,Non-OADS,/arxiv_data1/oa_pdf/4a/38/JOACP-31-293.PMC4541172.pdf
"Organising Chairman   HOD and Chairman   Department of Anaesthesiology and Critical care Sheri Kashmir  Institute of Medical Sciences (SKIMS) Srinagar, J&K   Org.Secy: Dr. Zulfiqar Ali Telephone: +9194190 86761 Email Id: nacsrinagar2015@gmail.com Website: http://www.aidiaa.org/NAC2015/NAC_home.html 5th National Conference of  Academy of Regional Anaesthesia  of India AORA 2015September 25th-27th, 2015J N Tata Auditorium,   National Science  Symposium  Complex,   Sir C V Raman  Avenue, Near-Indian  Institute Of Science,   Bengaluru,  Karnataka 560012Dr.",Non-OADS,/arxiv_data1/oa_pdf/4a/38/JOACP-31-293.PMC4541172.pdf
"Name of conference Dates Venue Name of organising secretary with contact details ASA Anesthesiology 2015 October 24-28,  2015San Diego, California  91911, United StatesEmail: annmtg@asahq.org URL: http://www.asahq.org/Annual-Meeting/Future-Annual- Meetings.aspx 4th International Conference on  Pain Management (ICPM 2015)  and supported by “The Society  of Ultrasound in Anaesthesia”  (SUA) UKNovember  7-9, 2015Shruti Auditorium,  SGPGIMS, Lucknow,  INDIADr Sanjay Dhiraaj   Organizing Secretary   Department of Anaesthesiology Sanjay Gandhi Postgraduate  Institute of Medical Sciences Raebareli Road, Lucknow 226014.",Non-OADS,/arxiv_data1/oa_pdf/36/fd/JOACP-31-308.PMC4541175.pdf
"Telephone: +91-80 04 904595   FAX: +91-522-   Cell: +91 98 39 450244   E-mail: 2015icpm@gmail.com http://www.icpm2015lko.com/ 7th Annual Conference-Indian  College Of Anaesthesiologists Icacon 2015November  13-15, 2015 Hotel Savera,  Dr. Radhakrishnan  Road, Chennai 600004Dr.",Non-OADS,/arxiv_data1/oa_pdf/36/fd/JOACP-31-308.PMC4541175.pdf
Available from: http://www.media.intersurgical.,Non-OADS,/arxiv_data1/oa_pdf/60/d4/JOACP-31-324.PMC4541177.pdf
"Name of conference Dates Venue Name of organising secretary with contact details 31st Annual National Conference  of Indian Society for Study of Pain  ISSPCON-2016 February  5th-7th, 2016Indore Dr. Pravesh Kanthed Telephone: 91 9301444007 Email Id: secretaryisspcon2016@gmail.com Website: http://www.isspcon2016.com/ 17th Annual Conference of Indian  Society of Neuroanesthesiology  and Critical Care ISNACC 2016 February  5th-7th, 2016Bengaluru Dr. Venkatesh H K Telephone: 919739974930 Email Id: isnacc2016@gmail.com Website: http://isnacc2016.org/index.html 22nd Annual Conference of Indian  Society of Critical Care Medicine  & International Sepsis Forum  CRITICARE 2016 February,  5th-9th, 2016Agra Dr. Ranvir Singh Tyagi,   Dr. Diptimala Agarwal Telephone: 919927778889 Email Id: criticare2016@gmail.com Website: http://criticare2016.com/Conference Calendar 2015",Non-OADS,/arxiv_data1/oa_pdf/7a/92/JOACP-31-344.PMC4541181.pdf
(https://ispub.com/ IJA/16/2/13279) [Last accessed on 2015 Jan 2].,Non-OADS,/arxiv_data1/oa_pdf/66/cc/JOACP-31-360.PMC4541184.pdf
"No 1, Ramachandra nagar, Porur, Chennai - 600116 Phone: +91 44 23860125 Mobile: +91 90426 06596 23rd International Conference of  the Indian Association of Palliative  Care IAPCON 2016February,  12-14th, 2016Pune Dr. Priyadarshini Kulkarni Telephone: 919158286161 Email Id: info@iapcon2016pune.com Website: http://iapcon2016pune.in/index.htmlConference Calendar 2015",Non-OADS,/arxiv_data1/oa_pdf/86/e4/JOACP-31-375.PMC4541187.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/e0/04/JOACP-31-382.PMC4541189.pdf
"cancer.gov/tools/design/power, http://www.gpower.hhu.de/, or  http://biostat.mc.vanderbilt.edu/wiki/Main/PowerSampleSize.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JOACP-31-394.PMC4541191.pdf
Available from: http://www.books.,Non-OADS,/arxiv_data1/oa_pdf/e7/92/JOACP-31-394.PMC4541191.pdf
Available from: http://www.cochrane-net.org/ openlearning/html/mod12-2.htm.,OADS,/arxiv_data1/oa_pdf/e7/92/JOACP-31-394.PMC4541191.pdf
Available from: http://www.fifa.com/aboutfifa/ footballdevelopment/ technicalsupport/ refereeing/laws-of-the- game/index html.,Non-OADS,/arxiv_data1/oa_pdf/74/02/JOACP-31-409b.PMC4541196.pdf
Available from: http://www.ibtimes.com.,Non-OADS,/arxiv_data1/oa_pdf/74/02/JOACP-31-409b.PMC4541196.pdf
Available from: http://www.fifa.com/aboutfifa/ footballdevelopment/ technicalsupport/ refereeing/laws-of-the- game/index html.,Non-OADS,/arxiv_data1/oa_pdf/5e/18/JOACP-31-410.PMC4541197.pdf
Available from: http://www.ibtimes.com.,Non-OADS,/arxiv_data1/oa_pdf/5e/18/JOACP-31-410.PMC4541197.pdf
We thank Vern Giammartino (http://www.verngiammar - tino.com/) for the graphical depiction of this process.,Non-OADS,/arxiv_data1/oa_pdf/19/aa/NRR-10-1023.PMC4541218.pdf
"Accepted:  2015-05-06 doi:10.4103/1673-5374.160059        http://www.nrronline.org/ Bass B, Upson S, Roy K, Montgomery EL, Jalonen TO, Murray IVJ  (2015) Glycogen and amyloid-beta: key players in the shift from  neuronal hyperactivity to hypoactivity observed in Alzheimer’s  disease?",Non-OADS,/arxiv_data1/oa_pdf/19/aa/NRR-10-1023.PMC4541218.pdf
"Accepted:  2015-05-26 doi:10.4103/1673-5374.160061          http://www.nrronline.org/ Wang WX, Springer JE (2015) Role of mitochondria in regulating  microRNA activity and its relevance to the central nervous system.",OADS,/arxiv_data1/oa_pdf/bf/c1/NRR-10-1026.PMC4541219.pdf
"Accepted:  2015-05-09 doi:10.4103/1673-5374.160063         http://www.nrronline.org/ Vidal F, Guzman L (2015) Dendrimer nanocarriers drug ac - tion: perspective for neuronal pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/a1/0d/NRR-10-1029.PMC4541220.pdf
Accepted:  2015-05-24 doi:10.4103/1673-5374.160064          http://www.nrronline.org/ Hynds DL (2015) Subcellular localization of Rho GTPases: implica - tions for axon regeneration.,OADS,/arxiv_data1/oa_pdf/a0/2b/NRR-10-1032.PMC4541221.pdf
Accepted:  2015-05-13 doi:10.4103/1673-5374.160067         http://www.nrronline.org/ Pita-Thomas W (2015) Magnetic nanotechnology to study and  promote axon growth.,Non-OADS,/arxiv_data1/oa_pdf/b3/44/NRR-10-1037.PMC4541223.pdf
"Accepted:  2015-04-29 doi:10.4103/1673-5374.160069         http://www.nrronline.org/ Vallotton P, Kapsa RMI (2015) “To measure is to know”: how ad - vances in image analysis are supporting neural repair strategies.",Non-OADS,/arxiv_data1/oa_pdf/5b/96/NRR-10-1040.PMC4541224.pdf
"Accepted:  2015-05-06 doi:10.4103/1673-5374.160071         http://www.nrronline.org/ Ulbrich F, Goebel U (2015) Argon: a novel therapeutic option to treat neu - ronal ischemia and reperfusion injuries?",Non-OADS,/arxiv_data1/oa_pdf/bc/ca/NRR-10-1043.PMC4541225.pdf
Accepted:  2015-05-21 doi:10.4103/1673-5374.160073          http://www.nrronline.org/ Seil FJ (2015) Circuit reorganization in cerebellar cultures after inju - ry.,OADS,/arxiv_data1/oa_pdf/44/31/NRR-10-1045.PMC4541226.pdf
Accepted:  2015-05-06 doi:10.4103/1673-5374.160074         http://www.nrronline.org/ Plantman S (2015) Novel rodent models of penetrating traumatic  brain injury.,Non-OADS,/arxiv_data1/oa_pdf/78/15/NRR-10-1047.PMC4541227.pdf
Accepted:  2015-06-10 doi:10.4103/1673-5374.160076          http://www.nrronline.org/ Kamat PK (2015) Streptozotocin induced Alzheimer’s disease like  changes and the underlying neural degeneration and regeneration  mechanism.,Non-OADS,/arxiv_data1/oa_pdf/11/68/NRR-10-1050.PMC4541228.pdf
"Accepted:  2015-05-11 doi:10.4103/1673-5374.160077         http://www.nrronline.org/ Castillo V , Mercado G, Hetz C (2015) Gene therapy in Parkinson’s disease:  targeting the endplasmic reticulum proteostasis network.",Non-OADS,/arxiv_data1/oa_pdf/c1/fa/NRR-10-1053.PMC4541229.pdf
"Accepted:  2015-04-28 doi:10.4103/1673-5374.160078         http://www.nrronline.org/ Kim DI, Park SH (2015) Glucagon peptide-like 1 receptor (GLP-1R)  expression per se: a new insight into neurodegenerative disease?",Non-OADS,/arxiv_data1/oa_pdf/33/fa/NRR-10-1055.PMC4541230.pdf
"Accepted:  2015-05-05 doi:10.4103/1673-5374.160079         http://www.nrronline.org/ Misra K, Sabaawy HE (2015) Minimally manipulated autologous ad - herent bone marrow cells (ABMCs): a promising cell therapy of spinal  cord injury.",Non-OADS,/arxiv_data1/oa_pdf/76/03/NRR-10-1058.PMC4541231.pdf
"Accepted:  2015-06-05 doi:10.4103/1673-5374.160081          http://www.nrronline.org/ Garber S, Hawryluk G (2015) Provision of nutrients after acute spinal  cord injury: the implications of feast and famine.",Non-OADS,/arxiv_data1/oa_pdf/85/f9/NRR-10-1061.PMC4541232.pdf
"Sergio A. Gerhke*, Jamil A. Sh ibli, Marcos B. Salles Coordinator of the Biotecnos Research Center, Santa Maria, Rio  Grande do Sul, Brazil (Gerhke SA) Department Research, Guarulhos University, Guarulhos, Brazil  (Gerhke SA, Shibli JA) Department of Health Sciences - School of Dentistry, 9 de Julho  University, São Paulo, SP , Brazil (Salles MB) *Correspondence to:  Sergio A. Gehrke, DDS, Ph.D.,  sergio.gehrke@hotmail.com Accepted:  2015-06-01 doi:10.4103/1673-5374.160082          http://www.nrronline.org/ Gerhke SA, Shibli JA, Salles MB (2015) Potential of the use of an an - tioxidant compound to promote peripheral nerve regeneration after  injury.",Non-OADS,/arxiv_data1/oa_pdf/c5/cf/NRR-10-1063.PMC4541233.pdf
Accepted:  2015-05-09 doi:10.4103/1673-5374.160091          http://www.nrronline.org/ Birgbauer E (2015) Lysophospholipids in retinal axon guidance: roles  and cell signaling.,Non-OADS,/arxiv_data1/oa_pdf/cd/83/NRR-10-1067.PMC4541235.pdf
"Avail - able at: http://live.episoc.baigentpreview.com/sites/default/files/ attachments/Chapter47McEvoy.pdf [Accessed November 6, 2014].",Non-OADS,/arxiv_data1/oa_pdf/0b/21/NRR-10-1107.PMC4541242.pdf
"Available at: http://books.google.com/ books?hl=en&lr=&id=Z8uwPwlPUw4C&oi=fnd&pg=PR1&d - q=Neurological+Disorders:+Public+Health+Challenges&ots=g - fmEz8YtQs&sig=j-61QPSMDGHrJi2_KEASAoyABks [Accessed  November 11, 2014].",Non-OADS,/arxiv_data1/oa_pdf/0b/21/NRR-10-1107.PMC4541242.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/98/TOORTHJ-9-275.PMC4541294.pdf
Images were analyzed using Tscratch software (http://www.cse-lab.ethz.ch.),OADS,/arxiv_data1/oa_pdf/17/52/TOORTHJ-9-262.PMC4541295.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/52/TOORTHJ-9-262.PMC4541295.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/ce/TOOPHTJ-9-131.PMC4541296.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/a8/TOOPHTJ-9-126.PMC4541297.pdf
[14] http://www.sccn.ucsd.edu/eeglab  [15] P.E.,Non-OADS,/arxiv_data1/oa_pdf/a5/4b/TOBEJ-9-151.PMC4541300.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/a3/TOBEJ-8-160.PMC4541301.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/72/TONURSJ-9-25.PMC4541305.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/f6/TOORTHJ-9-303.PMC4541306.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/da/TOORTHJ-9-313.PMC4541309.pdf
"DISCLOSURE  “Part of this article has already been published in J Bone Joint Surg Am, 2009 Jan 01; 91 (1): 3-13. http://dx.doi.org/ 10.2106/JBJS.H.00338”.",Non-OADS,/arxiv_data1/oa_pdf/68/34/TOORTHJ-9-324.PMC4541315.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/34/TOORTHJ-9-324.PMC4541315.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/80/TOORTHJ-9-270.PMC4541316.pdf
"Available from:  http://pivlab.blogspot.com  [10] Westerdale J, Belohlavek M, McMahon E, Jiamsripong P, Heys JJ,  Milano M. Flow velocity vector fields by ultrasound particle  imaging velocimetry: In vitro  comparison to optical flow  velocimetry.",OADS,/arxiv_data1/oa_pdf/3d/88/TOCMJ-9-62.PMC4541318.pdf
"Over the years, her Open AccessW C C Sze and others Stereotactic radiosurgery XX ID: 14-0106; August 2015 DOI: 10.1530/EDM-14-0106 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd",Non-OADS,/arxiv_data1/oa_pdf/48/24/edmcr-2015-140106.PMC4541329.pdf
W C C Sze and others Stereotactic radiosurgery XX ID: 14-0106; August 2015 DOI: 10.1530/EDM-14-0106 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/48/24/edmcr-2015-140106.PMC4541329.pdf
W C C Sze and others Stereotactic radiosurgery XX ID: 14-0106; August 2015 DOI: 10.1530/EDM-14-0106 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/48/24/edmcr-2015-140106.PMC4541329.pdf
W C C Sze and others Stereotactic radiosurgery XX ID: 14-0106; August 2015 DOI: 10.1530/EDM-14-0106 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/48/24/edmcr-2015-140106.PMC4541329.pdf
( doi:10.1007/s00066-002-0826-x ) Received in ﬁnal form 12 November 2014 Accepted 4 August 2015 W C C Sze and others Stereotactic radiosurgery XX ID: 14-0106; August 2015 DOI: 10.1530/EDM-14-0106 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/48/24/edmcr-2015-140106.PMC4541329.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/bc/TOORTHJ-9-296.PMC4541330.pdf
"This is an open access article licensed under the terms of the Creative C ommons Attribution Non -Commercial License (http://creativecommons.org/licenses/  by-nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/ca/TOBEJ-8-153.PMC4541331.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/c9/TOOPHTJ-9-116.PMC4541337.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/67/TOBEJ-8-147.PMC4541372.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/af/TOORTHJ-9-274.PMC4541406.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/45/TOORTHJ-9-356.PMC4541414.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/74/TOORTHJ-9-332.PMC4541416.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/45/TORMJ-9-112.PMC4541417.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/c2/TORJ-9-57.PMC4541420.pdf
Avail-able from: http://www.aaam.org/about-ais.html [Last accessed: November 2014].,Non-OADS,/arxiv_data1/oa_pdf/47/7a/TOORTHJ-9-283.PMC4541450.pdf
Available from: http://www.cdc.gov/nchs/fastats/deaths.htm [accessed 13 August 2013].,Non-OADS,/arxiv_data1/oa_pdf/47/7a/TOORTHJ-9-283.PMC4541450.pdf
Available from: http://www.ema.europa.eu.,Non-OADS,/arxiv_data1/oa_pdf/47/7a/TOORTHJ-9-283.PMC4541450.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/7a/TOORTHJ-9-283.PMC4541450.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/b0/TORMJ-9-81.PMC4541451.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/70/TORMJ-9-120.PMC4541452.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/19/TORMJ-9-92.PMC4541453.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/06/TOORTHJ-9-361.PMC4541454.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2014 |  92  | e51823 | Page 1 of 19Video Article Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles Eva Wagner*1,2,3, Sören Brandenburg*1,2, Tobias Kohl1,2, Stephan E. Lehnart1,2,3,4 1Heart Research Center Goettingen 2Clinic of Cardiology & Pulmonology, University Medical Center Goettingen 3German Center for Cardiovascular Research (DZHK) partner site Goettingen 4BioMET, Center for Biomedical Engineering & Technology, University of Maryland School of Medicine *These authors contributed equally Correspondence to: Stephan E. Lehnart at slehnart@med.uni-goettingen.de URL: http://www.jove.com/video/51823 DOI: doi:10.3791/51823 Keywords: Bioengineering, Issue 92, cardiac myocyte, atria, ventricle, heart, primary cell isolation, fluorescence microscopy, membrane tubule, transverse-axial tubule system, image analysis, image processing, T-tubule, collagenase Date Published: 10/15/2014 Citation: Wagner, E., Brandenburg, S., Kohl, T., Lehnart, S.E.",Non-OADS,/arxiv_data1/oa_pdf/7a/dc/jove-92-51823.PMC4541455.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51823/ Introduction In healthy striated muscle cells, tubular membrane structures with “transverse” orientations (T-tubules) perpendicular to the main cell axis are abundant.",Non-OADS,/arxiv_data1/oa_pdf/7a/dc/jove-92-51823.PMC4541455.pdf
"1.Open the image file of a di-8-ANEPPS stained myocyte in Fiji (http://fiji.sc/), a freely available variant of ImageJ which contains analysis plugins essential for image processing.",OADS,/arxiv_data1/oa_pdf/7a/dc/jove-92-51823.PMC4541455.pdf
For a detailed description of all possible output parameters please refer tohttp://fiji.sc/wiki/index.php/ AnalyzeSkeleton and related articles29-31.,OADS,/arxiv_data1/oa_pdf/7a/dc/jove-92-51823.PMC4541455.pdf
For a detailed description of possible output parameters please refer to http://fiji.sc/wiki/ index.php/AnalyzeSkeleton .,OADS,/arxiv_data1/oa_pdf/7a/dc/jove-92-51823.PMC4541455.pdf
"For this, use the “Directionality” plugin (http://fiji.sc/Directionality)29,31 which produces histogram data showing the orientation distribution of all TATS component orientations.",OADS,/arxiv_data1/oa_pdf/7a/dc/jove-92-51823.PMC4541455.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2015  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseApril 2015 |  98  | e52338 | Page 1 of 10Video Article Preparation, Imaging, and Quantification of Bacterial Surface Motility Assays Nydia Morales-Soto1,2, Morgen E. Anyan1, Anne E. Mattingly1, Chinedu S. Madukoma1, Cameron W. Harvey3, Mark Alber3, Eric Déziel4, Daniel B. Kearns5, Joshua D. Shrout1,2,6 1Department of Civil and Environmental Engineering and Earth Sciences, University of Notre Dame 2Eck Institute for Global Health, University of Notre Dame 3Department of Applied and Computational Mathematics and Statistics, University of Notre Dame 4INRS-Institut Armand-Frappier 5Department of Biology, Indiana University 6Department of Biological Sciences, University of Notre Dame Correspondence to: Joshua D. Shrout at joshua.shrout@nd.edu URL: http://www.jove.com/video/52338 DOI: doi:10.3791/52338 Keywords: Microbiology, Issue 98, Surface motility, Swarming, Imaging, Pseudomonas aeruginosa , Salmonella Typhimurium, Bacillus subtilis , Myxococcus xanthus , Flagella Date Published: 4/7/2015 Citation: Morales-Soto, N., Anyan, M.E., Mattingly, A.E., Madukoma, C.S., Harvey, C.W., Alber, M., Déziel, E., Kearns, D.B., Shrout, J.D.",Non-OADS,/arxiv_data1/oa_pdf/93/11/jove-98-52338.PMC4541456.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/52338/ Introduction Many bacteria move on surfaces using various means of self-propulsion.,Non-OADS,/arxiv_data1/oa_pdf/93/11/jove-98-52338.PMC4541456.pdf
Bruker Corporation Available from: http://www.bruker.com/service/support-upgrades/software-downloads/molecular- imaging.html (2014).,OADS,/arxiv_data1/oa_pdf/93/11/jove-98-52338.PMC4541456.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/c8/TORJ-9-46.PMC4541458.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/f9/TORMJ-9-97.PMC4541459.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/31/TORJ-9-51.PMC4541463.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/d0/TORMJ-9-104.PMC4541464.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/62/TORMJ-9-83.PMC4541465.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/73/TOORTHJ-9-321.PMC4541466.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/4a/TOORTHJ-9-367.PMC4541467.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/c9/TOORTHJ-9-347.PMC4541470.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2014 |  92  | e52190 | Page 1 of 7Video Article Measuring Attentional Biases for Threat in Children and Adults Vanessa LoBue1 1Department of Psychology, Rutgers University Correspondence to: Vanessa LoBue at vlobue@psychology.rutgers.edu URL: http://www.jove.com/video/52190 DOI: doi:10.3791/52190 Keywords: Behavior, Issue 92, Detection, threat, attention, attentional bias, anxiety, visual search Date Published: 10/19/2014 Citation: LoBue, V. Measuring Attentional Biases for Threat in Children and Adults.",Non-OADS,/arxiv_data1/oa_pdf/db/74/jove-92-52190.PMC4541474.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/52190/ Introduction For decades researchers have been interested in humans’ detection of various types of threatening stimuli.,Non-OADS,/arxiv_data1/oa_pdf/db/74/jove-92-52190.PMC4541474.pdf
http://www.nacp.,Non-OADS,/arxiv_data1/oa_pdf/08/25/aids-29-1701.PMC4541475.pdf
http://www.nacp.gov.pk/ library/reports/Surveillance%20&%20Research/HIV-AIDS%20 Surveillance%20Project-HASP/HIV%20Second%20Generation% 20Surveillance%20in%20Pakistan%20-%20National%20report% 20Round%20III%202008.pdf [Accessed 9 June 2015].,Non-OADS,/arxiv_data1/oa_pdf/08/25/aids-29-1701.PMC4541475.pdf
http://www.nacp.gov.pk/ library/reports/Surveillance%20&%20Research/HIV-AIDS%20 Surveillance%20Project-HASP/ HIV%20Second%20Generation% 20Surveillance%20in%20Pakistan%20-%20Round%202%20 Report%202006-07.pdf [Accessed 9 June 2015].,Non-OADS,/arxiv_data1/oa_pdf/08/25/aids-29-1701.PMC4541475.pdf
http://www.nacp.gov.pk/ library/reports/Surveillance%20&%20Research/HIV-AIDS%20 Surveillance%20Project-HASP/HIV%20Second%20Generation% 20Surveillance%20in%20Pakistan%20-%20Round%201%20 Report%20-%202005.pdf [Accessed 9 June 2015].,Non-OADS,/arxiv_data1/oa_pdf/08/25/aids-29-1701.PMC4541475.pdf
http://www-wds.worldban- k.org/external/default/WDSContentServer/WDSP/IB/2010/06/ 04/000333038_20100604011533/Rendered/PDF/ 548890PUB0EPI11C10Dislosed061312010.pdf [Accessed 9 June 2015].,Non-OADS,/arxiv_data1/oa_pdf/08/25/aids-29-1701.PMC4541475.pdf
"Van Lith1,2, Frauke Ohl1,2, Saskia S. Arndt1,2 1Department of Animals in Science and Society, Utrecht University 2Brain Center Rudolf Magnus Correspondence to: Maaike Labots at M.Labots@uu.nl URL: http://www.jove.com/video/52529 DOI: doi:10.3791/52529 Keywords: Behavior, Issue 98, Anxiety, behavior, cognition, exploration, locomotion, mice, modified hole board, rats, social interaction.",Non-OADS,/arxiv_data1/oa_pdf/2a/d2/jove-98-52529.PMC4541485.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/52529/ Introduction The modified hole board (mHB) is used to assess multiple dimensions of unconditioned behavior, mainly in mice and rats1.",Non-OADS,/arxiv_data1/oa_pdf/2a/d2/jove-98-52529.PMC4541485.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2015  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseApril 2015 |  98  | e52390 | Page 1 of 8Video Article Diffusion Imaging in the Rat Cervical Spinal Cord Elizabeth Zakszewski1, Brian Schmit2, Shekar Kurpad1, Matthew D. Budde1 1Department of Neurosurgery, Medical College of Wisconsin 2Department of Biomedical Engineering, Marquette University Correspondence to: Elizabeth Zakszewski at ezakszewski@mcw.edu URL: http://www.jove.com/video/52390 DOI: doi:10.3791/52390 Keywords: Neurobiology, Issue 98, spinal cord, magnetic resonance imaging, diffusion tensor imaging, respiratory gating, diffusion kurtosis imaging, rat, spine Date Published: 4/7/2015 Citation: Zakszewski, E., Schmit, B., Kurpad, S., Budde, M.D.",Non-OADS,/arxiv_data1/oa_pdf/03/c9/jove-98-52390.PMC4541495.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/52390/ Introduction Magnetic resonance imaging (MRI) is a noninvasive tool that provides a window into the brain and spinal cord in both health and disease.,Non-OADS,/arxiv_data1/oa_pdf/03/c9/jove-98-52390.PMC4541495.pdf
NOTE: Instructions for use of the command can be found at http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/TOPUP/TopupUsersGuide.,Non-OADS,/arxiv_data1/oa_pdf/03/c9/jove-98-52390.PMC4541495.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2015  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseApril 2015 |  98  | e52135 | Page 1 of 7Video Article Optimizing Attachment of Human Mesenchymal Stem Cells on Poly(ε- caprolactone) Electrospun Yarns Lucy A. Bosworth1, Sarah R. Rathbone1, Sarah H. Cartmell1 1School of Materials, The University of Manchester Correspondence to: Sarah H. Cartmell at sarah.cartmell@manchester.ac.uk URL: http://www.jove.com/video/52135 DOI: doi:10.3791/52135 Keywords: Bioengineering, Issue 98, Human mesenchymal stem cells, Electrospinning, Cell seeding, Cell attachment, Scaffold, Rotary vessel bioreactor, Cell number, Cell DNA assay, SEM, Low binding well plate, Poly(ε-caprolactone), Electrospun yarn Date Published: 4/10/2015 Citation: Bosworth, L.A., Rathbone, S.R., Cartmell, S.H.",Non-OADS,/arxiv_data1/oa_pdf/a3/f4/jove-98-52135.PMC4541498.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/52135/ Introduction Scaffolds are routinely being developed and researched for biomaterial and tissue-engineering applications.,Non-OADS,/arxiv_data1/oa_pdf/a3/f4/jove-98-52135.PMC4541498.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/53/ec/dddt-9-4649.PMC4541538.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4649–4656Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4649Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9020 9Myofibrotic malformation vessels: unique  angiodysplasia toward the progression of  hemorrhoidal disease sheng-long li1,* Fang-Yan Jing1–3,* li-li Ma2,3 li-li guo2,3 Feng na2,3 sheng-li an4 Yan Ye5 Jun-Ming Yang1 Ming Bao1 Dong Kang1 Xiao-lan sun1 Y ong-Jian Deng2,3 1Department of Anorectal Surgery,   2Department of Pathology, Nanfang  hospital, 3Department of Pathology,   School of Basic Medical Sciences,   4Department of Biostatistics, Southern  Medical University, 5Department  of General Surgery, Xintang  hospital, Zengcheng, guangzhou,   People’s Republic of China *These authors contributed equally  to this workBackground:  The etiology and pathogenesis of hemorrhoids is unclear, although hemorrhoids  are a worldwide disease in men and women, with peak prevalence at 45–65 years of age.",Non-OADS,/arxiv_data1/oa_pdf/53/ec/dddt-9-4649.PMC4541538.pdf
"Neovasculature  in the expression of CD105 might contribute to the development of hemorrhoids.5  Underlying morphopathophysiological abnormalities require more understanding to correspondence: Yong-Jian Deng Department of Pathology, Nanfang  Hospital and School of Basic Medical  sciences, southern Medical University,  Guangzhou 510515, People’s Republic  of China Tel +86 20 6278 9372 Fax +86 20 6278 9372 email dengyj@smu.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Li et al Running head recto: Myofibrotic malformation vessels in hemorrhoids DOI: http://dx.doi.org/10.2147/DDDT.S90209",Non-OADS,/arxiv_data1/oa_pdf/53/ec/dddt-9-4649.PMC4541538.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/53/ec/dddt-9-4649.PMC4541538.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/53/ec/dddt-9-4649.PMC4541538.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2a/72/dddt-9-4599.PMC4541540.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4599–4611Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4599Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8539 9Relaxin inhibits cardiac fibrosis and endothelial– mesenchymal transition via the notch pathway X Zhou1 X chen2 JJ cai2 lZ chen3 Ys gong4 lX Wang5 Z gao1 hQ Zhang1 WJ huang1 h Zhou1 1Department of cardiology, The  First affiliated hospital of Wenzhou  Medical University, 2Wenzhou  Medical University, 3Department  of clinical laboratory, Wenzhou  central hospital, 4institute of  hypoxia Medicine, Wenzhou  Medical University, 5Department  of respiratory Medicine, Wenzhou  Medical University, Wenzhou,   People’s  republic of chinaBackground:  Relaxin (RLX) can prevent cardiac fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/2a/72/dddt-9-4599.PMC4541540.pdf
"Zeisberg et al first showed that cardiac fibrosis is associ - ated with the emergence of fibroblasts originating from endothelial cells, suggesting  an EndMT similar to events that occur during formation of the atrioventricular cushion  in the embryonic heart.3 Then it has also been reported that endothelial cell-derived  endothelin-1 promoted cardiac fibrosis via the EndMT in a streptozotocin-induced  diabetic mouse model.4 In the high-fat-fed apolipoprotein E knockout mice model,  it was demonstrated that inflammatory stress exacerbates the progression of cardiac correspondence: h Zhou Department of cardiology, The First  Affiliated Hospital of Wenzhou Medical  University, Ouhai region, Wenzhou  325000, Zhejiang, People’s republic of  china Tel +86 139 6880 1939 email wyzh66@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zhou et al Running head recto: Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition DOI: http://dx.doi.org/10.2147/DDDT.S85399",Non-OADS,/arxiv_data1/oa_pdf/2a/72/dddt-9-4599.PMC4541540.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/2a/72/dddt-9-4599.PMC4541540.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/72/dddt-9-4599.PMC4541540.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4a/2c/dddt-9-4587.PMC4541541.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 4587–4597Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4587Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7949 9Pooled post hoc analysis of population  pharmacokinetics of oxycodone and  acetaminophen following a single oral dose  of biphasic immediate-release/extended-release  oxycodone/acetaminophen tablets ryan M Franke T erri Morton Krishna Devarakonda Department of clinical Pharmacology,   Mallinckrodt Pharmaceuticals,   hazelwood, MO, UsaAbstract:  This analysis evaluated the single-dose population pharmacokinetics (PK) of  biphasic immediate-release (IR)/extended-release (ER) oxycodone (OC)/acetaminophen (APAP)  7.5/325 mg tablets administered under fasted conditions and the effects of a meal on their  single-dose population PK.",Non-OADS,/arxiv_data1/oa_pdf/4a/2c/dddt-9-4587.PMC4541541.pdf
"comJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Franke et al Running head recto: IR/ER oxycodone/acetaminophen population PK DOI: http://dx.doi.org/10.2147/DDDT.S79499",Non-OADS,/arxiv_data1/oa_pdf/4a/2c/dddt-9-4587.PMC4541541.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4a/2c/dddt-9-4587.PMC4541541.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/2c/dddt-9-4587.PMC4541541.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/bf/copd-10-1613.PMC4541542.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1613–1622International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1613OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8461 8VitalQPlus: a potential screening tool for early  diagnosis of COPD Chee Fai sui1 long Chiau Ming2,3 Chin Fen neoh2,4 Baharudin Ibrahim1 1school of Pharmaceutical  sciences, Universiti sains Malaysia,   Penang, 2Faculty of Pharmacy,   Universiti T eknologi M ara, 3Brain  Degeneration and Therapeutics  group, 4Collaborative Drug  Discovery research (CDDr) group,   Pharmaceutical and life sciences  (Pls) Community of research (Co re),   UiTM, selangor, MalaysiaBackground:  This study utilized a validated combination of a COPD Population Screener  (COPD-PS) questionnaire and a handheld spirometric device as a screening tool for patients  at high risk of COPD, such as smokers.",Non-OADS,/arxiv_data1/oa_pdf/09/bf/copd-10-1613.PMC4541542.pdf
"The prevalence of moderate-to-severe COPD in those patients 30 years  and above in Malaysia was projected to be 4.7% in 2003, which translates to 448,000  cases, but this figure is now expected to be larger due to population aging.2Correspondence: Baharudin Ibrahim J01 room 110, school of Pharmaceutical  sciences, Universiti sains Malaysia,  11800 UsM, Penang, Malaysia Tel +60 4653 3888 ext 5839 Fax +60 4657 0017 email baharudin.ibrahim@usm.m y Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Sui et al Running head recto: VitalQPlus: COPD screening tool DOI: http://dx.doi.org/10.2147/COPD.S84618",Non-OADS,/arxiv_data1/oa_pdf/09/bf/copd-10-1613.PMC4541542.pdf
Available  from: http://www.acadmed.org.my/index.cfm?&menuid =67.,OADS,/arxiv_data1/oa_pdf/09/bf/copd-10-1613.PMC4541542.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/09/bf/copd-10-1613.PMC4541542.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/bf/copd-10-1613.PMC4541542.pdf
Available from: http://www.pharmatimes.com/Article/14-11-12/ Pharmacy_COPD_screening_could_save_%C2%A3264m_a_year.,Non-OADS,/arxiv_data1/oa_pdf/09/bf/copd-10-1613.PMC4541542.pdf
Available from:  http://lungfoundation.com.au/pharmacy-screening-may-hold-the-key- to-better-results-for-copd-patients/.,Non-OADS,/arxiv_data1/oa_pdf/09/bf/copd-10-1613.PMC4541542.pdf
"Available from: http://www.seatca.org/dmdocuments/15_the_modus_ operandi_of_cigarette_smuggling_in_malaysia.pd f. Accessed Dec 12,  2014.",Non-OADS,/arxiv_data1/oa_pdf/09/bf/copd-10-1613.PMC4541542.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2d/e5/copd-10-1623.PMC4541543.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1623–1631International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1623OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8714 7Discrepancies between modified Medical Research  Council dyspnea score and COPD assessment  test score in patients with COPD Chin Kook Rhee1 Jin Woo Kim2 Y ong Il hwang3 Jin hwa lee4 Ki-Suck Jung3 Myung Goo Lee5 Kwang Ha Y oo6 Sang Haak Lee7 Kyeong-Cheol Shin8 Hyoung Kyu Y oon9 1Division of Pulmonary, allergy and Critical Care  Medicine, Department of Internal Medicine, Seoul  St Mary’s Hospital, College of Medicine, The  Catholic University of Korea, Seoul, 2Division of  Pulmonary and Critical Care Medicine, Department  of Internal Medicine, Uijeongbu St Mary’s Hospital,  College of Medicine, The Catholic University of  Korea, Uijeongbu, 3Division of Pulmonary, allergy  and Critical Care Medicine, Department of Internal  Medicine, Hallym University Medical Center, Hallym  University College of Medicine, Anyang, 4Division of  Pulmonary and Critical Care Medicine, Department  of Internal Medicine, School of Medicine, Ewha  Womans University, Seoul, 5Division of Pulmonary,  Allergy and Critical Care Medicine, Department of  Internal Medicine, Hallym University Chuncheon  Sacred Heart Hospital, Hallym University College  of Medicine, Chuncheon, 6Division of Pulmonary,  Allergy and Critical Care Medicine, Department  of Internal Medicine, Konkuk University School  of Medicine, Seoul, 7Division of Pulmonary and  Critical Care Medicine, Department of Internal  Medicine, St Paul’s Hospital, College of Medicine,  The Catholic University of Korea, Seoul, 8regional  Center for respiratory Disease, Yeungnam  University Medical Center, Yeungnam University  College of Medicine, Daegu, 9Division of Pulmonary  and Critical Care Medicine, Department of Internal  Medicine, Yeouido St Mary’s Hospital, College of  Medicine, The Catholic University of Korea, Seoul,  Republic of KoreaBackground and objective:  According to the Global Initiative for Chronic Obstructive Lung  Disease (GOLD) guidelines, either a modified Medical Research Council (mMRC) dyspnea  score of $2 or a chronic obstructive pulmonary disease (COPD) assessment test (CAT) score  of $10 is considered to represent COPD patients who are more symptomatic.",Non-OADS,/arxiv_data1/oa_pdf/2d/e5/copd-10-1623.PMC4541543.pdf
"Keywords:  COPD, CAT, mMRC, concordance, discrepancy Introduction In the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) guide - lines, the patients’ symptoms can be assessed by either the modified Medical Research  Council (mMRC) dyspnea score or the chronic obstructive pulmonary disease (COPD)  assessment test (CAT) score.1 MRC was developed to help physicians establish clinical  grades of breathlessness for their patients with emphysema.2,3 A modified version of  this scale is used today and is based on five stages of breathlessness due to exertion.3,4  mMRC was well correlated with dyspnea index and lung function.4 The CAT is an  eight-item unidimensional measure of health status impairment in COPD.5,6 It was well  correlated with St George’s Respiratory Questionnaire for COPD patients (SGRQ-C)5  and provided a surprising insight into the severity of the effects of COPD.7 CAT score  was developed to be applicable worldwide and validated translations are available in  a wide range of languages.6Correspondence: Hyoung Kyu Yoon Division of Pulmonary and Critical Care Medicine,  Department of Internal Medicine, Yeouido St Mary’s  Hospital, College of Medicine, The Catholic University  of Korea, #62, Youido-dong, Youngdungpo-ku, Seoul,  150-713, Republic of Korea Tel +82 2 3779 2213 Fax +82 2 780 3132 email cmcyhg@catholic.ac.k r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Rhee et al Running head recto: Discrepancies between CAT and mMRC DOI: http://dx.doi.org/10.2147/COPD.S87147",Non-OADS,/arxiv_data1/oa_pdf/2d/e5/copd-10-1623.PMC4541543.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/2d/e5/copd-10-1623.PMC4541543.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/e5/copd-10-1623.PMC4541543.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/b4/dddt-9-4631.PMC4541544.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4631–4638Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4631Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8618 4PTEN insufficiency modulates ER + breast cancer  cell cycle progression and increases cell growth  in vitro and in vivo Kun-chun chiang1,4 huang-Yang chen1 shu-Yuan hsu2 Jong-hwei s Pang3 shang-Yu Wang4 Jun-T e hsu4 Ta-sen Yeh4 li-Wei chen5 sheng-Fong Kuo6 chi-chin sun7 Jim-Ming lee1 chun-n an Yeh4 horng-heng Juang2 1Department of general surgery,   chang gung Memorial hospital,   chang gung University, Keelung,   2Department of anatomy, 3graduate  institute of clinical Medical sciences,   4Department of general surgery,   5Department of gastroenterology,   6Department of endocrinology  and Metabolism, 7Department of  Ophthalmology, chang gung Memorial  hospital, chang gung University,   Keelung, Taiwan, republic of chinaAbstract:  Phosphatase and tensin homolog (PTEN), a well-known tumor suppressor gene  and frequently mutated or lost in breast cancer, possesses the negative regulation function over  the PI3K/Akt/mTOR pathway.",Non-OADS,/arxiv_data1/oa_pdf/e8/b4/dddt-9-4631.PMC4541544.pdf
"Phosphatase and tensin homolog (PTEN) deleted on chromosome 10 is well  identified as a tumor suppressor gene and found frequently mutated or deleted in a  variety of cancers, such as endometrial cancer, prostate cancer, small-cell lung can - cer, etc.5 For breast cancer, PTEN loss or mutation is found in a percentage of 13%,  24%, and 35% for luminal A, luminal B, and basal-like breast cancers, respectively.6  Clinically, PTEN loss has been linked to brain metastasis in breast cancer patients.7  PTEN promoter variations have also been shown to influence breast cancer recurrence  and patient survival.8 Depowski et al  also demonstrated that PTEN insufficiency was  linked with breast cancer poor prognosis.9 Further, for Her2-positive breast cancer  patients with recurrent or metastatic disease, PTEN loss might be a predictor for the  resistance of trastuzumab-based salvage treatment.10correspondence: horng-heng Juang Department of anatomy, chang gung  University, 259 Wen-hua 1st road,  Kwei-shan, Taoyuan 333, Taiwan,  republic of china Tel +886 3 2118800 Fax +886 3 2118112 email hhj143@mail.cgu.edu.t w  chun-nan Yeh general surgery Department, chang  gung Memorial hospital, 5, Fu-hsing  street, Kwei-shan, Taoyuan 333,  Taiwan, republic of china Tel +886 3 3281200 3219 Fax +886 3 328581 email yehchunnan@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Chiang et al Running head recto: PTEN insufficiency increases breast cancer growth DOI: http://dx.doi.org/10.2147/DDDT.S86184",Non-OADS,/arxiv_data1/oa_pdf/e8/b4/dddt-9-4631.PMC4541544.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e8/b4/dddt-9-4631.PMC4541544.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/b4/dddt-9-4631.PMC4541544.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/d7/copd-10-1599.PMC4541545.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1599–1612International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1599OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8126 6safety of inhaled glycopyrronium in patients with   COPD: a comprehensive analysis of clinical studies  and post-marketing data anthony D D’Urzo1 edward M Kerwin2 Kenneth r Chapman3 Marc Decramer4 robert Digiovanni5 Peter D’andrea6 huilin hu6 Pankaj goyal5 Pablo altman6 1Department of Family and  Community Medicine, University  of T oronto, T oronto, On , Canada;   2Clinical research Institute of  southern Oregon, PC, Medford,   Usa; 3asthma and airway Centre,   University health network, T oronto  Western hospital, T oronto, On ,   Canada; 4respiratory Division,   University of leuven, leuven,   Belgium; 5novartis Pharma ag,   Basel, switzerland; 6novartis  Pharmaceuticals Corporation, east  hanover, nJ, UsaBackground:  Chronic use of inhaled anticholinergics by patients with chronic obstructive  pulmonary disease (COPD) has raised long-term safety concerns, particularly cardiovascular.",Non-OADS,/arxiv_data1/oa_pdf/f3/d7/copd-10-1599.PMC4541545.pdf
"Keywords:  COPD, drug safety, glycopyrronium, post-marketing surveillance Introduction Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation  that is not only progressive but also irreversible.1 Inhaled bronchodilators are regarded  as foundational pharmacologic agents in the management of patients with COPD, pro - viding not only short-term symptom relief but also reducing the exacerbation frequency  and improving the quality of life.1 Long-acting muscarinic antagonists (LAMAs) (either  alone or in combination with β-agonists) have been found to be effective bronchodilators  for the treatment of patients with COPD.1 LAMAs may produce typical anticholinergic  side effects such as dry mouth, urinary retention, constipation, and nausea.2 Inhaled  tiotropium administered via soft mist inhaler at moderate and high dosages has been Correspondence: anthony D D’Urzo Department of Family and Community  Medicine, University of Toronto,  1670 Dufferin street, suite 107,   Toronto, On M6h3M2, Canada   Tel +1 41 6652 9336   Fax +1 41 6652 0218   email tonydurzo@sympatico.c a Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: D’Urzo et al Running head recto: Comprehensive safety analysis of glycopyrronium DOI: http://dx.doi.org/10.2147/COPD.S81266",Non-OADS,/arxiv_data1/oa_pdf/f3/d7/copd-10-1599.PMC4541545.pdf
He is  participating in research funded by the Canadian Institutes  of Health Research operating grant entitled: Canadian  Cohort Obstructive Lung Disease ( http://clinicaltrials.gov  -  NCT0092034 8).,Non-OADS,/arxiv_data1/oa_pdf/f3/d7/copd-10-1599.PMC4541545.pdf
Available from: http://www.goldcopd.or g/.,Non-OADS,/arxiv_data1/oa_pdf/f3/d7/copd-10-1599.PMC4541545.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f3/d7/copd-10-1599.PMC4541545.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/d7/copd-10-1599.PMC4541545.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/06/dddt-9-4613.PMC4541546.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4613–4620Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4613Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8599 3RGD-modified liposomes enhance efficiency  of aclacinomycin A delivery: evaluation of their  effect in lung cancer chan Feng1,* Xiaoyan li2,* chunyan Dong1 Xuemei Zhang1 Xie Zhang1 Y ong gao1 1Department of Oncology, Shanghai  east hospital, T ongji University,   shanghai, 2shanghai T enth People’s  hospital, T ongji University, shanghai,   People’s Republic of China *These authors contributed equally  to this workAbstract:  In this study, long-circulating Arg-Gly-Asp (RGD)-modified aclacinomycin A  (ACM) liposomes were prepared by thin film hydration method.",Non-OADS,/arxiv_data1/oa_pdf/37/06/dddt-9-4613.PMC4541546.pdf
"It is widely believed that tumor growth, invasion, and metastasis  occurs as a result of angiogenesis, and that if the blood vessels feeding the tumor are  inadequate, the tumor would become necrotic or apoptotic.6 Meanwhile, research correspondence: chunyan Dong shanghai east international Medical  center, 150 Jimo road, shanghai,  People’s Republic of China email chunyan_dong@yeah.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Feng et al Running head recto: RGD-modified aclacinomycin A liposomes in lung cancer DOI: http://dx.doi.org/10.2147/DDDT.S85993",Non-OADS,/arxiv_data1/oa_pdf/37/06/dddt-9-4613.PMC4541546.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/37/06/dddt-9-4613.PMC4541546.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/06/dddt-9-4613.PMC4541546.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2014 |  92  | e51638 | Page 1 of 8Video Article Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma Ayman I. Omar1 1Southern Illinois University School of Medicine Correspondence to: Ayman I. Omar at braindr11@yahoo.com URL: http://www.jove.com/video/51638 DOI: doi:10.3791/51638 Keywords: Medicine, Issue 92, Tumor Treating Fields, TTF System, TTF Therapy, Recurrent Glioblastoma, Bevacizumab, Brain Tumor Date Published: 10/27/2014 Citation: Omar, A.I.",Non-OADS,/arxiv_data1/oa_pdf/c8/d6/jove-92-51638.PMC4541554.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51638/ Introduction This novel TTF system is an FDA approved device that delivers intermediate frequency, low intensity alternating electric field directly to the brain for the treatment of recurrent glioblastomas1.",Non-OADS,/arxiv_data1/oa_pdf/c8/d6/jove-92-51638.PMC4541554.pdf
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/ cftopic/pma/pma.cfm?num=p100034 .,OADS,/arxiv_data1/oa_pdf/c8/d6/jove-92-51638.PMC4541554.pdf
http://www.cbtrus.org/2012-NPCR-SEER/CBTRUS_Report_2004-2008_3-23-2012.pdf (2012).,OADS,/arxiv_data1/oa_pdf/c8/d6/jove-92-51638.PMC4541554.pdf
http://www.cancer.gov/ clinicaltrials/search/view?cdrid=647437&version=HealthProfessional.,Non-OADS,/arxiv_data1/oa_pdf/c8/d6/jove-92-51638.PMC4541554.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1e/a8/cia-10-1319.PMC4541555.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1319–1326Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1319OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7939 8Association between physiological falls risk and   physical performance tests among community- dwelling older adults Devinder KA singh1 sharmila gK Pillai1 sin Thien Tan1 Chu Chiau Tai1 suzana shahar2 1Physiotherapy Programme, school  of rehabilitation sciences, 2nutrition  and Dietetics Programme, school of  healthcare sciences, Faculty of health  sciences, Universiti Kebangsaan  Malaysia, Jalan raja Muda Abdul Aziz,   Kuala lumpur, MalaysiaBackground:  Physical performance and balance declines with aging and may lead to increased  risk of falls.",Non-OADS,/arxiv_data1/oa_pdf/1e/a8/cia-10-1319.PMC4541555.pdf
"It is estimated  that approximately 13% of the 7 billion people worldwide are older adults aged 60 years  and above.1 This number is expected to increase in proportion to 21% in the year 2050.1  Malaysia faces a similar phenomenon with an estimated 7% out of 28 million population  consisting of older adults aged 60 years and above.2 By year 2035, this number is expected  to rise to 15%, and this is likely to gain Malaysia the status of an aging nation.3Correspondence: Devinder Kaur Ajit  singh Physiotherapy Programme, school of  rehabilitation sciences, Faculty of health  sciences, Universiti Kebangsaan Malaysia,  Jalan raja Muda Abdul Aziz, 50300,  Kuala lumpur, Malaysia Tel +60 3 2687 8025/8003 Fax +60 3 2687 8199 email devinderkas@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Singh et al Running head recto: Physical performance test to measure physiological falls risk DOI: http://dx.doi.org/10.2147/CIA.S79398",Non-OADS,/arxiv_data1/oa_pdf/1e/a8/cia-10-1319.PMC4541555.pdf
Available  from https://www.statistics.gov.my /.,OADS,/arxiv_data1/oa_pdf/1e/a8/cia-10-1319.PMC4541555.pdf
"Avail - able from: http://thestar.com.my/lifestyle/story.asp?file =/2010/10/25/ lifefocus/6865382&sec =lifefocu s. Accessed June 14, 2012.",Non-OADS,/arxiv_data1/oa_pdf/1e/a8/cia-10-1319.PMC4541555.pdf
Available  from: http://www.rehabmeasures.org/Lists/RehabMeasures/DispFor m. aspx?ID=1052.,Non-OADS,/arxiv_data1/oa_pdf/1e/a8/cia-10-1319.PMC4541555.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/1e/a8/cia-10-1319.PMC4541555.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/1e/a8/cia-10-1319.PMC4541555.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d7/7b/cia-10-1327.PMC4541557.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDove press submit your manuscript | www.dovepress.co m Dove press  1327Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CIA.S8622 9clinical interventions in aging 2015:10 1327–1334Clinical Interventions in Aging comparison of hydration and nutritional status  between young and elderly hemodialysis patients  through bioimpedance analysis Jung eun lee1,2 in Y oung Jo3 song Mi lee3 Woo Jeong Kim3 hoon Y oung choi2,4 sung Kyu ha4 hyung Jong Kim5 hyeong cheon Park2,4 1Department of internal Medicine,   Y ongin severance hospital, Y onsei  University college of Medicine,   2severance institute for Vascular and  Metabolic research, Y onsei University  college of Medicine, 3Department  of nutrition services, gangnam  severance hospital, 4Department of  internal Medicine, gangnam severance  hospital, Y onsei University college  of Medicine, seoul, 5Department of  internal Medicine, cha  Bundang  Medical center, cha University,   seongnam, KoreaBackground:  The number of elderly people on dialysis is increasing rapidly.",Non-OADS,/arxiv_data1/oa_pdf/d7/7b/cia-10-1327.PMC4541557.pdf
"Keywords:  fluid overload, malnutrition, hemodialysis, elderly patients, body composition Introduction Elderly patients account for an increasing proportion of patients on renal replace - ment therapy worldwide.1 Therefore, there has been a growing interest in elderly correspondence: hyeong cheon Park Department of internal Medicine,  gangnam severance hospital,  Yonsei University college of Medicine,  211 eonju-ro, gangnam-gu, seoul,  135-720, Korea Tel +82 2 2019 3310 Fax +82 2 3463 3882  email amp97@yuhs.a c  hyung Jong Kim Department of internal Medicine,  Bundang cha Medical center, cha  University, 59 Yatap-ro, Bundang-gu,  seongnam-si, gyeonggi-do, 463-712,  Korea Tel +82 31 780 5895 Fax +82 31 780 5981 email khj04@cha.ac.k r Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Lee et al Running head recto: Hydration and nutritional status in elderly hemodialysis patients DOI: http://dx.doi.org/10.2147/CIA.S86229",Non-OADS,/arxiv_data1/oa_pdf/d7/7b/cia-10-1327.PMC4541557.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/d7/7b/cia-10-1327.PMC4541557.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d7/7b/cia-10-1327.PMC4541557.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0b/ad/dddt-9-4621.PMC4541558.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4621–4629Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4621Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8641 5Pharmacokinetics and bioavailability study of  two ondansetron oral soluble film formulations  in fasting healthy male chinese volunteers Yubing Zhu1 Qian Zhang1 Jianjun Zou2 Meng Wan1 Zheng Zhao1 Junrong Zhu1 1Department of Pharmacy,   2laboratory of clinical Pharmacology,   nanjing First hospital, nanjing  Medical University, nanjing, Jiangsu,   People’s republic of chinaBackground:  Ondansetron oral soluble film is designed to be applied on top of the tongue  without requiring water to aid dissolution or swallowing, which is especially fitting for nausea  and vomiting patients.",Non-OADS,/arxiv_data1/oa_pdf/0b/ad/dddt-9-4621.PMC4541558.pdf
"Intravenous administration of medications was often limited with  complications such as phlebitis, infiltration, extravasation, and infections.3 Although  traditional oral formulations can be self-administered, it is not always possible if a correspondence: Qian Zhang nanjing First hospital, nanjing Medical  University, nanjing, Jiangsu 210006,  People’s republic of china Tel +86 25 8772 6280 Fax +86 25 8772 6287 email zhangq0619@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zhu et al Running head recto: Bioequivalence study of two ondansetron oral soluble film formulations DOI: http://dx.doi.org/10.2147/DDDT.S86415",Non-OADS,/arxiv_data1/oa_pdf/0b/ad/dddt-9-4621.PMC4541558.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/0b/ad/dddt-9-4621.PMC4541558.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/ad/dddt-9-4621.PMC4541558.pdf
Available from: http://www.wma.net/en/30publications/10policies/ b3/index.htm l 7. International Conference on Harmonisation Expert Working Group.,Non-OADS,/arxiv_data1/oa_pdf/0b/ad/dddt-9-4621.PMC4541558.pdf
Available from: http://www.fda.gov/downloads/ ICECI/EnforcementActions/BioresearchMonitoring/UCM133760.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0b/ad/dddt-9-4621.PMC4541558.pdf
Available from: http://www.fda.gov/ora/ complianceref/bimo/7348_001/default.htm.,Non-OADS,/arxiv_data1/oa_pdf/0b/ad/dddt-9-4621.PMC4541558.pdf
Available from: http://www.fda.gov/cder/guidance/4252fnl.htm  13.,Non-OADS,/arxiv_data1/oa_pdf/0b/ad/dddt-9-4621.PMC4541558.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/86/71/dmso-8-363.PMC4541559.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 363–386Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  363Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S3441 8A novel, long-acting glucagon-like peptide  receptor-agonist: dulaglutide Tara Gurung1 Deepson S Shyangdan1 Joseph Paul O’Hare2 Norman waugh1 1warwick evidence, 2Division of  Metabolic and vascular Health,   warwick Medical School, University  of warwick, Coventry, UK Correspondence: Tara Gurung   warwick evidence, warwick Medical  School, University of warwick, Gibbet  Hill Road, Coventry Cv4 7AL, UK   Tel +44 24 7615 0711   email t.gurung@warwick.ac.u kBackground:  Dulaglutide is a new, long-acting glucagon-like peptide analogue in the treatment  of type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/86/71/dmso-8-363.PMC4541559.pdf
On-going trials Searches for ongoing trials on https://clinicaltrials.go v  showed a number of on-going studies.,Non-OADS,/arxiv_data1/oa_pdf/86/71/dmso-8-363.PMC4541559.pdf
"Available from: http://www.idf.org/diabetesatla s.  Accessed December 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/86/71/dmso-8-363.PMC4541559.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Public_assessment_report/human/002825/ WC500179473.pd f. Accessed January 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/86/71/dmso-8-363.PMC4541559.pdf
Available from: https://investor.lilly.com/releasedetail.,Non-OADS,/arxiv_data1/oa_pdf/86/71/dmso-8-363.PMC4541559.pdf
Available from: http://www.nice.org.uk/guidance/cg6 6.,Non-OADS,/arxiv_data1/oa_pdf/86/71/dmso-8-363.PMC4541559.pdf
"Available from: http://www.sign.ac.uk/pdf/sign116.pd f.  Accessed December 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/86/71/dmso-8-363.PMC4541559.pdf
Available from: http://www.nice.org.uk/Guid - ance/InDevelopment/GID-CGWA VE061 2.,Non-OADS,/arxiv_data1/oa_pdf/86/71/dmso-8-363.PMC4541559.pdf
Available from: https://clinicaltrials.go v/ct2/show/ NCT01075282?term =NCT01075282&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/86/71/dmso-8-363.PMC4541559.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/86/71/dmso-8-363.PMC4541559.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/71/dmso-8-363.PMC4541559.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/99/dddt-9-4657.PMC4541560.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4657–4667Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4657Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8552 4epidural injections with or without steroids in   managing chronic low back pain secondary to   lumbar spinal stenosis: a meta-analysis of   13 randomized controlled trials Hai Meng Qi Fei Bingqiang wang Y ong Yang Dong Li Jinjun Li Nan Su Department of Orthopedics,   Beijing  Friendship  Hospital,  Capital  Medical University, Beijing, People’s  Republic of ChinaBackground:  Epidural injections of anesthetic with or without steroids are widely used for  treating lumbar spinal stenosis, a common cause of chronic low back pain, but there is a lack of  rigorous data comparing the effectiveness of epidural injections of anesthetic with and without  steroids.",Non-OADS,/arxiv_data1/oa_pdf/f7/99/dddt-9-4657.PMC4541560.pdf
"Keywords:  chronic low back pain, spinal stenosis, epidural injections, steroids, local  anesthetics Introduction Spinal stenosis is defined as a narrowing of spinal canal with encroachment on the  neural structures by surrounding bone and soft issue.1 In the Framingham Study,  prevalence of symptomatic lumbar spinal stenosis was estimated to be 27.2%.2 The  three most common causes of low back and leg pain are spinal stenosis, disc hernia - tion, and degenerative spondylolisthesis, for which surgery is usually performed.1,3–5  Moreover, in patients older than 65 years, lumbar spinal stenosis has been regarded as  the most frequent indication for spinal surgery.4–6 Numerous modalities of treatment, Correspondence: Nan Su Department of Orthopedics,  Beijing Friendship Hospital, Capital  Medical University, No 95, Yong’an Road,  Xicheng District, Beijing 100050, People’s  Republic of China Tel +86 13 8101 48569 email 898988619@qq.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Meng et al Running head recto: Steroids in managing chronic low back pain DOI: http://dx.doi.org/10.2147/DDDT.S85524",Non-OADS,/arxiv_data1/oa_pdf/f7/99/dddt-9-4657.PMC4541560.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f7/99/dddt-9-4657.PMC4541560.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/99/dddt-9-4657.PMC4541560.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/bf/cia-10-1311.PMC4541561.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1311–1318Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1311OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8880 5safety and feasibility of biventricular devices reuse  in general and elderly population – a single-center  retrospective cohort study Raluca Şoşdean1,2 Cristian Mornoş1,2 Bogdan enache1,2 Răzvan I Macarie2 Raluca Ianoş2 Ana-Maria Ştefea2 sorin Pescariu1,2 1Department of Cardiology, “Victor  Babeş” University of Medicine and  Pharmacy, 2Cardiology Clinic, Institute  of Cardiovascular Medicine, Timişoara,   romaniaIntroduction:  Cardiac resynchronization therapy (CRT) is known to have very important  beneficial effects on heart failure patients.",Non-OADS,/arxiv_data1/oa_pdf/5c/bf/cia-10-1311.PMC4541561.pdf
"It is proven to regress  the left ventricle’s pathological remodeling, reduce the degree of mitral regurgitation  if present, increase the left ventricle’s ejection fraction, ameliorate the patient’s clinical  status, increase the quality of life, and decrease heart failure hospitalization rate as well  as the mortality.1 The most representative clinical trials showed this therapy to reduce  all-cause mortality by 28% and new heart failure hospitalizations by 37% for these Correspondence: sorin Pescariu Cardiology Clinic, Institute of  Cardiovascular Medicine, 13A, gheorghe  Adam Street, Timişoara 300310, Romania Tel +40 256 207 355 Fax +40 256 207 362 email sorinpescariu@yahoo.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Şoşdean et al Running head recto: Biventricular cardiac device reuse DOI: http://dx.doi.org/10.2147/CIA.S88805",Non-OADS,/arxiv_data1/oa_pdf/5c/bf/cia-10-1311.PMC4541561.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/5c/bf/cia-10-1311.PMC4541561.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/5c/bf/cia-10-1311.PMC4541561.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2015  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseApril 2015 |  98  | e52410 | Page 1 of 7Video Article Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes Lara Stevanato1, Caroline Hicks1, John D. Sinden1 1ReNeuron Correspondence to: Lara Stevanato at lara-stevanato@reneuron.com URL: http://www.jove.com/video/52410 DOI: doi:10.3791/52410 Keywords: Developmental Biology, Issue 98, Clinical grade neural stem cells, miRNA profiling and effects, in vitro differentiation, three dimensional culture Date Published: 4/12/2015 Citation: Stevanato, L., Hicks, C., Sinden, J.D.",Non-OADS,/arxiv_data1/oa_pdf/02/ef/jove-98-52410.PMC4541566.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/52410/ Introduction Stem cell research plays a central role in regenerative medicine, which also spans the disciplines of tissue engineering, developmental cell biology, cellular therapeutics, gene therapy, and biomaterials (scaffolds and matrices).",Non-OADS,/arxiv_data1/oa_pdf/02/ef/jove-98-52410.PMC4541566.pdf
"3.1) Computational Analysis for miRNA Target Prediction 1.Browse PicTar (http://pictar.mdc-berlin.de/)21, online available algorithm for the identification of miRNA target prediction mRNAs.",OADS,/arxiv_data1/oa_pdf/02/ef/jove-98-52410.PMC4541566.pdf
"5.Similarly retrieve list of target mRNAs using DIANA-LAB ( http://diana.cslab.ece.ntua.gr/microT/ )23, and TargetScan (http:// www.targetscan.org/)24, alternative on line available algorithms.",OADS,/arxiv_data1/oa_pdf/02/ef/jove-98-52410.PMC4541566.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2015  Creative Commons Attribution-NonCommercial License April 2015 |  98  | e52645 | Page 1 of 6Video Article Dyeing Insects for Behavioral Assays: the Mating Behavior of Anesthetized Drosophila Rudi L. Verspoor1, Chloe Heys1, Thomas A. R. Price1 1Institute of Integrative Biology, University of Liverpool Correspondence to: Thomas A. R. Price at T.Price@liverpool.ac.uk URL: http://www.jove.com/video/52645 DOI: doi:10.3791/52645 Keywords: Neuroscience, Issue 98, Anesthesia, courtship, fruit fly, individual marking, individual tagging, male-male competition, mate choice, mate competition, mating latency, wing clipping Date Published: 4/22/2015 Citation: Verspoor, R.L., Heys, C., Price, T.A.R.",Non-OADS,/arxiv_data1/oa_pdf/50/50/jove-98-52645.PMC4541581.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/52645/ Introduction Over the last few decades there has been increasing interest in how sexual selection and competition between males impact on evolution1,2.",Non-OADS,/arxiv_data1/oa_pdf/50/50/jove-98-52645.PMC4541581.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2015  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseApril 2015 |  98  | e52526 | Page 1 of 11Video Article The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture Eva-Maria Materne*1, Ilka Maschmeyer*1,2, Alexandra K. Lorenz1, Reyk Horland1,2, Katharina M. S. Schimek1, Mathias Busek3, Frank Sonntag3, Roland Lauster1, Uwe Marx1,2 1Medical Biotechnology, Technische Universität Berlin 2TissUse GmbH 3Fraunhofer IWS *These authors contributed equally Correspondence to: Eva-Maria Materne at eva-maria.materne@tu-berlin.de URL: http://www.jove.com/video/52526 DOI: doi:10.3791/52526 Keywords: Bioengineering, Issue 98, Multi-organ chip, human-on-a-chip, body-on-a-chip, organs-on-a-chip, microphysiological systems, organoids, tissue engineering, in vitro  substance testing, toxicity test, liver, skin, vasculature Date Published: 4/28/2015 Citation: Materne, E.M., Maschmeyer, I., Lorenz, A.K., Horland, R., Schimek, K.M.S., Busek, M., Sonntag, F., Lauster, R., Marx, U.",Non-OADS,/arxiv_data1/oa_pdf/83/38/jove-98-52526.PMC4541596.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/52526/ Introduction Current monolayer or suspension cell culture assays for drug development are failing to emulate the human cellular microenvironment and, therefore, lead to a rapid dedifferentiation and loss of function in primary human cell cultures.",Non-OADS,/arxiv_data1/oa_pdf/83/38/jove-98-52526.PMC4541596.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2015  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseApril 2015 |  98  | e52318 | Page 1 of 6Video Article Calibrated Forceps Model of Spinal Cord Compression Injury Ashley McDonough*1,2, Angela Monterrubio*1,2, Jeanelle Ariza1,2, Verónica Martínez-Cerdeño1,2 1Department of Pathology and Laboratory Medicine, University of California, Davis 2Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children (Northern California) *These authors contributed equally Correspondence to: Verónica Martínez-Cerdeño at vmartinezcerdeno@ucdavis.edu URL: http://www.jove.com/video/52318 DOI: doi:10.3791/52318 Keywords: Medicine, Issue 98, SCI, compression model, compression injury, modified forceps, laminectomy, neurological deficit, murine spinal cord, reproducible animal model, reproducible deficit Date Published: 4/24/2015 Citation: McDonough, A., Monterrubio, A., Ariza, J., Martínez-Cerdeño, V. Calibrated Forceps Model of Spinal Cord Compression Injury.",Non-OADS,/arxiv_data1/oa_pdf/34/16/jove-98-52318.PMC4541603.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/52318/ Introduction Animal models of SCI are valuable tools for assessing the efficacy of therapeutic paradigms designed to mitigate damage as a consequence of trauma to the spinal cord.,Non-OADS,/arxiv_data1/oa_pdf/34/16/jove-98-52318.PMC4541603.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2015  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMay 2015 |  99  | e52798 | Page 1 of 7Video Article Assessment of Social Cognition in Non-human Primates Using a Network of Computerized Automated Learning Device (ALDM) Test Systems Joël Fagot1, Yousri Marzouki1, Pascal Huguet1, Julie Gullstrand1, Nicolas Claidière1 1CNRS, Federation 3C, and Laboratory of Cognitive Psychology, Aix-Marseille University Correspondence to: Joël Fagot at joel.fagot@univ-amu.fr URL: http://www.jove.com/video/52798 DOI: doi:10.3791/52798 Keywords: Behavior, Issue 99, Baboon, automated learning device, cultural transmission, emotion, social facilitation, cognition, operant conditioning.",Non-OADS,/arxiv_data1/oa_pdf/1a/2f/jove-99-52798.PMC4541642.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/52798/ Introduction Experimental laboratory investigations of primate cognition have almost systematically favored the test of isolated animals4, depending on the issue tackled.",Non-OADS,/arxiv_data1/oa_pdf/1a/2f/jove-99-52798.PMC4541642.pdf
"To  Sir Leonard Rogers, in the first place, we owe the basis of treat -The First Fellow of American College of Surgeons   to Come to Korea: Dr. Alfred Irving Ludlow   Choong Bai Kim Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.Yonsei Med J 2015 Sep;56(5):1171-1173 http://dx.doi.org/10.3349/ymj.2015.56.5.1171Editorial pISSN: 0513-5796 · eISSN: 1976-2437 Received:  May 13, 2015 Corresponding author:  Dr. Choong Bai Kim, Department of Surgery, Yonsei Uni - versity College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/5d/04/ymj-56-1171.PMC4541643.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Editorial Series: Frontiers of Medicine in Korea",Non-OADS,/arxiv_data1/oa_pdf/5d/04/ymj-56-1171.PMC4541643.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1171 1172The First Modern Surgery in Korea ment with emetin salts.,Non-OADS,/arxiv_data1/oa_pdf/5d/04/ymj-56-1171.PMC4541643.pdf
1173 http://dx.doi.org/10.3349/ymj.2015.56.5.1171Choong Bai Kim Medical Board decided to support the rebuilding of Severance  Hospital and its Medical School.,Non-OADS,/arxiv_data1/oa_pdf/5d/04/ymj-56-1171.PMC4541643.pdf
"To pre - vent recurrence of a similar situation, we should not only seek An Outbreak of Middle East Respiratory Syndrome  Coronavirus Infection in South Korea, 2015 Jun Yong Choi Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.Yonsei Med J 2015 Sep;56(5):1174-1176 http://dx.doi.org/10.3349/ymj.2015.56.5.1174Editorial pISSN: 0513-5796 · eISSN: 1976-2437 Received:  July 7, 2015 Corresponding author:  Dr. Jun Yong Choi, Department of Internal Medicine, Yon - sei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/46/7d/ymj-56-1174.PMC4541644.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/7d/ymj-56-1174.PMC4541644.pdf
"1175 http://dx.doi.org/10.3349/ymj.2015.56.5.1174Jun Yong Choi to improve and strengthen such systems and measures, but  also to develop trained experts and proper facilities.",Non-OADS,/arxiv_data1/oa_pdf/46/7d/ymj-56-1174.PMC4541644.pdf
Available at: http://www.mw.go.kr/front_ new/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ ID=0403&page=1&CONT_SEQ=324338.,Non-OADS,/arxiv_data1/oa_pdf/46/7d/ymj-56-1174.PMC4541644.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1174 1176MERS Outbreak in Korea care-associated Infection Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/46/7d/ymj-56-1174.PMC4541644.pdf
Available at: http://www.who.int/csr/ don/24-may-2015-mers-korea/en/.,Non-OADS,/arxiv_data1/oa_pdf/46/7d/ymj-56-1174.PMC4541644.pdf
Available at: http://www.wpro.who.int/mediacentre/releas - es/2015/20150613/en/.,Non-OADS,/arxiv_data1/oa_pdf/46/7d/ymj-56-1174.PMC4541644.pdf
"Key Words:   Gastric cancer, precision medicine, treatment Yonsei Med J 2015 Sep;56(5):1177-1185 http://dx.doi.org/10.3349/ymj.2015.56.5.1177Review Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  May 25, 2015  Corresponding author:  Dr. Jae-Ho Cheong, Department of Surgery, Yonsei Uni - versity College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4e/a3/ymj-56-1177.PMC4541645.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Although the overall incidence of gastric cancer has been de - creasing, it is still one of the most common malignances and  the leading cause of cancer-related death worldwide: there  were almost 1000000 new cases and over 720000 deaths in  2012.1 Geographically, nearly two-thirds of cases are concen - trated in Eastern Asia, especially, Korea, Japan, and China.",Non-OADS,/arxiv_data1/oa_pdf/4e/a3/ymj-56-1177.PMC4541645.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1177 1178Evolution of Gastric Cancer Treatment the future direction of gastric cancer treatment and translation - al research.,Non-OADS,/arxiv_data1/oa_pdf/4e/a3/ymj-56-1177.PMC4541645.pdf
"1179 http://dx.doi.org/10.3349/ymj.2015.56.5.1177Yoon Young Choi, et al.",OADS,/arxiv_data1/oa_pdf/4e/a3/ymj-56-1177.PMC4541645.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1177 1180Evolution of Gastric Cancer Treatment Based on the lessons learned from both Japanese trials, a new  phase III clinical trial (SENORITA trial, NCT01804998) of using  both Tc 99m and indocyanine green injection around tumors  through intra-operative endoscopy was initiated in Korea after  a quality control study (NCT01544413).55 The result of this trial  will guide the possibility of tailored and limited surgery for  EGC.",Non-OADS,/arxiv_data1/oa_pdf/4e/a3/ymj-56-1177.PMC4541645.pdf
"1181 http://dx.doi.org/10.3349/ymj.2015.56.5.1177Yoon Young Choi, et al.",OADS,/arxiv_data1/oa_pdf/4e/a3/ymj-56-1177.PMC4541645.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1177 1182Evolution of Gastric Cancer Treatment cancer.75 The study showed that patients assigned to treatment  with ramucirumab, a fully humanized IgG1 monoclonal anti - body inhibitor of VEGFR-2, had significantly improved survival  (HR 0.776, 95% CI 0.603 –0.998, p=0.047), with a median surviv - al of 5.2 months versus 3.8 months with placebo.",Non-OADS,/arxiv_data1/oa_pdf/4e/a3/ymj-56-1177.PMC4541645.pdf
"1183 http://dx.doi.org/10.3349/ymj.2015.56.5.1177Yoon Young Choi, et al.",OADS,/arxiv_data1/oa_pdf/4e/a3/ymj-56-1177.PMC4541645.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1177 1184Evolution of Gastric Cancer Treatment 2004;22:2759-61.,Non-OADS,/arxiv_data1/oa_pdf/4e/a3/ymj-56-1177.PMC4541645.pdf
http://dx.doi.org/10.1016/ j.gie.2015.01.019.,OADS,/arxiv_data1/oa_pdf/4e/a3/ymj-56-1177.PMC4541645.pdf
"1185 http://dx.doi.org/10.3349/ymj.2015.56.5.1177Yoon Young Choi, et al.",OADS,/arxiv_data1/oa_pdf/4e/a3/ymj-56-1177.PMC4541645.pdf
http://dx.doi.org/10.1200/JCO.2014.58.3930.,Non-OADS,/arxiv_data1/oa_pdf/4e/a3/ymj-56-1177.PMC4541645.pdf
"Key Words:   Targeted therapy, cancer genomics, biomarker, personalized medicineYonsei Med J 2015 Sep;56(5):1186-1198 http://dx.doi.org/10.3349/ymj.2015.56.5.1186Review Article pISSN: 0513-5796 · eISSN: 1976-2437 Received:  May 22, 2015 Corresponding author:  Dr. Soonmyung Paik, Severance Biomedical Science In - stitute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu,  Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
"1187 http://dx.doi.org/10.3349/ymj.2015.56.5.1186Hyun Seok Kim, et al.",OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1186 1188Cancer Cell Line Panels for Drug Discovery the inability of cell lines to account for their effects is viewed  as a limitation.,Non-OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
"1189 http://dx.doi.org/10.3349/ymj.2015.56.5.1186Hyun Seok Kim, et al.",OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
"tions in major tumor types, including glioblastoma, ovarian  carcinoma, colorectal cancer, lung squamous cancer, breast  cancer, acute myeloid leukemia, endometrial cancer, kidney cancer, bladder cancer, lung adenocarcinoma, and gastric can - cer (http://cancergenome.nih.gov).",Non-OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1186 1190Cancer Cell Line Panels for Drug Discovery and searchable through cBioPortal (http://www.cbioportal.,OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
"Furthermore, this group  built a web-based portal called the Cancer Therapeutics Re - sponse Portal (http://www.broadinstitute.org/ctrp) to help  researcher access to their discoveries.",OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
"The GDSC web portal  (http://www.cancerrxgene.org) provides a user-friendly inter - face that enables gene or drug queries to identify matching re - lationships.25 An earlier study from Jeffrey Settleman’s group at Harvard  examined the oncogenotypes of 500 cancer cell lines by tar - geted resequencing, genomic copy number variations, and  mRNA expression levels using a microarray platform.",OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
"1191 http://dx.doi.org/10.3349/ymj.2015.56.5.1186Hyun Seok Kim, et al.",OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
"The three  most common platforms for shRNA screens are pLKO by The  RNAi Consortium (TRC),73 pGIPZ from a collaboration be - tween Gregory Hannon at Cold Spring Harbor Laboratory and  Stephen Elledge at Harvard Medical School,74 and the open  source DECIPHER libraries (http://www.decipherproject.",Non-OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
"The first generation TRC library is based on a simple hairpin  structure and was used to identify essential cancer genes using  pooled hairpins; this method requires post-hoc deconvolution  of the individual hairpins.73 Further screenings for lineage-se - lective essential genes75,76 and selective vulnerabilities accord - ing to genetic and molecular subtype have identified numer - ous subtype-vulnerability relationships, including BRAF  mu- tant-BRAF/EGFR co-inhibition,65 KRAS  mutant-TBK1 inhibi- tion,77 KRAS  mutant-BCL-xL/MEK co-inhibition,78 Myc over- expression-SAE1/2 inhibition,79 RAS  mutant-PLK1 inhibition,80  and KRAS dependent cancer lines-STK33 inhibition.81 The  TRC library is currently being employed for a large-scale sc- reening for essential genes in a pan-cancer cell line panel as  part of “Project Achilles” (http://www.broadinstitute.org/achil - les).",Non-OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1186 1192Cancer Cell Line Panels for Drug Discovery Table 1.,OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
"1193 http://dx.doi.org/10.3349/ymj.2015.56.5.1186Hyun Seok Kim, et al.",OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1186 1194Cancer Cell Line Panels for Drug Discovery then compete against each other according to their impact on  cell growth.,OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
The KS statistic is  implemented in the Broad Institute’s GENE-E software pack - age (http://www.broadinstitute.org/cancer/software/GENE- E).,OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
"1195 http://dx.doi.org/10.3349/ymj.2015.56.5.1186Hyun Seok Kim, et al.",OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1186 1196Cancer Cell Line Panels for Drug Discovery 2005;11:971-81.,OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
"1197 http://dx.doi.org/10.3349/ymj.2015.56.5.1186Hyun Seok Kim, et al.",OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1186 1198Cancer Cell Line Panels for Drug Discovery netic events in cancer through somatic genome editing.,OADS,/arxiv_data1/oa_pdf/43/79/ymj-56-1186.PMC4541646.pdf
"Key Words:   Spinal surgery, geriatric patient, spinal stenosis, spondylolisthesis Yonsei Med J 2015 Sep;56(5):1199-1205 http://dx.doi.org/10.3349/ymj.2015.56.5.1199Review Article pISSN: 0513-5796 · eISSN: 1976-2437 Received:  March 6, 2015   Revised:  April 26, 2015 Accepted:  May 14, 2015 Corresponding author:  Dr.",Non-OADS,/arxiv_data1/oa_pdf/95/01/ymj-56-1199.PMC4541647.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/01/ymj-56-1199.PMC4541647.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1199 1200Geriatric Lumbar Surgery search engine was employed using medical subject terms of  “lumbar vertebrae” , “surgery” , and “geriatric” .",OADS,/arxiv_data1/oa_pdf/95/01/ymj-56-1199.PMC4541647.pdf
"1201 http://dx.doi.org/10.3349/ymj.2015.56.5.1199Jin-Young Lee, et al.",OADS,/arxiv_data1/oa_pdf/95/01/ymj-56-1199.PMC4541647.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1199 1202Geriatric Lumbar Surgery seven case series studies found that advanced age did not in - crease operation-associated complication,10-13 however, three  out of seven case series studies found contrary results, showing  the complication ranging from 52% to 70% (Table 2).7,14,16 Postoperative complication was divided into minor and ma - jor complication (Table 3).14 Minor complications included uri - nary tract infection (UTI) and ileus which do not affect clinical  outcome, whereas major complications included deep wound  infection, pneumonia, and renal failure, which affect clinical  outcome.14 Carreon, et al.14 found that 21% of geriatric patients  had at least one major complication and 70% of them had at  least one minor complication (Table 3).14 The major complica - tion was found in 49% of the patients older than 75 years old.14  Shabat, et al.7 showed that 52% of the patients had complica - tion.7 Most of them were minor (Table 3).7 However, Raffo and  Lauerman16 found that major complications occurred in 7 out of 20 patients (35%).",Non-OADS,/arxiv_data1/oa_pdf/95/01/ymj-56-1199.PMC4541647.pdf
"1203 http://dx.doi.org/10.3349/ymj.2015.56.5.1199Jin-Young Lee, et al.",OADS,/arxiv_data1/oa_pdf/95/01/ymj-56-1199.PMC4541647.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1199 1204Geriatric Lumbar Surgery term follow-up such as 10 years, there were no significant dif - ferences in clinical results between surgery and conservative  management for low back pain, because it is due to degenera - tive changes, although the patients treated operatively had  better outcomes with radicular pain.21,25-28 Second, there is no  data on patients who were lost to follow-up.",Non-OADS,/arxiv_data1/oa_pdf/95/01/ymj-56-1199.PMC4541647.pdf
"1205 http://dx.doi.org/10.3349/ymj.2015.56.5.1199Jin-Young Lee, et al.",OADS,/arxiv_data1/oa_pdf/95/01/ymj-56-1199.PMC4541647.pdf
"Key Words:   Bone, metastasis, pain, prostate cancer, visceraYonsei Med J 2015 Sep;56(5):1206-1212 http://dx.doi.org/10.3349/ymj.2015.56.5.1206Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 29, 2014   Revised:  October 27, 2014 Accepted:  November 14, 2014 Corresponding author:  Dr. Byung Ha Chung, Department of Urology and Urologi - cal Science Institute, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam- gu, Seoul 135-720, Korea.",Non-OADS,/arxiv_data1/oa_pdf/15/68/ymj-56-1206.PMC4541648.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/68/ymj-56-1206.PMC4541648.pdf
"1207 http://dx.doi.org/10.3349/ymj.2015.56.5.1206Kyo Chul Koo, et al.",OADS,/arxiv_data1/oa_pdf/15/68/ymj-56-1206.PMC4541648.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1206 1208Impact of Metastatic Site in Prostate Cancer RESULTS Patient characteristics Among 440 initially diagnosed treatment-naïve patients with  mPCa, 248 (56.4%), 158 (35.9%), and 34 (7.7%) patients were di - agnosed with bone metastasis only, visceral metastasis only,  and both bone and visceral metastases, respectively.",Non-OADS,/arxiv_data1/oa_pdf/15/68/ymj-56-1206.PMC4541648.pdf
"1209 http://dx.doi.org/10.3349/ymj.2015.56.5.1206Kyo Chul Koo, et al.",OADS,/arxiv_data1/oa_pdf/15/68/ymj-56-1206.PMC4541648.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1206 1210Impact of Metastatic Site in Prostate Cancer site in 90% of patients with mPCa.13 The propensity of PCa to  preferentially metastasize to bone may be explained by the  fact that the bone microenvironment provides a fertile setting  for the growth and aggressive development of PCa cells.14,15  Metastasis to the bone may contribute to the emergence of  CRPC and disease progression, and several studies have re - ported a number of factors in the bone microenvironment that  may facilitate castration resistance, namely, epidermal growth  factor, insulin-like growth factor (IGF), keratinocyte growth  factor (FGF-7), and interleukin (IL)-6.16-18 Moreover, factors  secreted from the local bone environment as a result of osteo - clastic bone resorption, namely IGF-I, transforming growth  factor-β, bone morphogenic proteins, parathyroid hormone- related protein, IL-1, and IL-6, have been shown to aid PCa  cells in escaping apoptosis, developing treatment-resistant  phenotypes, and continuing to proliferate and grow.19-21 An in vitro  experimental study found that co-culture of PCa cells  with bone stromal cell lines induces PCa cells to become an - drogen resistant.22 Our results are consistent with a popula - tion-based study of metastatic CRPC patients in which surviv - al of men with visceral metastasis was affected by the degree  of bone involvement.23 These observations imply that the mo - lecular basis for the development of androgen resistance is  linked to fundamental changes in the bone microenviron - ment, which may provide an explanation for the increased  overall survival seen in patients treated by bone-targeted ra - diopharmaceuticals that exert a potent effect on both PCa  cells and host cells within the bone.15,24 We observed that bone metastasis is associated with an in - creased risk of progression to CRPC and CSM and that this as - sociation is stronger for bone metastasis complicated with  pain.",Non-OADS,/arxiv_data1/oa_pdf/15/68/ymj-56-1206.PMC4541648.pdf
"1211 http://dx.doi.org/10.3349/ymj.2015.56.5.1206Kyo Chul Koo, et al.",OADS,/arxiv_data1/oa_pdf/15/68/ymj-56-1206.PMC4541648.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1206 1212Impact of Metastatic Site in Prostate Cancer 9.,Non-OADS,/arxiv_data1/oa_pdf/15/68/ymj-56-1206.PMC4541648.pdf
http://dx.doi.org/10.1016/j.eururo.2014.07.020.,OADS,/arxiv_data1/oa_pdf/15/68/ymj-56-1206.PMC4541648.pdf
"Key Words:   Breast cancer, metachronous, multiple primary neoplasms, survival, synchronousYonsei Med J 2015 Sep;56(5):1213-1220 http://dx.doi.org/10.3349/ymj.2015.56.5.1213Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  May 27, 2014  Revised:  October 26, 2014 Accepted:  October 28, 2014 Corresponding author:  Dr. Seho Park, Department of Surgery, Yonsei University  College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d6/4b/ymj-56-1213.PMC4541649.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/4b/ymj-56-1213.PMC4541649.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1213 1214Breast Cancer with Multiple Primary Cancers in treatment.2,3 With increasing incidence and survival rates of  such malignancies, the number of cancer survivors continues  to increase in Korea.",Non-OADS,/arxiv_data1/oa_pdf/d6/4b/ymj-56-1213.PMC4541649.pdf
"1215 http://dx.doi.org/10.3349/ymj.2015.56.5.1213Janghee Lee, et al.",OADS,/arxiv_data1/oa_pdf/d6/4b/ymj-56-1213.PMC4541649.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1213 1216Breast Cancer with Multiple Primary Cancers formation available to identify the date of cancer diagnosis, 166  cases (18.3%) had a past history of malignancy between 6  months and 5 years before diagnosis of breast cancer, and 275  cases (30.5%) developed MPCs between 6 months and 5 years  after diagnosis of breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/d6/4b/ymj-56-1213.PMC4541649.pdf
"1217 http://dx.doi.org/10.3349/ymj.2015.56.5.1213Janghee Lee, et al.",OADS,/arxiv_data1/oa_pdf/d6/4b/ymj-56-1213.PMC4541649.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1213 1218Breast Cancer with Multiple Primary Cancers dence interval (CI), 1.48 –2.44] according to age at diagnosis of  breast cancer.15,16 However, there has been no official study on  MPCs from the nationwide Korean Central Cancer Registry.",Non-OADS,/arxiv_data1/oa_pdf/d6/4b/ymj-56-1213.PMC4541649.pdf
"1219 http://dx.doi.org/10.3349/ymj.2015.56.5.1213Janghee Lee, et al.",OADS,/arxiv_data1/oa_pdf/d6/4b/ymj-56-1213.PMC4541649.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1213 1220Breast Cancer with Multiple Primary Cancers BK, et al.",OADS,/arxiv_data1/oa_pdf/d6/4b/ymj-56-1213.PMC4541649.pdf
"Key Words:   Head and neck cancer, dysphagia, modified barium swallow, radiotherapy, aspirationYonsei Med J 2015 Sep;56(5):1221-1226 http://dx.doi.org/10.3349/ymj.2015.56.5.1221Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  July 21, 2014   Revised:  October 27, 2014    Accepted:  November 17, 2014 Corresponding author:  Dr. Young Hak Park, Department of Otorhinolaryngology  Head and Neck Surgery, Yeouido St. Mary’s Hospital, 10 63-ro, Yeongdeungpo-gu,  Seoul 150-713, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c3/7f/ymj-56-1221.PMC4541650.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/7f/ymj-56-1221.PMC4541650.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1221 1222Dysphagia Patterns of Head and Neck Cancer gia patterns by using a modified barium swallow (MBS) test  and to identify the factors affecting dysphagia, especially aspi - ration, following treatment of head and neck cancer.",Non-OADS,/arxiv_data1/oa_pdf/c3/7f/ymj-56-1221.PMC4541650.pdf
"1223 http://dx.doi.org/10.3349/ymj.2015.56.5.1221So-Yoon Lee, et al.",OADS,/arxiv_data1/oa_pdf/c3/7f/ymj-56-1221.PMC4541650.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1221 1224Dysphagia Patterns of Head and Neck Cancer were older age (65.0%), DARS primaries (75.0%), higher stage  disease (66.7%), and history of radiotherapy (68.8%).",Non-OADS,/arxiv_data1/oa_pdf/c3/7f/ymj-56-1221.PMC4541650.pdf
"1225 http://dx.doi.org/10.3349/ymj.2015.56.5.1221So-Yoon Lee, et al.",OADS,/arxiv_data1/oa_pdf/c3/7f/ymj-56-1221.PMC4541650.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1221 1226Dysphagia Patterns of Head and Neck Cancer al.,Non-OADS,/arxiv_data1/oa_pdf/c3/7f/ymj-56-1221.PMC4541650.pdf
"Key Words:   Primary vascular dysregulation, triflusal, finger Doppler, endothelin-1, microvascular circulation Yonsei Med J 2015 Sep;56(5):1227-1234 http://dx.doi.org/10.3349/ymj.2015.56.5.1227Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  March 6, 2014   Revised:  October 13, 2014 Accepted:  October 16, 2014 Corresponding author:  Dr. Hyuk-Jae Chang, Division of Cardiology, Severance  Cardiovascular Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro,  Seodaemun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/14/38/ymj-56-1227.PMC4541651.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/38/ymj-56-1227.PMC4541651.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1227 1228Triflusal for Primary Vascular Dysregulation cific treatment.,Non-OADS,/arxiv_data1/oa_pdf/14/38/ymj-56-1227.PMC4541651.pdf
"1229 http://dx.doi.org/10.3349/ymj.2015.56.5.1227Sanghoon Shin, et al.",OADS,/arxiv_data1/oa_pdf/14/38/ymj-56-1227.PMC4541651.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1227 1230Triflusal for Primary Vascular Dysregulation by week 6; however, no further improvement was seen after  crossover from triflusal to aspirin.",Non-OADS,/arxiv_data1/oa_pdf/14/38/ymj-56-1227.PMC4541651.pdf
"1231 http://dx.doi.org/10.3349/ymj.2015.56.5.1227Sanghoon Shin, et al.",OADS,/arxiv_data1/oa_pdf/14/38/ymj-56-1227.PMC4541651.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1227 1232Triflusal for Primary Vascular Dysregulation Fig.,Non-OADS,/arxiv_data1/oa_pdf/14/38/ymj-56-1227.PMC4541651.pdf
"1233 http://dx.doi.org/10.3349/ymj.2015.56.5.1227Sanghoon Shin, et al.",OADS,/arxiv_data1/oa_pdf/14/38/ymj-56-1227.PMC4541651.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1227 1234Triflusal for Primary Vascular Dysregulation ICT, & Future Planning (MSIP; 2012027176).",Non-OADS,/arxiv_data1/oa_pdf/14/38/ymj-56-1227.PMC4541651.pdf
"Key Words:   Microvascular dysfunction, ST-segment elevation myocardial infarction, index of microcirculatory resistance, door-    to-balloon time, symptom-onset-to-balloon timeYonsei Med J 2015 Sep;56(5):1235-1243 http://dx.doi.org/10.3349/ymj.2015.56.5.1235Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 29, 2014   Revised:  November 3, 2014 Accepted:  November 20, 2014 Corresponding author:  Dr. Seong-Ill Woo, Division of Cardiology, Inha University  Hospital, 27 Inhang-ro, Jung-gu, Incheon 400-711, Korea.",Non-OADS,/arxiv_data1/oa_pdf/dd/fb/ymj-56-1235.PMC4541652.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/fb/ymj-56-1235.PMC4541652.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1235 1236IMR in Patients with STEMI has the most influence on microvascular integrity are limited.,Non-OADS,/arxiv_data1/oa_pdf/dd/fb/ymj-56-1235.PMC4541652.pdf
"1237 http://dx.doi.org/10.3349/ymj.2015.56.5.1235Yong-Soo Baek, et al.",OADS,/arxiv_data1/oa_pdf/dd/fb/ymj-56-1235.PMC4541652.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1235 1238IMR in Patients with STEMI WMSI values than the Low and Mid IMR groups, although the  difference in the values was not significant ( p=0.162) (Table 1).",OADS,/arxiv_data1/oa_pdf/dd/fb/ymj-56-1235.PMC4541652.pdf
"1239 http://dx.doi.org/10.3349/ymj.2015.56.5.1235Yong-Soo Baek, et al.",OADS,/arxiv_data1/oa_pdf/dd/fb/ymj-56-1235.PMC4541652.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1235 1240IMR in Patients with STEMI Aging is an important factor contributing to atherosclerosis  and arteriosclerosis.18 It has been reported that arterial aging is  associated not only macrovascular resistance but also with im -paired microcirculation due to the diminution of the capillary  bed, which accompanies atrophy of subcutaneous and other  tissues.18,19 The presence of structural alterations in the micro - Table 4.",Non-OADS,/arxiv_data1/oa_pdf/dd/fb/ymj-56-1235.PMC4541652.pdf
"1241 http://dx.doi.org/10.3349/ymj.2015.56.5.1235Yong-Soo Baek, et al.",OADS,/arxiv_data1/oa_pdf/dd/fb/ymj-56-1235.PMC4541652.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1235 1242IMR in Patients with STEMI aspiration as an adjunctive therapy to primary PCI for STEMI  may reduce IMR and have beneficial effects on myocardial  microcirculation.40 Our data showed that thrombus aspiration  was more frequent in the High IMR group, compared with the  Low IMR group; however, the difference was not significant,  although there may be an operator-dependent bias in the  thrombus aspiration, which was determined by operator at the  time of the primary PCI.",Non-OADS,/arxiv_data1/oa_pdf/dd/fb/ymj-56-1235.PMC4541652.pdf
"1243 http://dx.doi.org/10.3349/ymj.2015.56.5.1235Yong-Soo Baek, et al.",OADS,/arxiv_data1/oa_pdf/dd/fb/ymj-56-1235.PMC4541652.pdf
"Key Words:   Atrial fibrillation, eNOS gene, catheter ablation, recurrenceYonsei Med J 2015 Sep;56(5):1244-1250 http://dx.doi.org/10.3349/ymj.2015.56.5.1244Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  September 5, 2014   Revised:  December 15, 2014 Accepted:  December 16, 2014 Corresponding author:  Dr. Hui-Nam Pak, Department of Cardiology, Yonsei Uni - versity Health System, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4f/e3/ymj-56-1244.PMC4541653.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/e3/ymj-56-1244.PMC4541653.pdf
"1245 http://dx.doi.org/10.3349/ymj.2015.56.5.1244Jaemin Shim, et al.",OADS,/arxiv_data1/oa_pdf/4f/e3/ymj-56-1244.PMC4541653.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1244 1246eNOS3 Gene Polymorphism and Recurrence of AF colored gray, and high voltage areas (>5.0 mV) were colored  purple.",OADS,/arxiv_data1/oa_pdf/4f/e3/ymj-56-1244.PMC4541653.pdf
"1247 http://dx.doi.org/10.3349/ymj.2015.56.5.1244Jaemin Shim, et al.",OADS,/arxiv_data1/oa_pdf/4f/e3/ymj-56-1244.PMC4541653.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1244 1248eNOS3 Gene Polymorphism and Recurrence of AF DISCUSSION We found that the eNOS SNP rs1799983  is associated with  ERAF after catheter ablation.,Non-OADS,/arxiv_data1/oa_pdf/4f/e3/ymj-56-1244.PMC4541653.pdf
"1249 http://dx.doi.org/10.3349/ymj.2015.56.5.1244Jaemin Shim, et al.",OADS,/arxiv_data1/oa_pdf/4f/e3/ymj-56-1244.PMC4541653.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1244 1250eNOS3 Gene Polymorphism and Recurrence of AF A. Angiotensin-converting enzyme and endothelial nitric oxide  synthase polymorphisms in patients with atrial fibrillation.,Non-OADS,/arxiv_data1/oa_pdf/4f/e3/ymj-56-1244.PMC4541653.pdf
"Key Words:   PCSK9, in silico , protein-protein interaction, LDL receptor, hypercholesterolemia, inhibitorYonsei Med J 2015 Sep;56(5):1251-1257 http://dx.doi.org/10.3349/ymj.2015.56.5.1251Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  November 19, 2014   Revised:  December 2, 2014 Accepted:  December 10, 2014 Corresponding author:  Dr. Sahng Wook Park, Department of Biochemistry and  Molecular Biology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodae - mun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/aa/de/ymj-56-1251.PMC4541654.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/de/ymj-56-1251.PMC4541654.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1251 1252In silico  Screening of PCSK9 Inhibitors successful approaches in several clinical human trials.6-8 Inhibi - tion of PCSK9 synthesis by siRNA9 or inhibition of PCSK9 bind - ing to the LDLR by small peptide inhibitors10,11 are other prom - ising approaches to the development of hypercholesterolemia  therapeutics.",Non-OADS,/arxiv_data1/oa_pdf/aa/de/ymj-56-1251.PMC4541654.pdf
"1253 http://dx.doi.org/10.3349/ymj.2015.56.5.1251Dong-Kook Min, et al.",OADS,/arxiv_data1/oa_pdf/aa/de/ymj-56-1251.PMC4541654.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1251 1254In silico  Screening of PCSK9 Inhibitors Fig.,Non-OADS,/arxiv_data1/oa_pdf/aa/de/ymj-56-1251.PMC4541654.pdf
"1255 http://dx.doi.org/10.3349/ymj.2015.56.5.1251Dong-Kook Min, et al.",OADS,/arxiv_data1/oa_pdf/aa/de/ymj-56-1251.PMC4541654.pdf
"CB_36), which had the highest docking score (Supplementary  Table 1, only online), and its three-dimensional analogs  (#7632817 and #7338220) proposed by ChemBridge’s online  website (http://www.hit2lead.com/) were evaluated for in vi - tro parameters in HepG2 cells.",OADS,/arxiv_data1/oa_pdf/aa/de/ymj-56-1251.PMC4541654.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1251 1256In silico  Screening of PCSK9 Inhibitors abled standard laboratories to carry out a large-scale screen - ing of small molecular inhibitors of protein-protein interaction  for drug development at ease.,Non-OADS,/arxiv_data1/oa_pdf/aa/de/ymj-56-1251.PMC4541654.pdf
"1257 http://dx.doi.org/10.3349/ymj.2015.56.5.1251Dong-Kook Min, et al.",OADS,/arxiv_data1/oa_pdf/aa/de/ymj-56-1251.PMC4541654.pdf
"Key Words:  Resistant hypertension, sleep apnea, polysomnography, obesity, body mass indexYonsei Med J 2015 Sep;56(5):1258-1265 http://dx.doi.org/10.3349/ymj.2015.56.5.1258Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  March 6, 2015   Revised:  April 23, 2015    Accepted:  May 8, 2015 Co-corresponding authors:  Dr. Hyung-Ju Cho, Department of Otorhinolaryngology,  Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120- 752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/41/6c/ymj-56-1258.PMC4541655.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/6c/ymj-56-1258.PMC4541655.pdf
"1259 http://dx.doi.org/10.3349/ymj.2015.56.5.1258Hyun Jin Min, et al.",OADS,/arxiv_data1/oa_pdf/41/6c/ymj-56-1258.PMC4541655.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1258 1260Resistant Hypertension and Sleep Apnea Severity of OSA in patients with controlled or resistant  HTN OSA, which was characterized by an AHI≥5, was diagnosed in  73.7% (302/410) and 87.7% (57/65) of patients in the controlled  and resistant HTN groups, respectively (Table 2, Fig.",Non-OADS,/arxiv_data1/oa_pdf/41/6c/ymj-56-1258.PMC4541655.pdf
"1261 http://dx.doi.org/10.3349/ymj.2015.56.5.1258Hyun Jin Min, et al.",OADS,/arxiv_data1/oa_pdf/41/6c/ymj-56-1258.PMC4541655.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1258 1262Resistant Hypertension and Sleep Apnea the aggravation of OSA, and it is well established in non-obese  patients.31 However, Jafari and Mohsenin32 showed that fluid shift  does not significantly change the respiratory disturbance index, way30 and the redistribution of intravascular and interstitial flu - id in the pharyngeal structure.",Non-OADS,/arxiv_data1/oa_pdf/41/6c/ymj-56-1258.PMC4541655.pdf
"1263 http://dx.doi.org/10.3349/ymj.2015.56.5.1258Hyun Jin Min, et al.",OADS,/arxiv_data1/oa_pdf/41/6c/ymj-56-1258.PMC4541655.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1258 1264Resistant Hypertension and Sleep Apnea al.,Non-OADS,/arxiv_data1/oa_pdf/41/6c/ymj-56-1258.PMC4541655.pdf
"1265 http://dx.doi.org/10.3349/ymj.2015.56.5.1258Hyun Jin Min, et al.",OADS,/arxiv_data1/oa_pdf/41/6c/ymj-56-1258.PMC4541655.pdf
"Key Words:   Pyelonephritis, E. coli , cefotaxime, cefuroximeYonsei Med J 2015 Sep;56(5):1266-1273 http://dx.doi.org/10.3349/ymj.2015.56.5.1266Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  October 6, 2014   Revised:  December 8, 2014 Accepted:  December 8, 2014 Corresponding author:  Dr. Seong-Heon Wie, Department of Internal Medicine,  St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, 93  Jungbu-daero, Paldal-gu, Suwon 442-723, Korea.",Non-OADS,/arxiv_data1/oa_pdf/99/1d/ymj-56-1266.PMC4541656.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/1d/ymj-56-1266.PMC4541656.pdf
"1267 http://dx.doi.org/10.3349/ymj.2015.56.5.1266U-Im Chang, et al.",OADS,/arxiv_data1/oa_pdf/99/1d/ymj-56-1266.PMC4541656.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1266 1268Second- and Third-Generation Cephalosporin for APN Defervescence or resolution of fever was defined as the afe - brile state of body temperature ≤37.0°C and its continuation for  at least 24 hours.8 Time to defervescence was defined as the  time from the initiation of cefuroxime or cefotaxime therapy to  an afebrile state.,Non-OADS,/arxiv_data1/oa_pdf/99/1d/ymj-56-1266.PMC4541656.pdf
"1269 http://dx.doi.org/10.3349/ymj.2015.56.5.1266U-Im Chang, et al.",OADS,/arxiv_data1/oa_pdf/99/1d/ymj-56-1266.PMC4541656.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1266 1270Second- and Third-Generation Cephalosporin for APN Table 1.,OADS,/arxiv_data1/oa_pdf/99/1d/ymj-56-1266.PMC4541656.pdf
"1271 http://dx.doi.org/10.3349/ymj.2015.56.5.1266U-Im Chang, et al.",OADS,/arxiv_data1/oa_pdf/99/1d/ymj-56-1266.PMC4541656.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1266 1272Second- and Third-Generation Cephalosporin for APN Comparison of laboratory findings and microbiologi - cal outcomes after 72 –96 hours of cefuroxime or cefo - taxime treatment  The median CRP levels after 72 –96 hours of antimicrobial  therapy were 4.21 (IQR, 2.27 –6.78) mg/dL and 3.54 (IQR, 1.92 – 5.72) mg/dL, respectively, in the cefuroxime and cefotaxime  groups and were not significantly different ( p=0.135).",OADS,/arxiv_data1/oa_pdf/99/1d/ymj-56-1266.PMC4541656.pdf
"1273 http://dx.doi.org/10.3349/ymj.2015.56.5.1266U-Im Chang, et al.",OADS,/arxiv_data1/oa_pdf/99/1d/ymj-56-1266.PMC4541656.pdf
"Key Words:   IL-10 , IL-6 , polymorphism, tuberculosis, susceptibility, meta-analysisYonsei Med J 2015 Sep;56(5):1274-1287 http://dx.doi.org/10.3349/ymj.2015.56.5.1274Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  October 14, 2014   Revised:  December 1, 2014 Accepted:  December 15, 2014 Corresponding author:  Dr. Hui Xiong, Department of Pharmacy, Renmin Hospi - tal, Hubei University of Medicine, 39 Chaoyang Mid-Road Shiyan, 442000, Hubei  Province, P .R.",Non-OADS,/arxiv_data1/oa_pdf/03/d3/ymj-56-1274.PMC4541657.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/d3/ymj-56-1274.PMC4541657.pdf
"1275 http://dx.doi.org/10.3349/ymj.2015.56.5.1274Zunqiong Ke, et al.",OADS,/arxiv_data1/oa_pdf/03/d3/ymj-56-1274.PMC4541657.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1274 1276A Meta-Analysis for IL-10  and IL-6 Variants  Table 1.,OADS,/arxiv_data1/oa_pdf/03/d3/ymj-56-1274.PMC4541657.pdf
"1277 http://dx.doi.org/10.3349/ymj.2015.56.5.1274Zunqiong Ke, et al.",OADS,/arxiv_data1/oa_pdf/03/d3/ymj-56-1274.PMC4541657.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1274 1278A Meta-Analysis for IL-10  and IL-6 Variants  Table 2.,OADS,/arxiv_data1/oa_pdf/03/d3/ymj-56-1274.PMC4541657.pdf
"1279 http://dx.doi.org/10.3349/ymj.2015.56.5.1274Zunqiong Ke, et al.",OADS,/arxiv_data1/oa_pdf/03/d3/ymj-56-1274.PMC4541657.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1274 1280A Meta-Analysis for IL-10  and IL-6 Variants  Table 3.,OADS,/arxiv_data1/oa_pdf/03/d3/ymj-56-1274.PMC4541657.pdf
"1281 http://dx.doi.org/10.3349/ymj.2015.56.5.1274Zunqiong Ke, et al.",OADS,/arxiv_data1/oa_pdf/03/d3/ymj-56-1274.PMC4541657.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1274 1282A Meta-Analysis for IL-10  and IL-6 Variants  model (AA vs. AC+CC: OR=1.33, 95% CI=1.10 –1.62) (Table 3).",OADS,/arxiv_data1/oa_pdf/03/d3/ymj-56-1274.PMC4541657.pdf
"1283 http://dx.doi.org/10.3349/ymj.2015.56.5.1274Zunqiong Ke, et al.",OADS,/arxiv_data1/oa_pdf/03/d3/ymj-56-1274.PMC4541657.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1274 1284A Meta-Analysis for IL-10  and IL-6 Variants  Sensitivity analysis Sensitivity analysis was performed by sequentially excluding  individual studies, including studies which was not in agree - ment with HWE.",Non-OADS,/arxiv_data1/oa_pdf/03/d3/ymj-56-1274.PMC4541657.pdf
"1285 http://dx.doi.org/10.3349/ymj.2015.56.5.1274Zunqiong Ke, et al.",OADS,/arxiv_data1/oa_pdf/03/d3/ymj-56-1274.PMC4541657.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1274 1286A Meta-Analysis for IL-10  and IL-6 Variants  sociated also with an increased risk of TB in homozygous  model in the PTB+EPTB mixed sample.,Non-OADS,/arxiv_data1/oa_pdf/03/d3/ymj-56-1274.PMC4541657.pdf
"1287 http://dx.doi.org/10.3349/ymj.2015.56.5.1274Zunqiong Ke, et al.",OADS,/arxiv_data1/oa_pdf/03/d3/ymj-56-1274.PMC4541657.pdf
"Key Words:    Nonalcoholic fatty liver disease, subclinical coronary atherosclerosis, metabolic syndrome, multidetector computed  tomographyYonsei Med J 2015 Sep;56(5):1288-1295 http://dx.doi.org/10.3349/ymj.2015.56.5.1288Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  June 25, 2014   Revised:  October 10, 2014 Accepted:  October 17, 2014 Corresponding author:  Dr. Jong Ho Kim, Emergency Care Center, Soonchunhyang  University Cheonan Hospital, 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan 330- 721, Korea.",Non-OADS,/arxiv_data1/oa_pdf/93/a4/ymj-56-1288.PMC4541658.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/a4/ymj-56-1288.PMC4541658.pdf
"1289 http://dx.doi.org/10.3349/ymj.2015.56.5.1288Min Kyoung Kang, et al.",OADS,/arxiv_data1/oa_pdf/93/a4/ymj-56-1288.PMC4541658.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1288 1290NAFLD and Coronary Atherosclerosis mL, Tyco Healthcare, Montreal, Canada).",Non-OADS,/arxiv_data1/oa_pdf/93/a4/ymj-56-1288.PMC4541658.pdf
"1291 http://dx.doi.org/10.3349/ymj.2015.56.5.1288Min Kyoung Kang, et al.",OADS,/arxiv_data1/oa_pdf/93/a4/ymj-56-1288.PMC4541658.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1288 1292NAFLD and Coronary Atherosclerosis reported as the mean±standard deviation.,Non-OADS,/arxiv_data1/oa_pdf/93/a4/ymj-56-1288.PMC4541658.pdf
"1293 http://dx.doi.org/10.3349/ymj.2015.56.5.1288Min Kyoung Kang, et al.",OADS,/arxiv_data1/oa_pdf/93/a4/ymj-56-1288.PMC4541658.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1288 1294NAFLD and Coronary Atherosclerosis tein (CRP) was found, which indicates that NAFLD may con - tribute to the inflammatory CVD milieu, predisposing to ath - erosclerosis and CVD.17-19 In addition to a direct predisposition  to atherosclerosis, cytokines may have an indirect effect as  well, as cytokines may be involved in insulin resistance.",Non-OADS,/arxiv_data1/oa_pdf/93/a4/ymj-56-1288.PMC4541658.pdf
"1295 http://dx.doi.org/10.3349/ymj.2015.56.5.1288Min Kyoung Kang, et al.",OADS,/arxiv_data1/oa_pdf/93/a4/ymj-56-1288.PMC4541658.pdf
"Key Words:   Dickkopf-1, hepatocellular carcinoma, biomarkerYonsei Med J 2015 Sep;56(5):1296-1306 http://dx.doi.org/10.3349/ymj.2015.56.5.1296Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  November 5, 2014   Revised:  December 22, 2014 Accepted:  December 23, 2014 Co-corresponding authors:  Dr. Kwang-Hyub Han, Department of Internal Medi - cine, Institute of Gastroenterology, Yonsei University College of Medicine, 50-1  Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/7f/7f/ymj-56-1296.PMC4541659.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/7f/ymj-56-1296.PMC4541659.pdf
"1297 http://dx.doi.org/10.3349/ymj.2015.56.5.1296Seung Up Kim, et al.",OADS,/arxiv_data1/oa_pdf/7f/7f/ymj-56-1296.PMC4541659.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1296 1298DKK-1 as a Biomarker for Hepatocellular Carcinoma portal fibrosis with a few septa; F3, numerous septa without  cirrhosis; and F4, cirrhosis.",Non-OADS,/arxiv_data1/oa_pdf/7f/7f/ymj-56-1296.PMC4541659.pdf
"1299 http://dx.doi.org/10.3349/ymj.2015.56.5.1296Seung Up Kim, et al.",OADS,/arxiv_data1/oa_pdf/7f/7f/ymj-56-1296.PMC4541659.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1296 1300DKK-1 as a Biomarker for Hepatocellular Carcinoma sion capability, DKK-1 was overexpressed or knock-downed in  293 or Huh7 cells, with low or moderate DKK-1 secretion lev - els, respectively.",Non-OADS,/arxiv_data1/oa_pdf/7f/7f/ymj-56-1296.PMC4541659.pdf
"1301 http://dx.doi.org/10.3349/ymj.2015.56.5.1296Seung Up Kim, et al.",OADS,/arxiv_data1/oa_pdf/7f/7f/ymj-56-1296.PMC4541659.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1296 1302DKK-1 as a Biomarker for Hepatocellular Carcinoma ng/mL; p=0.690).,Non-OADS,/arxiv_data1/oa_pdf/7f/7f/ymj-56-1296.PMC4541659.pdf
"1303 http://dx.doi.org/10.3349/ymj.2015.56.5.1296Seung Up Kim, et al.",OADS,/arxiv_data1/oa_pdf/7f/7f/ymj-56-1296.PMC4541659.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1296 1304DKK-1 as a Biomarker for Hepatocellular Carcinoma protein with a crucial role in limb and head development in  Xenopus embryos, and as an upstream regulator of T-cell fac - tor/β-catenin that forms a negative feedback loop in the ca - nonical Wnt signaling pathway, favoring appropriate cell  growth.10,34 In normal tissues DKK-1 is hardly expressed, ex - cept in placenta and embryonic tissues.35 Paradoxically, how - ever, DKK-1 has been shown to be secreted from some tumor  into blood stream, suggesting that serum DKK-1 may be a  useful biomarker for numerous cancers including HCC.36-39  Serum DKK-1 is an advantageous biomarker because it is  non-invasiveness, has a simple detection protocol, and is in - expensive to quantify.40 Therefore, integration of serum DKK- 1 along with serum AFP and sonographic findings may im - prove and optimize diagnostic work-ups and surveillance  strategies for HCC.39 Recently, Yu, et al.23 found that DKK-1 expression level was  associated with β-catenin staining pattern in HCC cell lines,  and that DKK-1 overexpression correlated with β-catenin cy - toplasmic/nuclear accumulation in clinical HCC samples.",Non-OADS,/arxiv_data1/oa_pdf/7f/7f/ymj-56-1296.PMC4541659.pdf
"1305 http://dx.doi.org/10.3349/ymj.2015.56.5.1296Seung Up Kim, et al.",OADS,/arxiv_data1/oa_pdf/7f/7f/ymj-56-1296.PMC4541659.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1296 1306DKK-1 as a Biomarker for Hepatocellular Carcinoma 14.,Non-OADS,/arxiv_data1/oa_pdf/7f/7f/ymj-56-1296.PMC4541659.pdf
"Key Words:   TRESK protein, rat, neuralgia, painYonsei Med J 2015 Sep;56(5):1307-1315 http://dx.doi.org/10.3349/ymj.2015.56.5.1307Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  July 7, 2014   Revised:  November 19, 2014 Accepted:  December 17, 2014 Co-corresponding authors:  Dr. Youngkwon Ko, Department of Anesthesia and  Pain Medicine, Chungnam National University Hospital, 282 Munhwa-ro, Jung-gu,  Daejeon 301-721, Korea.",Non-OADS,/arxiv_data1/oa_pdf/55/2f/ymj-56-1307.PMC4541660.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Neuropathic pain is well known as a leading cause of chronic  pain, but there is still no solid treatment.",Non-OADS,/arxiv_data1/oa_pdf/55/2f/ymj-56-1307.PMC4541660.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1307 1308Higher Expression of TRESK in the Spinal Dorsal Horn can affect pain perception leading to spontaneous pain, hy - peralgesia, and allodynia.5-7 Hyperexcitability in the DRG or  spinal dorsal horn is the basic mechanism of neuropathic pain  in several pain models.5,7,8 If K 2p acts as a major regulator of ex - citability in the spinal cord, it is highly likely that it is also in - volved in the mechanism underlying neuropathic pain.",Non-OADS,/arxiv_data1/oa_pdf/55/2f/ymj-56-1307.PMC4541660.pdf
"1309 http://dx.doi.org/10.3349/ymj.2015.56.5.1307Hee Youn Hwang, et al.",OADS,/arxiv_data1/oa_pdf/55/2f/ymj-56-1307.PMC4541660.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1307 1310Higher Expression of TRESK in the Spinal Dorsal Horn old for each image and to compensate for subtle variability in  immunostaining, we counted only neurons that were at least  85% darker than the average gray level in each image after  background subtraction and shading correction.",Non-OADS,/arxiv_data1/oa_pdf/55/2f/ymj-56-1307.PMC4541660.pdf
"1311 http://dx.doi.org/10.3349/ymj.2015.56.5.1307Hee Youn Hwang, et al.",OADS,/arxiv_data1/oa_pdf/55/2f/ymj-56-1307.PMC4541660.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1307 1312Higher Expression of TRESK in the Spinal Dorsal Horn RNA isolation and quantitative real-time PCR TRESK gene expression increased in the ipsilateral lumbar spi - nal cord at 0, 7, 14, 21, and 28 days after SNL in rats.",OADS,/arxiv_data1/oa_pdf/55/2f/ymj-56-1307.PMC4541660.pdf
"1313 http://dx.doi.org/10.3349/ymj.2015.56.5.1307Hee Youn Hwang, et al.",OADS,/arxiv_data1/oa_pdf/55/2f/ymj-56-1307.PMC4541660.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1307 1314Higher Expression of TRESK in the Spinal Dorsal Horn neuropathic pain, as TRESK may have different roles in indi - vidual pain modulation pathways.",Non-OADS,/arxiv_data1/oa_pdf/55/2f/ymj-56-1307.PMC4541660.pdf
"1315 http://dx.doi.org/10.3349/ymj.2015.56.5.1307Hee Youn Hwang, et al.",OADS,/arxiv_data1/oa_pdf/55/2f/ymj-56-1307.PMC4541660.pdf
"Key Words:   Deep brain stimulation, dyskinesias, Parkinson disease, subthalamic nucleusYonsei Med J 2015 Sep;56(5):1316-1321 http://dx.doi.org/10.3349/ymj.2015.56.5.1316Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  September 5, 2014   Revised:  November 18, 2014 Accepted:  December 4, 2014 Corresponding author:  Dr. Jin Woo Chang, Division of Stereotactic and Function - al Neurosurgery, Department of Neurosurgery, Brain Research Institute, Yonsei Uni - versity College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/ymj-56-1316.PMC4541661.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/ymj-56-1316.PMC4541661.pdf
"1317 http://dx.doi.org/10.3349/ymj.2015.56.5.1316Ji Hee Kim, et al.",OADS,/arxiv_data1/oa_pdf/86/1b/ymj-56-1316.PMC4541661.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1316 1318Subthalamic DBS for Levodopa-Induced Dyskinesia tient was also determined without reducing the LEDD.,Non-OADS,/arxiv_data1/oa_pdf/86/1b/ymj-56-1316.PMC4541661.pdf
"1319 http://dx.doi.org/10.3349/ymj.2015.56.5.1316Ji Hee Kim, et al.",OADS,/arxiv_data1/oa_pdf/86/1b/ymj-56-1316.PMC4541661.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1316 1320Subthalamic DBS for Levodopa-Induced Dyskinesia effect of continuous high-frequency electrical stimulation in  the target.22,23,29 Thus, STN surgery could induce a stable and  continuous functional state with reduced fluctuations in basal  ganglia activity, which mimics the effect of continuous dopa - mine stimulation, a process that occurs during the infusion of  dopamine receptor agonists.23,30,31 Krack, et al.23 described the  effect of chronic high-frequency stimulation of the STN on  peak-dose dyskinesia as being related directly to the function - al inhibition of the STN and indirectly to the replacement of  pulsatile dopaminergic stimulation by continuous functional  inhibition of the STN.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/ymj-56-1316.PMC4541661.pdf
"1321 http://dx.doi.org/10.3349/ymj.2015.56.5.1316Ji Hee Kim, et al.",OADS,/arxiv_data1/oa_pdf/86/1b/ymj-56-1316.PMC4541661.pdf
"Key Words:   Moyamoya disease, FLAIR, MRI, ivy sign, old lesion, supraclinoid carotid stenosisYonsei Med J 2015 Sep;56(5):1322-1327 http://dx.doi.org/10.3349/ymj.2015.56.5.1322Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  September 26, 2014  Revised:  December 9, 2014 Accepted:  December 14, 2014 Corresponding author:  Dr. Kyung-Yul Lee, Department of Neurology, Gangnam  Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam- gu, Seoul 135-720, Korea.",Non-OADS,/arxiv_data1/oa_pdf/5a/e8/ymj-56-1322.PMC4541662.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/e8/ymj-56-1322.PMC4541662.pdf
"1323 http://dx.doi.org/10.3349/ymj.2015.56.5.1322Kwon-Duk Seo, et al.",OADS,/arxiv_data1/oa_pdf/5a/e8/ymj-56-1322.PMC4541662.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1322 1324Ivy Sign and Clinical Severity in Moyamoya Disease Imaging acquisitions and analyses MRI was performed with 3.0-T scanner (Achieva, Philips Me- dical Systems, Best, the Netherlands).",OADS,/arxiv_data1/oa_pdf/5a/e8/ymj-56-1322.PMC4541662.pdf
"1325 http://dx.doi.org/10.3349/ymj.2015.56.5.1322Kwon-Duk Seo, et al.",OADS,/arxiv_data1/oa_pdf/5a/e8/ymj-56-1322.PMC4541662.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1322 1326Ivy Sign and Clinical Severity in Moyamoya Disease mined in seven patients.,OADS,/arxiv_data1/oa_pdf/5a/e8/ymj-56-1322.PMC4541662.pdf
"1327 http://dx.doi.org/10.3349/ymj.2015.56.5.1322Kwon-Duk Seo, et al.",OADS,/arxiv_data1/oa_pdf/5a/e8/ymj-56-1322.PMC4541662.pdf
"Key Words:   Intracranial aneurysms, hemodynamic factors, parent artery segmentation, boundary conditions, computational fluid    dynamicsYonsei Med J 2015 Sep;56(5):1328-1337 http://dx.doi.org/10.3349/ymj.2015.56.5.1328Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  January 14, 2015   Revised:  April 19, 2015 Accepted:  April 26, 2015 Corresponding author:  Dr. Yong Bae Kim, Department of Neurosurgery, Gangnam  Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam- gu, Seoul 135-720, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a1/5f/ymj-56-1328.PMC4541663.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/5f/ymj-56-1328.PMC4541663.pdf
"1329 http://dx.doi.org/10.3349/ymj.2015.56.5.1328Yufeng Hua, et al.",OADS,/arxiv_data1/oa_pdf/a1/5f/ymj-56-1328.PMC4541663.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1328 1330Hemodynamic Analysis of Intracranial Aneurysm cation on the CFD result has yet to be discussed.,Non-OADS,/arxiv_data1/oa_pdf/a1/5f/ymj-56-1328.PMC4541663.pdf
"1331 http://dx.doi.org/10.3349/ymj.2015.56.5.1328Yufeng Hua, et al.",OADS,/arxiv_data1/oa_pdf/a1/5f/ymj-56-1328.PMC4541663.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1328 1332Hemodynamic Analysis of Intracranial Aneurysm id with a density of 1060 kg/m3 and a viscosity of 4 mPa·s.,Non-OADS,/arxiv_data1/oa_pdf/a1/5f/ymj-56-1328.PMC4541663.pdf
"1333 http://dx.doi.org/10.3349/ymj.2015.56.5.1328Yufeng Hua, et al.",OADS,/arxiv_data1/oa_pdf/a1/5f/ymj-56-1328.PMC4541663.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1328 1334Hemodynamic Analysis of Intracranial Aneurysm Fig.,Non-OADS,/arxiv_data1/oa_pdf/a1/5f/ymj-56-1328.PMC4541663.pdf
"1335 http://dx.doi.org/10.3349/ymj.2015.56.5.1328Yufeng Hua, et al.",OADS,/arxiv_data1/oa_pdf/a1/5f/ymj-56-1328.PMC4541663.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1328 1336Hemodynamic Analysis of Intracranial Aneurysm requirement ( L>20D), in order to perform more reliable eval - uation of the hemodynamic factors.",Non-OADS,/arxiv_data1/oa_pdf/a1/5f/ymj-56-1328.PMC4541663.pdf
"1337 http://dx.doi.org/10.3349/ymj.2015.56.5.1328Yufeng Hua, et al.",OADS,/arxiv_data1/oa_pdf/a1/5f/ymj-56-1328.PMC4541663.pdf
"Key Words:  Differential diagnosis, focal lymphocytic thyroiditis, papillary thyroid cancer Yonsei Med J 2015 Sep;56(5):1338-1344 http://dx.doi.org/10.3349/ymj.2015.56.5.1338Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  July 25, 2014   Revised:  October 24, 2014 Accepted:  November 5, 2014 Corresponding author:  Dr. Eun Jig Lee, Division of Endocrinology, Department of  Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodae - mun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/0d/de/ymj-56-1338.PMC4541664.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/de/ymj-56-1338.PMC4541664.pdf
"1339 http://dx.doi.org/10.3349/ymj.2015.56.5.1338Sena Hwang, et al.",OADS,/arxiv_data1/oa_pdf/0d/de/ymj-56-1338.PMC4541664.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1338 1340Focal Lymphocytic Thyroiditis and Thyroid Cancer entiating between PTC and FLT using receiver operating char - acteristic (ROC) curve analysis, which was 2.50 μIU/mL, with a  sensitivity of 53% and specificity of 80%.",OADS,/arxiv_data1/oa_pdf/0d/de/ymj-56-1338.PMC4541664.pdf
"1341 http://dx.doi.org/10.3349/ymj.2015.56.5.1338Sena Hwang, et al.",OADS,/arxiv_data1/oa_pdf/0d/de/ymj-56-1338.PMC4541664.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1338 1342Focal Lymphocytic Thyroiditis and Thyroid Cancer cation (OR=12.487, p=0.042) and presence of a DTD pattern on  US (OR=17.079, p=0.004) remained significant in large FLTs  ≥10 mm.",Non-OADS,/arxiv_data1/oa_pdf/0d/de/ymj-56-1338.PMC4541664.pdf
"1343 http://dx.doi.org/10.3349/ymj.2015.56.5.1338Sena Hwang, et al.",OADS,/arxiv_data1/oa_pdf/0d/de/ymj-56-1338.PMC4541664.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1338 1344Focal Lymphocytic Thyroiditis and Thyroid Cancer ments based on nodule size.20 Our study also showed different  predictors for FLT according to nodule size.,OADS,/arxiv_data1/oa_pdf/0d/de/ymj-56-1338.PMC4541664.pdf
"Key Words:   Volume NTTM software, nuchal translucency, angle deviation, image size, tissue harmonic imaging, speckle reduction  filterYonsei Med J 2015 Sep;56(5):1345-1351 http://dx.doi.org/10.3349/ymj.2015.56.5.1345Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 29, 2014   Revised:  December 10, 2014 Accepted:  December 11, 2014 Corresponding author:  Dr. Ja-Young Kwon, Division of Maternal-Fetal Medicine,  Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Yon - sei University Health System, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/6b/7b/ymj-56-1345.PMC4541665.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/7b/ymj-56-1345.PMC4541665.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1345 1346Image Settings for Using Volume NTTM ables a sharper image to be obtained without degrading the  image quality caused by using a low frequency in the NT mea - surement.8 Also, speckle should be filtered out to measure the  exact NT value, as speckle can be a confounding factor in the  captured ultrasound image.9 In light of these findings, the aim of this study was to evalu - ate the influence of magnification, angle of acquisition, THI,  and SRF on NT measurements using Volume NTTM.",Non-OADS,/arxiv_data1/oa_pdf/6b/7b/ymj-56-1345.PMC4541665.pdf
"1347 http://dx.doi.org/10.3349/ymj.2015.56.5.1345Hee Young Cho, et al.",OADS,/arxiv_data1/oa_pdf/6b/7b/ymj-56-1345.PMC4541665.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1345 1348Image Settings for Using Volume NTTM confirm that they were normally distributed.,OADS,/arxiv_data1/oa_pdf/6b/7b/ymj-56-1345.PMC4541665.pdf
"1349 http://dx.doi.org/10.3349/ymj.2015.56.5.1345Hee Young Cho, et al.",OADS,/arxiv_data1/oa_pdf/6b/7b/ymj-56-1345.PMC4541665.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1345 1350Image Settings for Using Volume NTTM NT measurement.,OADS,/arxiv_data1/oa_pdf/6b/7b/ymj-56-1345.PMC4541665.pdf
"1351 http://dx.doi.org/10.3349/ymj.2015.56.5.1345Hee Young Cho, et al.",OADS,/arxiv_data1/oa_pdf/6b/7b/ymj-56-1345.PMC4541665.pdf
Available at: https://fetalmedicine.org/.,Non-OADS,/arxiv_data1/oa_pdf/6b/7b/ymj-56-1345.PMC4541665.pdf
"Key Words:   Breast neoplasms, diagnosis; breast neoplasms, ultrasonography; cancer screeningYonsei Med J 2015 Sep;56(5):1352-1358 http://dx.doi.org/10.3349/ymj.2015.56.5.1352Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 29, 2014   Revised:  January 10, 2015 Accepted:  January 14, 2015 Corresponding author:  Dr. Boo-Kyung Han, Department of Radiology, Samsung  Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gang - nam-gu, Seoul 135-710, Korea.",Non-OADS,/arxiv_data1/oa_pdf/36/98/ymj-56-1352.PMC4541666.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Mammographic screening is the only proven modality to re - duce mortality of breast cancer, with the rates ranging from 10  to 30%.1-4 Screening breast ultrasound (US) is known to have a  substantial role in the detection of early breast cancer in high  risk women or women with dense breasts.5-10 In 2009, a law was  first enacted in the state of Connecticut requiring all mammog -raphy reports to inform patients of the availability of screening  breast US and MRI to women with dense breasts.",Non-OADS,/arxiv_data1/oa_pdf/36/98/ymj-56-1352.PMC4541666.pdf
"1353 http://dx.doi.org/10.3349/ymj.2015.56.5.1352Ji-Young Hwang, et al.",OADS,/arxiv_data1/oa_pdf/36/98/ymj-56-1352.PMC4541666.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1352 1354Screening Breast US Audit in Asian Women category.,Non-OADS,/arxiv_data1/oa_pdf/36/98/ymj-56-1352.PMC4541666.pdf
"1355 http://dx.doi.org/10.3349/ymj.2015.56.5.1352Ji-Young Hwang, et al.",OADS,/arxiv_data1/oa_pdf/36/98/ymj-56-1352.PMC4541666.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1352 1356Screening Breast US Audit in Asian Women obulated margin (retrospectively, much different from the oth - ers) and it newly appeared since previous imaging.",Non-OADS,/arxiv_data1/oa_pdf/36/98/ymj-56-1352.PMC4541666.pdf
"1357 http://dx.doi.org/10.3349/ymj.2015.56.5.1352Ji-Young Hwang, et al.",OADS,/arxiv_data1/oa_pdf/36/98/ymj-56-1352.PMC4541666.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1352 1358Screening Breast US Audit in Asian Women 2007;8:397-402.,Non-OADS,/arxiv_data1/oa_pdf/36/98/ymj-56-1352.PMC4541666.pdf
"Key Words:   Peritoneal dialysis, noninfectious complication, childrenYonsei Med J 2015 Sep;56(5):1359-1364 http://dx.doi.org/10.3349/ymj.2015.56.5.1359Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 12, 2014   Revised:  October 13, 2014 Accepted:  October 23, 2014 Corresponding author:  Dr. Jae Il Shin, Department of Pediatrics, Yonsei Univer - sity College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/73/0a/ymj-56-1359.PMC4541667.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION For pediatric patients with end stage renal disease (ESRD), the  ultimate goal of treatment is successful kidney transplantation.",Non-OADS,/arxiv_data1/oa_pdf/73/0a/ymj-56-1359.PMC4541667.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1359 1360Noninfectious Complications of Peritoneal Dialysis pital between June 1, 1986 (when detailed medical data were  available) and December 31, 2012 were reviewed retrospec - tively.",Non-OADS,/arxiv_data1/oa_pdf/73/0a/ymj-56-1359.PMC4541667.pdf
"1361 http://dx.doi.org/10.3349/ymj.2015.56.5.1359Ji Eun Kim, et al.",OADS,/arxiv_data1/oa_pdf/73/0a/ymj-56-1359.PMC4541667.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1359 1362Noninfectious Complications of Peritoneal Dialysis complications of PD at Severance Hospital in Korea.,Non-OADS,/arxiv_data1/oa_pdf/73/0a/ymj-56-1359.PMC4541667.pdf
"1363 http://dx.doi.org/10.3349/ymj.2015.56.5.1359Ji Eun Kim, et al.",OADS,/arxiv_data1/oa_pdf/73/0a/ymj-56-1359.PMC4541667.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1359 1364Noninfectious Complications of Peritoneal Dialysis the lipid profile of pediatric patients.,Non-OADS,/arxiv_data1/oa_pdf/73/0a/ymj-56-1359.PMC4541667.pdf
"Key Words:  Attention deficit hyperactivity disorder, heart rate variability, methylphenidate, autonomic nervous systemYonsei Med J 2015 Sep;56(5):1365-1371 http://dx.doi.org/10.3349/ymj.2015.56.5.1365Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  June 23, 2014   Revised:  October 8, 2014 Accepted:  November 5, 2014 Corresponding author:  Dr. Moon-Soo Lee, Department of Psychiatry, Korea Univer - sity, College of Medicine, Korea University Guro Hospital, 148 Gurodong-ro, Guro-gu,  Seoul 152-703, Korea.",Non-OADS,/arxiv_data1/oa_pdf/32/7a/ymj-56-1365.PMC4541668.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/7a/ymj-56-1365.PMC4541668.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1365 1366   Changes of HRV Parameters in ADHD Children other words, mental effort is the exertion necessary to regulate  the subject’s current state.4 Mental effort has been operationalized by the use of various  indices of psychophysiological state, particularly cardiovascu - lar measures, and previous studies have used cardiovascular  activity to index mental effort.5,6 When the efficiency of cognitive inhibition is compared be - tween children with ADHD and healthy age-matched con - trols, children with ADHD were found to be capable of mental  inhibition, but required more effort to do so.7 This also means  that children with ADHD exert greater mental effort to main - tain a particular performance level than healthy children do.",Non-OADS,/arxiv_data1/oa_pdf/32/7a/ymj-56-1365.PMC4541668.pdf
"1367 http://dx.doi.org/10.3349/ymj.2015.56.5.1365Hayeon Jennifer Kim, et al.",OADS,/arxiv_data1/oa_pdf/32/7a/ymj-56-1365.PMC4541668.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1365 1368   Changes of HRV Parameters in ADHD Children cant positive correlation between baseline and endpoint mea - sures (mean heart rate: r=0.394, RMSSD: r=0.546, TP: r=0.350,  LF: r=0.324, HF: r=0.330).",Non-OADS,/arxiv_data1/oa_pdf/32/7a/ymj-56-1365.PMC4541668.pdf
"1369 http://dx.doi.org/10.3349/ymj.2015.56.5.1365Hayeon Jennifer Kim, et al.",OADS,/arxiv_data1/oa_pdf/32/7a/ymj-56-1365.PMC4541668.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1365 1370   Changes of HRV Parameters in ADHD Children altered autonomic functioning and ADHD is established, but  the role of the autonomic regulatory responses in ADHD is  less well understood, and the mechanisms for these changes  in parasympathetic dominance in ADHD remain unclear.",Non-OADS,/arxiv_data1/oa_pdf/32/7a/ymj-56-1365.PMC4541668.pdf
"1371 http://dx.doi.org/10.3349/ymj.2015.56.5.1365Hayeon Jennifer Kim, et al.",OADS,/arxiv_data1/oa_pdf/32/7a/ymj-56-1365.PMC4541668.pdf
"Key Words:   Lung transplantation, postoperative complications, surgical anastomosisYonsei Med J 2015 Sep;56(5):1372-1378 http://dx.doi.org/10.3349/ymj.2015.56.5.1372Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 5, 2014   Revised:  October 29, 2014 Accepted:  December 2, 2014 Corresponding author:  Dr. Hyo Chae Paik, Department of Thoracic and Cardio - vascular Surgery, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodae - mun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b0/56/ymj-56-1372.PMC4541669.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/56/ymj-56-1372.PMC4541669.pdf
"1373 http://dx.doi.org/10.3349/ymj.2015.56.5.1372Eun Na Cho, et al.",OADS,/arxiv_data1/oa_pdf/b0/56/ymj-56-1372.PMC4541669.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1372 1374   Anastomotic Airway Complications after LTx tabolites.,Non-OADS,/arxiv_data1/oa_pdf/b0/56/ymj-56-1372.PMC4541669.pdf
"1375 http://dx.doi.org/10.3349/ymj.2015.56.5.1372Eun Na Cho, et al.",OADS,/arxiv_data1/oa_pdf/b0/56/ymj-56-1372.PMC4541669.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1372 1376   Anastomotic Airway Complications after LTx Early anastomotic airway complications after LTx Early anastomotic airway complications were defined as com - plications that developed within 3 months of LTx.,Non-OADS,/arxiv_data1/oa_pdf/b0/56/ymj-56-1372.PMC4541669.pdf
"1377 http://dx.doi.org/10.3349/ymj.2015.56.5.1372Eun Na Cho, et al.",OADS,/arxiv_data1/oa_pdf/b0/56/ymj-56-1372.PMC4541669.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1372 1378   Anastomotic Airway Complications after LTx Moreno, et al.6 reported that the risk factors for anastomotic  complications include double LTx, post-transplantation airway  colonization, and post-transplant intubation longer than 72  hours.",Non-OADS,/arxiv_data1/oa_pdf/b0/56/ymj-56-1372.PMC4541669.pdf
"Key Words:   Etanercept, knee osteoarthritis, painYonsei Med J 2015 Sep;56(5):1379-1383 http://dx.doi.org/10.3349/ymj.2015.56.5.1379Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 11, 2014   Revised:  September 9, 2014 Accepted:  September 23, 2014 Corresponding author:  Dr. Seiji Ohtori, Department of Orthopaedic Surgery, Grad - uate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/dc/99/ymj-56-1379.PMC4541670.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Many patients suffer from knee osteoarthritis (OA) pin.",Non-OADS,/arxiv_data1/oa_pdf/dc/99/ymj-56-1379.PMC4541670.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1379 1380Etanercept for Knee Pain ly to experience neuropathic pain.5,6 One of the sources of knee pain in OA is believed to be relat - ed to local chronic inflammation and sensory nerve injury of  the knee joints, which involves the production of inflammatory  cytokines such as tumor necrosis factor- α (TNFα), interleukin  (IL)-6, and nerve growth factor (NGF) in the synovial mem - brane and subchondral bone; these cytokines are believed to  promote pain from OA.7-9 TNFα and IL-6 concentrations in sy - novial fluid are correlated with knee OA progression and West - ern Ontario and McMaster Universitie’s Osteoarthritis Index  (WOMAC) scores, including a pain score, in patients with knee  OA.7 Knee samples obtained from patients during surgery  showed that sensory nerve fibers, cyclooxygenase, TNF α, and  NGF are significantly increased, and these findings are closely  related with the pathogenesis of pain.8,9 A systematic review of recommendations and guidelines for  the management of knee OA has been reported.10 Pharmaco - logic modalities most recommended include acetaminophen/ paracetamol (first-line) and non-steroidal anti-inflammatory  drugs (NSAIDs) (topical or oral, second-line), and intra-articu - lar corticosteroids are generally recommended for knee OA,  while tramadol is recommended and consideration can be  given to opioid treatment for refractory symptoms.",Non-OADS,/arxiv_data1/oa_pdf/dc/99/ymj-56-1379.PMC4541670.pdf
"1381 http://dx.doi.org/10.3349/ymj.2015.56.5.1379Seiji Ohtori, et al.",OADS,/arxiv_data1/oa_pdf/dc/99/ymj-56-1379.PMC4541670.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1379 1382Etanercept for Knee Pain tanezumab was significantly associated with a reduction in  joint pain and improvement in function compared with place - bo.13 Patients (n=83) with a KL grade of 2 –4 were evaluated via  radiographic assessment: by week 8, intravenous injection of  tanezumab significantly improved knee pain and the WOMAC  score compared with placebo,15 while seven patients reported  adverse events of abnormal peripheral sensation such as allo - dynia, paresthesia, dysesthesia, thermohypoesthesia, and hy - popallesthesia.",Non-OADS,/arxiv_data1/oa_pdf/dc/99/ymj-56-1379.PMC4541670.pdf
Available at: http://www.cdc.gov/arthritis/arthri - tis/osteoarthritis.htm.,Non-OADS,/arxiv_data1/oa_pdf/dc/99/ymj-56-1379.PMC4541670.pdf
"1383 http://dx.doi.org/10.3349/ymj.2015.56.5.1379Seiji Ohtori, et al.",OADS,/arxiv_data1/oa_pdf/dc/99/ymj-56-1379.PMC4541670.pdf
"Key Words:  Musculoskeletal pain, vitamin D deficiency, childrenYonsei Med J 2015 Sep;56(5):1384-1388 http://dx.doi.org/10.3349/ymj.2015.56.5.1384Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 11, 2014   Revised:  October 18, 2014 Accepted:  October 25, 2014 Corresponding author:  Dr. Sun Young Joo, Department of Orthopedic Surgery,  Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Ko - rea, 56 Dongsu-ro, Bupyeong-gu, Incheon 403-720, Korea.",Non-OADS,/arxiv_data1/oa_pdf/40/bd/ymj-56-1384.PMC4541671.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/bd/ymj-56-1384.PMC4541671.pdf
"1385 http://dx.doi.org/10.3349/ymj.2015.56.5.1384Min Jung Park, et al.",OADS,/arxiv_data1/oa_pdf/40/bd/ymj-56-1384.PMC4541671.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1384 1386Vitamin D Deficiency and Lower-Extremity Pain The average serum 25-(OH)D level was lowest in the winter  (17.2±5.5 ng/mL) and highest in the fall (22.7±8.4 ng/mL) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/40/bd/ymj-56-1384.PMC4541671.pdf
"1387 http://dx.doi.org/10.3349/ymj.2015.56.5.1384Min Jung Park, et al.",OADS,/arxiv_data1/oa_pdf/40/bd/ymj-56-1384.PMC4541671.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1384 1388Vitamin D Deficiency and Lower-Extremity Pain Association between nonspecific skeletal pain and vitamin D defi - ciency.,Non-OADS,/arxiv_data1/oa_pdf/40/bd/ymj-56-1384.PMC4541671.pdf
"Key Words:   Total thyroidectomy, thyroid-associated orbitopathy, TSH receptor autoantibody, thyroid cancer, thyroid benign massYonsei Med J 2015 Sep;56(5):1389-1394 http://dx.doi.org/10.3349/ymj.2015.56.5.1389Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 29, 2014   Revised:  October 28, 2014 Accepted:  December 1, 2014 Corresponding author:  Dr. Jin Sook Yoon, Department of Ophthalmology, Sever - ance Hospital, Institute of Vision Research, Yonsei University College of Medicine,  50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/12/4e/ymj-56-1389.PMC4541672.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/4e/ymj-56-1389.PMC4541672.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1389 1390TAO after Total Thyroidectomy performed from 1966 to 1993 to remove thyroid nodules, only  four GD cases (0.24%) were reported.",Non-OADS,/arxiv_data1/oa_pdf/12/4e/ymj-56-1389.PMC4541672.pdf
"1391 http://dx.doi.org/10.3349/ymj.2015.56.5.1389Sun Young Jang, et al.",OADS,/arxiv_data1/oa_pdf/12/4e/ymj-56-1389.PMC4541672.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1389 1392TAO after Total Thyroidectomy roid cancer who tested positive for TBII yet showed normal  thyroid function, suggesting that TAO may develop due to sys - temic autoimmunity and may not be induced by hyperthyroid -ism.",Non-OADS,/arxiv_data1/oa_pdf/12/4e/ymj-56-1389.PMC4541672.pdf
"1393 http://dx.doi.org/10.3349/ymj.2015.56.5.1389Sun Young Jang, et al.",OADS,/arxiv_data1/oa_pdf/12/4e/ymj-56-1389.PMC4541672.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1389 1394TAO after Total Thyroidectomy sification, characterization, and response to treatment.",Non-OADS,/arxiv_data1/oa_pdf/12/4e/ymj-56-1389.PMC4541672.pdf
"Key Words:   Facial bones, aging, computed tomography, vector, AsianYonsei Med J 2015 Sep;56(5):1395-1400 http://dx.doi.org/10.3349/ymj.2015.56.5.1395Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  September 30, 2014   Revised:  December 16, 2014 Accepted:  December 16, 2014 Corresponding author:  Dr. Jung Ho Bae, Department of Otorhinolaryngology-Head  and Neck Surgery, Ewha Womans University, School of Medicine, 1071 Anyangcheon- ro, Yangcheon-gu, Seoul 158-710, Korea.",Non-OADS,/arxiv_data1/oa_pdf/49/df/ymj-56-1395.PMC4541673.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/df/ymj-56-1395.PMC4541673.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1395 1396Analysis of Age-Related Changes in Asian Face  ferences between Caucasian and Asian skeletal facial structures  with aging.,Non-OADS,/arxiv_data1/oa_pdf/49/df/ymj-56-1395.PMC4541673.pdf
"1397 http://dx.doi.org/10.3349/ymj.2015.56.5.1395Soo Jin Kim, et al.",OADS,/arxiv_data1/oa_pdf/49/df/ymj-56-1395.PMC4541673.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1395 1398Analysis of Age-Related Changes in Asian Face  young, middle, and old age groups, respectively.",Non-OADS,/arxiv_data1/oa_pdf/49/df/ymj-56-1395.PMC4541673.pdf
"1399 http://dx.doi.org/10.3349/ymj.2015.56.5.1395Soo Jin Kim, et al.",OADS,/arxiv_data1/oa_pdf/49/df/ymj-56-1395.PMC4541673.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1395 1400Analysis of Age-Related Changes in Asian Face  those studies conducted on Caucasians.7,9,11 These ethnic differ - ences may be explained by characteristic features of Asian fa - cial skeletons.",Non-OADS,/arxiv_data1/oa_pdf/49/df/ymj-56-1395.PMC4541673.pdf
"Key Words:   Cardiac arrest, mortality, surgeryYonsei Med J 2015 Sep;56(5):1401-1407 http://dx.doi.org/10.3349/ymj.2015.56.5.1401Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  July 25, 2014   Revised:  October 20, 2014 Accepted:  October 27, 2014 Corresponding author:  Dr. Bon-Nyeo Koo, Department of Anesthesiology and  Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College  of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/47/44/ymj-56-1401.PMC4541674.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/44/ymj-56-1401.PMC4541674.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1401 1402Predicting Mortality after Intraoperative Cardiac Arrest logical status and operative severity.1,4 Although much atten - tion has rightly been focused on issues surrounding the fre- quency and risk factors of cardiac arrest in surgical patients,  there is relatively little information regarding risk assessment  tools that can predict its outcome.",Non-OADS,/arxiv_data1/oa_pdf/47/44/ymj-56-1401.PMC4541674.pdf
"1403 http://dx.doi.org/10.3349/ymj.2015.56.5.1401Shin Hyung Kim, et al.",OADS,/arxiv_data1/oa_pdf/47/44/ymj-56-1401.PMC4541674.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1401 1404Predicting Mortality after Intraoperative Cardiac Arrest Among the 51 patients who experienced intraoperative car - diac arrest, the overall predicted 30-day mortality rates using  POSSUM and P-POSSUM were 65.5% and 57.5%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/47/44/ymj-56-1401.PMC4541674.pdf
"1405 http://dx.doi.org/10.3349/ymj.2015.56.5.1401Shin Hyung Kim, et al.",OADS,/arxiv_data1/oa_pdf/47/44/ymj-56-1401.PMC4541674.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1401 1406Predicting Mortality after Intraoperative Cardiac Arrest hospitals demonstrated that several patient characteristics and  medical conditions were associated with lower survival rates  after perioperative arrest.4 These predictors included older age  and the presence of congestive heart failure, shock, metabolic  abnormality, metastatic malignancy, renal insufficiency, sep - sis, myocardial infarction, and neurologic disability.",Non-OADS,/arxiv_data1/oa_pdf/47/44/ymj-56-1401.PMC4541674.pdf
"1407 http://dx.doi.org/10.3349/ymj.2015.56.5.1401Shin Hyung Kim, et al.",OADS,/arxiv_data1/oa_pdf/47/44/ymj-56-1401.PMC4541674.pdf
"Key Words:   Airway obstruction, obstructive sleep apnea-hypopnea syndrome, propofol, pharmacodynamic modeling, sedation,  target-controlled infusionYonsei Med J 2015 Sep;56(5):1408-1414 http://dx.doi.org/10.3349/ymj.2015.56.5.1408Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 11, 2014   Revised:  October 22, 2014 Accepted:  October 24, 2014 Corresponding author:  Dr. Dong Woo Han, Department of Anesthesiology and  Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College  of Medicine, Gangnam Severance Hospital, 211 Eonju-ro, Gangnam-gu, Seoul 135-720,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/4a/c7/ymj-56-1408.PMC4541675.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/c7/ymj-56-1408.PMC4541675.pdf
"1409 http://dx.doi.org/10.3349/ymj.2015.56.5.1408Bon-Nyeo Koo, et al.",OADS,/arxiv_data1/oa_pdf/4a/c7/ymj-56-1408.PMC4541675.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1408 1410Propofol-Induced Sedation and Airway Obstruction were estimated using the function “LIKELIHOOD LAPLACE  METHOD=conditional” in Nonlinear Mixed Effects Modeling  (NONMEM) software (version VII; GloboMax, Hanover, MD,  USA).",OADS,/arxiv_data1/oa_pdf/4a/c7/ymj-56-1408.PMC4541675.pdf
"A non-parametric bootstrap procedure was performed for in - ternal validation using Perl-speaks-NONMEM (PsN) (version  3.6.2, http://psn.sourceforge.net), and the original data set was  randomly sampled to generate 2000 bootstrap replicates.",OADS,/arxiv_data1/oa_pdf/4a/c7/ymj-56-1408.PMC4541675.pdf
"1411 http://dx.doi.org/10.3349/ymj.2015.56.5.1408Bon-Nyeo Koo, et al.",OADS,/arxiv_data1/oa_pdf/4a/c7/ymj-56-1408.PMC4541675.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1408 1412Propofol-Induced Sedation and Airway Obstruction and airway-obstruction score in patients with OSAHS and  found that the AHI was a significant covariate of Ce50 in the  dynamic relationship between propofol Ce and severe airway  obstruction.,OADS,/arxiv_data1/oa_pdf/4a/c7/ymj-56-1408.PMC4541675.pdf
"1413 http://dx.doi.org/10.3349/ymj.2015.56.5.1408Bon-Nyeo Koo, et al.",OADS,/arxiv_data1/oa_pdf/4a/c7/ymj-56-1408.PMC4541675.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1408 1414Propofol-Induced Sedation and Airway Obstruction 2013;123:2300-5.,Non-OADS,/arxiv_data1/oa_pdf/4a/c7/ymj-56-1408.PMC4541675.pdf
"Key Words:   Postoperative nausea and vomiting, 5-HT3 receptor, ondansetron, genetic polymorphismYonsei Med J 2015 Sep;56(5):1415-1420 http://dx.doi.org/10.3349/ymj.2015.56.5.1415Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  September 19, 2014   Revised:  November 20, 2014 Accepted:  December 9, 2014 Corresponding author:  Dr. Seung Ho Choi, Department of Anesthesiology and  Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College  of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a2/51/ymj-56-1415.PMC4541676.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/51/ymj-56-1415.PMC4541676.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1415 1416Polymorphism of 5-HT3B Receptor Gene receptor antagonists due to gene polymorphisms related to  pharmacokinetics.1,3 However, the variations in gene coding  for the 5-HT3 receptor as a target structure of the drug may  also affect the extent of PONV and the antiemetic effects of  5-HT3 receptor antagonists.8-11 In previous pharmacogenomic studies, Y129S and -100_   -102AAG deletion variants of the 5-HT3B receptor gene were  found to be possibly associated with nausea induced by parox - etine and the clinical response of 5-HT3 receptor antagonists  for chemotherapy-induced nausea and vomiting (CINV), re - spectively.9,10,12,13 We thus hypothesized that these polymor - phisms might have a relationship with the therapeutic failure of  5-HT3 receptor antagonists for PONV treatment.",Non-OADS,/arxiv_data1/oa_pdf/a2/51/ymj-56-1415.PMC4541676.pdf
"1417 http://dx.doi.org/10.3349/ymj.2015.56.5.1415Min-Soo Kim, et al.",OADS,/arxiv_data1/oa_pdf/a2/51/ymj-56-1415.PMC4541676.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1415 1418Polymorphism of 5-HT3B Receptor Gene gery; however, the Y129S genotypes were not related to the  clinical response to ondansetron.",Non-OADS,/arxiv_data1/oa_pdf/a2/51/ymj-56-1415.PMC4541676.pdf
"1419 http://dx.doi.org/10.3349/ymj.2015.56.5.1415Min-Soo Kim, et al.",OADS,/arxiv_data1/oa_pdf/a2/51/ymj-56-1415.PMC4541676.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1415 1420Polymorphism of 5-HT3B Receptor Gene ABCB1 polymorphisms with the efficacy of ondansetron for post - operative nausea and vomiting.,Non-OADS,/arxiv_data1/oa_pdf/a2/51/ymj-56-1415.PMC4541676.pdf
"Key Words:   Alveolar recruitment, one-lung ventilation, positive end-expiratory pressure, supine positionYonsei Med J 2015 Sep;56(5):1421-1427 http://dx.doi.org/10.3349/ymj.2015.56.5.1421Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  October 21, 2014   Revised:  November 17, 2014 Accepted:  November 21, 2014 Corresponding author:  Dr. Young Jun Oh, Department of Anesthesiology and Pain  Medicine, Anesthesia and Pain Research Institute, Severance Hospital, Yonsei Uni - versity College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/90/14/ymj-56-1421.PMC4541677.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/14/ymj-56-1421.PMC4541677.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1421 1422One-Lung Ventilation in the Supine Position has been proposed to minimize atelectasis in the ventilated  lung and thus improve oxygenation.10-15 On the other hand,  the application of PEEP alone may paradoxically increase pul - monary vascular resistance and the shift of blood flow to the  non-ventilated lung, leading to an increase in Qs/Qt and im - pairment of oxygenation.15-17 Therefore, considering that only  slight gravity-dependent pulmonary shift takes place in the  supine position, PEEP per se likely demonstrates both posi - tive and negative effects on Qs/Qt and V/Q matching.",Non-OADS,/arxiv_data1/oa_pdf/90/14/ymj-56-1421.PMC4541677.pdf
MATERIALS AND METHODS This study was approved by the Institutional Review Board  (ref: 4-2011-0301) and registered at http://clinicaltrials.gov  (NCT 01652612).,Non-OADS,/arxiv_data1/oa_pdf/90/14/ymj-56-1421.PMC4541677.pdf
"1423 http://dx.doi.org/10.3349/ymj.2015.56.5.1421Yong Seon Choi, et al.",OADS,/arxiv_data1/oa_pdf/90/14/ymj-56-1421.PMC4541677.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1421 1424One-Lung Ventilation in the Supine Position but also increased arterial oxygenation with no significant  change of Qs/Qt.,Non-OADS,/arxiv_data1/oa_pdf/90/14/ymj-56-1421.PMC4541677.pdf
"1425 http://dx.doi.org/10.3349/ymj.2015.56.5.1421Yong Seon Choi, et al.",OADS,/arxiv_data1/oa_pdf/90/14/ymj-56-1421.PMC4541677.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1421 1426One-Lung Ventilation in the Supine Position patients with normal preoperative pulmonary function un - dergoing micro-coagulation therapy for hepatic tumors.4 In  the other trial, although none of the patients developed hypox - emia, significantly lower PaO 2 values were observed in the su - pine position than in the lateral position during a 15 min- study period of OLV before the start of surgery.6 However, there  were several differences between those studies and our study.",Non-OADS,/arxiv_data1/oa_pdf/90/14/ymj-56-1421.PMC4541677.pdf
"1427 http://dx.doi.org/10.3349/ymj.2015.56.5.1421Yong Seon Choi, et al.",OADS,/arxiv_data1/oa_pdf/90/14/ymj-56-1421.PMC4541677.pdf
"Key Words:  Crowding, clinical protocol, health resourcesYonsei Med J 2015 Sep;56(5):1428-1436 http://dx.doi.org/10.3349/ymj.2015.56.5.1428Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  July 7, 2014   Revised:  October 25, 2014    Accepted:  November 13, 2014 Corresponding author:  Dr.",Non-OADS,/arxiv_data1/oa_pdf/bc/8e/ymj-56-1428.PMC4541678.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/8e/ymj-56-1428.PMC4541678.pdf
"1429 http://dx.doi.org/10.3349/ymj.2015.56.5.1428Won Chul Cha, et al.",OADS,/arxiv_data1/oa_pdf/bc/8e/ymj-56-1428.PMC4541678.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1428 1430The Long-Term Effect of an Independent Capacity Protocol ing the ICP , patient data were converted into time-series data.",OADS,/arxiv_data1/oa_pdf/bc/8e/ymj-56-1428.PMC4541678.pdf
"1431 http://dx.doi.org/10.3349/ymj.2015.56.5.1428Won Chul Cha, et al.",OADS,/arxiv_data1/oa_pdf/bc/8e/ymj-56-1428.PMC4541678.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1428 1432The Long-Term Effect of an Independent Capacity Protocol nificantly lower than the other centers’ slope of -0.0080 hour/ week (95% CI: -0.012 to -0.0042) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/bc/8e/ymj-56-1428.PMC4541678.pdf
"1433 http://dx.doi.org/10.3349/ymj.2015.56.5.1428Won Chul Cha, et al.",OADS,/arxiv_data1/oa_pdf/bc/8e/ymj-56-1428.PMC4541678.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1428 1434The Long-Term Effect of an Independent Capacity Protocol have not produced consistent results.,OADS,/arxiv_data1/oa_pdf/bc/8e/ymj-56-1428.PMC4541678.pdf
"1435 http://dx.doi.org/10.3349/ymj.2015.56.5.1428Won Chul Cha, et al.",OADS,/arxiv_data1/oa_pdf/bc/8e/ymj-56-1428.PMC4541678.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1428 1436The Long-Term Effect of an Independent Capacity Protocol Lowe RA.,OADS,/arxiv_data1/oa_pdf/bc/8e/ymj-56-1428.PMC4541678.pdf
Available at:  http://www.nemc.or.kr/egen/inf.emsin13.do.,Non-OADS,/arxiv_data1/oa_pdf/bc/8e/ymj-56-1428.PMC4541678.pdf
"Key Words:   Spontaneous pneumomediastinum, chest pain, adolescentYonsei Med J 2015 Sep;56(5):1437-1442 http://dx.doi.org/10.3349/ymj.2015.56.5.1437Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 25, 2014   Revised:  November 4, 2014 Accepted:  November 12, 2014 Corresponding author:  Dr. June Huh, Department of Pediatrics, Heart Vascular  Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of  Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/ymj-56-1437.PMC4541679.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Spontaneous pneumomediastinum (SPM) is rare in pediatric  practice, with an incidence of about 1/30000 emergency de - partment referrals1,2 and an average age of 17.5 to 25 years.1-3  SPM is self-limiting and benign in nature, and it usually occurs  in young healthy men without any trigger events or diseas - es.1,2,4 A pressure gradient exists between the peripheral pul - monary alveoli and the hilum, and increased intra-alveolar pressure causes rupture of the terminal alveoli.5-7 Alveolar rup - ture allows air to extend along the pulmonary vasculature to - wards the hilum, the peribronchial spaces, and subsequently,  into the mediastinum.2 The most common symptoms at pre - sentation are the acute onset of pleuritic or retrosternal chest  pain and dyspnea.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/ymj-56-1437.PMC4541679.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1437 1438Spontaneous Pneumomediastinum in Adolescents with Chest Pain the ages of 10 and 18 years who were discharged from Sam - sung Changwon Hospital with a diagnosis of SPM between  March 2005 and June 2013.,Non-OADS,/arxiv_data1/oa_pdf/8d/9f/ymj-56-1437.PMC4541679.pdf
"1439 http://dx.doi.org/10.3349/ymj.2015.56.5.1437Sung Hoon Kim, et al.",OADS,/arxiv_data1/oa_pdf/8d/9f/ymj-56-1437.PMC4541679.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1437 1440Spontaneous Pneumomediastinum in Adolescents with Chest Pain partment referrals.1,2 Among 416 patients, 319 patients initially  presented to the emergency (76.7%) during the study period.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/ymj-56-1437.PMC4541679.pdf
"1441 http://dx.doi.org/10.3349/ymj.2015.56.5.1437Sung Hoon Kim, et al.",OADS,/arxiv_data1/oa_pdf/8d/9f/ymj-56-1437.PMC4541679.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1437 1442Spontaneous Pneumomediastinum in Adolescents with Chest Pain REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/9f/ymj-56-1437.PMC4541679.pdf
"Key Words:   Snakebite, antivenom, severity, surgical managementYonsei Med J 2015 Sep;56(5):1443-1448 http://dx.doi.org/10.3349/ymj.2015.56.5.1443Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  February 27, 2014   Revised:  November 14, 2014 Accepted:  November 21, 2014 Corresponding author:  Dr. Jung Ho Rha, Department of Orthopedics, Yonsei  University Wonju College of Medicine, 20 Ilsan-ro, Wonju 220-701, Korea.",Non-OADS,/arxiv_data1/oa_pdf/42/2f/ymj-56-1443.PMC4541680.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Venomous snakes have specialized teeth (fangs) that release  venom from venom glands connected to the fangs.",Non-OADS,/arxiv_data1/oa_pdf/42/2f/ymj-56-1443.PMC4541680.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1443 1444Snakebite in Korea pitals as well.,OADS,/arxiv_data1/oa_pdf/42/2f/ymj-56-1443.PMC4541680.pdf
"1445 http://dx.doi.org/10.3349/ymj.2015.56.5.1443Jung Ho Rha, et al.",OADS,/arxiv_data1/oa_pdf/42/2f/ymj-56-1443.PMC4541680.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1443 1446Snakebite in Korea female ratio was approximately 2.3:1.,OADS,/arxiv_data1/oa_pdf/42/2f/ymj-56-1443.PMC4541680.pdf
"1447 http://dx.doi.org/10.3349/ymj.2015.56.5.1443Jung Ho Rha, et al.",OADS,/arxiv_data1/oa_pdf/42/2f/ymj-56-1443.PMC4541680.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1443 1448Snakebite in Korea quent complications, such as anaphylactic shock; therefore,  Crotalidae Polyvalent Immune F ab, which utilizes the binding  site of immunoglobulin with the snake toxin, was developed in  2002, and it has received approval from the Korea Food and  Drug Administration.",Non-OADS,/arxiv_data1/oa_pdf/42/2f/ymj-56-1443.PMC4541680.pdf
"Key Words:   High-dose vitamin C, multiple pulmonary metastases, hepatocellular carcinomaYonsei Med J 2015 Sep;56(5):1449-1452 http://dx.doi.org/10.3349/ymj.2015.56.5.1449Case Report pISSN: 0513-5796 · eISSN: 1976-2437 Received:  June 17, 2014   Revised:  August 22, 2014 Accepted:  October 3, 2014 Corresponding author:  Dr. Jae-Yong Shim, Department of Family Medicine, Yonsei  University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-720, Korea.",Non-OADS,/arxiv_data1/oa_pdf/46/67/ymj-56-1449.PMC4541681.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Ascorbate (vitamin C) is a fundamental vitamin for human life  as an important antioxidant by blocking damage from free radi - cals,1 and acts as a cofactor for hydroxyl enzymes in collagen  synthesis which has been thought to prevent tumor spread - ing.2,3 On the other hand, high-dose vitamin C can act as a pro- oxidant, conferring selective toxic effects on cancer cells.4 Also,  it may exert anti-inflammatory activity resulting in suppression  of tumor proliferation, angiogenesis, and metastasis.5 High- dose vitamin C supplementation has been widely used as com - plementary and alternative medicine, particularly in cancer  patients.6 Although there is a paucity of clinical research data to  confirm the effects of vitamin C on cancer, some interesting case reports have suggested the clinical prospect of high-dose  vitamin C therapy.7,8 One of these is similar to our report, except  it involved multiple pulmonary metastases originating from re - nal cell cancer.8 Here, we report a case of regression of multiple  pulmonary metastases originating from hepatocellular carci - noma after high-dose vitamin C therapy.",Non-OADS,/arxiv_data1/oa_pdf/46/67/ymj-56-1449.PMC4541681.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1449 1450Pulmonary Metastasis and High-Dose Vitamin C with anorexia and general weakness in September 2011 re - questing high-dose vitamin C to manage her symptoms.,Non-OADS,/arxiv_data1/oa_pdf/46/67/ymj-56-1449.PMC4541681.pdf
"1451 http://dx.doi.org/10.3349/ymj.2015.56.5.1449Min-Seok Seo, et al.",OADS,/arxiv_data1/oa_pdf/46/67/ymj-56-1449.PMC4541681.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1449 1452Pulmonary Metastasis and High-Dose Vitamin C can only be reached by intravenous administration.16 There - fore, further clinical studies to evaluate the anti-cancer effects  of intravenous high-dose vitamin C are warranted.",Non-OADS,/arxiv_data1/oa_pdf/46/67/ymj-56-1449.PMC4541681.pdf
"Key Words:   Invasive aspergillosis, colon perforation, immunocompetent hostYonsei Med J 2015 Sep;56(5):1453-1456 http://dx.doi.org/10.3349/ymj.2015.56.5.1453Case Report pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 11, 2014   Revised:  September 19, 2014 Accepted:  September 22, 2014 Corresponding author:  Dr. Hoon Suk Park, Division of Nephrology, Department  of Internal Medicine, College of Medicine, The Catholic University of Korea, St.  Vincent’s Hospital, 93 Jungbu-daero, Paldal-gu, Suwon 442-723, Korea.",Non-OADS,/arxiv_data1/oa_pdf/33/6c/ymj-56-1453.PMC4541682.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Invasive aspergillosis (IA) usually occurs in immunocompro - mised hosts.1 Classical risk factors include prolonged neutro - penia, use of high-dose steroids or immunosuppressive agents,  and conditions leading to impaired cellular immune respons - es such as human immunodeficiency virus infection or hema - tologic malignancies.1-3 IA typically involves the lungs, but may also infect the nasal  sinuses, central nervous system, and rarely gastrointestinal (GI)  system.1,3,4 GI aspergillosis is usually the result of organ involve - ment from disseminated systemic infection; isolated GI asper -gillosis is rare even in immunocompromised hosts.",Non-OADS,/arxiv_data1/oa_pdf/33/6c/ymj-56-1453.PMC4541682.pdf
http://dx.doi.org/10.3349/ymj.2015.56.5.1453 1454Colonic Aspergillosis in an Immunocompetent Host phy (CT) scans showed multiple consolidation and ground  glass opacities in both lung fields (Fig.,Non-OADS,/arxiv_data1/oa_pdf/33/6c/ymj-56-1453.PMC4541682.pdf
"1455 http://dx.doi.org/10.3349/ymj.2015.56.5.1453Seon Ah Cha, et al.",OADS,/arxiv_data1/oa_pdf/33/6c/ymj-56-1453.PMC4541682.pdf
"http://dx.doi.org/10.3349/ymj.2015.56.5.1453 1456Colonic Aspergillosis in an Immunocompetent Host Chapuis B, et al.",OADS,/arxiv_data1/oa_pdf/33/6c/ymj-56-1453.PMC4541682.pdf
"Mil Med 2003;  168:969-74.The Preventive Effect of Belongings in Penetrating  Trauma Sezai Çubuk1 and Orhan Yücel2 1Department of Thoracic Surgery, Gata Medical Faculty, Ankara;   2Department of Thoracic Surgery, Gata Haydarpasa Teaching Hospital, Istanbul, Turkey.Yonsei Med J 2015 Sep;56(5):1457-1457 http://dx.doi.org/10.3349/ymj.2015.56.5.1457Letter to the Editor pISSN: 0513-5796 · eISSN: 1976-2437 Received:  January 30, 2015 Accepted:  April 17, 2015 Corresponding author:  Dr. Sezai Çubuk, Department of Thoracic Surgery, Gata  Medical Faculty, Gata Gogus Cerrahisi AD, 06010 Etlik, Ankara, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/ab/22/ymj-56-1457.PMC4541683.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/22/ymj-56-1457.PMC4541683.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b4/c0/10620_2015_Article_3675.PMC4541702.pdf
March 2012. http://www.nashp.org/pub lication/shared-decisionmaking-advancing-patient-centered-care- through-state-and-federal .,Non-OADS,/arxiv_data1/oa_pdf/b4/c0/10620_2015_Article_3675.PMC4541702.pdf
http://dx.doi.org/10.1590/S1806-37132015000300001Bringing the JBP and its readers closer together O JBP mais próximo do leitor Rogério Souza1 1.,Non-OADS,/arxiv_data1/oa_pdf/42/a9/1806-3713-jbpneu-41-03-00209.PMC4541754.pdf
Souza R http://dx.doi.org/10.1590/S1806-371320150003000013.,Non-OADS,/arxiv_data1/oa_pdf/42/a9/1806-3713-jbpneu-41-03-00209.PMC4541754.pdf
2014;20(6):285-6.  http://dx.doi.org/10.1016/j.rppneu.2014.11.001 4.,OADS,/arxiv_data1/oa_pdf/42/a9/1806-3713-jbpneu-41-03-00209.PMC4541754.pdf
2014;40(1):30-7. http://dx.doi.org/10.1590/ S1806-37132014000100005 6.,Non-OADS,/arxiv_data1/oa_pdf/42/a9/1806-3713-jbpneu-41-03-00209.PMC4541754.pdf
2013;39(4):427-33.  http://dx.doi.org/10.1590/S1806-37132013000400005 8.,Non-OADS,/arxiv_data1/oa_pdf/42/a9/1806-3713-jbpneu-41-03-00209.PMC4541754.pdf
2013;39(2):238-41.  http://dx.doi.org/10.1590/S1806-37132013000200016 9.,Non-OADS,/arxiv_data1/oa_pdf/42/a9/1806-3713-jbpneu-41-03-00209.PMC4541754.pdf
2014;40(6):609-16. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/a9/1806-3713-jbpneu-41-03-00209.PMC4541754.pdf
2014;40(4):421-4. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/a9/1806-3713-jbpneu-41-03-00209.PMC4541754.pdf
2015;41(1):1-2. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/a9/1806-3713-jbpneu-41-03-00209.PMC4541754.pdf
2014;40(4):325-6. http://dx.doi.org/10.1590/ S1806-37132014000400001 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/42/a9/1806-3713-jbpneu-41-03-00209.PMC4541754.pdf
"http://dx.doi.org/10.1590/S1806-37132015000004483Six-minute walk test and respiratory muscle strength in  patients with uncontrolled severe asthma: a pilot study* Teste de caminhada de seis minutos e força muscular respiratória em  pacientes com asma grave não controlada: um estudo piloto Luiz Fernando Ferreira Pereira1, Eliane Viana Mancuzo2,   Camila Farnese Rezende3, Ricardo de Amorim Côrrea4 Abstract Objective: To evaluate respiratory muscle strength and six-minute walk test (6MWT) variables in patients with  uncontrolled severe asthma (UCSA).",Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
"Pereira LFF, Mancuzo EV, Rezende CF, Corrêa RA http://dx.doi.org/10.1590/S1806-37132015000004483The diagnosis of severe asthma was based  on the American Thoracic Society/European  Respiratory Society (ATS/ERS) criteria,(13) as follows:  •	major	criteria—use	 of	oral	corticosteroids	 for	 at least six months per year and continuous  use of high-dose ICs (≥  1,600 µg of  budesonide or equivalent) in association  with LABAs  •	minor	criteria—FEV1 of < 80%; PEF variability  > 20%; daily use of short-acting β2 agonists;  use of more than three courses of oral  corticosteroids per year; history of near-fatal  asthma; one or more emergency room visits  in the previous year; and rapid decline in  lung function after a decrease in the dose  of corticosteroid therapy  The patients who were included in the present  study received outpatient treatment for at least  six months in order to control environmental  factors and comorbidities, as well as to improve  inhaler technique and treatment adherence.",Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
"Six-minute walk test and respiratory muscle strength in  patients with uncontrolled severe asthma: a pilot study http://dx.doi.org/10.1590/S1806-37132015000004483software, version 16 (Minitab Inc., State College,  MA, USA).",Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
"Pereira LFF, Mancuzo EV, Rezende CF, Corrêa RA http://dx.doi.org/10.1590/S1806-37132015000004483normal, 7 (28%) and 11 (44%) of the 25 patients  studied had reduced MIP and MEP (of < 65% of  predicted), respectively (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
Six-minute walk test and respiratory muscle strength in  patients with uncontrolled severe asthma: a pilot study http://dx.doi.org/10.1590/S1806-37132015000004483controlled despite treatment.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
"Pereira LFF, Mancuzo EV, Rezende CF, Corrêa RA http://dx.doi.org/10.1590/S1806-37132015000004483submaximal test, and cardiac ischemia.",Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
Six-minute walk test and respiratory muscle strength in  patients with uncontrolled severe asthma: a pilot study http://dx.doi.org/10.1590/S1806-371320150000044832014 Oct 1].,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
2008;197(1):1-10. http://dx.doi.org/10.1677/JOE-07-0606 7.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
http://dx.doi.org/10.1378/ chest.97.3_Supplement.69S-a 8.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
2011;37(1):110-7.  http://dx.doi.org/10.1590/S1806-37132011000100016 9.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
1998;158(5 Pt 1):1384-7. http://dx.doi.org/10.1164/ ajrccm.158.5.9710086 10.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
2012;18(4):160-5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
2010;16(3):463-70.  http://dx.doi.org/10.1016/S0873-2159(15)30042-8 13.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
2000;162(6):2341-51. http://dx.doi.org/10.1164/ ajrccm.162.6.ats9-00 14.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
2002;166(1):111-7. http://dx.doi.org/10.1164/ ajrccm.166.1.at1102 15.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
2001;38(7):1980-7.  http://dx.doi.org/10.1016/S0735-1097(01)01652-7 16.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
1999;341(18):1351-7.  http://dx.doi.org/10.1056/NEJM199910283411804 17.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
2011;124(14):1520-6.  http://dx.doi.org/10.1161/CIRCULATIONAHA.110.005009 18.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
2007;33(4):397-406. http://dx.doi.org/10.1590/ S1806-37132007000400008 20.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
1998;12(5):1209-18 http://dx.doi.org/10.1183/090 31936.98.12051209 4.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
2014;43(2):343-73. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
"Pereira LFF, Mancuzo EV, Rezende CF, Corrêa RA http://dx.doi.org/10.1590/S1806-37132015000004483tables for clinical studies.",Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
1999;66(4):332-7. http://dx.doi.org/10.1159/000029403 29.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
2012;38(3):308- 14. http://dx.doi.org/10.1590/S1806-37132012000300005 30.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
1994;150(1):11-6. http://dx.doi.org/10.1164/ ajrccm.150.1.8025735 31.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
1998;53(1):39-42. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
2004;113(1):59-65. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
2010;36(2):159-66.  http://dx.doi.org/10.1590/S1806-37132010000200002 23.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
2012;49(3):317-23. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
Available from: https://www.academia.edu/5346814/ Guidelines_for_Data_Processing_and_Analysis_of_the_ International_Physical_Activity_Questionnaire_IPAQ_ Short_and_Long_Forms_Contents 25.,Non-OADS,/arxiv_data1/oa_pdf/d2/b8/1806-3713-jbpneu-41-03-00211.PMC4541755.pdf
"http://dx.doi.org/10.1590/S1806-37132015000004466Diagnostic yield of endobronchial ultrasound-guided  transbronchial needle aspiration for mediastinal   staging in lung cancer* Rendimiento diagnóstico de la ultrasonografía endobronquial con  aspiración transbronquial por aguja fina en el estudio de etapificación  mediastínica en pacientes con cáncer pulmonar Sebastián Fernández-Bussy1, Gonzalo Labarca2, Sofia Canals3,   Iván Caviedes4, Erik Folch5, Adnan Majid6 Abstract Object ive: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally  invasive diagnostic test with a high diagnostic yield for suspicious central pulmonary lesions and for mediastinal  lymph node staging.",Non-OADS,/arxiv_data1/oa_pdf/d6/3b/1806-3713-jbpneu-41-03-00219.PMC4541756.pdf
"Fernández-Bussy S, Labarca G, Canals S, Caviedes I, Folch E, Majid A http://dx.doi.org/10.1590/S1806-37132015000004466Alemana of Santiago, Universidad del Desarrollo ,  Santiago, Chile.",Non-OADS,/arxiv_data1/oa_pdf/d6/3b/1806-3713-jbpneu-41-03-00219.PMC4541756.pdf
"Diagnostic yield of endobronchial ultrasound-guided transbronchial  needle aspiration for mediastinal staging in lung cancer http://dx.doi.org/10.1590/S1806-37132015000004466was 93.9, whereas the likelihood ratio for a  negative diagnostic result was 0.06.",Non-OADS,/arxiv_data1/oa_pdf/d6/3b/1806-3713-jbpneu-41-03-00219.PMC4541756.pdf
"Fernández-Bussy S, Labarca G, Canals S, Caviedes I, Folch E, Majid A http://dx.doi.org/10.1590/S1806-37132015000004466diagnostic yield of pulmonary lesions suggestive  of cancer do not have the reference standard  applied to all positive histologic results.",Non-OADS,/arxiv_data1/oa_pdf/d6/3b/1806-3713-jbpneu-41-03-00219.PMC4541756.pdf
"Diagnostic yield of endobronchial ultrasound-guided transbronchial  needle aspiration for mediastinal staging in lung cancer http://dx.doi.org/10.1590/S1806-37132015000004466this study was conducted in a single center, with  the same operator.",Non-OADS,/arxiv_data1/oa_pdf/d6/3b/1806-3713-jbpneu-41-03-00219.PMC4541756.pdf
2003;123(5):1693-717. http://dx.doi.org/10.1378/ chest.123.5.1693 3.,Non-OADS,/arxiv_data1/oa_pdf/d6/3b/1806-3713-jbpneu-41-03-00219.PMC4541756.pdf
2009;103(10):1406-14. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d6/3b/1806-3713-jbpneu-41-03-00219.PMC4541756.pdf
2013;20(1):66-76. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d6/3b/1806-3713-jbpneu-41-03-00219.PMC4541756.pdf
2009;45(8):1389-96.  http://dx.doi.org/10.1016/j.ejca.2008.11.043 6.,OADS,/arxiv_data1/oa_pdf/d6/3b/1806-3713-jbpneu-41-03-00219.PMC4541756.pdf
2009;4(5):568-77. http://dx.doi.org/10.1097/ JTO.0b013e3181a0d82e 7.,Non-OADS,/arxiv_data1/oa_pdf/d6/3b/1806-3713-jbpneu-41-03-00219.PMC4541756.pdf
2009;9(4):413-23. http://dx.doi.org/10.1586/era.09.11 8.,Non-OADS,/arxiv_data1/oa_pdf/d6/3b/1806-3713-jbpneu-41-03-00219.PMC4541756.pdf
2015;3(4):282-9. http://dx.doi.org/10.1016/ S2213-2600(15)00029-6 10.,OADS,/arxiv_data1/oa_pdf/d6/3b/1806-3713-jbpneu-41-03-00219.PMC4541756.pdf
"Fernández-Bussy S, Labarca G, Canals S, Caviedes I, Folch E, Majid A http://dx.doi.org/10.1590/S1806-3713201500000446612.",Non-OADS,/arxiv_data1/oa_pdf/d6/3b/1806-3713-jbpneu-41-03-00219.PMC4541756.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d6/3b/1806-3713-jbpneu-41-03-00219.PMC4541756.pdf
2014;87(4):343-51. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d6/3b/1806-3713-jbpneu-41-03-00219.PMC4541756.pdf
"http://dx.doi.org/10.1590/S1806-37132015000004338Mobility therapy and central or peripheral catheter-related  adverse events in an ICU in Brazil* Realização de fisioterapia motora e ocorrência de eventos adversos  relacionados a cateteres centrais e periféricos em uma UTI brasileira Natália Pontes Lima, Gregório Marques Cardim da Silva,   Marcelo Park, Ruy Camargo Pires-Neto Abstract Objective: To determine whether mobility therapy is associated with central or peripheral catheter-related  adverse events in critically ill patients in an ICU in Brazil.",Non-OADS,/arxiv_data1/oa_pdf/3e/44/1806-3713-jbpneu-41-03-00225.PMC4541757.pdf
"Lima NP, Silva GMC, Park M, Pires-Neto RC http://dx.doi.org/10.1590/S1806-371320150000043381:6 resident in physical therapy/patient, and  1:10 senior physical therapist/patient.",Non-OADS,/arxiv_data1/oa_pdf/3e/44/1806-3713-jbpneu-41-03-00225.PMC4541757.pdf
"Mobility therapy and central or peripheral catheter-related adverse events in an ICU in Brazil http://dx.doi.org/10.1590/S1806-37132015000004338sessions; orthostasis, in 161 sessions; sitting in  an armchair, in 91 sessions; sitting on the edge  of the bed, in 60 sessions; and in-bed exercise,  in 879 sessions.",Non-OADS,/arxiv_data1/oa_pdf/3e/44/1806-3713-jbpneu-41-03-00225.PMC4541757.pdf
"Lima NP, Silva GMC, Park M, Pires-Neto RC http://dx.doi.org/10.1590/S1806-37132015000004338However, the large number of physical therapists  did not imply treatment aimed at more complex  levels of mobilization, the most prevalent activity  being in-bed exercise.",Non-OADS,/arxiv_data1/oa_pdf/3e/44/1806-3713-jbpneu-41-03-00225.PMC4541757.pdf
Mobility therapy and central or peripheral catheter-related adverse events in an ICU in Brazil http://dx.doi.org/10.1590/S1806-371320150000043382.,Non-OADS,/arxiv_data1/oa_pdf/3e/44/1806-3713-jbpneu-41-03-00225.PMC4541757.pdf
2008;36(8):2238-43. http://dx.doi.org/10.1097/ CCM.0b013e318180b90e 3.,Non-OADS,/arxiv_data1/oa_pdf/3e/44/1806-3713-jbpneu-41-03-00225.PMC4541757.pdf
2007;23(1):1-20. http://dx.doi.org/10.1016/j.ccc.2006.11.003 8.,OADS,/arxiv_data1/oa_pdf/3e/44/1806-3713-jbpneu-41-03-00225.PMC4541757.pdf
2011;2(1):32-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/44/1806-3713-jbpneu-41-03-00225.PMC4541757.pdf
2013;28(6):980-4. http://dx.doi.org/10.1016/j.jcrc.2013.06.001 12.,OADS,/arxiv_data1/oa_pdf/3e/44/1806-3713-jbpneu-41-03-00225.PMC4541757.pdf
http://dx.doi.org/10.1097/ CCM.0b013e3181957449 14.,Non-OADS,/arxiv_data1/oa_pdf/3e/44/1806-3713-jbpneu-41-03-00225.PMC4541757.pdf
2010;91(4):536-42. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3e/44/1806-3713-jbpneu-41-03-00225.PMC4541757.pdf
2009;373(9678):1874- 82. http://dx.doi.org/10.1016/S0140-6736(09)60658-9 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/3e/44/1806-3713-jbpneu-41-03-00225.PMC4541757.pdf
"Lima NP, Silva GMC, Park M, Pires-Neto RC http://dx.doi.org/10.1590/S1806-37132015000004338cohort study.",Non-OADS,/arxiv_data1/oa_pdf/3e/44/1806-3713-jbpneu-41-03-00225.PMC4541757.pdf
2010;25(2):254-62. http://dx.doi.org/10.1016/j.jcrc.2009.10.010and occupational therapy beginning from initiation of  mechanical ventilation.,Non-OADS,/arxiv_data1/oa_pdf/3e/44/1806-3713-jbpneu-41-03-00225.PMC4541757.pdf
2010;38(11):2089- 94. http://dx.doi.org/10.1097/CCM.0b013e3181f270c3 17.,Non-OADS,/arxiv_data1/oa_pdf/3e/44/1806-3713-jbpneu-41-03-00225.PMC4541757.pdf
"http://dx.doi.org/10.1590/S1806-37132015000004544Organizing pneumonia: chest HRCT findings* Pneumonia em organização: achados da TCAR de tórax Igor Murad Faria1, Gláucia Zanetti2, Miriam Menna Barreto3,   Rosana Souza Rodrigues4, Cesar Augusto Araujo-Neto5, Jorge Luiz Pereira e Silva5,   Dante Luiz Escuissato6, Arthur Soares Souza Jr7, Klaus Loureiro Irion8,   Alexandre Dias Mançano9, Luiz Felipe Nobre10, Bruno Hochhegger11, Edson Marchiori12  Abstract Objective: To determine the frequency of HRCT findings and their distribution in the lung parenchyma of  patients with organizing pneumonia.",Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
"http://dx.doi.org/10.1590/S1806-37132015000004544with the patients in the supine position and  without intravenous injection of iodinated contrast  material, a high spatial resolution filter (bone  filter) being used for image reconstruction.",Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
Organizing pneumonia: chest HRCT findings http://dx.doi.org/10.1590/S1806-37132015000004544of Diagnostic Imaging consensus guidelines.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
http://dx.doi.org/10.1590/S1806-37132015000004544and sixth decades of life.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
"Organizing pneumonia: chest HRCT findings http://dx.doi.org/10.1590/S1806-37132015000004544ground-glass opacities and consolidations, seen  in 89% and 83%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
http://dx.doi.org/10.1590/S1806-371320150000045443.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
2001;161(2):158-64. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
1997;157(12):1323-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
http://dx.doi.org/10.1016/j.ejrad.2010.10.003 7.,OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
2008;246(3):697-722.  http://dx.doi.org/10.1148/radiol.2462070712 8.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
2010;36(1):99-123. http://dx.doi.org/10.1590/ S1806-37132010000100016 10.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
2007;14(5):422-6.  http://dx.doi.org/10.1097/01.pap.0000249905.63211.a1 12.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
1985;312(3):152-8. http://dx.doi.org/10.1056/ NEJM198501173120304 14.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
1995;108(1):271-7. http://dx.doi.org/10.1378/ chest.108.1.271 15.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
2010;19(116):161-3. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
1992;158(3):515-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
2011;139(4):893-900. http://dx.doi.org/10.1378/ chest.10-0883 2.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
2006;28(2):422-46. http://dx.doi.org/10.118 3/09031936.06.00013505 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
Organizing pneumonia: chest HRCT findings http://dx.doi.org/10.1590/S1806-3713201500000454425.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
2011;140(3):789-91. http://dx.doi.org/10.1378/ chest.11-0055 26.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
2012;141(5):1260-6.  http://dx.doi.org/10.1378/chest.11-1050 27.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
http://dx.doi.org/10.2214/AJR.10.5762 28.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
2012;142(6):1469-73. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
1992;13:119- 33. http://dx.doi.org/10.1055/s-2007-1006264 18.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
1989;96(5):999-1004. http://dx.doi.org/10.1378/ chest.96.5.999 19.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
2008;335(1):34-9.  http://dx.doi.org/10.1097/MAJ.0b013e31815d829d 20.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
2010;195(4):916-22. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
1994;162(3):543-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
1994;18(2):136-47.  http://dx.doi.org/10.1097/00000478-199402000-00003 23.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
2002;12(6):1486- 96. http://dx.doi.org/10.1007/s00330-001-1211-3 24.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
2003;180(5):1251-4. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/1806-3713-jbpneu-41-03-00231.PMC4541758.pdf
"http://dx.doi.org/10.1590/S1806-37132015000004446Psychological criteria for contraindication in lung   transplant candidates: a five-year study* Critérios psicológicos para contraindicação em candidatos a   transplante pulmonar: um estudo de cinco anos Elaine Marques Hojaij1, Bellkiss Wilma Romano1, André Nathan Costa2,   Jose Eduardo Afonso Junior3, Priscila Cilene Leon Bueno de Camargo3,   Rafael Medeiros Carraro3, Silvia Vidal Campos4, Marcos Naoyuki Samano5,   Ricardo Henrique de Oliveira Braga Teixeira6 Abstract Lung transplantation presents a wide range of challenges for multidisciplinary teams that manage the care of the  recipients.",Non-OADS,/arxiv_data1/oa_pdf/74/ed/1806-3713-jbpneu-41-03-00246.PMC4541760.pdf
"Psychological criteria for contraindication in lung transplant candidates: a five-year study http://dx.doi.org/10.1590/S1806-37132015000004446team meetings held between May of 2009 and  May of 2014, with a focus on assessing the  psychological issues.",Non-OADS,/arxiv_data1/oa_pdf/74/ed/1806-3713-jbpneu-41-03-00246.PMC4541760.pdf
"http://dx.doi.org/10.1590/S1806-37132015000004446of lung transplant candidates, because certain  psychosocial factors can be used in order to  identify patients who should not undergo the  procedure.",Non-OADS,/arxiv_data1/oa_pdf/74/ed/1806-3713-jbpneu-41-03-00246.PMC4541760.pdf
2011;184(2):159-71. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/74/ed/1806-3713-jbpneu-41-03-00246.PMC4541760.pdf
2014;33(10):1009-24. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/74/ed/1806-3713-jbpneu-41-03-00246.PMC4541760.pdf
2006;129(5):1367- 74. http://dx.doi.org/10.1378/chest.129.5.1367 4.,Non-OADS,/arxiv_data1/oa_pdf/74/ed/1806-3713-jbpneu-41-03-00246.PMC4541760.pdf
Psychological criteria for contraindication in lung transplant candidates: a five-year study http://dx.doi.org/10.1590/S1806-37132015000004446report from the Pulmonary Scientific Council of the  International Society for Heart and Lung Transplantation.,Non-OADS,/arxiv_data1/oa_pdf/74/ed/1806-3713-jbpneu-41-03-00246.PMC4541760.pdf
2015;41(1):95-7. http://dx.doi.org/10.1590/ S1806-37132015000100012 7.,Non-OADS,/arxiv_data1/oa_pdf/74/ed/1806-3713-jbpneu-41-03-00246.PMC4541760.pdf
2006;3(1):39-47. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/74/ed/1806-3713-jbpneu-41-03-00246.PMC4541760.pdf
"http://dx.doi.org/10.1590/S1806-37132015000000059Small interstitial nodules Pequenos nódulos intersticiais Edson Marchiori1, Gláucia Zanetti2, Bruno Hochhegger3 1.",Non-OADS,/arxiv_data1/oa_pdf/a3/bd/1806-3713-jbpneu-41-03-00250.PMC4541761.pdf
"http://dx.doi.org/10.1590/S1806-37132015000004447Diagnosis of primary ciliary dyskinesia* Diagnóstico de discinesia ciliar primária Mary Anne Kowal Olm1, Elia Garcia Caldini2, Thais Mauad3 Abstract Primary ciliary dyskinesia (PCD) is a genetic disorder of ciliary structure or function.",Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
"Olm MAK, Caldini EG, Mauad T http://dx.doi.org/10.1590/S1806-37132015000004447bending (a forward power stroke and a backward  recovery stroke).",Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
Diagnosis of primary ciliary dyskinesia http://dx.doi.org/10.1590/S1806-37132015000004447and genetic analysis.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
"Olm MAK, Caldini EG, Mauad T http://dx.doi.org/10.1590/S1806-37132015000004447and flagellar axonemes(24,25) are controlled by  common genes and different genes.",OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
Diagnosis of primary ciliary dyskinesia http://dx.doi.org/10.1590/S1806-37132015000004447processes of nasal NO production and metabolism  in PCD patients have yet to be fully elucidated.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
"Olm MAK, Caldini EG, Mauad T http://dx.doi.org/10.1590/S1806-37132015000004447fibrocystic liver disease, retinitis pigmentosa,  and hydrocephalus.",Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
Diagnosis of primary ciliary dyskinesia http://dx.doi.org/10.1590/S1806-37132015000004447across centers.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
"Olm MAK, Caldini EG, Mauad T http://dx.doi.org/10.1590/S1806-37132015000004447ciliary defect elsewhere in the airways.",Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
Diagnosis of primary ciliary dyskinesia http://dx.doi.org/10.1590/S1806-37132015000004447structural defects—has been reported.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
"Olm MAK, Caldini EG, Mauad T http://dx.doi.org/10.1590/S1806-37132015000004447require more aggressive intravenous therapy and  long-term use of inhaled antibiotics.",Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
"Diagnosis of primary ciliary dyskinesia http://dx.doi.org/10.1590/S1806-37132015000004447require psychosocial support in order to cope with  the stigmata attached to the disease, including  infertility and possible school problems.",Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2010;36(6):1248-58. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2012;39(6):1482-91. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2011;111(1):295-302. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2001;27(5):262-68. http://dx.doi.org/10.1590/ S0102-35862001000500006 6.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2008;9(1):88. http://dx.doi.org/10.1038/nrm2278 8.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2009;11(7):473-87. http://dx.doi.org/10.1097/ GIM.0b013e3181a53562 9.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
1999;13(5):1177-88. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2012;6(6):663-82. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2011;268(3):383-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
1998;12(4):982-8. http://dx.doi.org/10.1183/09031936.98.12040982 15.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2014;44(6):1418-22. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2014;44(6):1579-88. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2003;112(3):518- 24. http://dx.doi.org/10.1016/S0091-6749(03)01799-8 18.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
"Olm MAK, Caldini EG, Mauad T http://dx.doi.org/10.1590/S1806-37132015000004447Rev.",Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2009;10(2):44-50. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2001;101(4):339-44. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2011;8(5):434-7. http://dx.doi.org/10.1513/ pats.201103-028SD 41.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2014;99(9):850-6.  http://dx.doi.org/10.1136/archdischild-2013-304831 45.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
1980;303(6):318-22. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2012;65(3):267-71. http://dx.doi.org/10.1136/ jclinpath-2011-200415 47.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2005;29(3-4):217-20. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2003;27(2):123-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2003;58(4):333-8.  http://dx.doi.org/10.1136/thorax.58.4.333 19.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2013;172(2):151-62. http://dx.doi.org/10.1007/ s00431-012-1785-6 20.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2010;181(4):307-14. http://dx.doi.org/10.1164/ rccm.200903-0459OC 22.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2015;4(1):2. http://dx.doi.org/10.1186/s13630-014-0011-8 24.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
1994;49(7):684-7. http://dx.doi.org/10.1136/thx.49.7.684 25.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2014;107(9):691-9. http://dx.doi.org/10.1093/ qjmed/hcu063 26.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
1990;142(3):674-9.  http://dx.doi.org/10.1164/ajrccm/142.3.674 27.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2009;21(3):320-5. http://dx.doi.org/10.1097/MOP.0b013e328329cddb 28.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2011;37(3):559-65. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2012;40(4):1024-32. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2014;44(6):1589-99. http://dx.doi.org/10.1183/09031936.00088614 32.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2013;10(6):574-81. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
Diagnosis of primary ciliary dyskinesia http://dx.doi.org/10.1590/S1806-37132015000004447Respir J.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
1997;10(10):2376-9. http://dx.doi.org/10.11 83/09031936.97.10102376 57.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2009;73(12):1630-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
1996;109(6):1541-4.  http://dx.doi.org/10.1378/chest.109.6.1541 59.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2001;71(6):2008-9.  http://dx.doi.org/10.1016/S0003-4975(00)02276-1 60.,OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2014;5:4418. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
1988;5(1):36-50. http://dx.doi.org/10.1002/ ppul.1950050109 53.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2004;169(4):459-67. http://dx.doi.org/10.1164/ rccm.200303-365OC 54.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
2007;188(5):1232-8. http://dx.doi.org/10.2214/ AJR.06.0965 55.,Non-OADS,/arxiv_data1/oa_pdf/66/be/1806-3713-jbpneu-41-03-00251.PMC4541762.pdf
"http://dx.doi.org/10.1590/S1806-37132015000004479PET/CT imaging in lung cancer: indications and findings* PET/TC em câncer de pulmão: indicações e achados Bruno Hochhegger1, Giordano Rafael Tronco Alves2, Klaus Loureiro Irion3,   Carlos Cezar Fritscher4, Leandro Genehr Fritscher5,   Natália Henz Concatto6, Edson Marchiori7 Abstract The use of PET/CT imaging in the work-up and management of patients with lung cancer has greatly increased  in recent decades.",Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
PET/CT imaging in lung cancer: indications and findings http://dx.doi.org/10.1590/S1806-37132015000004479subtype of the tumor.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
http://dx.doi.org/10.1590/S1806-37132015000004479treatment.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
PET/CT imaging in lung cancer: indications and findings http://dx.doi.org/10.1590/S1806-37132015000004479results in cases of low-growth lesions (either  primary or metastatic).,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
"http://dx.doi.org/10.1590/S1806-37132015000004479based on their morphological characteristics and  attenuation values, which can lead to debatable  conclusions in many situations.",Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
PET/CT imaging in lung cancer: indications and findings http://dx.doi.org/10.1590/S1806-37132015000004479and small supraclavicular lymph nodes).,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
"http://dx.doi.org/10.1590/S1806-37132015000004479will require further (invasive) investigation, which  will also increase health care system expenditures.",Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
"PET/CT imaging in lung cancer: indications and findings http://dx.doi.org/10.1590/S1806-37132015000004479staging of SCLC can also have implications for  the periodicity of follow-up evaluations, as well  as for the determination of toxicity profiles and  the prognostic assessment.",Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
http://dx.doi.org/10.1590/S1806-37132015000004479the results.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
PET/CT imaging in lung cancer: indications and findings http://dx.doi.org/10.1590/S1806-37132015000004479Med.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2010;104(12):1767-74. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2014;4(3):195-206. http://dx.doi.org/10.3978/j.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2009;48(2):59-69. http://dx.doi.org/10.3413/nukmed-0217 14.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2014;50(3):99-104. http://dx.doi.org/10.1016/j.arbres.2013.09.017 17.,OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2011;378(9804):1727-40. http://dx.doi.org/10.1016/ S0140-6736(10)62101-0 19.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2012;75(2):141-5. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2012;13(3):181-7. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2010;10:283.  http://dx.doi.org/10.1186/1472-6963-10-283 24.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2012;13(3):161-70. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
Available from: http://www2.inca.gov.br/wps/ wcm/connect/tiposdecancer/site/home/pulmao/definicao 2.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2013;2(3):171-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2012;81(5):988- 1001. http://dx.doi.org/10.1016/j.ejrad.2011.03.020 4.,OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2013;51(5):767-79. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2014;40(3):319-21. http://dx.doi.org/10.1590/ S1806-37132014000300016 7.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2013;2:208.  http://dx.doi.org/10.3389/fonc.2012.00208 8.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2012;2012:783739.  http://dx.doi.org/10.1155/2012/783739 9.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
J Thorac Oncol 2009;4(7):792- 801. http://dx.doi.org/10.1097/JTO.0b013e3181a7716e 10.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
http://dx.doi.org/10.1590/S1806-37132015000004479FDG PET/CT in the evaluation of solitary pulmonary  lesions - own experience.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2013;68(9):953-61. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
2002;32(4):240-71. http://dx.doi.org/10.1053/ snuc.2002.126059 27.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/1806-3713-jbpneu-41-03-00264.PMC4541763.pdf
"http://dx.doi.org/10.1590/S1806-37132015000004553Use of sirolimus in the treatment of  lymphangioleiomyomatosis: favorable responses in   patients with different extrapulmonary manifestations* Uso de sirolimo no tratamento de linfangioleiomiomatose:   resposta favorável em pacientes com diferentes   manifestações extrapulmonares Carolina Salim Gonçalves Freitas1, Bruno Guedes Baldi2, Mariana Sponholz Araújo1,  Glaucia Itamaro Heiden1, Ronaldo Adib Kairalla3, Carlos Roberto Ribeiro Carvalho4 Abstract Objective:  Lymphangioleiomyomatosis (LAM) is a rare disease that is currently considered a low-grade neoplasm  with metastatic potential and variable progression.",Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
"Freitas CSG, Baldi BG, Araújo MS, Heiden GI, Kairalla RA, Carvalho CRR http://dx.doi.org/10.1590/S1806-37132015000004553Case series Of a total of 10 patients with LAM treated  with sirolimus at our center during the study  period, we describe four cases of patients in  whom the drug was primarily used because of  extrapulmonary involvement.",Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
Use of sirolimus in the treatment of lymphangioleiomyomatosis:   favorable responses in patients with different extrapulmonary manifestations http://dx.doi.org/10.1590/S1806-37132015000004553enlargement.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
"Freitas CSG, Baldi BG, Araújo MS, Heiden GI, Kairalla RA, Carvalho CRR http://dx.doi.org/10.1590/S1806-37132015000004553Discussion In the four cases of patients with LAM  described above, the use of sirolimus (at 1-6  mg/day) had positive effects, particularly on on sirolimus (at 2 mg/day) because of the size of  the mass, which was symptomatic and posed a  risk of hemorrhage.",Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
"Use of sirolimus in the treatment of lymphangioleiomyomatosis:   favorable responses in patients with different extrapulmonary manifestations http://dx.doi.org/10.1590/S1806-37132015000004553are common, including hypercholesterolemia,  increased respiratory tract infections, diarrhea,  and stomatitis, as well as acne and other skin  disorders, they are usually mild and do not result  in treatment discontinuation.",Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
2010;35(1):14- 26. http://dx.doi.org/10.1183/09031936.00076209 4.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
http://dx.doi.org/10.1378/ chest.121.3_suppl.56S 5.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
2001;25(4):479-84. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
http://dx.doi.org/10.1148/ radiographics.22.suppl_1.g02oc13s185 7.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
1997;28(9):1071-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
"2006;129(5):1274- 81. http://dx.doi.org/10.1378/chest.129.5.1274extrapulmonary manifestations, including a  reduction in renal angiomyolipoma volume,  abdominal mass volume, and retroperitoneal  mass volume, as well as resolution of chylothorax.",Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
"Freitas CSG, Baldi BG, Araújo MS, Heiden GI, Kairalla RA, Carvalho CRR http://dx.doi.org/10.1590/S1806-37132015000004553Pneumol.",Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
2013;39(1):5-15. http://dx.doi.org/10.1590/ S1806-37132013000100002 18.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
2011;37(3):375-9. http://dx.doi.org/10.1590/ S1806-37132011000300015 19.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
2008;133(2):448-54. http://dx.doi.org/10.1378/ chest.07-2277 20.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
2011;364(17):1595-606. http://dx.doi.org/10.1056/ NEJMoa1100391 21.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
2011;12:66.  http://dx.doi.org/10.1186/1465-9921-12-66 23.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
2013;51(3):175-83. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
2014;190(11):1273-82. http://dx.doi.org/10.1164/ rccm.201405-0918OC10.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
2005;10(5):643-8.  http://dx.doi.org/10.1111/j.1440-1843.2005.00762.x 11.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
2001;164(6):1072-6. http://dx.doi.org/10.1164/ ajrccm.164.6.2102125 12.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
2010;138(3);674-81. http://dx.doi.org/10.1378/ chest.10-0573 15.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
2014;43(4):1114-23. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/a1/1806-3713-jbpneu-41-03-00275.PMC4541764.pdf
"http://dx.doi.org/10.1590/S1806-37132015000004247Formation of multiple pulmonary nodules   during treatment with leflunomide* Formação de múltiplos nódulos pulmonares   durante tratamento com leflunomida Gilberto Toshikawa Yoshikawa1, George Alberto da Silva Dias1, Satomi Fujihara1,  Luigi Ferreira e Silva2, Lorena de Britto Pereira Cruz3, Hellen Thais Fuzii4,   Roberta Vilela Lopes Koyama1 Abstract Pulmonary involvement is one of the extra-articular manifestations of rheumatoid arthritis and can be due to  the disease itself or secondary to the medications used in order to treat it.",Non-OADS,/arxiv_data1/oa_pdf/93/bc/1806-3713-jbpneu-41-03-00281.PMC4541765.pdf
http://dx.doi.org/10.1590/S1806-37132015000004247and fluconazole.,Non-OADS,/arxiv_data1/oa_pdf/93/bc/1806-3713-jbpneu-41-03-00281.PMC4541765.pdf
Formation of multiple pulmonary nodules during treatment with leflunomide http://dx.doi.org/10.1590/S1806-37132015000004247rheumatoid nodules can appear during treatment  with leflunomide; and there have been reports  of peripheral and/or pulmonary rheumatoid  nodules in patients undergoing treatment with  leflunomide.,Non-OADS,/arxiv_data1/oa_pdf/93/bc/1806-3713-jbpneu-41-03-00281.PMC4541765.pdf
2013;9(7):649-57. http://dx.doi.org/10.158 6/1744666X.2013.811173 3.,Non-OADS,/arxiv_data1/oa_pdf/93/bc/1806-3713-jbpneu-41-03-00281.PMC4541765.pdf
2003;9(4):246-52.  http://dx.doi.org/10.1097/01.rhu.0000081260.50171.bf 7.,Non-OADS,/arxiv_data1/oa_pdf/93/bc/1806-3713-jbpneu-41-03-00281.PMC4541765.pdf
http://dx.doi.org/10.1590/S1806-3713201500000424753-year-old woman with arthritis and pulmonary nodules.,Non-OADS,/arxiv_data1/oa_pdf/93/bc/1806-3713-jbpneu-41-03-00281.PMC4541765.pdf
2001;344(13):997-1004. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/bc/1806-3713-jbpneu-41-03-00281.PMC4541765.pdf
2006;25(3):384-8. http://dx.doi.org/10.1007/ s10067-005-0024-1Crit Care Med.,Non-OADS,/arxiv_data1/oa_pdf/93/bc/1806-3713-jbpneu-41-03-00281.PMC4541765.pdf
2007;28(4):430-40. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/bc/1806-3713-jbpneu-41-03-00281.PMC4541765.pdf
2007;47(3):228-31. http://dx.doi.org/10.1590/S0482-50042007000300015 10.,Non-OADS,/arxiv_data1/oa_pdf/93/bc/1806-3713-jbpneu-41-03-00281.PMC4541765.pdf
1977;72(4):538-40. http://dx.doi.org/10.1378/chest.72.4.538 11.,Non-OADS,/arxiv_data1/oa_pdf/93/bc/1806-3713-jbpneu-41-03-00281.PMC4541765.pdf
"http://dx.doi.org/10.1590/S1806-37132015000000026Intracavitary pulmonary aspergilloma: endoscopic aspects Aspergiloma pulmonar intracavitário: aspectos endoscópicos Evelise Lima1, André Louis Lobo Nagy1, Rodrigo Abensur Athanazio2  1.",Non-OADS,/arxiv_data1/oa_pdf/43/00/1806-3713-jbpneu-41-03-00285.PMC4541766.pdf
2014;57(5):257-70.  http://dx.doi.org/10.1111/myc.12152 2.,Non-OADS,/arxiv_data1/oa_pdf/43/00/1806-3713-jbpneu-41-03-00285.PMC4541766.pdf
2014;146(5):1358-68. http://dx.doi.org/10.1378/ chest.14-0917 3.,Non-OADS,/arxiv_data1/oa_pdf/43/00/1806-3713-jbpneu-41-03-00285.PMC4541766.pdf
"2011;52(5):787-92.  http://dx.doi.org/10.3349/ymj.2011.52.5.787Figure 1 - In A, CT scan of the chest showing an  intracavitary mass suggestive of fungus ball.",Non-OADS,/arxiv_data1/oa_pdf/43/00/1806-3713-jbpneu-41-03-00285.PMC4541766.pdf
"http://dx.doi.org/10.1590/S1806-37132015000004444Reversed halo sign in acute schistosomiasis Sinal do halo invertido em esquistossomose aguda Arthur Soares Souza Jr.1, Antonio Soares Souza2,   Luciana Soares-Souza3, Gláucia Zanetti4, Edson Marchiori5 To the Editor:  1.",Non-OADS,/arxiv_data1/oa_pdf/1a/8c/1806-3713-jbpneu-41-03-00286.PMC4541767.pdf
"Reversed halo sign in acute schistosomiasis http://dx.doi.org/10.1590/S1806-37132015000004444(4-6) In the present case, the reversed halo sign was  observed in a patient with acute schistosomiasis.",Non-OADS,/arxiv_data1/oa_pdf/1a/8c/1806-3713-jbpneu-41-03-00286.PMC4541767.pdf
2011;37(6):823-5. http://dx.doi.org/10.1590/ S1806-37132011000600018 2.,Non-OADS,/arxiv_data1/oa_pdf/1a/8c/1806-3713-jbpneu-41-03-00286.PMC4541767.pdf
2006;186(5):1300-3. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/8c/1806-3713-jbpneu-41-03-00286.PMC4541767.pdf
"Souza Jr AS, Souza AS, Soares-Souza L, Zanetti G, Marchiori E http://dx.doi.org/10.1590/S1806-37132015000004444tuberculosis: criteria for differential diagnosis from  cryptogenic organizing pneumonia.",Non-OADS,/arxiv_data1/oa_pdf/1a/8c/1806-3713-jbpneu-41-03-00286.PMC4541767.pdf
2011;197(6):1324-7. http://dx.doi.org/10.2214/AJR.11.6543 6.,Non-OADS,/arxiv_data1/oa_pdf/1a/8c/1806-3713-jbpneu-41-03-00286.PMC4541767.pdf
2012;190(4):389-94.  http://dx.doi.org/10.1007/s00408-012-9392-x4.,Non-OADS,/arxiv_data1/oa_pdf/1a/8c/1806-3713-jbpneu-41-03-00286.PMC4541767.pdf
2010;65(9):770-1.  http://dx.doi.org/10.1016/j.crad.2010.02.015 5.,OADS,/arxiv_data1/oa_pdf/1a/8c/1806-3713-jbpneu-41-03-00286.PMC4541767.pdf
"http://dx.doi.org/10.1590/S1806-37132015000000005Nontuberculous mycobacteria in respiratory specimens:  clinical significance at a tertiary care hospital   in the north of Portugal Micobactérias não tuberculosas em espécimes respiratórios: significado  clínico em um hospital terciário no norte de Portugal Hans Dabó1, Vanessa Santos1, Anabela Marinho2, Angélica Ramos3,   Teresa Carvalho3, Manuela Ribeiro3, Adelina Amorim2 To the Editor: 1.",Non-OADS,/arxiv_data1/oa_pdf/43/d4/1806-3713-jbpneu-41-03-00292.PMC4541769.pdf
"Nontuberculous mycobacteria in respiratory specimens: clinical significance  at a tertiary care hospital in the north of Portugal http://dx.doi.org/10.1590/S1806-37132015000000005retreatment—1 was cured, 1 died from lung cancer  while still under treatment, and 1 is still under  treatment at this writing—and in another case,  the decision was not to treat, because the patient  had been diagnosed with advanced cancer.",Non-OADS,/arxiv_data1/oa_pdf/43/d4/1806-3713-jbpneu-41-03-00292.PMC4541769.pdf
"Dabó H, Santos V, Marinho A, Ramos A, Carvalho T, Ribeiro M, Amorim A http://dx.doi.org/10.1590/S1806-371320150000000052.",Non-OADS,/arxiv_data1/oa_pdf/43/d4/1806-3713-jbpneu-41-03-00292.PMC4541769.pdf
2007;175(4):367-416. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/1806-3713-jbpneu-41-03-00292.PMC4541769.pdf
2008;14(3):323-37. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/1806-3713-jbpneu-41-03-00292.PMC4541769.pdf
2013;42(6):1604-13. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/1806-3713-jbpneu-41-03-00292.PMC4541769.pdf
2010;42(8):626-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/1806-3713-jbpneu-41-03-00292.PMC4541769.pdf
"2014;2014:894976. http://dx.doi.org/10.1155/2014/894976authors have suggested that the decline in the  incidence of tuberculosis has decreased the cross- protective mycobacterial immunity associated with  M. tuberculosis  infection, which has somehow  promoted an increase in the incidence of NTM  infection.",Non-OADS,/arxiv_data1/oa_pdf/43/d4/1806-3713-jbpneu-41-03-00292.PMC4541769.pdf
2014;6(3):210-20.  http://dx.doi.org/10.3978/j.issn.2072-1439.2013.12.24 Submitted: 9 January 2015.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/1806-3713-jbpneu-41-03-00292.PMC4541769.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Correspondence: Susan A. Berry (berry002@umn.edu).",Non-OADS,/arxiv_data1/oa_pdf/d6/6f/nihms-715177.PMC4541808.pdf
Revised May 2007; < http://www.fda.gov/Food/ GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/MedicalFoods/ucm054048.htm > 2.,Non-OADS,/arxiv_data1/oa_pdf/d6/6f/nihms-715177.PMC4541808.pdf
"2010 2010 Updated: 1  October 2010: http://www.healthyms.com/msdhsite/index.cfm/41,3983,128,508,pdf/WICFoods %2Epdf 3.",Non-OADS,/arxiv_data1/oa_pdf/d6/6f/nihms-715177.PMC4541808.pdf
2008.  http://www.ncsl.org/default.aspx?tabid=13865 6.,Non-OADS,/arxiv_data1/oa_pdf/d6/6f/nihms-715177.PMC4541808.pdf
2011.  statehealthfacts.org statehealthfacts.org http://www.statehealthfacts.org/comparebar.jsp?,Non-OADS,/arxiv_data1/oa_pdf/d6/6f/nihms-715177.PMC4541808.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/eb/main.PMC4542015.pdf
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61108 .,OADS,/arxiv_data1/oa_pdf/f7/eb/main.PMC4542015.pdf
"Speci ﬁcations Organism/cell line/tissueZebra ﬁsh brain Sex Male and female Sequencer or array typeIllumina Genome Analyzer IIx Data format Raw: FASTQ ﬁles Experimental factorsStrain (AB, Scienti ﬁc Hatcheries, LSB, HSB), sex (male, female) Experimental featuresRNA-sequencing analysis of male and female zebra ﬁsh brains in four different strains (AB, Scienti ﬁc Hatcheries, LSB, HSB), 17 weeks post-fertilization Consent All procedures approved by the North Carolina State University Institutional Animal Care and Use Committee Sample source locationExperiments were conducted at North Carolina State University, Raleigh, North Carolina, USA http://dx.doi.org/10.1016/j.gdata.2015.06.004 2213-5960/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f7/eb/main.PMC4542015.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/eb/main.PMC4542015.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/f7/eb/main.PMC4542015.pdf
"To view a copyof this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Carbon metabolism associated with e-SOx D Vasquez-Cardenas et al 1978 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/a2/b3/ismej201510a.PMC4542026.pdf
"Statistical analysis Statistical analysis was conducted mainly under Matlab environment (The MathWorks, Natick, MA, USA) and R (http://www.r-project.org/).",OADS,/arxiv_data1/oa_pdf/63/d0/ismej201511a.PMC4542028.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)The phylo-functional core in human gut microbiota J Zhang et al 1990 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/63/d0/ismej201511a.PMC4542028.pdf
"To view a copyof this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Microbial mediation of carbon stock in Tibet HY u e et al 2020 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/75/c0/ismej201519a.PMC4542033.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information acc ompanies this paper on The ISME Journal web site (http://www.nature.com/ismej)Do CRISPR –Cas systems hinder genetic innovation?",Non-OADS,/arxiv_data1/oa_pdf/b3/4f/ismej201520a.PMC4542034.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2015  Creative Commons Attribution-NonCommercial License May 2015 |  99  | e52686 | Page 1 of 9Video Article Three-Dimensional (3D) Tumor Spheroid Invasion Assay Maria Vinci1,2, Carol Box2, Suzanne A. Eccles2 1Division of Molecular Pathology, The Institute of Cancer Research 2Division of Cancer Therapeutics, The Institute of Cancer Research Correspondence to: Maria Vinci at maria.vinci@icr.ac.uk URL: http://www.jove.com/video/52686 DOI: doi:10.3791/52686 Keywords: Medicine, Issue 99, invasion, metastasis, 3D, tumor spheroids, extracellular matrix, imaging, high-throughput, drug development.",Non-OADS,/arxiv_data1/oa_pdf/f1/bf/jove-99-52686.PMC4542056.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/52686/ Introduction Classical anticancer drug development is largely focused on the use of in vitro cell-based assays to screen for cytotoxic agents that inhibit tumor cell proliferation and/or promote programmed cell death (apoptosis).,Non-OADS,/arxiv_data1/oa_pdf/f1/bf/jove-99-52686.PMC4542056.pdf
"[4] http://dx.doi.org/10.1787/9789264183896-en, accessed April 2014.",Non-OADS,/arxiv_data1/oa_pdf/b2/24/JCTH-3-078.PMC4542078.pdf
"[6] http://www.cdc.gov/diabetes/data/statistics/2014statisticsreport.html, accessed October 24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/cb/d0/JCTH-3-009.PMC4542082.pdf
"[11] http://www.sovaldi.com/, accessed December 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/85/b0/JCTH-3-027.PMC4542085.pdf
"[24] http://www.harvoni.com/, accessed December 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/85/b0/JCTH-3-027.PMC4542085.pdf
"[42] http://clinicaltrials.gov/ct2/show/NCT02175758, accessed June 2014.",Non-OADS,/arxiv_data1/oa_pdf/08/24/JCTH-3-036.PMC4542086.pdf
"[43] http://clinicaltrials.gov/ct2/show/NCT022 49182, accessed September 2014.",Non-OADS,/arxiv_data1/oa_pdf/08/24/JCTH-3-036.PMC4542086.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2015  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMay 2015 |  99  | e52610 | Page 1 of 11Video Article Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses Siriphan Manocheewa1, Erinn C. Lanxon-Cookson1, Yi Liu1, J. Victor Swain1, Jan McClure1, Ushnal Rao1, Brandon Maust1, Wenjie Deng1, Justine E. Sunshine1, Moon Kim1, Morgane Rolland3,4, James I. Mullins1,2 1Department of Microbiology, University of Washington 2Departments of Medicine and Laboratory Medicine, University of Washington 3U.S Military HIV Research Program, Walter Reed Army Institute of Research 4Henry M. Jackson Foundation Correspondence to: James I. Mullins at jmullins@u.washington.edu URL: http://www.jove.com/video/52610 DOI: doi:10.3791/52610 Keywords: Immunology, Issue 99, HIV-1, Recombinant, Mutagenesis, Viral replication fitness, Growth competition, Fitness calculation Date Published: 5/4/2015 Citation: Manocheewa, S., Lanxon-Cookson, E.C., Liu, Y., Swain, J.V., McClure, J., Rao, U., Maust, B., Deng, W., Sunshine, J.E., Kim, M., Rolland, M., Mullins, J.I.",Non-OADS,/arxiv_data1/oa_pdf/9b/1c/jove-99-52610.PMC4542137.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/52610/ Introduction Viral replication fitness is defined as the capacity of a virus to produce infectious progeny in a given environment1 and is an important contributing factor in determining the prevalence of a virus variant at the population level over time2.,Non-OADS,/arxiv_data1/oa_pdf/9b/1c/jove-99-52610.PMC4542137.pdf
Assess these properties using the OligoAnalyzer web tool (https://www.idtdna.com/analyzer/Applications/OligoAnalyzer/).,OADS,/arxiv_data1/oa_pdf/9b/1c/jove-99-52610.PMC4542137.pdf
2.Use the GRC web tool ( http://indra.mullins.microbiol.washington.edu/grc/ ) to calculate viral growth rate ( g).,OADS,/arxiv_data1/oa_pdf/9b/1c/jove-99-52610.PMC4542137.pdf
6.Use the GRC web tool ( http://indra.mullins.microbiol.washington.edu/grc/ ) to calculate relative viral fitness ( d).,OADS,/arxiv_data1/oa_pdf/9b/1c/jove-99-52610.PMC4542137.pdf
"If the average base call accuracy is less than 85%, redo step 6.10.1 to 6.10.3 5.Use the ChromatQuan web tool ( http://indra.mullins.microbiol.washington.edu/cgi-bin/chromatquant.cgi ) to calculate viral ratio at each time point.",OADS,/arxiv_data1/oa_pdf/9b/1c/jove-99-52610.PMC4542137.pdf
6.Use the GRC web tool ( http://indra.mullins.microbiol.washington.edu/grc/ ) and the recorded peak intensities as the input to calculate viral relative fitness ( d).,OADS,/arxiv_data1/oa_pdf/9b/1c/jove-99-52610.PMC4542137.pdf
"JoVE Cambridge, MA Available from: http://www.jove.com/ science-education/5070/restriction-enzyme-digests (2014).",Non-OADS,/arxiv_data1/oa_pdf/9b/1c/jove-99-52610.PMC4542137.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/05/rjv108.PMC4542138.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Journal of Exposure Science and Environmental Epidemiology website (http:// www.nature.com/jes)Mortality and nitrogen dioxide in Canadian cities Crouse et al 489 © 2015 Nature America, Inc. Journal of Exposure Science and Environmental Epidemiology (2015), 482 –489",Non-OADS,/arxiv_data1/oa_pdf/82/26/jes201489a.PMC4542139.pdf
"R: A Language and Environment for Statistical Computing .RF o u n d a t i o n for Statistical Computing: Vienna, Austria, 2014 URL http://www.R-project.org/].",Non-OADS,/arxiv_data1/oa_pdf/c0/df/jes201511a.PMC4542140.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Journal of Exposure Science and Environmental Epidemiology website (http:// www.nature.com/jes) APPENDIX 1 Appendix 1 CAFEH Study Cohort SummaryCAFEH is a community-based participatory research (CBPR) study of traf ﬁc-related air pollution (TRAP) and cardiovascular health in individuals 40+ years of age living in close proximity to the majorhighways interstate 93 and/or Interstate 90 (NIEHS ES015462; PI Brugge).",Non-OADS,/arxiv_data1/oa_pdf/c0/df/jes201511a.PMC4542140.pdf
Available at: http://www.who.int/iris/bitstream/10665/97008/1/9789241564694_eng.pdf?ua=1 .,Non-OADS,/arxiv_data1/oa_pdf/d1/fc/ofv111.PMC4542141.pdf
"A citation analysis of papers publishedin the regular versus AAM track, carried out by Phil Davis Con-sulting (Ithaca, NY; http://phil-davis.org ), revealed no difference in the citation rate, suggesting that the papers are comparable inquality when assessed by that parameter (Fig.",OADS,/arxiv_data1/oa_pdf/00/20/mBio.01222-15.PMC4542184.pdf
http://dx.doi.org/10.1038/510330a .,Non-OADS,/arxiv_data1/oa_pdf/00/20/mBio.01222-15.PMC4542184.pdf
http://dx.doi.org/10.1001/jama.272.2.149 .,Non-OADS,/arxiv_data1/oa_pdf/00/20/mBio.01222-15.PMC4542184.pdf
http://dx.doi.org/10.1258/ jrsm.99.4.178 .,Non-OADS,/arxiv_data1/oa_pdf/00/20/mBio.01222-15.PMC4542184.pdf
http://dx.doi.org/ 10.1001/jama.287.21.2784 .,Non-OADS,/arxiv_data1/oa_pdf/00/20/mBio.01222-15.PMC4542184.pdf
Nature 515:480 – 482. http://dx.doi.org/10.1038/515480a .,Non-OADS,/arxiv_data1/oa_pdf/00/20/mBio.01222-15.PMC4542184.pdf
http://dx.doi.org/ 10.3390/life4020225 .,OADS,/arxiv_data1/oa_pdf/00/20/mBio.01222-15.PMC4542184.pdf
Notes Rec http://dx.doi.org/10.1098/rsnr.2015.0029 .,Non-OADS,/arxiv_data1/oa_pdf/00/20/mBio.01222-15.PMC4542184.pdf
http://dx.doi.org/10.1038/sj.gt.3302635 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1038/nbt0910-917 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1016/S1010 -7940(02)00577-8 .,OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1016/ j.spinee.2007.05.012 .,OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1038/n35101999 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/ 10.1097/CJI.0b013e3182993eb9 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.2174/ 1874471011104030197 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1038/ nrc1891 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
Trends Biochem Sci35:411– 418. http://dx.doi.org/10.1016/j.tibs.2010.02.003 .,OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1371/ journal.pone.0006999 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1016/ j.vetimm.2012.09.034 .,OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1371/journal.pone.0069678 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1016/S0304 -4157(96)00011-1 .,OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1126/science.1114580 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter.Science 279:84 – 88. http://dx.doi.org/10.1126/science.279.5347.84 .,OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
Infect Immun 82:873– 881. http://dx.doi.org/10.1128/ IAI.01539-13 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1016/S0167-4889(99)00070-1 .,OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.4049/jimmunol.0803737 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
Structure 4:665– 678. http://dx.doi.org/10.1016/S0969-2126(96)00073-1 .,OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1371/journal.pone.0090252 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1371/journal.pone.0029941 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1016/j.jmb.2010.01.070 .Neuron-Speciﬁc Delivery Platform July/August 2015 Volume 6 Issue 4 e00734-15®mbio.asm.org 7,OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
Mastoparan-7 rescues botuli- num toxin-A poisoned neurons in a mouse spinal cord cell culture model.Toxicon 76:37– 43. http://dx.doi.org/10.1016/j.toxicon.2013.09.002 .,OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
BMC Pharmacol 9:12. http://dx.doi.org/10.1186/1471-2210-9-12 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1038/nature05387 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/ 10.1038/nature05411 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1126/science.1123654 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
"http://dx.doi.org/10.1371/ journal.pone.0020352 .40.Mukherjee J, Dmitriev I, Debatis M, Tremblay JM, Beamer G, Kash- entseva EA, Curiel DT, Shoemaker CB .",OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1371/journal.pone.0106422 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1038/nature05290 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
Neurol Clin 26:675– 697. http://dx.doi.org/ 10.1016/j.ncl.2008.03.011 .,OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/ 10.1128/IAI.00057-12 .,Non-OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1016/S0041-0101(01)00124-6 .,OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1385/1-59259-052-7:27 .Chen et al.,OADS,/arxiv_data1/oa_pdf/d4/63/mBio.00734-15.PMC4542185.pdf
http://dx.doi.org/10.1016/j.cell.2013.09.006 .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
Nat Rev Genet 11:31– 46. http://dx.doi.org/10.1038/nrg2626 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
Nat Rev Genet 13: 36 – 46. http://dx.doi.org/10.1038/nrg3117 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1038/nbt.3103 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
Nat Biotechnol 32:829 – 833. http://dx.doi.org/10.1038/nbt.2950 .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
BMC Genomics 14:675. http://dx.doi.org/10.1186/1471-2164 -14-675 .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1371/journal.pone.0047768 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/ 10.1038/nmeth.2474 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
Curr Opin Biotech-nol24:690 – 698. http://dx.doi.org/10.1016/j.copbio.2013.01.009 .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/ 10.1038/nbt.2478 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1534/ g3.114.011197 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
Nat Rev Microbiol 10:417– 430. http://dx.doi.org/10.1038/nrmicro2790 .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
Front Genet 5:37.http://dx.doi.org/ 10.3389/fgene.2014.00037 .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1002/ bies.201300155 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
Nature 517:608 – 611. http://dx.doi.org/10.1038/ nature13907 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1016/ j.tplants.2014.02.003 .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1186/gb-2013-14-9-r101 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1101/gr.152660.112 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1002137 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
Nat Biotechnol 33:623– 630. http://dx.doi.org/ 10.1038/nbt.3238 .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
BMC Bioinformatics 13:238. http://dx.doi.org/10.1186/ 1471-2105-13-238 .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1093/bioinformatics/btt086 .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1126/science.1194573 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1038/ nrg2165 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
Genome Biol 5:225. http://dx.doi.org/10.1186/gb-2004-5-6-225 .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/ 10.1016/j.gene.2012.07.042 .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
J Hered 100:648 – 655. http://dx.doi.org/10.1093/ jhered/esp065 .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1146/ annurev.micro.57.030502.091029 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.7554/ eLife.00569 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1093/bioinformatics/btn102 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1038/ nature08850 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
Genome Biol 16:12.http://dx.doi.org/10.1186/s13059 -014-0567-z .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1126/science.1241130 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1371/ journal.pgen.1004261 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1371/ journal.pgen.1002070 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1093/nar/gkq543 .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1093/nar/ 27.2.573 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://www.repeatmasker.org .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1093/nar/gkm286 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
Cytogenet Genome Res 110: 462– 467. http://dx.doi.org/10.1159/ 000084979 .,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://dx.doi.org/10.1186/gb-2009-10 -3-r25 .,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
http://arxiv.org/abs/ 1207.3907v1 .PacBio and Optical Mapping Yield Gapless Genome July/August 2015 Volume 6 Issue 4 e00936-15®mbio.asm.org 11,OADS,/arxiv_data1/oa_pdf/5c/b5/mBio.00936-15.PMC4542186.pdf
The resulting phylogenies were edited withFigTree v1.3.1 ( http://tree.bio.ed.ac.uk/software/ﬁgtree/ ) and Adobe Il- lustrator.,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/ 10.1007/978-1-4419-9086-0_13 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1007/978-1-4419-9086-0_12 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
Micro- biol Mol Biol Rev 64:624 – 653. http://dx.doi.org/10.1128/ MMBR.64.3.624-653.2000 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1038/ismej.2007.113 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1099/mic.0.2006/004077-0 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1146/ annurev.micro.62.081307.162918 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1016/ S0300-9084(02)01421-9 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1146/ annurev.micro.56.012302.161024 .14.,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1007/978-3-540-36604-1 _6.,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1016/S0300 -9084(02)01422-0 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/ 10.1099/mic.0.036848-0 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1128/JB.01458-08 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1038/nature00823 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.2174/1381612053381666 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1038/ nrmicro1273 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1128/AAC.05031-11 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1111/1574-6976.12079 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/ 10.1046/j.1365-2958.2000.02135.x .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1128/AEM.00141 -08.,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/ 10.1038/nsmb.2995 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1099/mic.0.056002-0 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1128/ AEM.69.4.1875-1883.2003 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1146/annurev-phyto-072910 -095242 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
Nat Rev Mol Cell Biol 7:601– 611. http://dx.doi.org/10.1038/nrm1984 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1111/j.1364-3703.2009.00587.x .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/ 10.1093/jxb/erj217 .Phage-Derived Bacteriocins in Pseudomo nas syringae July/August 2015 Volume 6 Issue 4 e00452-15®mbio.asm.org 9,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/ 10.1042/BST20120206 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/ 10.1111/j.1574-6968.2007.01010.x .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1016/S0966-842X(02)02307-7 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1074/ jbc.M112.400150 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1016/j.mib.2014.09.010 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
Antimicrob Agents Chemother 6:76 – 83. http://dx.doi.org/10.1128/AAC.6.1.76 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1093/nar/gkt391 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1093/nar/ gks1243 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1073/ pnas.0504930102 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1016/S0042 -6822(03)00198-3 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/ 10.1073/pnas.0711589105 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
BMC Microbiol 9:224. http://dx.doi.org/10.1186/1471-2180-9-224 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1006/jmbi.2002.5437 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1007/978-1 -4614-0980-9_5 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
BMC Microbiol 9:8.http://dx.doi.org/10.1186/ 1471-2180-9-8 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1128/ JB.184.7.1974-1987.2002 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1104/ pp.87.2.325 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1128/AEM.01450-09 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1093/molbev/mss106 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1016/j.syapm.2010.10.005 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
MicrobiolMol Biol Rev 75:423– 433. http://dx.doi.org/10.1128/MMBR.00014-11 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1371/journal.pgen.1002784 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1371/ journal.pone.0105547 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1128/AEM.68.10.5170-5176.2002 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1111/j.1365-2672.1966.tb03483.x .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
Annu Rev Phytopathol 14:451– 465. http://dx.doi.org/10.1146/annurev.py.14.090176.002315 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/ 10.1111/1462-2920.12492 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
Microbiol Mol Biol Rev 68:560 – 602. http://dx.doi.org/10.1128/ MMBR.68.3.560-602.2004 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1094/MPMI-11 -13-0354-R .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1111/j.1758 -2229.2012.00331.x .http://dx.doi.org/10.1111/j.1758 -2229.2012.00331.x .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1093/nar/gkt1223 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1093/molbev/mst010 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1093/ molbev/msu088 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1039/c2np20085f .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
Mol Plant Microbe Interact 22:52– 62. http://dx.doi.org/10.1094/MPMI-22-1-0052 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1073/ pnas.1731982100 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
J Bacteriol187:6488 – 6498. http://dx.doi.org/10.1128/JB.187.18.6488-6498.2005 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1073/ pnas.0409660102 .,Non-OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
Mol Plant Microbe Interact 25:877– 888. http://dx.doi.org/10.1094/MPMI-08-11-0218 .,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
Mol Microbiol 62:26 – 44. http://dx.doi.org/ 10.1111/j.1365-2958.2006.05350.x .Phage-Derived Bacteriocins in Pseudomo nas syringae July/August 2015 Volume 6 Issue 4 e00452-15®mbio.asm.org 11,OADS,/arxiv_data1/oa_pdf/e5/49/mBio.00452-15.PMC4542187.pdf
http://dx.doi.org/10.1038/newbio239117a0 .,Non-OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
Biochim Biophys Acta 1808: 851– 865. http://dx.doi.org/10.1016/ j.bbamem.2010.08.016 .,OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
http://dx.doi.org/ 10.1021/bi7010064 .,Non-OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
http://dx.doi.org/10.1128/JB.00064-12 .,Non-OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
http://dx.doi.org/10.1021/ja073340u .,Non-OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
http://dx.doi.org/10.1016/ j.chembiol.2010.09.009 .,OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
http://dx.doi.org/10.1039/c2md20043k .,OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
J Med Chem 54:4954 – 4963. http://dx.doi.org/10.1021/jm1016126 .,OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
http://dx.doi.org/10.1016/j.bmcl.2013.08.026 .,OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
Broadening the spectrum of beta-lactam antibiotics through inhibition of signal peptidase type I. An-timicrob Agents Chemother 56:4662– 4670. http://dx.doi.org/10.1128/ AAC.00726-12 .,Non-OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
http://dx.doi.org/10.1128/AAC.04597-14 .,Non-OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
http://dx.doi.org/10.1016/S0959-440X(02)00295-6 .,OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
http://dx.doi.org/10.1016/ j.plasmid.2009.01.003 .,OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
http://dx.doi.org/10.1128/AAC.01459-10 .,Non-OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
http://dx.doi.org/10.1038/85686 .,Non-OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
http://dx.doi.org/10.1007/s00253-005-1898-1 .,Non-OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
http://dx.doi.org/10.1271/bbb.110115 .,Non-OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
http://dx.doi.org/10.1128/JB.00028-14 .,Non-OADS,/arxiv_data1/oa_pdf/32/cd/mBio.01178-15.PMC4542188.pdf
"In 2005, the U.S. government established the NationalScience Advisory Board for Biosecurity (NSABB) to address issuesrelated to biosecurity and dual-use research ( http://osp.od.nih .gov/ofﬁce-biotechnology-activities/biosecurity/nsabb ).",Non-OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
"One of the major ac-complishments of the NSABB was to draft a deﬁnition for DURCas “life sciences research that, based on current understanding,can be reasonably anticipated to provide knowledge, information,products, or technologies that could be directly misapplied to posea signiﬁcant threat with broad potential consequences to publichealth and safety, agricultural crops and other plants, animals, theenvironment, materiel, or national security.” In addition to deﬁn-ing the type of research that should elicit heightened concern, theNSABB recommended that research be examined for DURC po-tential throughout its life span, from experimental conception toﬁnal dissemination of the results ( http://osp.od.nih.gov/sites /default/ﬁles/resources/Framework%20for%20transmittal%20duplex%209-10-07.pdf ) and developed tools for communi- cating ﬁndings that meet the deﬁnition ( http://osp.od.nih.gov/ sites/default/ﬁles/resources/Communication_Tools%20_Dual_Use_Potential.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
"After the manuscript arrives at ASM, the editorialstaff screens the manuscript to determine whether the researchinvolves one of the microbes or toxins listed in the Select Agentsand Toxins List (SATL; http://www.selectagents.gov/SelectAgent- sandToxinsList.html ).",Non-OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
http://dx.doi.org/10.1089/bsp.2012.0011 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
J Infect Dis 209: 167. http://dx.doi.org/ 10.1093/infdis/jit528 .,OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
http://dx.doi.org/10.1128/ mBio.00991-13 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
http://dx.doi.org/10.1128/ mBio.01882-14 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
J Virol 88:6533– 6534. http://dx.doi.org/10.1128/JVI.00886-14 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
http://dx.doi.org/10.1128/ mBio.01985-14 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
http://dx.doi.org/10.1128/AEM.03001-14 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
J Virol 87:4795– 4796. http://dx.doi.org/10.1128/JVI.00474-13 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
Appl EnvironMicrobiol 81:4233– 4234. http://dx.doi.org/10.1128/AEM.01322-15 .,OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
J Infect Dis 207: 207. http://dx.doi.org/10.1093/infdis/jis528 .,OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
J Virol 88:6535– 6537. http://dx.doi.org/10.1128/JVI.00875-14 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
http://dx.doi.org/ 10.1038/nrmicro2299 .,OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
Appl Environ Microbiol77:4508 – 4519. http://dx.doi.org/10.1128/AEM.02033-10 .,OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
BMC Biotechnol9:74. http://dx.doi.org/10.1186/1472-6750-9-74 .,OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
http://dx.doi.org/10.1371/ journal.pmed.1001813 .Editorial July/August 2015 Volume 6 Issue 4 e01236-15®mbio.asm.org 3,Non-OADS,/arxiv_data1/oa_pdf/5a/e7/mBio.01236-15.PMC4542189.pdf
J Bacteriol 186:4209 – 4217. http://dx.doi.org/10.1128/JB.186.13.4209-4217.2004 .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1111/ j.1365-2958.2011.07562.x .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1128/IAI.00148-12 .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1093/infdis/jiu001 .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1542/peds.2012-1928 .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
BMC Med 13:146. http://dx.doi.org/ 10.1186/s12916-015-0382-8 .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1111/j.1365-2958.2009.06623.x .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
Mol Mi-crobiol 62:641– 654. http://dx.doi.org/10.1111/j.1365-2958.2006.05392.x .,OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/ 10.1128/IAI.01379-08 .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1046/j.1365 -2958.1996.01538.x .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1038/nrmicro3235 .,OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1128/ IAI.69.4.2650-2658.2001 .,OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1371/journal.pone.0027535 .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1084/jem.20011288 .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
Eur J Immunol 30: 415– 422. http://dx.doi.org/10.1002/1521-4141(200002)30:2 /H11021415::AID -IMMU415 /H110223.0.CO;2-X .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1016/ j.micinf.2014.04.003 .,OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1046/j.1365-2958.2002.03107.x .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1111/mmi.12036 .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1159/000082076 .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2009.06860.x .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
J Mol Biol 376:414 – 426. http://dx.doi.org/10.1016/j.jmb.2007.10.088 .,OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1006/jmbi.1994.1478 .,OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1093/ emboj/20.18.5040 .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
Infect Im- mun 73:4960 – 4971. http://dx.doi.org/10.1128/IAI.73.8.4960-4971.2005 .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1016/S0966-842X(01)02174-6 .,OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/ 10.1128/IAI.73.6.3618-3626.2005 .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1086/589753 .,OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1128/mBio.00500-15 .,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
Cell 80: 611– 620. http://dx.doi.org/10.1016/0092-8674(95)90515-4 .,OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1128/ IAI.73.11.7317-7323.2005 .45.,Non-OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
Mol Syst Biol 7:539. http://dx.doi.org/ 10.1038/msb.2011.75 .,OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
http://dx.doi.org/10.1093/ bioinformatics/btp033 .Melvin et al.,OADS,/arxiv_data1/oa_pdf/12/05/mBio.01189-15.PMC4542190.pdf
"All data were analyzed with R (version 2.14.0; R Foundation for Statistical Computing, http://www.R-project.org ).",OADS,/arxiv_data1/oa_pdf/97/a8/mBio.01129-15.PMC4542191.pdf
The growth curves of the S. aureus re- porter strains were compared using the compare GrowthCurves functionof the statmod package (version 1.4.21; http://CRAN.R-project.org/ package /H11005statmod ).,OADS,/arxiv_data1/oa_pdf/97/a8/mBio.01129-15.PMC4542191.pdf
http://dx.doi.org/10.1099/mic.0.27955-0 .,Non-OADS,/arxiv_data1/oa_pdf/97/a8/mBio.01129-15.PMC4542191.pdf
http://dx.doi.org/10.1007/s11101-013-9295-3 .,Non-OADS,/arxiv_data1/oa_pdf/97/a8/mBio.01129-15.PMC4542191.pdf
http://dx.doi.org/10.1128/ AAC.05919-11 .,Non-OADS,/arxiv_data1/oa_pdf/97/a8/mBio.01129-15.PMC4542191.pdf
http://dx.doi.org/10.1002/ppul.21193 .,Non-OADS,/arxiv_data1/oa_pdf/97/a8/mBio.01129-15.PMC4542191.pdf
http://dx.doi.org/10.1093/shm/13.2.221 .,OADS,/arxiv_data1/oa_pdf/97/a8/mBio.01129-15.PMC4542191.pdf
Virulence 2:445– 459. http://dx.doi.org/10.4161/ viru.2.5.17724 .,Non-OADS,/arxiv_data1/oa_pdf/97/a8/mBio.01129-15.PMC4542191.pdf
http://dx.doi.org/10.1002/pca.2495 .,Non-OADS,/arxiv_data1/oa_pdf/97/a8/mBio.01129-15.PMC4542191.pdf
http://dx.doi.org/ 10.1128/AEM.02766-10 .,Non-OADS,/arxiv_data1/oa_pdf/97/a8/mBio.01129-15.PMC4542191.pdf
Planta Med 72: 875– 880. http://dx.doi.org/10.1055/s-2006-947167 .,OADS,/arxiv_data1/oa_pdf/97/a8/mBio.01129-15.PMC4542191.pdf
http://dx.doi.org/10.1111/j.1600 -0463.2009.02580.x .,Non-OADS,/arxiv_data1/oa_pdf/97/a8/mBio.01129-15.PMC4542191.pdf
J Wine Res 1:77– 80. http://dx.doi.org/10.1080/ 09571269008717858 .,Non-OADS,/arxiv_data1/oa_pdf/97/a8/mBio.01129-15.PMC4542191.pdf
http://dx.doi.org/ 10.1371/journal.pbio.1000412 .,Non-OADS,/arxiv_data1/oa_pdf/97/a8/mBio.01129-15.PMC4542191.pdf
"http://dx.doi.org/10.1002/ bimj.200810425 .A 1,000-Year-Old Antistaphylococcal Remedy July/August 2015 Volume 6 Issue 4 e01129-15 ®mbio.asm.org 7",Non-OADS,/arxiv_data1/oa_pdf/97/a8/mBio.01129-15.PMC4542191.pdf
http://dx.doi.org/10.1038/hdy.1965.65 .,OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
http://dx.doi.org/10.1007/BF00341717 .,Non-OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
http://dx.doi.org/10.1126/science.6801762 .,Non-OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
http://dx.doi.org/10.1534/genetics.111.137760 .,Non-OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
http://dx.doi.org/10.1038/ nature02391 .,Non-OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
http://dx.doi.org/10.1038/nature02392 .,Non-OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
http://dx.doi.org/10.1146/annurev-cellbio -101512-122326 .,OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
http://dx.doi.org/10.1128/ IAI.06014-11 .,Non-OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
EMBO Rep 16:24 – 43. http://dx.doi.org/10.15252/embr.201439363 .13.,Non-OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
http://dx.doi.org/ 10.1016/j.ceb.2009.03.007 .,OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
http://dx.doi.org/10.1523/JNEUROSCI.3258-14.2014 .,Non-OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
http://dx.doi.org/10.1111/j.1462-5822.2008.01160.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
Sci Rep 5:7763. http://dx.doi.org/ 10.1038/srep07763 .,Non-OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
http://dx.doi.org/ 10.1371/journal.pone.0011113 .,Non-OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
Eukaryot Cell 7:58 – 67. http://dx.doi.org/10.1128/EC.00370 -07.,OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
http://dx.doi.org/10.1128/EC.00318-06 .,Non-OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
http://dx.doi.org/10.1111/mmi.12572 .,Non-OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
J Biol Chem 278:49636 – 49643. http://dx.doi.org/ 10.1074/jbc.M307996200 .,OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
Mol Microbiol 81:640 – 658. http://dx.doi.org/ 10.1111/j.1365-2958.2011.07719.x .,OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
Proteome Sci 12:9. http://dx.doi.org/10.1186/1477-5956-12-9 .,OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
Front Immunol 5:403. http://dx.doi.org/10.3389/ ﬁmmu.2014.00403 .,Non-OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
http://dx.doi.org/10.1126/science.1097640 .Sup35p Packaging in Extracellular Vesicles July/August 2015 Volume 6 Issue 4 e01017-15®mbio.asm.org 5,Non-OADS,/arxiv_data1/oa_pdf/dc/25/mBio.01017-15.PMC4542192.pdf
Curr Opin Immunol 35:1– 8. http://dx.doi.org/10.1016/j.coi.2015.05.001 .,OADS,/arxiv_data1/oa_pdf/3f/8e/mBio.01269-15.PMC4542193.pdf
http://dx.doi.org/10.1016/ j.immuni.2012.08.010 .,OADS,/arxiv_data1/oa_pdf/3f/8e/mBio.01269-15.PMC4542193.pdf
http://dx.doi.org/10.1021/ja057404h .,Non-OADS,/arxiv_data1/oa_pdf/3f/8e/mBio.01269-15.PMC4542193.pdf
J Am Chem Soc 133: 8014 – 8027. http://dx.doi.org/10.1021/ja202103e .,OADS,/arxiv_data1/oa_pdf/3f/8e/mBio.01269-15.PMC4542193.pdf
AngewChem Int Ed Engl 48:8952– 8957. http://dx.doi.org/10.1002/ anie.200904778 .,OADS,/arxiv_data1/oa_pdf/3f/8e/mBio.01269-15.PMC4542193.pdf
http://dx.doi.org/ 10.1016/j.molcel.2009.10.004 .,OADS,/arxiv_data1/oa_pdf/3f/8e/mBio.01269-15.PMC4542193.pdf
http://dx.doi.org/10.1128/ mBio.00638-15 .,Non-OADS,/arxiv_data1/oa_pdf/e1/52/mBio.01120-15.PMC4542194.pdf
Lancet http://dx.doi.org/10.1016/S0140-6736(15)60454-8 .,OADS,/arxiv_data1/oa_pdf/e1/52/mBio.01120-15.PMC4542194.pdf
http://dx.doi.org/10.1093/infdis/jit504 .,Non-OADS,/arxiv_data1/oa_pdf/e1/52/mBio.01120-15.PMC4542194.pdf
http://dx.doi.org/10.1038/ cddis.2013.367 .,Non-OADS,/arxiv_data1/oa_pdf/e1/52/mBio.01120-15.PMC4542194.pdf
http://dx.doi.org/10.1128/JVI.02576-13 .,Non-OADS,/arxiv_data1/oa_pdf/e1/52/mBio.01120-15.PMC4542194.pdf
http://dx.doi.org/10.1016/ j.bbrc.2014.02.091 .,OADS,/arxiv_data1/oa_pdf/e1/52/mBio.01120-15.PMC4542194.pdf
BMCPharmacol Toxicol 15:67. http://dx.doi.org/10.1186/2050-6511-15-67 .,Non-OADS,/arxiv_data1/oa_pdf/e1/52/mBio.01120-15.PMC4542194.pdf
Phylogenetic reconstruction was performed using the maximum likelihood algorithm in the MEGA package (46) and visualizedwith FigTree ( http://tree.bio.ed.ac.uk/software/ﬁgtree ).,OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
J Antibiot (Tokyo) 67: 631– 644. http://dx.doi.org/10.1038/ja.2014.111 .,OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1086/491711 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1093/jac/dkg128 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1128/ AAC.01516-07 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1002/prot.22009 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1074/jbc.M112.405522 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/ 10.1073/pnas.1402259111 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1111/j.1742-4658.2008.06516.x .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
Chem Rev 111:6919 – 6946. http://dx.doi.org/10.1021/cr2000702 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1128/AAC.44.6.1660 -1666.2000 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
J Bacteriol 184: 6457– 6464. http://dx.doi.org/10.1128/JB.184.23.6457-6464.2002 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1046/j.1365 -2958.2003.03737.x .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
D-Ala- D-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium.Antimicrob Agents Chemother 55:4606 – 4612. http://dx.doi.org/ 10.1128/AAC.00714-11 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/ 10.1016/j.bbapap.2009.03.006 .,OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
BMC Struct Biol 9:53. http://dx.doi.org/10.1186/ 1472-6807-9-53 .,OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1107/ S1399004714009419 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1074/jbc.M201615200 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1093/ oxfordjournals.jbchem.a022517 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/ 10.1002/1439-7633(20020802)3:8 /H11021789::AID-CBIC789 /H110223.0.CO;2-D .,OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1107/S1399004713024838 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/ 10.1371/journal.pone.0048301 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
Cell Mol Life Sci 68: 817– 831. http://dx.doi.org/10.1007/s00018-010-0571-8 .,OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1128/ AAC.49.1.21-25.2005 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1146/annurev -genet-102209-163517 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/ 10.1016/j.drup.2004.02.003 .,OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1128/ AAC.02556-12 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/ 10.1016/j.mib.2009.06.013 .,OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1007/978 -1-59745-196-3_7 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1021/ bi00317a016 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
Acta Crystallogr D BiolCrystallogr 62:859 – 866. http://dx.doi.org/10.1107/S0907444906019949 .,OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1107/ S0907444909052925 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1107/ S0907444904026460 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1093/nar/ gkq366 .,OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
Mol Syst Biol 7:539. http://dx.doi.org/10.1038/ msb.2011.75 .,OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/10.1093/molbev/msr121 .,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
http://dx.doi.org/ 10.1128/mBio.02180-14 .Meziane-Cherif et al.,Non-OADS,/arxiv_data1/oa_pdf/79/5c/mBio.00806-15.PMC4542195.pdf
"For determination of the FtsZ cellular concentration, the intensityof the bands was quantiﬁed using ImageJ ( http://imagej.nih.gov/ij/ ) and the recombinant pneumococcal FtsZ samples were used as the referencesamples.",OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1038/34472 .Jacq et al.,OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
EMBO J26:4694 – 4708. http://dx.doi.org/10.1038/sj.emboj.7601895 .,OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1128/MMBR.00021-10 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1111/j.1749 -6632.2012.06818.x .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.7554/eLife.04601 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1126/ science.1239248 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/ 10.1126/science.1154520 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1038/emboj.2009.277 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1016/ j.ceb.2013.08.006 .,OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1111/mmi.12331 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1371/ journal.pone.0012680 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1111/mmi.12408 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1371/ journal.pbio.1001389 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1111/j.1574 -6976.2007.00098.x .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1111/1462 -2920.12189 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1038/nature13966 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
Mol Microbiol 94:21– 40. http://dx.doi.org/10.1111/ mmi.12745 .,OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/ 10.1002/cm.21054 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1128/JB.02157-12 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1371/ journal.pone.0098362 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/ 10.1073/pnas.1215175109 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1038/nbt1037 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
Mol Microbiol 50: 845– 855. http://dx.doi.org/10.1046/j.1365-2958.2003.03767.x .,OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1371/journal.pgen.1004275 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1111/j.1365-2958.2004.04432.x .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1038/nmeth.2784 .,OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1128/ JB.186.17.5775-5781.2004 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1074/ jbc.M500895200 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
https://www.aaai.org/Papers/KDD/1996/ KDD96-037.pdf .PALM Nanostructure of Pneumococcal FtsZ July/August 2015 Volume 6 Issue 4 e01108-15®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1038/ nmeth.1274 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1128/ mBio.01700-14 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2011.07962.x .43.,Non-OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/ 10.1128/AEM.67.11.5190-5196.2001 .,OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
Mol Microbiol 80:612– 627. http://dx.doi.org/10.1111/j.1365-2958.2011.07579.x .,OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.1073/ pnas.1201882109 .Jacq et al.,OADS,/arxiv_data1/oa_pdf/4d/19/mBio.01108-15.PMC4542196.pdf
http://dx.doi.org/10.2105/ AJPH.2007.119933 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/10.1038/274334a0 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://www.whitehouse.gov/blog/2014/10/17/doing-diligence- assess-risks-and-beneﬁts-life-sciences-gain-function-research .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
Virology 89: 613– 617. http://dx.doi.org/10.1016/0042-6822(78)90203-9 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
"Virology 89:632– 636. http://dx.doi.org/10.1016/0042-6822(78)90207-6 .8.Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, Yampolskaya O .",OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/10.2307/2885382 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/10.3201/eid1201.051254 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
J Infect Dis135:681– 686. http://dx.doi.org/10.1093/infdis/135.4.681 .,OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
J Infect Dis 173: 453– 456. http://dx.doi.org/10.1093/infdis/ 173.2.453 .,OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/10.1099/0022-1317-48-2 -383 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/10.1038/nm1141 .,OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
J Virol 82: 8947– 8950. http://dx.doi.org/10.1128/JVI.00101-08 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/10.1056/NEJMp0904572 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://www.nytimes.com/ 2009/05/15/health/policy/15ﬂu.html?_r /H110050.,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://www.cidrap.umn.edu/news-perspective/2009/05/who-rejects-idea-novel-h1n1-virus-lab-derived .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/10.1371/ journal.pone.0011184 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://thebulletin.org/threatened- pandemics-and-laboratory-escapes-self-fulﬁlling-prophecies7016 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
Front Public Health 2:77. http://dx.doi.org/10.3389/ fpubh.2014.00077 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dels.nas.edu/ Workshop-Summary/Potential-Risks-Beneﬁts-Gain/21666 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://www.absaconference.org/pdf56/ XI200Lipsitch.pdf .Opinion/Hypothesis July/August 2015 Volume 6 Issue 4 e01013-15®mbio.asm.org 5,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
Nat Rev Microbiol13:58 – 64. http://dx.doi.org/10.1038/nrmicro3405 .,OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://news.sciencemag.org/biology/2014/07/lab- incidents-lead-safety-crackdown-cdc .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://news.sciencemag.org/ biology/2014/12/moratorium-risky-experiments-lifted-mers-mouse-studies .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://news.sciencemag.org/biology/2015/02/ nih-moving-ahead-review-risky-virology-studies .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
Virology 89: 613– 617. http://dx.doi.org/10.1016/0042-6822(78)90203-9 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
Virology 89:632– 636. http://dx.doi.org/10.1016/0042-6822(78)90207-6 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
Evolution of human inﬂuenza A viruses in nature: recombination contributes to genetic variation of H1N1 strains.Proc Natl Acad Sci U S A 76:6547– 6551. http://dx.doi.org/10.1073/ pnas.76.12.6547 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
Cell 18:73– 83. http://dx.doi.org/10.1016/0092-8674(79)90355-6 .,OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
J Gen Virol 56:437– 440. http://dx.doi.org/10.1099/0022-1317-56-2 -437 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/10.1017/S002217240006424X .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/10.1093/infdis/ 149.1.108 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
Acta Trop 83:1– 6. http://dx.doi.org/10.1016/S0001-706X(02)00050-5 .,OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/10.1038/nm1141 .,OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/10.1128/JVI.00986-06 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/10.3201/eid1201.051254 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/10.1002/0470114207 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
J Virol 82: 8947– 8950. http://dx.doi.org/10.1128/JVI.00101-08 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://www.npr.org/templates/story/ story.php?storyId /H11005113446539 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/10.1079/ 9781845936259.0041 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
Swine ﬂu: just the latest chapter in a 91-year pandemic era.http://www.wired.com/2009/06/swineﬂuhistory/ .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://www.motherjones.com/blue-marble/2009/06/swine-ﬂu- accidentally-resurrected-dead .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/ 10.1056/NEJMra0904322 .,OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://dx.doi.org/10.1371/ journal.pone.0011184 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
Sci Rep 3:1698. http://dx.doi.org/10.1038/srep01698 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://thebulletin.org/threatened- pandemics-and-laboratory-escapes-self-fulﬁlling-prophecies7016 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://news.sciencemag.org/sites/ default/ﬁles/media/Letter%20to%20Barroso_0.pdf .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://www.cidrap.umn.edu/news-perspective/2014/06/commentary-case-against-gain-function-experiments-reply-fouchier-kawaoka.,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
Front Public Health 2:77. http://dx.doi.org/10.3389/ fpubh.2014.00077 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
http://gizmodo.com/the-beneﬁts-and-dangers- of-designing-mutant-super-vi-1599301288 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
doi: http://dx.doi.org/10.1128/mBio.02062-14 .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/mBio.01013-15.PMC4542197.pdf
"Inthisstudy,weutilizeSABERversion1.07(http://saber.ga ts-inc.com)temperatureobservationstoidentify thespatialstructureandtimeofoccurrencefortheW3QTDWintheMLTregion.Weselectanaltitudeof85km,whichisclosetothealtitudeofthelowerQTDWamplitudepeakatthemesopauseandismoreeasily CHANGETAL.",OADS,/arxiv_data1/oa_pdf/d9/7a/jgra0119-4786.PMC4542201.pdf
"TIDIzonalwindobservations(http://timed.hao.ucar.edu/tidi/)areutilizedinthisstudytodeterminechanges inbackgroundzonalwindsat85kmand100kmintheMLTregionthatoccurwithtimescalesontheorder ofthoseofasingleQTDWevent;thesearepotentiallyrelatedtothepresenceoftheQTDW.Weutilizethe backgroundzonalwindsforthisstudy,aszonalmeanmeridionalwindsareconsiderablyweakerthanthezonalmeanzonalwinds,makingthebackgroundmeridionalwindsmoresusceptibletoaliasingorother typesofcontamination.Retrievalofthebackgroundzonalwindsislimitedbythelocaltimeprecessionrate oftheTIMEDsatelliteorbit,whichrequires63daystocover24hofsolarlocaltime.Thefulllocaltimecov- erageisrequiredtounambiguouslyseparatethetides,stationaryPWs,andzonalmeancomponents,sothe TIMEDorbitalprecessionperiodisnotusefulforresolvingchangesshorterthanthoseoccurringonseasonal timescales.",Non-OADS,/arxiv_data1/oa_pdf/d9/7a/jgra0119-4786.PMC4542201.pdf
"Usingtheatomicoxygen135.6nmandN 2Lyman-Birge-Hopﬁeld(LBH)emissionbandsinthefarultraviolet, altitudeproﬁlesofN2,O,andO2andtemperaturehavebeenretrievedfromthelimbscandata;version10of thelimbdatabaseisonlineathttp://guvi.jhuapl.edu/site/data/guvi-dataproducts.shtml.ColumnO/N2den- sityratios( ΣO/N2)arederivedfromthediskdata,alsoonlineatthesamesite.Thecolumndensityratiois deﬁnedastheratiooftheverticalOcolumndensitytotheN2columndensity,abovethealtitudewherethe N2columndensityis 1017cm−2(around130–140km,dependingonsolaractivity).Thisprovidestheoptimal algorithmicconversionfromthedisk135.6nm/LBHintensityratiointo ΣO/N2forcomparisonwithmod- els(detailsaregivenby Strickland et al.",OADS,/arxiv_data1/oa_pdf/d9/7a/jgra0119-4786.PMC4542201.pdf
", 2009](ftp://ftp.unibe.ch/aiub/CODE/).TheresultingGIMscontainglobalsnapshotsofTECwithageographic latitude ×longituderesolutionof 2.5×5◦every2h.Inthisstudy,theGIMTECsateachgeomagneticlatitude arezonallyaveragedatalllongitudesat1600hlocaltime,whichisrepresentativeofdaytimeconditionswhentheEIAsarestrongest.",Non-OADS,/arxiv_data1/oa_pdf/d9/7a/jgra0119-4786.PMC4542201.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/ed/main.PMC4542220.pdf
"E-mail  address:  ula.nur@lshtm.ac.uk  (U.  Nur).Contents  lists  available  at  ScienceDirect Cancer  Epidemiology The  International  Journal  of  Cancer  Epidemiology,  Detection,  and  Prevention jou  r  nal  h  o  mep  age:  w  ww.c  an  cer  ep  idem  io  log  y.n  et http://dx.doi.org/10.1016/j.canep.2015.05.0061877-7821/ /C223 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/15/ed/main.PMC4542220.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/15/ed/main.PMC4542220.pdf
"The  English  Indices  of  Deprivation  2004  – Summary  (Revised);  2004,  http://www.communities.gov.uk/archived/publi- cations/communities/indicesdeprivation.",Non-OADS,/arxiv_data1/oa_pdf/15/ed/main.PMC4542220.pdf
Public  Health  (Oxf) 2015.  http://dx.doi.org/10.1093/pubmed/fdv038 .,Non-OADS,/arxiv_data1/oa_pdf/15/ed/main.PMC4542220.pdf
contributed equally to this article.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /AEM.01545-15 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
An additional requirement for potential marker genes was that the neighboring genes (located upstream or downstream)are at least a distance of 3 kb to avoid any undesired locus effects.For the in silico analysis we used the T. reesei genome database ( http://genome.jgi-psf.org/Trire2/Trire2.home.html ) and found that the homologs of the A. niger argH (coding for the arginino- succinate lyase [EC 4.3.2.1]) ( 35) and A. nidulans lysF (coding for the mitochondrial homoaconitate hydratase [EC 4.2.1.36]) ( 36) fulﬁlled these criteria.,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
"However, this is in our opinion rather unlikely, as the con-served domain search on http://www.ncbi.nlm.nih.gov/Structure /cdd/wrpsb.cgi predicts the protein to be a homoaconitase with an E value of 0e /H1100100.",Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org/10.1007/s10295-008-0327-8 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
Curr Opin Biotechnol 14:438 – 443. http://dx.doi.org/10.1016 /S0958-1669(03)00099-5 .,OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org/10.1016 /0014-5793(95)01255-5 .,OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org/10.1074/jbc.275.8.5817 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org/10 .1074/jbc.M003624200 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
Mol Genet Genomics 266:56 – 63. http://dx.doi.org/10 .1007/s004380100518 .,OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
Eukaryot Cell 5:447– 456. http://dx.doi.org/10.1128/EC.5.3.447-456.2006 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
From an electrophoretic mobility shift assay to isolated transcription factors: a fast genomic-proteomic approach.BMC Genomics 11:644. http://dx.doi.org/10.1186/1471-2164-11-644 .,OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2012.08083.x .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
Biotechnol Biofuels 7:14. http://dx.doi.org/10.1186/1754 -6834-7-14 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org/10.1099/mic.0 .053132-0 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
BMC Genomics 14:657. http://dx.doi.org/10.1186/1471-2164-14 -657 .,OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org/10.1016/0378 -1119(87)90110-7 .,OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org/10.1007 /BF00336788 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
Biotechnol Biofuels 5:1.http://dx.doi .org/10.1186/1754-6834-5-1 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
Nat Biotechnol 16:839 – 842. http://dx.doi.org/10.1038/nbt0998 -839 .,OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org/10.1128 /AEM.02100-10 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org/10 .1016/0014-5793(88)80665-3 .,OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
Biosci Biotechnol Biochem 66:404 – 406. http://dx.doi.org/10.1271/bbb.66.404 .Derntl et al.,OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org/10.1007/BF00324665 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
Microb Cell Fact 13:33.http://dx.doi.org/10 .1186/1475-2859-13-33 .,OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org /10.1007/s00294-005-0011-8 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org/10.1007 /BF00351679 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org/10.1007/BF00321118 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi .org/10.1007/BF00633830 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi .org/10.1128/AEM.72.3.2126-2133.2006 .,OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org/10.1080 /13693780802546541 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi .org/10.1007/BF00713933 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi .org/10.1007/s004380050494 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
http://dx.doi.org /10.1128/MCB.21.1.298-309.2001 .,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
Transgenic Res 10:409 – 422. http://dx.doi.org/10.1023 /A:1012032000383 .Genomic Manipulation Strategies for Trichoderma reesei September 2015 Volume 81 Number 18 aem.asm.org 6323 Applied and Environmental Microbiology,Non-OADS,/arxiv_data1/oa_pdf/ba/25/zam6314.PMC4542242.pdf
Supplemental material for this article may be found at http://dx.doi.org/10.1128 /AEM.01263-15 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
"Genomic DNA of theCBS1483 strain was used to obtain four paired libraries with differentTABLE 1 Strains used in this study Strain Description Reference or source S. pastorianus CBS1483 Group II brewer’s yeast, Heineken’s bottom yeast, July 1927 18 S. pastorianus A1 Group II, WS34/70 isolate 42 S. pastorianus A1/H11001B11 Group II, WS34/70 isolate 42 S. pastorianus A2 Group II, WS34/70 isolate 42 S. pastorianus Spy1 Group II, industrial strain descendant of S. pastorianus CBS1483 S. pastorianus Spy2 Group II, industrial strain Mexican bottom-fermenting yeast S. pastorianus CBS1260 Group II, Frohberg-type bottom-fermenting yeast, March 1937 13,14 S. pastorianus var.monacensis CBS1503 Group I, S. monacensis type strain, original culture, 1908 13,14 S. pastorianus var.carlsbergensis CBS1513 Group I, S. carlsbergensis type strain, October 1947 13,14 S. cerevisiae CEN.PK113-7D MAT aSUC2 MAL2-8c 78,79 S. cerevisiae CEN.PK112 MAT a/MAT/H9251 Euroscarfa S. cerevisiae FRY153 3n ahttp://web.uni-frankfurt.de/fb15/mikro/euroscarf/ .van den Broek et al.",Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
"To be ableto process the publically available data for strains CBS1503, CBS1513, andCBS1260 ( http://www.ebi.ac.uk/ena/data/view/PRJEB4654 ), the original Solid4 color space data were converted to fastq.",OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
The mapped reads were extracted from the sequence align- ment map and converted into a base space fastq format using SamTo-Fastq.jar from Picard tools (version 1.113; http://picard.sourceforge.net ).,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
The sequence data gener- ated in this study are searchable at NCBI Entrez ( http://www.ncbi.nlm .nih.gov/ ) under BioProject number PRJNA266750 (accession number SRP049726 ).Table 2 describes the structure of the searchable data.,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
"Biosample Expt Run SRS743281 SRX758142 SRR1649181 SRX758143 SRR1649182SRX758140 SRR1649179SRX758141 SRR1649180 SRS743282 SRX758144 SRR1649183 SRX758145 SRR1649190SRX758149 SRR1649191 SRS743429 SRX758305 SRR1658893 SRS743428 SRX758304 SRR1658892 SRS743430 SRX758306 SRR1658889 aThe data are searchable at NCBI Entrez ( http://www.ncbi.nlm.nih.gov/ ) under Bio - Project number PRJNA266750 (accession number SRP049726 ), and the whole-genome shotgun accession number is JTFI00000000 .van den Broek et al.",OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1111/j.1574-6976.2007 .00076.x .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1128/AEM .02769-05 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1016/S0065-2164(09)69006-7 .,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
Antonie van Leeuwenhoek 53:77– 84. http://dx.doi .org/10.1007/BF00419503 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10 .1016/S0723-2020(99)80041-1 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
Proteomics 7:4135– 4147. http://dx.doi.org/10.1002/pmic .200601020 .,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1534/g3.113.010090 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1371/journal.pone.0092203 .Chromosome Copy Number Variation in S. pastorianus September 2015 Volume 81 Number 18 aem.asm.org 6265 Applied and Environmental Microbiology,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1111/mec.12702 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1101/gr.076075.108 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1007/s00294 -004-0504-x .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
Nature 405:451– 454. http://dx.doi.org /10.1038/35013058 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
Appl Environ Microbiol 75:4573– 4579. http://dx.doi.org/10.1128/AEM .00351-09 .,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10 .1371/journal.pgen.1003366 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1002/yea.320080703 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
Bioinformatics 27:578 – 579. http://dx.doi.org/10.1093/bioinformatics/btq683 .,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1186/gb-2009-10-3-r25 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1186/gb-2012-13-6 -r56.,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
BMCBioinformatics 12:491. http://dx.doi.org/10.1186/1471-2105-12-491 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1093 /bioinformatics/bts601 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1101/gr.089532.108 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi .org/10.1093/bioinformatics/btu170 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org /10.1093/bioinformatics/btp698 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1093/nar/24.13.2519 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
Neurosci Lett 339: 62– 66. http://dx.doi.org/10.1016 /S0304-3940(02)01423-4 .,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1093/nar/gkp045 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1016/S0378-1097(03)00815-2 .,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1111/1567-1364.12051 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1111/1567-1364.12024 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
Metab Eng13:638 – 647. http://dx.doi.org/10.1016/j.ymben.2011.07.005 .,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
Yeast 29:435– 442. http://dx.doi.org/10.1002/yea .2922 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1002/yea.320110403 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1111/j .1365-2958.2006.05072.x .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org /10.1007/s00253-010-2843-5 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
Yeast 31:421– 430. http://dx.doi.org/10.1002/yea.3037 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
Cold Spring Harbor Symp Quant Biol 75:445– 451. http://dx.doi .org/10.1101/sqb.2010.75.025 .,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1126 /science.1142210 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org /10.1038/42711 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org /10.1371/journal.pgen.1000705 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
FEMS Yeast Res http://dx.doi.org/10.1111/j.1567 -1364.2012.00787.x.,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org /10.1111/j.1567-1364.2011.00776.x .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi .org/10.1073/pnas.1305949110 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1093/femsyr /fov005 .,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1007/s10295-015-1597-6 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1054/bjoc.2000.1458 .,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org /10.1159/000077512 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1016/j.ccr.2006.12.003 .,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
BMC Genomics 12: 526. http://dx.doi.org/10.1186/1471-2164-12-526 .,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1101/gr.133967.111 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1101/gr.128991 .111.,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
Genetics 174:839 – 850. http://dx.doi.org/10.1534/genetics.106.062166 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org /10.1038/nature07743 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1128/EC.00134-14 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1002/yea.2960 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
BMC Genomics 6:53. http://dx.doi.org/10.1186/1471-2164-6-53 .,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
BMC Evol Biol 12:46. http://dx.doi.org/10.1186/1471-2148 -12-46 .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
Genome Res 22:115– 124. http://dx.doi.org/10.1101/gr.121285.111 .,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
http://dx.doi.org/10.1111/j .1574-6968.2008.01480.x .,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
Mi- crob Cell Fact 11:36. http://dx.doi.org/10.1186/1475-2859-11-36 .,OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
Method Microbiol 36:629 – 666. http://dx.doi.org/10.1016 /S0580-9517(06)36025-4 .Chromosome Copy Number Variation in S. pastorianus September 2015 Volume 81 Number 18 aem.asm.org 6267 Applied and Environmental Microbiology,Non-OADS,/arxiv_data1/oa_pdf/97/05/zam6253.PMC4542246.pdf
"Journal of  Preventive Medicine  & Public Health 195 Copyright © 2015  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:195-202    •  http://dx.doi.org/10.3961/jpmph.15.026 Dental Care Utilization for Examination and Regional   Deprivation Cheol-Sin Kim1, Sun-Young Han1, Seung Eun Lee2, Jeong-Hee Kang3, Chul-Woung Kim4,5 1Research Institute for Dental Care Policy, Korean Dental Association, Seoul; 2Graduate School of Public Health, Seoul National University, Seoul;  3Department of Nursing Science, Youngdong University, Youngdong; 4Department of Preventive Medicine, Chungnam National University School  of Medicine, Daejeon; 5Research Institute for Medical Sciences, Chungnam National University School of Medicine, Daejeon, KoreaOriginal Article Objectives: Receiving proper dental care plays a significant role in maintaining good oral health.",Non-OADS,/arxiv_data1/oa_pdf/2d/90/jpmph-48-4-195.PMC4542294.pdf
"Key words:  Utilization, Dental care, Dental health surveys, Residence characteristics, Multilevel analysis Received:  April 13, 2015 Accepted:   July 17, 2015    Corresponding author:  Chul-Woung Kim, MD, PhD 55 Munhwa-ro, Joong-gu, Daejeon 301-747, Korea Tel: +82-42-580-8268, Fax:  +82-42-580-8261 E-mail:  woung@cnu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Accessing suitable dental care services is a vital component  of good oral health management [1].",Non-OADS,/arxiv_data1/oa_pdf/2d/90/jpmph-48-4-195.PMC4542294.pdf
Journal of  Preventive Medicine  & Public Health 179 Copyright © 2015  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:179-179    •  http://dx.doi.org/10.3961/jpmph.15.047 Urgent Call for Research on Middle East Respiratory   Syndrome (MERS) in KoreaEditorial The largest outbreak of Middle East Respiratory Syndrome  Coronavirus (MERS-CoV) outside of Saudi Arabia has essentially   ended in the Republic of Korea (hereafter Korea).,Non-OADS,/arxiv_data1/oa_pdf/98/00/jpmph-48-4-179.PMC4542295.pdf
"Journal of  Preventive Medicine  & Public Health 216 Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:216-224    •  http://dx.doi.org/10.3961/jpmph.15.021 Effects of Smoking on Menopausal Age: Results From the  Korea National Health and Nutrition Examination Survey,  2007 to 2012 Hee Jung Yang, Pae Sun Suh, Soo Jeong Kim, Soon Young Lee Department of Preventive Medicine and Public Health, Ajou University School of Medicine, Suwon, KoreaOriginal Article Objectives: Decreased fertility and impaired health owing to early menopause are significant health issues.",Non-OADS,/arxiv_data1/oa_pdf/ca/d6/jpmph-48-4-216.PMC4542296.pdf
"PhD 206 World cup-ro, Yeongtong-gu, Suwon 443-721, Korea Tel: +82-31-219-5301, Fax:  +82-31-219-5084 E-mail:  solee@ajou.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Menopause is an inevitable physical change experienced by  women during the aging process.",Non-OADS,/arxiv_data1/oa_pdf/ca/d6/jpmph-48-4-216.PMC4542296.pdf
Avail - able from: http://stats.oecd.org/index.aspx?DataSetCode =,OADS,/arxiv_data1/oa_pdf/ca/d6/jpmph-48-4-216.PMC4542296.pdf
"Journal of  Preventive Medicine  & Public Health 188 Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:188-194    •  http://dx.doi.org/10.3961/jpmph.15.020 Associations Between the Continuity of Ambulatory Care  of Adult Diabetes Patients in Korea and the Incidence of  Macrovascular Complications  Young-Hoon Gong, Seok-Jun Yoon, Hyeyoung Seo, Dongwoo Kim Department of Preventive Medicine, Korea University College of Medicine, Seoul, KoreaOriginal Article Objectives: The goal of this study was to identify association between the continuity of ambulatory care of diabetes patients in South  Korea (hereafter Korea) and the incidence of macrovascular complications of diabetes, using claims data compiled by the National  Health Insurance Services of Korea.",OADS,/arxiv_data1/oa_pdf/f6/bf/jpmph-48-4-188.PMC4542297.pdf
"Key words:  Diabetes mellitus, Diabetes complications, Continuity of care, Primary health care Received:  March 31, 2015 Accepted:  July 17, 2015 Corresponding author:  Seok-Jun Yoon, MD, PhD 73 Inchon-ro, Seongbuk-gu, Seoul 136-705, Korea Tel: +82-2-2286-1412 Fax:  +82-2-927-7220 E-mail:  yoonsj02@korea.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION The epidemiological traits of diseases are changing.",Non-OADS,/arxiv_data1/oa_pdf/f6/bf/jpmph-48-4-188.PMC4542297.pdf
Available from: http://vizhub.healthdata.,Non-OADS,/arxiv_data1/oa_pdf/f6/bf/jpmph-48-4-188.PMC4542297.pdf
Available from: https://www.idf.org/sites/ default/files/EN_6E_Atlas_Full_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f6/bf/jpmph-48-4-188.PMC4542297.pdf
"Journal of  Preventive Medicine  & Public Health 180 Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:180-187    •  http://dx.doi.org/10.3961/jpmph.15.022 The Economic Burden of Cancers Attributable to   Metabolic Syndrome in Korea Dongwoo Kim1, Seok-Jun Yoon1, Young-Hoon Gong1, Young Ae Kim2, Hye-Young Seo3, Jihyun Yoon3, A-Rim Kim3 1Department of Preventive Medicine, Korea University College of Medicine, Seoul; 2Cancer Policy Branch, National Cancer Control Institute, National  Cancer Center, Goyang; 3Department of Public Health, Graduate School of Korea University, Seoul, KoreaOriginal Article Objectives: Metabolic syndrome is an important etiologic factor in the development of certain types of cancers.",Non-OADS,/arxiv_data1/oa_pdf/38/36/jpmph-48-4-180.PMC4542298.pdf
"Key words:  Metabolic syndrome, Neoplasm, Economic burden Received:  March 31, 2015 Accepted:  July 8, 2015 Corresponding author:  Seok-Jun Yoon, MD, PhD 73 Inchon-ro, Seongbuk-gu, Seoul 136-705, Korea Tel: +82-2-2286-1412, Fax:  +82-2-927-7220 E-mail : yoonsj02@korea.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Metabolic syndrome (MS) is an overall concept that includes  diabetes, hypertension, obesity, and dyslipidemia.",Non-OADS,/arxiv_data1/oa_pdf/38/36/jpmph-48-4-180.PMC4542298.pdf
Available from: http://kosis.kr/ wnsearch/totalSearch.jsp (Korean).,Non-OADS,/arxiv_data1/oa_pdf/38/36/jpmph-48-4-180.PMC4542298.pdf
Available from: http://www.keb.co.kr (Korean).,Non-OADS,/arxiv_data1/oa_pdf/38/36/jpmph-48-4-180.PMC4542298.pdf
"Journal of  Preventive Medicine  & Public Health 203 Copyright © 2015  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:203-215    •  http://dx.doi.org/10.3961/jpmph.14.057 Correlations Between the Incidence of National Notifiable  Infectious Diseases and Public Open Data, Including   Meteorological Factors and Medical Facility Resources Jin-Hwa Jang1,2, Ji-Hae Lee2,3, Mi-Kyung Je2,3, Myeong-Ji Cho2, Young Mee Bae4,5, Hyeon Seok Son2,3, Insung Ahn1 1Biomedical Prediction Technology Laboratory, Convergence Technology Research Division, Korea Institute of Science and Technology  Information, Daejeon; 2Laboratory of Computational Biology and Bioinformatics, Institute of Public Health and Environment, Graduate School of  Public Health, Seoul National University, Seoul; 3Graduate Program in Bioinformatics, College of Natural Science, Seoul National University, Seoul;  4Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine, Seoul; 5Institute of Endemic Diseases, Seoul  National University Medical Research Center, Seoul, KoreaOriginal Article Objectives: This study was performed to investigate the relationship between the incidence of national notifiable infectious diseases  (NNIDs) and meteorological factors, air pollution levels, and hospital resources in Korea.",OADS,/arxiv_data1/oa_pdf/16/3a/jpmph-48-4-203.PMC4542299.pdf
"Key words:  Infectious disease, Correlation coefficient, Incidence, Meteorology Received:  December 29, 2014 Accepted:  July 22, 2015 Corresponding author:  Insung Ahn, PhD 245 Daehak-ro, Yuseong-gu, Daejeon 305-806, Korea Tel: +82-42-869-1053 Fax:  +82-42-869-1687 E-mail:  isahn@kisti.re.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Outbreaks of infectious diseases are shaped by ecological  and environmental factors, as well as social, economic, and pISSN 1975-8375 eISSN 2233-4521  demographic structures and their interactions [1].",Non-OADS,/arxiv_data1/oa_pdf/16/3a/jpmph-48-4-203.PMC4542299.pdf
"Public data were extracted from the Public Data Portal  (www.data.go.kr), the Diseases Web Statistics System (http:// is.cdc.go.kr/nstat/index.jsp), the Korean Statistical Information  Service (http://kosis.kr), the Korea Meteorological Administra - tion (http://sts.kma.go.kr), the Ministry of the Environment  (http://stat.me.go.kr), and Seoul City Open Data Square (http:// data.seoul.go.kr).",OADS,/arxiv_data1/oa_pdf/16/3a/jpmph-48-4-203.PMC4542299.pdf
"Correlational analysis between the monthly incidence of nationally notifiable infectious diseases and monthly average  temperature, humidity, and air pollution-related factors in Korea during 2013  Nationally notifiable  infectious diseases Monthly Tem factors  (Avg) Monthly humidity factors  (Avg) Monthly air pollution-related factors  (Avg) Tem (°C) High Tem (°C) Low Tem (°C) RF (mm) RH (%) PM 2.5 (μg/m3)SO 2 (ppm) O3 (ppm) NO 2 (ppm) CO (ppm) Group 1    Typhoid fever -0.163 -0.166 -0.155 -0.081 -0.113 0.670* 0.596* 0.301 0.376 0.388    Paratyphoid fever 0.484 0.480 0.485 0.135 0.287 -0.131 -0.263 0.421 -0.365 -0.303    Bacillary dysentery -0.332 -0.355 -0.314 -0.099 0.073 0.163 0.204 -0.604* 0.354 0.464    Hepatitis A 0.117 0.131 0.114 0.481 0.019 0.204 0.025 0.527 -0.177 -0.245    EHEC 0.696* 0.679* 0.705* 0.208 0.548 -0.553 -0.574 0.320 -0.617* -0.499 Group 2    Pertussis -0.008 -0.003 -0.018 -0.226 -0.008 -0.209 -0.225 -0.398 0.008 0.035    Tetanus 0.390 0.362 0.411 0.720** 0.670* -0.447 -0.482 -0.001 -0.518 -0.330    Measles 0.549 0.577* 0.524 -0.040 0.111 -0.261 -0.275 0.559 -0.306 -0.448    Mumps 0.207 0.202 0.203 0.032 0.300 -0.268 -0.255 -0.225 -0.105 -0.035    Rubella 0.590* 0.570 0.605* 0.634* 0.637* -0.513 -0.516 0.266 -0.589* -0.454    Japanese encephalitis 0.268 0.271 0.250 -0.078 0.103 -0.638* -0.538 -0.158 -0.366 -0.318    Chicken pox -0.401 -0.405 -0.396 -0.233 -0.131 0.533 0.561 -0.335 0.600* 0.610*    Acute hepatitis B -0.040 -0.076 -0.009 0.434 0.445 -0.125 -0.141 -0.456 -0.049 0.115    Mother hepatitis B -0.340 -0.342 -0.341 -0.185 -0.113 0.063 0.049 -0.560 0.286 0.314    Pp hepatitis B -0.426 -0.444 -0.414 -0.052 -0.030 0.059 0.085 -0.655* 0.305 0.372 Group 3    Malaria 0.949** 0.934** 0.957** 0.636* 0.767** -0.673* -0.749** 0.591* -0.884** -0.753**    Scarlet fever -0.397 -0.391 -0.401 -0.264 -0.198 0.421 0.461 -0.311 0.546 0.485    Legionellosis 0.401 0.394 0.399 0.403 0.319 -0.493 -0.443 0.384 -0.468 -0.464    Endemic typhus -0.161 -0.143 -0.181 -0.251 -0.091 0.024 0.005 -0.460 0.230 0.234    Scrub typhus -0.125 -0.108 -0.148 -0.212 -0.107 -0.264 -0.257 -0.458 0.046 0.003    Leptospirosis 0.248 0.270 0.214 -0.213 0.029 -0.647* -0.579* -0.235 -0.307 -0.346    Brucellosis 0.453 0.457 0.443 0.531 0.374 -0.383 -0.495 0.414 -0.535 -0.524    Leprosy -0.008 0.022 -0.022 -0.266 -0.257 0.518 0.444 0.333 0.346 0.183    CJD 0.171 0.190 0.153 -0.143 -0.201 -0.088 -0.008 0.504 -0.124 -0.235    Primary syphilis 0.236 0.230 0.231 0.115 0.378 -0.365 -0.382 -0.308 -0.205 -0.085    Secondary syphilis 0.630* 0.614* 0.634* 0.436 0.663* -0.611* -0.650* 0.062 -0.646* -0.467    Congenital syphilis -0.194 -0.211 -0.183 0.097 0.093 0.013 0.052 -0.464 0.133 0.277    V. vulnificus  sepsis 0.529 0.521 0.522 0.131 0.369 -0.783** -0.700* 0.018 -0.628* -0.510    M meningitis -0.022 0.015 -0.049 -0.130 -0.304 0.388 0.257 0.359 0.188 0.000    HFRS -0.056 -0.041 -0.079 -0.215 -0.030 -0.364 -0.319 -0.506 -0.008 -0.029 Group 4    Dengue fever 0.690* 0.654* 0.711** 0.437 0.726** -0.739** -0.738** 0.109 -0.776** -0.518    Q fever   0.682* 0.657* 0.703* 0.420 0.662* -0.608* -0.663* 0.148 -0.682* -0.526    Lyme disease 0.317 0.301 0.319 0.128 0.323 -0.425 -0.421 -0.090 -0.312 -0.184    SFTS 0.797** 0.782** 0.808** 0.723** 0.777** -0.505 -0.635* 0.438 -0.737** -0.595* Data were obtained from the Public Data Portal (www.data.go.kr), Diseases Web Statistics System (http://is.cdc.go.kr/nstat/index.jsp), the Korean Statistical  Information Service (http://kosis.kr), the Korea Meteorological Administration (http://sts.kma.go.kr) and the Ministry of the Environment (http://stat.me.go.kr).",OADS,/arxiv_data1/oa_pdf/16/3a/jpmph-48-4-203.PMC4542299.pdf
Data were extracted from the Public Data Portal (www.data.go.kr) and Seoul City Open Data Square (http://data.seoul.go.kr).,OADS,/arxiv_data1/oa_pdf/16/3a/jpmph-48-4-203.PMC4542299.pdf
of beds (IV)    Pearson correlation 0.456* -0.079 0.599** 1    Significance (two-tailed) 0.022 0.707 0.002 Data were obtained from the Public Data Portal (www.data.go.kr) and Seoul City Open Data Square (http://data.seoul.go.kr).,OADS,/arxiv_data1/oa_pdf/16/3a/jpmph-48-4-203.PMC4542299.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/16/3a/jpmph-48-4-203.PMC4542299.pdf
Available from: https://www.data.go.kr/ main.jsp#/L21haW4 =(Korean).,OADS,/arxiv_data1/oa_pdf/16/3a/jpmph-48-4-203.PMC4542299.pdf
Available from: http://www.cdc.gov/flu/pandemic-re -sources/tools/communityflu.htm.,Non-OADS,/arxiv_data1/oa_pdf/16/3a/jpmph-48-4-203.PMC4542299.pdf
Available from: http://www.cdc.gov/flu/ pandemic-resources/tools/fluaid.htm.,Non-OADS,/arxiv_data1/oa_pdf/16/3a/jpmph-48-4-203.PMC4542299.pdf
Descriptive statistics of climactic and air pollution-related variables VariablesMonthly average Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Average temperature (°C) -3.4 -1.2 5.1 10 18.2 24.4 25.5 27.7 21.8 15.8 6.2 -0.2 Average high temperature (°C) 0.3 2.8 10.8 15 23.6 29.2 28.3 31.1 25.9 21.2 10.7 3.5 Average low temperature (°C) -6.6 -4.9 0.7 5.7 13.7 20.5 23.4 24.8 18 10.9 2.1 -3.5 Rainfall (mm) 22.1 74.1 27.3 71.7 132 28.3 676.2 148.6 138.5 13.5 46.8 24.7 Relative humidity (%) 57 54 49 54 58 60 79 69 63 58 58 60 PM 2.5 (μg/m3) 63.88 44.52 55.36 52.24 55.33 40.12 34.16 35 28.08 29.16 42.56 55.04 SO 2 (ppm) 0.008 0.006 0.006 0.006 0.006 0.005 0.004 0.004 0.004 0.004 0.005 0.007 O3 (ppm) 0.012 0.018 0.023 0.031 0.034 0.033 0.024 0.027 0.023 0.017 0.012 0.009 NO 2 (ppm) 0.045 0.038 0.037 0.034 0.035 0.03 0.022 0.024 0.026 0.03 0.036 0.043 CO (ppm) 0.9 0.6 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.4 0.6 0.8 Data were obtained from the Korea Meteorological Administration (http://sts.kma.go.kr).,Non-OADS,/arxiv_data1/oa_pdf/16/3a/jpmph-48-4-203.PMC4542299.pdf
Data were extracted from the Pub - lic Data Portal (www.data.go.kr) and Seoul City Open Data Square (http://data.seoul.go.kr).,OADS,/arxiv_data1/oa_pdf/16/3a/jpmph-48-4-203.PMC4542299.pdf
"International Journal of Preventive Medicine 2015, 6:71 http://www.ijpvmjournal.net/content/6/1/71REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/dc/46/IJPVM-6-71.PMC4542326.pdf
"International Journal of Preventive Medicine 2015, 6:73 http://www.ijpvmjournal.net/content/6/1/73Cardiovascular disease is the leading cause of death  universal.",Non-OADS,/arxiv_data1/oa_pdf/71/da/IJPVM-6-73.PMC4542328.pdf
"International Journal of Preventive Medicine 2015, 6:73 http://www.ijpvmjournal.net/content/6/1/73group were received two capsules of placebo twice  daily (each capsule containing lactose powder [Health  Burst Co.]).",Non-OADS,/arxiv_data1/oa_pdf/71/da/IJPVM-6-73.PMC4542328.pdf
"International Journal of Preventive Medicine 2015, 6:73 http://www.ijpvmjournal.net/content/6/1/73also its signaling product CRP .",Non-OADS,/arxiv_data1/oa_pdf/71/da/IJPVM-6-73.PMC4542328.pdf
"International Journal of Preventive Medicine 2015, 6:73 http://www.ijpvmjournal.net/content/6/1/73The results of this double‑blind, randomized clinical  trial demonstrate that intake of CoQ10 (200 mg/day) for  12 weeks, leads to significant increase in serum HDL‑C  in MI patients.",Non-OADS,/arxiv_data1/oa_pdf/71/da/IJPVM-6-73.PMC4542328.pdf
"International Journal of Preventive Medicine 2015, 6:73 http://www.ijpvmjournal.net/content/6/1/73T wo limitations of the present study should be  mentioned.",Non-OADS,/arxiv_data1/oa_pdf/71/da/IJPVM-6-73.PMC4542328.pdf
"International Journal of Preventive Medicine 2015, 6:67 http://www.ijpvmjournal.net/content/6/1/67overall mortality.",Non-OADS,/arxiv_data1/oa_pdf/b3/42/IJPVM-6-67.PMC4542329.pdf
"International Journal of Preventive Medicine 2015, 6:67 http://www.ijpvmjournal.net/content/6/1/67samples have to be precipitated with precipitation reagent  to extract the analyte.",Non-OADS,/arxiv_data1/oa_pdf/b3/42/IJPVM-6-67.PMC4542329.pdf
"International Journal of Preventive Medicine 2015, 6:67 http://www.ijpvmjournal.net/content/6/1/67Table 2a: Comparison of vitamin D status of the  participants based on the results of CPBA‑EIA and HPLC  methods according to the first category (no (%)) CPBA  HPLCSevere  deficiencyIntermediate  deficiencyMild  deficiencyNormal total Severe  deficiency 34 (13.2) 20 (7.8) 15 (5.8) 8 (3.1) 77 Intermediate  deficiency37 (14.4) 18 (7.0) 20 (7.8) 11 (4.3) 86 Mild  deficiency24 (9.3) 15 (5.8) 17 (6.6) 9 (3.5) 65 Sufficiency 10 (3.9) 9 (3.5) 5 (1.9) 5 (1.9) 29 Total 105 62 57 33 257 P>0.05 Table 2b: Comparison of the occurrence of severe vitamin  D deficiency and vitamin D insufficiency/sufficiency  among the participants based on the results of CPBA‑EIA  and HPLC methods according to the first category (no (%)) CPBA HPLCSevere  deficiencyInsufficiency/ sufficiencyTotal Severe deficiency 34 (13.2) 43 (16.7) 77 Insufficiency/sufficiency 71 (27.6) 109 (42.3) 180 Total 105 152 257 P>0.05Table 1: Comparison of vitamin D status measured by HPLC  and CPBA according to two usual cut off points (no (%)) Method Vitamin D statusNo.",Non-OADS,/arxiv_data1/oa_pdf/b3/42/IJPVM-6-67.PMC4542329.pdf
"International Journal of Preventive Medicine 2015, 6:67 http://www.ijpvmjournal.net/content/6/1/67Table 2c: Comparison of vitamin D status of the participants based on the results of CPBA‑EIA and HPLC methods  according to the second category (no (%)) CPBA HPLC Severe deficiency Intermediate deficiency Mild deficiency Sufficiency total Severe deficiency 199 (77.4) 17 (6.6) 5 (1.9) 2 (0.8) 223 Intermediate deficiency 10 (3.9) 1 (7.4) 2 (0.8) 0 13 Mild deficiency 12 (4.7) 0 1 (0.4) 0 13 Sufficiency 7 (2.7) 0 1 (0.4) 0 8 Total 228 18 9 2 257 P>0.05 Table 2d: Comparison of the occurrence of severe vitamin  D deficiency and vitamin D insufficiency/sufficiency among  the participants based on the results of CPBA‑EIA and HPLC  methods according to the second category (no (%)) CPBA HPLC Severe  deficiencyInsufficiency/ sufficiencyTotal Severe deficiency 199 29 228 Insufficiency/sufficiency 24 5 29 Total 223 34 257 P>0.05 Table 3: CPBA sensitivity, specificity, accuracy, positive  and negative predictive values compared to HPLC in two  set of cut‑offs CPBA compared to  HPLC (%)First set  of cut‑offs Second set  of cut‑offs  Sensitivity 44.2 88.7 Specificity 60.6 17.2 Accuracy 55.6 79.7 Positive predictive value 32.4 89.3 Negative predictive value 71.7 15.223‑lactone.",Non-OADS,/arxiv_data1/oa_pdf/b3/42/IJPVM-6-67.PMC4542329.pdf
"International Journal of Preventive Medicine 2015, 6:67 http://www.ijpvmjournal.net/content/6/1/67done at the Laboratory of Nutrition Research, NNFTRI.",Non-OADS,/arxiv_data1/oa_pdf/b3/42/IJPVM-6-67.PMC4542329.pdf
"International Journal of Preventive Medicine 2015, 6:69 http://www.ijpvmjournal.net/content/6/1/69remained in preschool children from 16.0% in China  to 64.0% in Bangladesh.",Non-OADS,/arxiv_data1/oa_pdf/c1/e0/IJPVM-6-69.PMC4542332.pdf
"International Journal of Preventive Medicine 2015, 6:69 http://www.ijpvmjournal.net/content/6/1/69According to regular education in Iran, educational  level categorized in three groups: (1) Uneducated, (2)  1–12 years schooling and (3) college.",Non-OADS,/arxiv_data1/oa_pdf/c1/e0/IJPVM-6-69.PMC4542332.pdf
"International Journal of Preventive Medicine 2015, 6:69 http://www.ijpvmjournal.net/content/6/1/69children more than Hispanic children suffer from  stunting.",Non-OADS,/arxiv_data1/oa_pdf/c1/e0/IJPVM-6-69.PMC4542332.pdf
"International Journal of Preventive Medicine 2015, 6:69 http://www.ijpvmjournal.net/content/6/1/69Public health programs that aim to reduce malnutrition  should primary focus on the low economic especially  in Sistani ethnic group.",Non-OADS,/arxiv_data1/oa_pdf/c1/e0/IJPVM-6-69.PMC4542332.pdf
Available from: http://www.unicef.org/ specialsession/about/sgreport‑pdf/02_ChildMalnutrition_D7341Insert_ English.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/e0/IJPVM-6-69.PMC4542332.pdf
Available from:  http://www.sci.org.ir.,Non-OADS,/arxiv_data1/oa_pdf/c1/e0/IJPVM-6-69.PMC4542332.pdf
"International Journal of Preventive Medicine 2015, 6:68 http://www.ijpvmjournal.net/content/6/1/68for noncommunicable disease, social stigmatization  resulting in sadness and loneliness, engagement in  high‑risk behaviors and undesirable stereotyping.",Non-OADS,/arxiv_data1/oa_pdf/c7/f1/IJPVM-6-68.PMC4542333.pdf
"International Journal of Preventive Medicine 2015, 6:68 http://www.ijpvmjournal.net/content/6/1/68RESULTS Eight reviews (four systematic reviews and  four meta‑analyses) examined a total of 106  papers [Appendix 3].",Non-OADS,/arxiv_data1/oa_pdf/c7/f1/IJPVM-6-68.PMC4542333.pdf
"International Journal of Preventive Medicine 2015, 6:68 http://www.ijpvmjournal.net/content/6/1/68 Table 1: Details of the studies included in the review Author (Year)/ Type of reviewMain objective  of the study/  age range (year)Design of the studies  included (Number of  studies)Selection criteria Databases  searchedPeriod of  searchResearch countries/ regions/CityComment Brown, T.  (2009)/SRTo determine the  effectiveness  of school-based  interventions  that focus on  improving diet  and PA behaviors  in school children  (4.",Non-OADS,/arxiv_data1/oa_pdf/c7/f1/IJPVM-6-68.PMC4542333.pdf
"International Journal of Preventive Medicine 2015, 6:68 http://www.ijpvmjournal.net/content/6/1/68 Table 1: Details of the studies included in the review Author (Year)/ Type of reviewMain objective  of the study/  age range (year)Design of the studies  included (Number of  studies)Selection criteria Databases  searchedPeriod of  searchResearch countries/ regions/CityComment Harris, K. C.  (2009)/Meta- analysisTo determine  the effect of  school-based PA  interventions on  body mass index  (BMI) in children.",Non-OADS,/arxiv_data1/oa_pdf/c7/f1/IJPVM-6-68.PMC4542333.pdf
"International Journal of Preventive Medicine 2015, 6:68 http://www.ijpvmjournal.net/content/6/1/68 Table 1: Details of the studies included in the review Author (Year)/ Type of reviewMain objective  of the study/  age range (year)Design of the studies  included (Number of  studies)Selection criteria Databases  searchedPeriod of  searchResearch countries/ regions/CityComment Lissau, I.",Non-OADS,/arxiv_data1/oa_pdf/c7/f1/IJPVM-6-68.PMC4542333.pdf
"International Journal of Preventive Medicine 2015, 6:68 http://www.ijpvmjournal.net/content/6/1/68 Table 2: Details of the interventions included in the reviewed articles Author (Year) /SR or  meta-analysisComponents of  intervention* Theory used for  behavior changeIntervention/ follow-up duration Outcomes measured Overall result  Brown,T.",Non-OADS,/arxiv_data1/oa_pdf/c7/f1/IJPVM-6-68.PMC4542333.pdf
"International Journal of Preventive Medicine 2015, 6:68 http://www.ijpvmjournal.net/content/6/1/68 Table 2: Details of the interventions included in the reviewed articles Author (Year) /SR or  meta-analysisComponents of  intervention* Theory used for  behavior changeIntervention/ follow-up duration Outcomes measured Overall result  Kanekar (2008)/Meta- analysisAfter school dance,  lessons to reduce TV,  videogames and video  use, reducing carbonated  drink consumption, family  involvement, increasing  knowledge on heart disease,  healthy exercise, diabetes,  classroom curriculum, food  service, PA Social cognitive theory  in 2 studies3 month to 3  years/3 months to  1 yearAnthropometric: BMI, waist circumferences, height,  weight, percentage of body fat.",Non-OADS,/arxiv_data1/oa_pdf/c7/f1/IJPVM-6-68.PMC4542333.pdf
"International Journal of Preventive Medicine 2015, 6:68 http://www.ijpvmjournal.net/content/6/1/68TV viewing reduction were equally effective, and PA  intervention did not cause body weight reduction.",Non-OADS,/arxiv_data1/oa_pdf/c7/f1/IJPVM-6-68.PMC4542333.pdf
"International Journal of Preventive Medicine 2015, 6:68 http://www.ijpvmjournal.net/content/6/1/68lower increase of BMI was seen in the intervention group  as compared with the control group.",Non-OADS,/arxiv_data1/oa_pdf/c7/f1/IJPVM-6-68.PMC4542333.pdf
"International Journal of Preventive Medicine 2015, 6:68 http://www.ijpvmjournal.net/content/6/1/68various interventions may cause participants to respond  differently.",Non-OADS,/arxiv_data1/oa_pdf/c7/f1/IJPVM-6-68.PMC4542333.pdf
"International Journal of Preventive Medicine 2015, 6:68 http://www.ijpvmjournal.net/content/6/1/684 Body mass index should not be applied as the sole  criterion for adiposity reduction studies/program 5 It is crucial to evaluate not only wanted but also  unwanted effects of an intervention 6 Before initiation of a program, assessment and  overcoming potential barriers to implementation are  essential.",Non-OADS,/arxiv_data1/oa_pdf/c7/f1/IJPVM-6-68.PMC4542333.pdf
Available from: http://www.gla.,Non-OADS,/arxiv_data1/oa_pdf/c7/f1/IJPVM-6-68.PMC4542333.pdf
"International Journal of Preventive Medicine 2015, 6:68 http://www.ijpvmjournal.net/content/6/1/68APPENDIX 1 Pub med (((meta‑analysis [pt] OR meta‑analysis [tw] OR metanalysis [tw]) OR ((review [pt] OR guideline [pt] OR consensus  [ti] OR guideline* [ti] OR literature [ti] OR overview [ti] OR review [ti]) AND ((Cochrane [tw] OR Medline [tw] OR  CINAHL [tw] OR (National [tw] AND Library [tw])) OR (handsearch* [tw] OR search* [tw] OR searching [tw]) AND  (hand [tw] OR manual [tw] OR electronic [tw] OR bibliographi* [tw] OR database* OR (Cochrane [tw] OR Medline  [tw] OR CINAHL [tw] OR (National [tw] AND Library [tw]))))) OR ((synthesis [ti] OR overview [ti] OR review [ti]  OR survey [ti]) AND (systematic [ti] OR critical [ti] OR methodologic [ti] OR quantitative [ti] OR qualitative [ti] OR  literature [ti] OR evidence [ti] OR evidence‑based [ti]))) BUTNOT (case* [ti] OR report [ti] OR editorial [pt] OR  comment [pt] OR letter [pt]) ) AND (obes* OR overweight) AND (child*) AND (prevention) 220 titles, 89 selected  by title.",Non-OADS,/arxiv_data1/oa_pdf/c7/f1/IJPVM-6-68.PMC4542333.pdf
"International Journal of Preventive Medicine 2015, 6:68 http://www.ijpvmjournal.net/content/6/1/68APPENDIX 3: CITATION ANALYSIS OF THE STUDIES INCLUDED SRs/SSs Brown 38 Doak 24 Gonzalez 19 Harris 18 Kanekar 5 Katz 21 Lissau 14 Silveria 24 Citations Alexandrov 1992  *       1 Amaro 2006 *       * 2 Anderson 2005        * 1 Aquilani 2007        * 1 Ashfield-Watt 2009        * 1 Ask 2006 *       * 2 ASK 2010        * 1 Baranowski 2000        * 1 Baranowski 2003        * 1 Bere 2006        * 1 Burke 1998    *  *   2 Bush 1989  *       1 Caballero 2003 * *   * * *  5 Carrel 1999         1 Carrel 2002         1 Carrel 2005   * *     2 Chavarro 2005    *     1 Chen 2001      *   1 Coleman 2005   * *   *  3 Danielzik 2007 *  *      2 Donnelly 1996 * *  *   *  4 Dwyer 1983  *       1 Eliakim 2007 *        1 Flores 1995 * *     *  3 Foster 2008        * 1 Gortmaker 1999 * *    * *  4 Graf2005 *  *      2 Grey 2004   *   *   2 Haerens 2006 *        1 Harrell 1996  * *      2 Harrell 2005     *    1 Harrison 2006 *        1 Haung 2007   *      1 He 2009        * 1 Home 2009        * 1 Hopper 2005    *     1 James 2004 * * *  * * * * 7 James 2007 *        1 Jamner 2004 *        1 Jiang 2007   *     * 2 Kafato 2005   *      1 Kafato 2007 *        1 Kain 2004 * * * *  * *  6 Killen 1988  *       1 Lazzar 2007 *  *      2 Linden 2006 *   *     2 Lionis 1991      *   1 Lobstein 2004   *      1 Lohman 2003    *  *   2 Luepker1996 * *  *     3 Lytle 2004        * 1 MacKelvie 2003    *     1 MacKelvie 2004    *     1 Contd",Non-OADS,/arxiv_data1/oa_pdf/c7/f1/IJPVM-6-68.PMC4542333.pdf
"International Journal of Preventive Medicine 2015, 6:68 http://www.ijpvmjournal.net/content/6/1/68APPENDIX 3: CONTINUED SRs/SSs Brown 38 Doak 24 Gonzalez 19 Harris 18 Kanekar 5 Katz 21 Lissau 14 Silveria 24 Citations Mangunkusumo 2007        * 1 Manios 1998 * *       2 Manios 1999 *        1 Manios 2002 *  *      1 Martens 2008        * 1 McMurray 2002  *       1 Moore & Tapper 2008        * 1 MoSuwan 1998 *     *   2 Muckelbauer 2009        * 1 Muller 2001  *     *  2 Nader 1999      *   1 Neumark-Sztainer 2003    * * * *  4 Pangrazi 2003 *      *  2 Pate 2005 *   *   *  3 Perry 1998        * 1 Perry 2004        * 1 Reynolds 2000        * 1 Robbins 2006 *        1 Robinson1999 * * *   * *  5 Robinson2003     *  *  2 Rodgers 2001  * *      2 Rosenbaum 2007 *        1 Sahota 2001 * *    * *  4 Sallis 1993 * *  *  *   3 Sallis 1997 *        1 Sallis 2003 *     *   2 Schofield *        1 Sichieri 2009        * 1 Simonetti 1986  *       1 Singh 2006 *        1 Singh 2007 *        1 Skybo 2002      *   1 Spiegel 2006 *  * *       Stephens 1998 *        1 Stock 2007    *     1 Tamir 1990      *   1 Taylor 2007 *        1 Te Velde 2008        * 1 Travino 2005 *        1 Travino 2004 *        1 Trudenu 2000 *        1 Trudenu 2001 *        1 Valdimarsson 2006 *        1 Vandongen 1995 * *         Viskic-Stalec 2007 *        1 Walter 1985      *   1 Walter 1988  *    *   2 Walter 1989  *       1 Warren 2003 *     * *  3 Watts 2005   *      1 Webber 2008    *     1 Williamson 2007 *        1 Yin 2005   *    *  2 Total 47 24 19 18 5 21 15 24 174 SRs: Systematic reviews.",Non-OADS,/arxiv_data1/oa_pdf/c7/f1/IJPVM-6-68.PMC4542333.pdf
"International Journal of Preventive Medicine 2015, 6:70  http://www.ijpvmjournal.net/content/6/1/70•	Xanthophylls: The oxygenated carotenoids which  are derivatives of these hydrocarbons.",Non-OADS,/arxiv_data1/oa_pdf/99/95/IJPVM-6-70.PMC4542334.pdf
"International Journal of Preventive Medicine 2015, 6:70  http://www.ijpvmjournal.net/content/6/1/70of lycopene are quite different from those of other  commonly consumed carotenoids, making it uniquely present in specific subcellular environments.",Non-OADS,/arxiv_data1/oa_pdf/99/95/IJPVM-6-70.PMC4542334.pdf
"International Journal of Preventive Medicine 2015, 6:70  http://www.ijpvmjournal.net/content/6/1/70Gupta et al.",Non-OADS,/arxiv_data1/oa_pdf/99/95/IJPVM-6-70.PMC4542334.pdf
"International Journal of Preventive Medicine 2015, 6:70  http://www.ijpvmjournal.net/content/6/1/70Chandra et al.",Non-OADS,/arxiv_data1/oa_pdf/99/95/IJPVM-6-70.PMC4542334.pdf
"International Journal of Preventive Medicine 2015, 6:70  http://www.ijpvmjournal.net/content/6/1/7023.",Non-OADS,/arxiv_data1/oa_pdf/99/95/IJPVM-6-70.PMC4542334.pdf
and N.Y. are co-ﬁrst authors.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /JVI.01174-15 .,Non-OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
"The SGPV genome was translated by Gene- MarkS software ( http://exon.biology.gatech.edu/ )(18); long (/H1102280-nucle- otide) intergenic regions were checked for the presence of ORFs, andORFs ranging from 50 to 100 codons were annotated to be predictedprotein-coding genes if they showed signiﬁcant sequence similarity toother proteins or to a conserved domain in the National Center for Bio-technology Information Conserved Domains Database ( 19) or contained predicted transmembrane helices and/or a signal peptide.",OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
"Transmem-brane helices were predicted using the TMHMM server ( http://www.cbs .dtu.dk/services/TMHMM/ )(20), and signal peptides were predicted us- ing the SignalP (version 4.1) server ( http://www.cbs.dtu.dk/services /SignalP/ )(21).",OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
"For phylogenetic analysis, protein sequences were aligned using the MUSCLE program( 26)(http://www.ncbi.nlm.nih.gov/pubmed/15034147 ), and columns containing a large fraction of gaps (greater than 30%) and columnswith low information content ( 27) were removed from the alignment.",OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
The alignment was used to construct an initial maximum likelihood(ML) phylogenetic tree with the FastTree program ( http://www.ncbi .nlm.nih.gov/pubmed/20224823 ) with default parameters ( 28).,OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
http://dx.doi.org/10.1128/JVI.77.13.7590-7600.2003 .,Non-OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
http://dx.doi.org/10.3147/jsfp.43.89 .,Non-OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
http://dx.doi.org/10.1007/s00705-008-0117-7 .,Non-OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
http://dx.doi.org/10.1111/tbed.12293 .,Non-OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
"http://dx.doi.org/10.3354/dao065197 .10.Seno R, Hata N, Fukuda H. 2003.",OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
http://dx.doi.org/10.1111/j.1365-2761.2007.00893.x .,Non-OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
http://dx.doi.org/10 .1016/j.fsi.2011.11.003 .,OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
Physiol Biochem Zool 73:446 – 453. http://dx.doi.org/10.1086/317737 .,Non-OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
http://dx.doi.org /10.1111/j.1469-7580.2008.00943.x .,Non-OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
J Mol Biol 215:403– 410. http://dx.doi.org/10.1016 /S0022-2836(05)80360-2 .,OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
Genome Res 18:821– 829. http://dx.doi .org/10.1101/gr.074492.107 .,OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
http://dx.doi.org/10.1093/nar/gki487 .,Non-OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
http://dx.doi.org/10.1093/nar/gks1243 .,Non-OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
http://dx.doi.org/10 .1006/jmbi.2000.4315 .,OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
Int J Neural Systems 8:581– 599. http://dx.doi.org/10.1142/S0129065797000537 .,OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
http://dx.doi.org/10.1093/nar/27.2.573 .,Non-OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
Virology 466:38 – 52.http://dx.doi.org/10.1016/j.virol.2014.06.032 .,Non-OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
Virol J 6:223. http://dx.doi.org/10.1186 /1743-422X-6-223 .,Non-OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
http://dx.doi.org/10.1093/nar /gkh340 .,Non-OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
Bioinformatics 27:1164 – 1165. http://dx.doi.org/10.1093/bioinformatics/btr088 .,OADS,/arxiv_data1/oa_pdf/98/ef/zjv9348.PMC4542343.pdf
